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Abstract: Teil I Supramolekulare zweikernige Eisen(II)-Komplexe [Fe 2 L3 ]4+ sind helikale Zylinder
die dank ihren ausserordentlichen DNS Bindungseigenschaften potentielle Antikrebsmittel sind. Die
Zylinder können einerseits spezifisch an Y-förmige dreiarmige DNS Kreuzungen binden. Es wurde aber
auch eine Anlagerung an die grosse Furche doppelsträngiger DNS gezeigt. Die geeignete Grösse und
Form der Helikate sowie ihre hohe elektrostatische Ladung sind verantwortlich für diese nichtkovalenten
Wechselwirkungen. Behandlung von Krebszelllinien mit den zylinderförmigen Komplexen resultierten
in erhöhten Zellsterblichkeitsraten ohne das Erbgut der Zellen zu schädigen. Dieser alternative Mecha-
nismus des Eisen(II) Supramoleküls könnte ein vielversprechender Schritt in Richtung Behandlung von
Krebs sein, welcher schon Resitenzen gegen andere Chemotherapeutika aufweist. Die nichtkovalente Art
der Erkennung von dreiarmigen Kreuzungen könnte somit die Entwicklung neuartiger Medikamente er-
möglichen. RNS erfüllt verschiedene regulatorische Funktionen in einer Zelle. Da DNS und RNS eine
sehr ähnliche Struktur aufweisen, stellte sich die Frage ob der Zylinder auch an RNS binden würde. RNS
kommt meist als einzelsträngiges Molekül vor welches ein hohes natürliches Vorkommen an dreiarmigen
Kreuzungen als potentielle Zielbindungsstellen enthält Die Beeinflussung der RNS in lebenden Zellen
könnte ein Schlüsselelement in der Antitumoraktivität des Zylinders sein. In der ersten Studie dieser
Dissertation wurden deshalb verschiedene RNS Konstrukte künstlichem oder natürlichem Ursprungs als
Ziel für die Eisen(II) Zylinder verwendet. Das RNS Analogon der kürzlich entdeckten dreiarmigen DNS
Kreuzung konnten erfolgreich kristallisiert und die Struktur mittels Röntgenkristallografie charakterisiert
werden. Ferner wurden zwei weitere Kristallstrukturen der dreiarmigen RNS Kreuzung mit Kobalt(II)
und Nickel(II) Zylindern gelöst. Diese drei Kristallstrukturen haben eine identische Topologie. Der
Metallzylinder befindet sich im Zentrum der dreiarmigen RNS Kreuzung. Die inneren Ringe der aroma-
tischen Liganden des Zylinders sind in ￿-Stapelwechselwirkung mit den zentralen Basenpaaren der RNS,
die als drei Doppelhelices vom Inneren der dreiarmigen Kreuzung wegführt. Ein Vergleich der bekannten
Kristallstruktur der dreiarmige DNS Kreuzung mit der dreiarmige RNS Kreuzung zeigt einen struk-
turellen Unteschied: Die enge Öffnung an der einen Seite der dreiarmigen DNS Kreuzung beschränkt die
innere Platzierung des Zylinders auf eine gewisse Tiefe. Der Zylinder kann aber mit der dreiarmigen RNS
Kreuzung eine maximale ￿-Stapeloberfläche einnehmen: beide Öffnungen der Kreuzung sind weit genug für
eine freie Beweglichkeit des Zylinders und ermöglichen somit eine energetisch optimale Geometrie. Dies
ist die erste Charakterisierung einer induzierten dreiarmigen RNS Kreuzung, die spezifisch durch einen
supramolekularen Zylinder erkannt wurde. Teil II Tertiärstrukturen grosser Polyanionen wie DNS oder
gerade RNS (z.B. Ribozyme) schliessen eine hochkomplexe dreidimensionale Architektur ein, die Haar-
nadelstrukturen, Schlaufen und viele andere lokale Strukturen beinhalten. Zur Ladungskompensation
und um den Nukleinsäuren eine Faltung in die native Struktur zu ermöglichen, sind mono- und divalente
Metallionen wie Na+, K+, Mg2+, or Ca2+ eine Grundvoraussetzung. Spezifisch gebundene Metallionen
koordinieren dabei mit hoher Selektivität an die Phosphatsauerstoffatome sowie an die verschiedenen
funktionellen Gruppen der Nukleosidreste, wie Carbonylgruppen, Ringstickstoffe oder Hydroxylgruppen.
Nebst innersphere (direkt gebunden) Interaktionen ist ein weitreichendes Netzwerk an Wasserstoffbrücken
durch outersphere (via ein Ligandatom) Koordination entscheidend um eine starke Bindung zu erreichen.
Um den Ursprung dieser Selektivität aufzuklären erstellten wir eine neue Datenbank: MINAS - Metal
Ions in Nucleic AcidS (Metallionen in Nukleinsäurestrukturen) beinhaltet die exakten geometrischen In-
formationen über Liganden der ersten (innersphere) und zweiten (outersphere) Koordinationssphäre jedes
Metallions in Nukleinsäurestrukturen, die in der PDB abgelegt sind. Das Einschliessen der zweiten Koor-
dinationssphäre in der MINAS Datenbank erlaubt somit ein erstes Mal auch den Effekt weiter entfernter
Liganden auf die Metallionenbindung zu beurteilen: Dies ist zum Beispiel wichtig, da in RNS Metallionen
Katalyse über Distanzen von bis zu 20 Å beeinflussen können. Zusätzlich ermöglichen die Informationen
über Nukletoide, die sich in der Nähe der Bindungstaschen befinden, eine detailierte Suche aller po-
tentieller Ligandenkombinationen und aller möglichen Koordinationsbereiche von Metallionen. MINAS
ist deshalb ein ideales neues Instrument um Metallionenbindungstaschen in Nukleinsäuren statistisch
zu klassifizieren, allgemeine Schlussfolgerung über die verschiedenen Koordinationseigenschaften dieser
Ionen zu ziehen und verschiedene Bindungsarten von Metallionen in Nukleinsäuren zu vergleichen. Die
zweite Studie dieser Dissertation beinhaltet die Erstellung der MINAS Datenbank sowie die Auswertung
der Bindungsstellen von nahezu 100’000 Metallionen verschiedener Nukleinsäurestrukturen. Diese glob-
ale Strukturenanalyse zeigt die bevorzugten Bindungsstellen für verschiedene Metallionen. Die Daten
zeigen erwartete Präferenzen für Liganden, die sich für Alkali-, Erdalkali- und Übergangsmetalle unter-
scheiden. Das anionische Phosphatrückgrat ist die häufigste Bindungsstelle für Metalle in Nukleinsäuren,
besonders für Mg2+, dem häufigsten Metallion in der MINAS Datenbank mit über 70’000 Einträgen.
Bis zu vier gleichzeitige Koordinationen zu Phosphatsauerstoffatomen wurden gefunden. Des Weiteren
zeichnet sich die Hoogsteen Seite von Guanin als die häufigste ungeladene Bindungsstelle aus. Ihre
Wasserstoffbrücken-Donor-Eigenschaft macht N7 und O6 zu perfekten Liganden für Metallionenkoordi-
nation. In der letzten Studie dieser Dissertation wurden Kationen-￿ und Anionen-￿ Wechselwirkungen
innerhalb von Nukleinsäuren untersucht. Diese nichtkovalenten molekularen Wechselwirkungen wur-
den z.B in kleinen aromatischen Molekülen, die mit Metallionen interagieren, sowie in der Anordnung
von Kristallstrukturen beobachtet. Im biomolekularen Kontext spielen Ionen-￿ Bindungen eine wichtige
Rolle indem sie den Transport von Metallionen durch Ionenkanäle ermöglichen oder zu einer erfolgre-
ichen Ligand-Rezeptorerkennung beitragen. Erkennung von Nukleinsäuren durch geladene Seitenketten
von Proteinen kann ebenfalls durch Kationen-￿ Wechselwirkungen stattfinden. Um das Ausmass der
Kationen-￿ und Anionen-￿ Wechselwirkungen in DNS-und RNS-Systemen zu untersuchen, wurde eine
Suche durch alle Nukleinsäurestrukturen die in der PDB abgelegt sind durchgeführt. Die automatisierte
Analyse von tausenden von Nukleobasen zeigte, dass von allen negativ geladenen Spezies, die häufig-
ste Anionen-￿ Wechselwirkung durch eine intramolekulare Interaktion von Phosphatsauerstoffatomen mit
den ￿-Systemen von Nukleobasen auftritt. Kationen-￿ Interaktionen werden ebenfalls durch verschiedene
Spezies eingegangen, einschliesslich einiger Metallionen. Den grössten Teil der Kationen-￿ Wechselwirkun-
gen macht Arginin aus, dessen positiv geladene Seitenkette mit den Nukleobasen interagieren kann, wenn
ein Protein an DNS oder an RNS bindet.
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Part I 
Studies on the Stabilization of RNA Structures through 
Metallo-supramolecular Helicates 

1Part I  Introduction 
 
Introduction Part I 
In 2001, the research group of Michael J. Hannon first reported the binding of metallo-
supramolecular cylinders to DNA.[1] These cylinders are tetracationic dinuclear complexes 
with a triple-helical architecture. Synthesis and structure of such a di-iron(II) cylinder are 
illustrated in Figure 1.[2] The cylindrical design of these helicates mimics the binding units of 
proteins such as zinc fingers that are involved in DNA recognition. If natural, double-stranded 
DNA is treated with the iron(II) helicates, an intramolecular coiling of the DNA can be 
observed.[1] This effect can be visualized by Atomic force microscopy (AFM), as shown in 
Figure 2. Noteworthy, it is stronger for the M enantiomer than for the P enantiomer of the 
cylinder.[3] 
 
 
Figure 1. Synthesis of the iron(II) metallo-supramolecular cylinder [Fe2L3]Cl4: 
Ligand L (C25H20N4 = N,N'-bis(pyridin-2-ylmethylene)-4,4'-diaminodiphenylmethane) (1) is prepared 
by stirring a solution of ethanol containing pyridine-2-carbaldehyde and 4,4'-methylenedianiline. 
Direct addition of iron(II) chloride to this solution yields the M and P enantiomers of the cylinder in 
equal amounts. 
 
 
 
Figure 2. Intramolecular coiling is observed in the AFM images of DNA double strands when treated 
with the iron(II) helicate. The left AFM image shows an untreated double-stranded DNA. The coiled 
DNA on the right results from incubation with the Fe2L3 cylinder. The coiling is stronger in DNA 
double strands when treated with the M enantiomer only.  
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Another mode of interaction was discovered during investigations on short double-stranded 
DNA. In this context, the Fe(II) cylinder binds at the center of a DNA three-way junction; this 
could not be predicted from the behavior found with long double stranded DNA (Figure 3).[4] 
Three-way junctions occur naturally in DNA, e.g., in the replication fork which could be a 
potential target for future drug design.[5] This is a new mode of non-covalent DNA 
recognition and revealed a potential structural target for highly specific drugs. 
 
 
Figure 3. Three-way junction formation of DNA hexamers when co-crystallized with the 
M enantiomer of the Fe2L3 cylinder.[4] (PDB ID: 2ET0) 
 
Using the cylinder as potential anti-cancer drug, investigations showed that cancer cell lines 
are affected with a similar potency as cisplatin. [Fe2L3]4+, however, exhibited no 
genotoxicity, meaning the DNA remained intact and there is also no mutagenicity caused by 
the iron cylinder.[6] 
 
RNA naturally occurs mostly as a single-stranded molecule, enabling a much wider structural 
diversity than DNA.[7] RNA can consist of a multitude of structural motifs. One example are 
kissing loops that are long-range base pairings between hairpin stem-loops, where loop 
nucleotides interact through Watson-Crick base pairs (Figure 4).[8] Such kissing loops have 
been found in tRNA, mRNA and rRNA.[9] Another motif is the so-called pseudoknot where 
the loop nucleotides of a hairpin form a helix with a remote complementary part of the RNA. 
This formed secondary helix and the hairpin’s helix inside such a pseudoknot stack coaxially 
onto each other (Figure 5). Pseudoknots occur in many native RNA structures, for example in 
the RNA component of the human telomerase.[10] Furthermore, RNA can form quadruplex 
structures, where guanines are involved quadruple base pairs. They are stabilized by 
potassium ions aligning in the center of the guanine quartets (Figure 6). RNA quadruplexes 
are found as transcription products of the telomeric ends of DNA.[11] RNA chains can also 
branch out into junctions interconnecting multiple helices. The ribosome is an excellent 
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example of a large RNA with many of these junctions, including three-way junctions, in its 
native structure.[12] With this diverse nature of RNA in mind, the question arose whether the 
cylinder would also bind to RNA in a similar way as it binds to DNA. This might not only 
give rise to even more structural targets when designing new specific drugs but also answer 
the question if the cytostatic activity of the cylinder might originate in the recognition of 
RNA. Since RNA fulfills many more functions than just information carriage, using it as a 
new drug target could lead to new treatment possibilities with different modes of action.[13] 
RNA has been used before as a drug target, e.g., for aminoglycoside antibiotics such as 
neomycin. Modes of action are for example the binding to bacterial ribosomal RNA which 
leads to miscoding during translation.[14] One potential target could be the aptameric region of 
bacterial riboswitches in the fight against multi-drug resistant bacterial strains.[15] 
 
 
Aims of the first part of this thesis 
 
Chapter 1 describes the successful co-crystallization of an RNA three-way junction with the 
iron(II) cylinder. Furthermore, native gel studies on elongated RNA three-way junctions were 
conducted. In Chapter 2, all co-crystallization trials with various RNA systems and various 
metallo-cylinders are provided: Crystal structures of the cobalt(II) and nickel(II) cylinder 
analogs interacting with analogous RNA three-way junctions were successfully solved. 
Furthermore, as a byproduct of the attempt to crystallize elongated RNA three-way junctions, 
an octameric duplex RNA structure of high resolution could be solved. This structure could 
serve as a metal ion binding model system for further studies. 
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Figure 4. A kissing loop from the HIV-1 dimerization initiation site. The two “kissing” hairpins that 
interact through their loops are depicted in green and yellow, respectively.[8] (PDB ID: 1K9W) 
 
 
 
 
Figure 5. Example of a pseudoknot from telomerase RNA. The yellow and the red stems are stacking 
coaxially and they are additionally interconnected through their loops (blue). In this particular 
pseudoknot, the loops form base triplets with the two stems.[16] (PDB ID: 2K96) 
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Figure 6. A quadruplex of human telomeric RNA:[17] (top) side view of the quadruplex containing 
potassium ions in pink; (bottom) one guanine quadruple coordinating a pink potassium ion. 
(PDB ID: 3IBK)  
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Erkennung und Stabilisierung einer Y-verzweigten RNA durch einen zylinderförmigen 
supramolekularen Dieisen(II)-Komplex werden von R. K. O. Sigel, B. Spingler, M. J. Hannon, 
E. Freisinger et al. in der Zuschrift auf S.11727 ff. beschrieben. Der potenzielle Antikrebswirkstoff 
passt genau in den zentralen RNA-Hohlraum und stabilisiert die Architektur im Festkörper ebenso 
wie unter nativen Gelbedingungen. (Bild: Joachim Schnabl) 
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Chapter 1 
Binding of a Designed Anti-Cancer Drug to the Central Cavity 
of an RNA Three-Way Junction 
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Switzerland 
 
† These authors contributed equally to this work 
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published in 
Angew. Chem. Int. Ed. 2013, DOI: 10.1002/anie.201305079 
 
ABSTRACT 
Nucleic acids are exciting biomolecular targets because they offer the potential to regulate 
information transfer at the beginning, before the genetic code is translated into proteins. 
Metal complexes that bind to DNA have been of particular interest, with the cationic charge 
that metals impart being particularly attractive for recognition of these polyanions.[1] 
Examples include complexes that co-ordinate to the bases,[2] intercalate[3] or phosphate bind[4] 
to regular duplex DNA or, more recently, that recognise less common DNA structures such as 
bulges,[5] quadruplexes[6] or junctions.[7] Such complexes have been explored as therapeutic 
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drugs,[2] fluorescence imaging agents,[8] footprinting agents,[9] and for nanotechnology 
applications.[10] 
RNA binding by metal complexes is much less well understood.[11] Yet, RNA is an 
emerging biomedical target because its high structural diversity makes it highly suitable for 
supramolecular recognition. For example, a Diels–Alderase ribozyme was developed by in 
vitro selection[12] and riboswitches have evolved naturally that are key to bacterial gene 
regulation. Both types of functional RNAs depend on specific ligand binding, for example, to 
a three-way junction (3WJ)-type cage as in the Diels–Alderase and the purine riboswitch, [13] 
with subsequent structural rearrangement. 
Hannon, Coll and colleagues recently described the binding of a nano-sized dimetallic 
metal complex (a metallo-supramolecular cylinder) to the central cavity of a DNA 3WJ.[7a] 
Given that junctions are common RNA structures, their recognition seemed an attractive 
initial step towards RNA structural recognition agents. Herein, we report the ability of a 
di-iron(II) supramolecular cylinder to recognize an RNA 3WJ and use X-ray crystallography 
to characterize the binding mode. While there are some crystal structures of RNAs with 
simple hexaqua or hexammine cations,[14] to the best of our knowledge this is the first 
crystallographic study of a designed metal complex bound to RNA. 
We first crystallized the di-iron(II) supramolecular cylinder with a palindromic RNA 
hexanucleotide sequence (Figure 1A), which was selected to allow a direct comparison with 
the structure of the analogous DNA in complex with the cylinder.[7a,c,d] Crystals diffracting to 
1.91 Å were obtained under similar crystallization conditions and contain exclusively the 
M enantiomer of the cylinder. The structure reveals an RNA 3WJ with the cylinder sitting at 
the heart of the junction (Figure 1B). Additional cylinder molecules reside at the GC termini 
of the duplex RNA arms that radiate from the junction, with the bases making π-stacking 
interactions with the cylinder phenylene rings forming what is in effect an additional 
non-covalent pseudo-junction. 
11
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Figure 1. Formation of an RNA 3WJ stabilized by a cylindrical di-iron(II) complex, [Fe2L3]4+ 
(L=C25H20N4). a) Palindromic RNA sequence used for crystallization (left) next to the three RNA 
strands S1, S2, and S3 as used in the gel studies. The M and P enantiomers of the cylinder and the 
formation of the 3WJ stabilized by a cylinder molecule are shown on the right. b) The crystal structure 
of the RNA 3WJ complexed with the cylinder as seen from the top (left) and a surface representation 
from the side (right). c) Side view of the corresponding DNA 3WJ/cylinder complex as a surface 
representation (PDB: 2ET0). Panels (b) and (c) were prepared with MOLMOL and DS Visualizer 
3.5.15] 
 
While the overall structure obtained is highly similar to the one of the DNA 3WJ, distinct 
differences exist in the mode of recognition of the cylinder by the RNA 3WJ. These variations 
mainly originate from the specific conformation of the DNA versus the RNA oligonucleotide. 
Whereas the double-stranded parts of the DNA in the 3WJ adopt a B-form, the RNA shows 
its usual A-form. Overall, the DNA 3WJ resembles a truncated cone (Figure 1C) with a 
narrower top being formed by the 3’ ends (Figure 2A), while the 5’ ends point away from the 
central opening. The top and bottom openings of the RNA 3WJ are more similar in size 
(Figure 1B) with the 3’ and 5’ ends bent away from the central opening, effectively side-
stepping any interaction with the cylinder. Accordingly, the narrowest part of the RNA 
junction is formed by the central adenine and uracil bases. In the DNA 3WJ, two main 
interactions with the cylinder are described: 1) the bases at the junction form a p-stacking 
interaction with the central phenylene rings of the cylinder (Figure 2B), and 2) the terminal 
pyridine rings of the cylinder engage in van der Waals interactions with the C5’ sugar 
moieties. The opening at the top of the cone is sufficiently narrow that the cylinder does not 
penetrate it (Figure 2A). It is unclear whether the narrow opening originates from the rigidity 
of the 3WJ structure or is caused by attractive interactions with the cylinder. This question 
will be of importance for the discussion below. The central π-stacking interactions with the 
12
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cylinder can also be observed in the RNA 3WJ (Figure 2B). Here the uracil base also interacts 
with one phenylene, while the cylinder is shifted such that each adenine base now stacks with 
two central phenylenes of one ligand and a C1’H-π interaction is formed. Superimposing both 
structures based on the central AT and AU base pairs reveals a shift of the cylinder by 2.0 Å 
towards the 3’-end in the RNA structure. Given that the π-stacking interaction between the 
RNA bases and the phenylene rings of the cylinder constitutes the only interactions observed, 
and considering that the position of the cylinder within the junction is not constricted by the 
narrowness of the 3’-end as in the DNA structure (Figure 2B), the cylinder should be allowed 
to move freely within the RNA junction to maximize the stabilization from the π-stacking 
interactions with the bases of the junction. Consequently, the position of the cylinder within 
the DNA 3WJ, which does not seem to be free to move and optimize the stacking interactions, 
should result in a lower contribution of the stacking interaction to the stability of the structure. 
The overall stabilization in the DNA versus the RNA structure is also dependent on whether 
the 3’-ends in the DNA structure merely sterically restrict the optimal positioning of the 
cylinder within the junction or provide additional stabilization through van der Waals 
interactions. The structure of the cylinder is virtually the same in both DNA and RNA 3WJs, 
that is, it is not influenced by the different stacking 
interactions.
 
Figure 2. Comparison of the morphologies of the RNA/DNA 3WJcylinder complexes. a) Space-filling 
models of the RNA (left) and DNA (right) 3WJs with the cylinder (green) seen from the top. Cytidine 
5 forms the top edge of the 3WJ, which is much narrower in the DNA (C5-C4’, grey atoms; C5-C5’, 
black; C5-O1P, red; RNA/DNA=8.0/ 5.9 Å, 8.5/5.3 Å, and 11.6/5.9 Å, respectively, from the central 
cylinder axis). b) Stacking interactions between the AU (gold) and AT (cyan) base pairs with the two 
central B and C rings of the cylinder (green). 
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To complement our studies we were curious to see RNA 3WJ formation, and the influence 
of the cylinder, in solution (Supporting Information, Figures S1–S5). We chose three RNA 
sequences that potentially form a 3WJ analogous to a known DNA 3WJ (Figure 1A).[7c] 
Cylinder-promoted formation of the 3WJ was followed by native gel electrophoresis, in 
which the S1 RNA strand was 5’ end labeled with 32P-phosphate. 200 nm of each RNA strand 
was used in the presence of 100 mm NaCl at 4°C (Figure 3A). In the absence of Mg2+ ions or 
the cylinder, distinct self-assembly of the three strands into either an open dimer or a 3WJ 
was observed. Whereas additional MgCl2 (10 mm) had virtually no effect, excess cylinder 
clearly stabilized the 3WJ and reduced the amount of dimer (78% 3WJ, 14% dimer, 8% single 
strand; distributions of the three states under all conditions tested are summarized in Figure 
S1). The strong stabilization of the 3WJ by the cylinder was verified using a bulkier cylinder 
[Fe2(L-CF3)3]4+ with the same charge but having two central trifluoromethyl groups on each 
ligand that will not fit into a 3WJ. Indeed, no additional 3WJ formation was induced 
(Figure 3; Figures S1,S2). This stabilizing effect goes beyond the pure electrostatic interaction 
with duplex RNA, because the stabilizing effect of 20 µM cylinder is clearly larger than that 
of 10 mM Mg2+ (Figure 3), which is in agreement with the extensive stacking interactions 
observed in the crystal structure. Interestingly, while the M enantiomer shows a higher 
affinity than P towards DNA,[7c] no difference between M and P cylinders could be detected 
for RNA 3WJ formation under any conditions tested, within the error limits (Figure 3C; 
Figures S1,S3). 
At 4 °C the open RNA dimers are relatively stable. Raising the temperature to 25 °C lead 
to melting of the two strands at both low and high RNA concentration (Figure 3B; 
Figure S2B). Even in the presence of a tenfold excess of a racemic mixture of the cylinders no 
open dimer, but instead 80% 3WJ, was present in solution. Again, the bulky cylinder did not 
additionally promote 3WJ formation (Figure 3B). These findings indicate that the perfect size 
and shape of the di-iron(II) cylinder plays the major role in stabilization of the RNA 3WJ. 
To confirm the binding between the RNA and the cylinder we performed UV/Vis and circular 
dichroism (CD) experiments (Figure S4). Increasing amounts of a racemic mixture of the 
cylinder, which itself shows no CD signal, were added to the three RNA strands using a 
constant concentration of RNA and increasing amounts of cylinder. The overlay of the CD 
spectra of the RNA 3WJ in the presence of up to ten equivalents of racemic cylinder shows 
that the spectrum of the RNA retains its typical shape (CD signal below 300 nm) throughout 
the titration, confirming that the A-form conformation of the double helical RNA arms 
remains unchanged (Figure S4A; note that the concentration of RNA is 50 times higher in the 
CD experiment than the gel studies). The corresponding UV/Vis spectra show that the 
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presence of the RNA has no effect on the metal-to-ligand charge transfer (MLCT) band 
between 400 and 650 nm, confirming the structural integrity of the cylinder (Figure S4B). 
However, in the same MLCT region, the CD spectra show an increased negative elipticity 
corroborating a binding event between the di-iron(II) cylinder and the RNA.  
 
 
 
 
Figure 3. Formation of an RNA 3WJ in the presence of increasing amounts of the di-iron(II) [Fe2L3]4+ 
complex followed by 15% native gel electrophoresis (200 nM each S1*, S2, and S3; 100 mM NaCl; 
ratios 3WJ:cylinder are 1:0.5, 1:1, 1:2, and 1:10 (lanes 7-10 and 13-17)).  a) At 4 °C, almost no single 
stranded S1* is visible anymore upon addition of racemic cylinder, but open dimer (S1*/S2 and 
S1*/S3) and 3WJ.  b) At 25 °C, almost all RNA is present as 3WJ at 10 fold excess of cylinder, 
whereas no dimer can be detected anymore.  c) The M and P enantiomers stabilise the RNA 3WJ 
equally (25 °C). Lanes 11 (a, b) and 17 (c) are the controls containing the bulky cylinder [Fe2(L-
CF3)3]4+, which does not show an enhanced stabilisation of the RNA 3WJ compared to the RNA alone 
(lane 3). Lanes 1-6 (a, b, c) as well as lanes 11 and 12 (c) are controls missing either one or two RNA 
strands or the cylinder as indicated. 
d) Competition of RNA versus DNA 3WJ formation in the presence of the di-iron(II) complex 
[Fe2L3]4+ followed by 20% native gel electrophoresis (200 nM each S1*, S2, and S3; 25 °C; 100 mM 
NaCl; ratio of preformed 3WJ to cylinder is 1:1 (lanes 4-9 and 13-18)); equivalents of the added 3WJ 
are 1:0.2, 1:0.5, 1:1, 1:2 and 1:5(lanes 5-9 and 14-18)). Upon addition of increasing amounts of RNA 
3WJ (orange) to preformed DNA 3WJ (blue), DNA 3WJ decreases in favor of formed RNA 3WJ 
(lanes 4-9). The reverse effect is observed when titrating DNA 3WJ to a preformed RNA 3WJ-
cylinder complex (lanes 13-18). Lanes 1-3 and 10-12 are controls missing either one or two 
RNA/DNA strands or the cylinder as indicated. 
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Having shown that the cylinder stabilizes an RNA 3WJ, the question arises whether the 
cylinder preferentially binds to DNA or RNA. We established an assay to follow the 
competition between analogous RNA and DNA 3WJs. Up to five equivalents of RNA 3WJ 
were added to a constant concentration of the competing DNA 3WJ-cylinder complex. A 
decrease in DNA 3WJ accompanied by a simultaneous increase in RNA 3WJ was observed 
(Figure 3D; note, RNA migrates slower on the native gel than DNA). The inverse experiment 
was conducted and showed the same overall effect: an increase in DNA 3WJ was paralleled 
by a decrease of RNA 3WJ, although the concurrent increase in single-stranded RNA S1 
seemed less pronounced. The difference in the inherent stabilities of the RNA and DNA 3WJs 
complicates quantification of the cylinder binding preferences; while the RNA 3WJ might be 
slightly preferred over the DNA 3WJ, it is also more stable in the absence of cylinder, which 
might be reflected in the experiment. However, despite the inherent structural differences in 
the binding of the cylinder to the two nucleic acid junctions, they compete with one another 
for cylinder binding. It appears that the difference in Gibbs free energy for binding must be 
small and that the interaction between the cylinder and the nucleic acid junctions is 
sufficiently dynamic to allow for equilibration.  
Small-molecule recognition by nucleic acids and the accompanying stabilization of a 
specific structure or a subsequent structural change are key to natural processes, for example, 
in riboswitches as well as for medical applications, but are so far only poorly understood. This 
study is the first of its kind to characterize in detail the binding of a designed anticancer 
di-iron(II) supramolecular cylinder to an RNA 3WJ 1) at atomic resolution in the solid state, 
2) in solution, and 3) to establish the competition with a respective DNA 3WJ. Both nucleic 
acid 3WJs were similarly stabilized by the cylinder. This is surprising because of their 
inherent structural differences and the dynamic nature of the recognition of 3WJs by 
metal-based drugs. 
 
Experimental Section 
The cylinder-RNA interaction was investigated by native polyacrylamide gel electrophoresis 
(PAGE) whereby one strand S1* was radioactively labelled with [γ-32P]-ATP. CD and 
UV/Vis titrations were performed at constant RNA 3WJ concentration (10 µM) and 0.5 to 10 
equivalents of each di-iron(II) cylinder enantiomer. Crystals of the cylinder-RNA complex 
were grown at 20 °C under the following conditions: 50 mM Tris-HCl, pH 8.5, 165 mM 
Mg(OAc)2, 15% PEG 400. Diffraction data were recorded at the X06DA beamline of the 
Swiss Light Source (Paul Scherrer Institute, Villigen, Switzerland). Full materials and 
methods are available in the Supporting Information. 
The atomic coordinates have been deposited with the PDB under accession code 4JIY. 
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Material and Methods 
Chemicals, equipment and general procedures: Chemicals were purchased from Sigma-
Aldrich-Fluka (Buchs, Switzerland) or Acros (Geel, Belgium) and are all at least puriss p.a. 
grade if not stated otherwise. All RNA oligonucleotides (HPLC grade) were either purchased 
from Microsynth (Balgach, Switzerland) or from PURIMEX (Grebstein, Germany). The RNA 
concentrations were determined with a Varian Cary 500 UV spectrophotometer. The CD data 
were recorded with a JASCO J-180 Spectropolarimeter (JASCO Corporation, Japan). For all 
CD and UV/Vis titration experiments a quartz cuvette with 10 mm path length was used. The 
RNA was radioactive labelled using the T4 polynucleotide kinase from Promega (Mannheim, 
Germany) and [γ-32P]-ATP from Perkin Elmer (Schwerzenbach, Switzerland). 40% (w/v) 
29:1 Acrylamide-Bisacrylamide (sequencing grade) and 10xTBE (0.89 M Tris, Borate pH 
8.5, 0.2 M Na2EDTA, electrophoretic sequencing grade) buffer  from National Diagnostics 
(Atlanta, USA) were used for the gel studies. All gels were analysed with either a Typhoon 
9400 or a Storm 860 bioimaging scanner and quantified with ImageQuant TL 
(GE Healthcare).The di-iron(II) cylinder [Fe2L3]4+as well as the bulky cylinder 
[Fe2(L-CF3)3]4+were synthesized and purified as described earlier.[16] 
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Gel electrophoresis studies: The S1* RNA strand 5'-CGGAACGGCACUCG was labelled 
with [γ-32P]-ATP and T4 polynucleotide kinase at the 5'-end and purified by 18% denaturing 
polyacrylamide gel electrophoresis (PAGE) by standard methods. The band was cut out, 
eluted with ME buffer (40 mM MOPS pH 6; 10 mM EDTA by crush-and-soak, lyophilized, 
redissolved in ddH2O and stored at –20 °C. The formation of the3WJ was analysed by 15% 
native PAGE using TB buffer (90 mM Tris-HCl, pH 8.3, 90 mM boric acid) at either 4 °C or 
25 °C. For the RNA/DNA-cylinder complex formation either 10 nM RNA (S1, S2, S3 each) 
and 10 µM NaCl, or 200 nM RNA and 100 mM NaCl were used. Prior to gel electrophoresis, 
the samples were incubated for one hour at the appropriate temperature.  
 
Spectroscopic studies: CD and UV/Vis titrations were performed at 25 °C with a quartz 
cuvette of 10 mm length. CD spectra were averaged over five scans and all measurements 
were performed in 90 mM sodium cacodylate buffer at pH 7.0 in the presence of 100 mM 
NaCl. The concentration of the RNA 3WJ was kept constant at 10 µM during titration by 
using a stock solution of 500 µM [Fe2L3]4+ containing 10 µM of each RNA strand. Titrations 
were performed from 0.5 up to 10 equivalents of each di-iron(II) cylinder enantiomer. Prior to 
measurement, the RNA was heated to 95 °C for five minutes and subsequently left to cool 
down to room temperature. 
 
X-ray crystallography: The di-iron(II) complex [Fe2L3]Cl4 (L = C25H20N4) was synthesised 
according to the literature described by Hannon and co-workers [16b]. The RNA 
oligonucleotide 5'-CGUACG was purchased PAGE purified and desalted. Crystals were 
grown at 20 °C in 1 µL sitting drops containing 2 mM RNA and 5 mM racemic cylinder. The 
reservoir solution contained 50 mM Tris-HCl (2-amino-2-(hydroxymethyl)-1,3-propanediol 
hydrochloride, pH = 8.5), 165 mM Mg(OAc)2, and 15% PEG 400. Growth of purple 
octahedral crystals could be observed after seven to ten days. Identical crystals could be 
obtained in the same conditions but with 180 mM Mg(OAc)2 and 20% PEG 400. For 
cryoprotection, the crystals were transferred to a reservoir solution containing no PEG 400 but 
25% glycerol. Single crystal (0.15 x 0.15 x 0.15 mm3) diffraction data were recorded at 100 K 
at the Swiss Light Source (Paul Scherrer Institute, Villigen, Switzerland) using the X06DA 
beamline (λ = 1 Å) with a mar225 mosaic CCD detector. The data sets were indexed and 
integrated with XDS.[17] After having recorded a multiple anomalous wavelength (MAD) data 
set at the Fe-K absorption edge, the structure was solved with SHELXC/D/E [18] using the 
GUI HKL2MAP.[19] Refinement of the 1.91 Å resolution data was done with SHELXL.[20] 
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The observed R factor is 22.3% (Rfree = 27.1%). The structure crystallises in the cubic space 
group P213, which is a non-isomorphic subgroup of P4132, the space group in which the 
structure of the analogous DNA 3WJ was determined. Further details regarding data 
collection and refinement are provided in Table S1. Atomic coordinates and diffraction data 
have been deposited in the RCSB Protein Data Bank under accession code 4JIY. 
 
Additional Results 
Gel electrophoresis studies:  Quantification of all gels is summarised in Fig. S1. At a 
concentration of 20 nM of each RNA strand about 8% 3WJ is formed in the presence of 10 
µM NaCl at 4 °C (Fig. S2A). In addition a slightly stronger band runs between the single 
strand and the 3WJ corresponding to the open dimers S1*/S2, S1*/S3, and S2/S3 (the latter 
one is not visible; only S1 is labelled). In contrast to the corresponding DNA 3WJ,[7c] the 
addition of 10 µM MgCl2 does not significantly enhance junction formation (Fig. S2A). 
Increasing amounts of racemic cylinder (0.5, 1, 2, and 10 equivalents relative to each RNA 
strand and thus also the potential maximum concentration of 3WJ) does not drastically change 
the ratio between single strand, open dimer and 3WJ. The observation of an effect at 200nM 
but not at 20nMRNA implies that the binding constant is of the order of 106-107 M–1 which 
would be consistent with previous estimates of the binding constant of this class of molecules 
to DNAs.[16a,c] 
 
Spectroscopic studies:  Increasing concentration of either pure M or P enantiomer, lead to a 
steady increase in both the intensity of the UV spectra as well as the MLCT bands in the CD 
(Fig. S4 and Fig. S5 for racemic cylinder). However, this increase is less pronounced for the 
M-enantiomer (Fig. S5B and S5E). Indeed, the ratio between the UV absorption and the CD 
signal at 567 nm is constant for both enantiomers in the absence of RNA 3WJ (blue squares 
and line in Fig. S5C and S5F). In contrast, in the presence of RNA this ratio is only constant 
for the P-enantiomer, whereas it increases linearly for the M-enantiomer. This picture is 
consistent with the results described in above paragraph that the MLCT band of the P-
enantiomer arise if a racemic mixture is titrated to the RNA 3WJ. At the same time, the 
increasing ratio of the UV/CD signal intensities show that preferentially the M-enantiomers 
binds to the RNA 3WJ in solution. This is well in line with the crystal structure: Modelling 
the P enantiomer into the 3WJ shows that although it fits, the intermolecular stacking 
interactions between cylinder and RNA are lost, explaining the small difference in binding 
affinity. 
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Table S1.  Data collection and refinement statistics of the RNA 3WJ containing the di-
iron(II) cylinder [Fe2L3]4+(L = C25H20N4) (PDB accession code 4JIY). 
Data collection     
Data set Peak Inflection Remote High resolution 
λ (Å) 1.7389 1.7411 1.7149 0.9999 
Space group P213 
Unit cell parameters a = b = c = 44.954 Å 
α = β = γ = 90° 
a = b = c = 45.745 Å 
α = β = γ = 90° 
Resolution range (Å) 25.95-2.45 25.99-2.43 25.95-2.42 26.41-1.91 
Number of reflections  
total 21498 24475 25505 35899 
unique 2165 2206 2261 4814 
Completeness (%)a 100 (100) 98.0(88.5) 99.6 (98.1) 99.7 (98.6) 
<I/σI>a 21.79 (1.52) 34.55 (2.64) 36.24 (3.01) 27.66 (2.84) 
Average multiplicity 9.93 11.09 11.28 7.46 
Rmrgd-Fa,b 8.1 (78.2) 5.6 (56.1) 5.3 (51.6) 5.0 (60.1) 
Phasing[21]     
FOMc  0.522(0.346)   
Connectivity c  0.742(0.689)   
Pseudo free CC c  53.5(35.8)   
Map CC c  67.2(47.7)   
Refinement     
Rfactor (free Rfactor)d    22.3 (27.1) 
r.m.s. deviations from target values 
Bond lengths (Å) 0.009 
Bond angle distances (Å) 0.027 
Average B-factors (Å2) 
Fe2+ 44.5 
Drug 47.0 
RNA 51.7 
Solvent 57.9 
Number of Fe2+e 4/3f 
Number of drug atomse 58 
Number of RNA atomse 125 
Number of  solvent moleculese 39 
a Outermost resolution shell values in parentheses.   b For definition of Rmrgd-F see reference 
[22].   c The numbers in parentheses are for the wrong enantiomer.   dRfactor = {Σhkl ||Fo| - k |Fc|| 
/ Σhkl |Fo|} x100, with Fo and Fc as the observed and calculated structure factor.   e Per 
asymmetric unit.   f Each of the four Fe2+ atoms has an occupancy of 1/3 due to location on a 
special position in the unit cell. 
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Fig. S1.  Summary of the percentages formed of single stranded RNA (S1*, ss, red bars), 
open dimer (S1*/S2 or S1*/S3, ds, green bars), and RNA 3WJ (S1*/S2/S3, blue bars) under 
different conditions given as determined by native gel electrophoresis. Concentration are 
either 10 nM each S1*, S2, and S3 with 10 µM NaCl (low salt, ls), or 200 nM each S1*, S2, 
and S3 with 100 mM NaCl (high salt, hs). M/P denotes a racemic mixture of the [Fe2L3]4+ 
cylinder, whereas M and P are the purified enantiomers. 
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Fig. S2.  Formation of RNA 3WJ under different conditions as followed by 15% native gel 
electrophoresis at 4 °C (A) and 25 °C (B). Increasing racemic [Fe2L3]4+ cylinder is added 
yielding ratios 3WJ:cylinder of 0.5, 1, 2, and 10 (lanes 7-10), with a 3WJ concentration of 20 
nM and 10 µM NaCl. Lane 11 is a control containing the bulky cylinder [Fe2(L-CF3)3]4++, 
which does not additionally stabilise an3WJ. At 4 °C, the cylinder has about the same 
stabilising effect on open dimer and 3WJ formation as the addition of 10 µM MgCl2. At 25 
°C, no dimer formation can be observed under any conditions, and the cylinder has a slightly 
stronger stabilising effect compared to Mg2+. 
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Fig. S3.  Formation of RNA 3WJ in the presence of either M or P enantiomer of the di-
iron(II) cylinder[Fe2L3]4+ under different conditions as followed by 15% native gel 
electrophoresis at (A) 20 nM each of S1*, S2, and S3 (10 µM NaCl, 4 °C), (B) 20 nM each of 
S1*, S2, and S3 (10 µM NaCl, 25 °C), and (C) 200 nM each of S1*, S2, and S3 (100 mM 
NaCl, 4 °C). Increasing M- or P- cylinder is added yielding ratios 3WJ:cylinder of 0.5, 1, 2, 
and 10 (lanes 7-10 and 13-17). Lane 17 is a control containing the bulky cylinder [Fe2(L-
CF3)3]4+, which does not stabilise a 3WJ. No distinct difference in 3WJ stabilisation between 
the M and P enantiomer can be detected at any condition. As seen in Fig. S1, at low 
RNA/NaCl concentration, the cylinder has about the same stabilising effect on dimer and 3WJ 
formation as the addition of 10 µM MgCl2 (4 °C, A) and at 25 °C, no dimer formation can be 
observed but the cylinder has a stronger stabilising effect compared to Mg2+ (B). At high 
RNA/NaCl concentration the stabilising effect of the cylinder is clearly more pronounced and 
also superior to 10 mM Mg2+ (C). 
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Fig. S4.  Change of the CD and UV/Vis spectra of 10 µM RNA 3WJ upon increasing 
concentrations of racemic cylinder [Fe2L3]4+.  (A) The upcoming signal of the cylinder 
between 500 and 600 nm with increasing concentration shows that one enantiomer is slightly 
preferred over the second. The spectrum to the right of the red line is enlarged on the y-scale 
by a factor of ten.  (B) The RNA keeps its A-form upon cylinder addition as is obvious from 
the spectrum between 200 and 400 nm. 
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Fig. S5.  Change of UV/Vis and CD spectra of the RNA 3WJ upon increasing concentrations 
of [Fe2L3]4+ cylinder. Panels A, B, and C show the titration with the M enantiomer, whereas 
panel D, E, and F depict titrations with the P enantiomer. The M enantiomer is present at an 
enantiomeric excess of 80%, whereas the P enantiomer is pure. The baseline shifts towards 
higher absorption with increased cylinder concentrations results from Mie scattering caused 
by incipient aggregation of the dissolved components [23]. The shape of the CD spectrum is 
thereby not affected because this effect is independent of the enantiomer applied. The CD 
ellipticities are compared by plotting the ratios of CD signal and the UV absorption both at 
567 nm in the absence (blue squares) and the presence (red squares) of RNA (panels C and 
F). This ration is constant in the absence of RNA 3WJ for both enantiomers (blue squares). In 
contrast, this ratio increases with subsequent addition of the M enantiomer to the RNA 3WJ 
(C), the ratio remains constant in the case of P enantiomer addition (F). This picture is 
consistent with the attenuation of the M-enantiomer ellipticity at 567 nm if racemic cylinder is 
added (Fig. S4A). Concentrations used are 10 µM RNA 3WJ and 100 mM NaCl). 
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Chapter 2 
Additional Co-crystallization Trials of various RNA sequences and 
metallo-cylinder modifications 
1 Introduction 
The successful determination of the crystal structure of the iron(II) (Fe2L3) cylinder inside a 
hexameric RNA three-way junction (3WJ) (see Chapter 1) led to the question whether more 
RNA systems would show a respective behavior in presence of a metallo-cylinder. 
Single-stranded RNA molecules contain many secondary structure elements including 
junctions. One prominent example of a large naturally occurring RNA is the ribosome which 
contains many 3WJs as illustrated in Figure 1.[1] Since the crystal structure of the hexameric 
RNA 3WJ contains only a very short RNA, we here used longer systems of up to 12 
nucleotides in length for the same crystallization trials. Longer systems should help 
comparing the results to natural RNA strands where 3WJs reside usually inside much more 
extended systems. Furthermore, we tried to co-crystallize the cylinder with a naturally 
occurring 3WJ located in domain 1 of a group II intron, a ribozyme that is under extensive 
study in our research group.[2] The crystallization trials were performed with the iron(II) 
cylinder as well as cylinders containing nickel(II) and cobalt(II). Furthermore, cylinders with 
modified ligands were used for crystallization experiments. All used cylinders are depicted in 
Figure 2. The modified cylinders were kindly provided by our collaboration partners from the 
group of the Michael J. Hannon of the University of Birmingham. 
The only successful crystallization experiments containing metallo-supramolecular cylinders 
were two additional analogs of the 5´-CGUACG-3´ three-way junction presented in the 
previous chapter. Instead of iron, one crystal system contained the Co2L3 complex and the 
other Ni2L3. One further crystal structure could be solved: Colorless crystals of the octameric 
palindrome RNA sequence 5´-UCGUACGA-3´ grew in the presence of the Co(II) cylinder 
complex. However, the crystals contained no cylinder molecules but showed an RNA duplex 
at a resolution of 1.48 Å. In this high-resolution structure, Ca2+ binding sites are present and 
the duplex is a compressed A-RNA double helix. 
All other crystallization trials either produced no crystals at all or the crystal quality was too 
poor to allow solving of the structures. 
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Figure 1. Secondary structure of the 23S rRNA (green) and the 16S rRNA (blue) from Thermus 
thremophilus. Three-way junctions are highlighted with a red circle.[1] 
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Figure 2. Cylinder ligands in various modifications. 1: the original ligand L as used in Co2L3, Fe2L3, 
and Ni2L3.[3] 2: instead of a pyridine residue this ligand contains an isoquinoline group at the ends.[4] 
3: the hydrogen atoms of the central aliphatic carbon are replaced by two CF3 groups.[5] 4-7: To the 
end of each ligand the enantiomers of arginine[6] and serine[6-7] were attached. Ligands 1-3 were 
synthesized by Ariel Mucha and ligands 4-7 were synthesized by Lucia Cardo. 
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2 RNA three-way junctions containing the cylinder complexes Ni2L3 and Co2L3 
2.1 Results 
The nickel(II) and the cobalt(II) cylinder showed the same behaviour towards the hexameric 
RNA oligonucleotide as the iron(II) cylinder which is discussed in the previous chapter. 
Figure 3 shows the crystals of the Fe2L3 with RNA as well as the crystals that grew from the 
cobalt(II) and nickel(II) cylinder-RNA solutions. Only one crystal containing Co2L3 could be 
grown. In further trials only precipitate formed upon mixing the RNA and the cobalt(II) 
cylinder, but no new crystals were observed. The three crystal structures are shown in 
Figure 4. All structures have a very high similarity. They share the same space group and 
almost identical unit cell dimensions (see Table 1 and Table 2 as well as Table S1 of the 
Supporting Information in Chapter 1). Comparison of the structures of the Fe2L3 three-way 
junction with the Ni(II) structure yields an RMSD of 0.119 Å. For the Co(II) structure an 
RMSD of 0.174 Å compared with the Fe2L3 three-way junction was calculated. The 
structures were overlaid with PyMOL (see Figure 5).[8] The isomorphous crystal systems all 
have a metallo-cylinder at the heart of the junction. Further cylinder molecules are located at 
the GC termini of the duplex RNA arms at the periphery of the junction. The guanines and 
cytosines are in π-stacking interactions with the cylinder phenylene rings, forming additional 
non-covalent pseudo-junctions in the same manner as the DNA three-way junction reported 
by Hannon et al.[9] For an easier understanding of this 3D crystal network these terminal 
pseudo-junctions are shown as a two-dimensional lattice-representation in Figure 6. 
 
 
Figure 3. The crystals of the 3WJs grown with the hexameric RNA 5´-CGUACG-3´. In A and C the 
precipitations that were always present when mixing the cylinder with RNA are clearly visible 
A: Iron(II) cylinder with RNA (see Chapter 1). The crystal diffracted X-rays to a resolution of 1.91 Å. 
B: Crystal containing the nickel(II) cylinder and RNA that diffracted to a resolution of 2.14 Å. C: The 
only crystal that grew from a mixture of the cobalt(II) cylinder and RNA. It diffracted to a resolution 
of 2.75 Å. The precipitate is clearly visible as orange-yellow slabs. Possibly, the low solubility of this 
precipitate was the reason why these crystals were not reproducible.  
33
Part I Chapter 2: Additional Co-crystallization Trials of RNA and Cylinders
 
 
Figure 4. Front and side view of the three 3WJs with the different metallo-cylinders. A: 
1.91 Å-resolution structure of the iron(II) cylinder 3WJ (see Chapter 1). B: 2.14 Å structure of the 
nickel(II) cylinder 3WJ. C: 2.75  Å-resolution structure of a cobalt(II) cylinder inside the same RNA 
3WJ. 
 
 
 
Figure 5. Left: Overlay of the Ni2L3-RNA three-way junction (yellow) and the Fe2L3-RNA three-way 
junction (purple) with an RMSD of 0.119 Å. Right: Overlay of the Co2L3-RNA three-way junction 
(orange) and the Fe2L3-RNA three-way junction (purple) with an RMSD of 0.174 Å. The structures 
were overlaid with PyMOL.[8]  
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Figure 6. Two-dimensional model of the crystal lattice containing the RNA 3WJs. The cylinders 
viewed from the top, depicted as a purple circle with a black dot in the center, represent the ones 
bound inside the RNA 3WJ. In this two-dimensional depiction, the terminal cylinders, shown from the 
side, only interconnect two junctions. In the real crystal system three 3WJs are interconnected by these 
terminal cylinders forming the 3D network of 3WJs.  
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2.2 Materials and Methods 
The nickel(II) complex [Ni2L3]Cl4 (L = C25H20N4) was provided by courtesy of Ariel Mucha 
in the group of Michael J. Hannon.[3] The RNA oligonucleotide 5´-CGUACG-3´ was 
purchased PAGE purified and desalted from PURIMEX (Grebstein, Germany). Crystals were 
grown at 20 °C in 1 µL sitting drops containing 1.25 mM RNA and 2.5 mM racemic cylinder. 
The reservoir solution contained 50 mM Tris-HCl (2-amino-2-(hydroxymethyl)-1,3-
propanediol hydrochloride, pH = 8.0), 10 mM MgCl2, and 5% dioxane corresponding to 
condition #19 of the Doudna sparse matrix screen.[10] Growth of yellow cubic crystals could 
be observed after three days (Figure 3B). For cryoprotection, the crystals were transferred to a 
reservoir solution containing increasing amounts of dioxane (15 %, 20 %, and 25 %). Single 
crystal (0.15 x 0.15 x 0.15 mm3) diffraction data were recorded at 100 K at the Swiss Light 
Source (SLS) at the Paul Scherrer Institute in Villigen, Switzerland using the X06DA 
beamline (λ = 1 Å) with a PILATUS 2M detector. The data sets were indexed and integrated 
with XDS.[11] After having recorded a single anomalous wavelength (SAD) data set at the 
Ni-K absorption edge, the structure was solved with SHELXC/D/E[12] using the GUI 
HKL2MAP.[13] Refinement of the 2.14 Å resolution data was done with the PHENIX suite.[14] 
The observed R factor is 19.0% (Rfree = 19.4%). The structure crystallizes in the cubic space 
group P213, which is a non-isomorphic subgroup of P4132, the space group in which the 
structure of the analogous DNA 3WJ (PDB ID 2ET0) was determined. Further details 
regarding data collection and refinement are provided in Table 1. The crystal structure is 
isomorphous to the structure of the Fe2L3 RNA 3WJ. 
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Table 1. Data collection and refinement statistics of the RNA 3WJ containing the nickel(II) cylinder 
[Ni2L3]4+(L = C25H20N4). 
Data collection     
Data set Peak (SAD) High resolution 
λ (Å) 1.48503 0.9999 
Space group P213  
Unit cell parameters a = b = c = 45.896 Å, α = β = γ = 90° 
Resolution range (Å) 45.93-2.28 32.45-2.145 
Number of reflections  
total  36941 
unique 1608 1886 
Completeness (%)a  99.37 (93.96) 
<I/σI>a  101.79 (11.94) 
Average multiplicitya  19.6 (18.5) 
Rmrgd-Fa,b  3.1 (27.67) 
Refinement   
Rfactor (free Rfactor)c  19.0 (19.4) 
r.m.s. deviations from target values 
Bond lengths (Å) 0.005 
Bond angle distances (Å) 0.93 
Average B-factors (Å2) 
Drug 44.8 
RNA 47.6 
Solvent  
Number of Ni2+d 4/3e 
Number of drug atomsd 58 
Number of RNA atomsd 125 
Number of  solvent moleculesd 39 
a Outermost resolution shell values in parentheses.b For definition of Rmrgd-F see 
reference [15]. cRfactor = {Σhkl ||Fo| - k |Fc || / Σhkl |Fo|} x100, with Fo and Fc as the observed and 
calculated structure factor. d Per asymmetric unit. e Each of the four Ni2+ atoms has an 
occupancy of 1/3 due to location on a special position in the unit cell. 
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The cobalt(II) complex [Co2L3]Cl4 (L = C25H20N4) was also provided by courtesy of Ariel 
Mucha in the group of Michael J. Hannon.[3] The RNA oligonucleotide 5´-CGUACG-3´ was 
purchased PAGE purified and desalted from PURIMEX (Grebstein, Germany). Crystals were 
grown at 20 °C in 1 µL sitting drops containing 1.25 mM RNA and 2.5 mM racemic cylinder. 
The reservoir solution contained 50 mM MES (2-(N-morpholino)ethanesulfonic acid, 
pH = 6.0), 10 mM MgCl2, and 15% 2-propanol corresponding to condition #7 of the Natrix 
sparse matrix screen ordered from Hampton Research. Growth of only one orange-yellow 
cubic crystal could be observed after three days (Figure 3C). For cryoprotection, the crystals 
were transferred to a reservoir solution containing increasing amounts of 2-propanol (20 %, 
25 %, and 30 %). Single crystal (0.15 x 0.15 x 0.15 mm3) diffraction data were recorded at 
100 K at the SLS using the X06DA beamline (λ = 1 Å) with a PILATUS 2M detector. The 
data sets were indexed and integrated with XDS.[11] The structure was solved with molecular 
replacement and subsequently refined using the PHENIX suite at a resolution of 2.74 Å.[14] 
The observed R factor is 16.0% (Rfree = 26.7%). The structure crystallizes in the cubic space 
group P213, which is a non-isomorphic subgroup of P4132, the space group in which the 
structure of the analogous DNA 3WJ (PDB ID 2ET0) was determined. Further details 
regarding data collection and refinement are provided inTable 2. Also this crystal structure is 
isomorphous to the structure of the Fe2L3 RNA 3WJ. 
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Table 2. Data collection and refinement statistics of the RNA 3WJ containing the cobalt(II) cylinder 
[Co2L3]4+(L = C25H20N4). 
Data collection     
Data set High resolution 
λ (Å) 0.9999 
Space group P213 
Unit cell parameters a = b = c = 46.066 Å, α = β = γ = 90° 
Resolution range (Å) 32.57-2.748 
Number of reflections  
total 9837 
unique 939 
Completeness (%)a 100.0 (100.0) 
<I/σI>a 11.42 (11.39) 
Average multiplicitya 16.8 (16.2) 
Rmrgd-Fa,b 47.8 (45.9) 
Refinement  
Rfactor (free Rfactor)c 16.0 (26.7) 
r.m.s. deviations from target values 
Bond lengths (Å) 0.014 
Bond angle distances (Å) 0.72 
Average B-factors (Å2) 
Drug 46.6 
RNA 54.7 
Solvent  
Number of Co2+d 4/3e 
Number of drug atomsd 58 
Number of RNA atomsd 125 
Number of  solvent moleculesd 39 
a Outermost resolution shell values in parentheses.b For definition of Rmrgd-F see 
reference [15]. cRfactor = {Σhkl ||Fo| - k |Fc || / Σhkl |Fo|} x100, with Fo and Fc as the observed and 
calculated structure factor. d Per asymmetric unit. e Each of the four Co2+ atoms has an 
occupancy of 1/3 due to location on a special position in the unit cell. 
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3 Crystallization of an Octameric Duplex RNA 
3.1 Results 
In the attempt to investigate whether more elongated systems than a six nucleotide long RNA 
strand would crystallize as an RNA 3WJ, the octanucleotide 5´-UCGUACGA-3´ was 
co-crystallized with the yellow colored cobalt(II) cylinder complex. Colorless needle-shaped 
crystals grew after two days. The lack of color already hinted at the absence of cobalt(II) 
cylinder in these crystals. In theory, these crystals could also grow in the without addition of 
the cobalt(II) cylinder. Crystallization trials without Co2L3 were so far not performed. At 
first, a complete dataset was recorded at the synchrotron and solving of the structure was tried 
by molecular replacement. Since the sequence of the RNA was known, a minimized A-RNA 
duplex model of the octamer was generated by entering the sequence with Coot.[16] However, 
all phasing trials failed and the model could never be fit into the electron density map. At a 
second beam time at the SLS, a P-SAD experiment was successfully performed using the 
needle-shaped crystals which allowed to record a highly redundant data set by measuring at 
several positions of the same crystal. Since the anomalous signal of phosphorous is weak 
compared to the signals of, e.g., transition metals, a high redundancy of data is required for a 
significant amount of anomalous scattering signal.[17] A crystal smaller in size would have 
suffered from radiation damage long before reaching this high redundancy. The high 
redundancy of high quality data was collected by always measuring in a new region of the 
crystal that was not yet affected by radiation damage, hence taking advantage of its needle 
shape. 
The structure could be successfully solved with the data from the P-SAD experiment 
(Figure 7). The trial of solving the crystal structure from a dataset with molecular replacement 
failed because the models chosen for the phasing were not as compressed as the final P-SAD 
structure unveiled (Figure 7). In the structure, four Ca2+ binding sites were located 
(Figure 8 A): One is innersphere-bound to the phosphate oxygen, two are outersphere-bound 
to the backbone. They are also connected to further phosphates of neighboring asymmetric 
units in the crystal. The fourth Ca2+ is located inside the duplex, making an innersphere bond 
to the O4 of a uracil residue (Figure 8B). The blunt ends of the asymmetric units in the crystal 
are connected via end-on stacking creating an infinite RNA double helix throughout the lattice 
(Figure 8C). 
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Figure 7. Comparison of an “ideal“ octameric RNA duplex (left) vs. the 5´-UCGUACGA-3´ duplex 
solved by P-SAD (right). The “ideal” duplex was generated with Coot[16] and represents a simulated, 
energy-minimized A-RNA duplex in solution. The crystal structure on the right is squeezed in such a 
way that hydrogen bonds from U1O5’ to the OP2 of C2 of the other strand are formed. 
 
 
Figure 8. Detailed view of the octameric duplex 5´-UCGUACGA-3´. A: Full view on the crystal 
structure with four calcium ions (green). One of the three peripheral Ca2+ ions is innersphere bound to 
a phosphate oxygen. All three of them are involved in inner- or outersphere connections between 
neighboring asymmetric units, however, with incomplete coordination spheres. B: Ca2+ ion bound to 
the O4 of U4 inside the duplex. It is additionally bound to six water ligands. The total of seven ligands 
create a pentagonal bipyramidal geometry. C: the crystal system of the RNA duplex shows an end-on 
stacking as well as the Ca2+ ions in the asymmetric units.  
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3.2 Materials and Methods 
3.3 RNA purification and crystallization conditions 
The RNA oligonucleotides where ordered “desalted” from Microsynth, Switzerland, in a 
quantity of 2 µmol. The RNA was PAGE purified with a 20 % denaturing gel at 40 watts for 
6.5 hours. After cutting out the band corresponding to the octanucleotide, the RNA was 
extracted from the PAGE by crush and soak using appropriate buffers: 10 mM Tris-HCl, 
pH = 7.5, 200 mM NaCl, 1 mM EDTA, pH = 8.5. The gel was separated from the eluted RNA 
by centrifugation (9'500 rpm Sorvall RC 6+ centrifuge, SA-600 rotor, 1 min, at 4 °C). The 
supernatant was collected and ethanol precipitated (3 volumes 100 % ice-cold ethanol and 
50 mM NaCl). The solution was incubated overnight at -20 °C. Then, the solution was 
centrifuged at 9500 rpm for 30 min at 4 °C , and the pellet was dried using a speedvac 
(Eppendorf). The RNA extraction from the gel was repeated in order to increase the yield of 
purified RNA. Finally, the RNA pellet was suspended in 1 mL of ddH2O and applied onto a 
Nap-10 column purchased from GE-Healthcare for desalting and to get rid of remaining gel 
pieces. The RNA was eluted from the column with 1.5 mL ddH2O and lyophilized. The 
concentration of the purified and resuspended RNA was determined with a UV/Vis 
spectrophotometer (Agilent) or Nanodrop and adjusted to 1.2 mM. 
Crystals were grown in condition #47 of the Natrix 2 screen of Hampton Research containing 
0.2 M CaCl2, 28 % PEG 400, 2 mM Spermine in a 50 mM HEPES sodium buffer at pH 7.5. 
Prior to crystallization, the RNA was heated to 50 °C for 1 min and left for cooling to room 
temperature for another minute. Then, the RNA of 1.2 mM was mixed 1:1 with a solution of 
2.5 mM Co2L3 (L= C25H20N4). From this mixture, drops of 400 nL were mixed with 400 nL 
of the above mentioned Natrix 2 condition #47 and incubated at 20 °C.  
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3.4 Cryofreezing and loop mounting 
Preliminary diffraction tests on an Agilent PX Scanner (Frame width: 0.5°, 6 frames, 100sec 
frame time) showed already a good diffraction image with a resolution of about 2.5 Å 
(Figure 9). 
 
  
Figure 9. In-house plate screening of needle-shaped colorless crystals on an Agilent PX Scanner. The 
observerd resolution was 2.5 Å. 
 
Cryofreezing was done at the X06DA beamline at the Swiss Light Source (Paul Scherrer 
Institute, Villigen, Switzerland). The cryosolution contained the mother liquor with 25 % 
glycerol. Crystals were picked at the beam line and immediately mounted onto the goniometer 
allowing them to freeze in the cryostream. The loop had to be chosen large enough to be able 
to bear the needle-shaped inside in full length (see Figure 10). If the loop had a diameter too 
small in size, the spicular crystal slightly bent which was visible in the diffraction where 
smeared spots were observed. 
Further details regarding data collection and refinement are provided in Table 3. 
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Figure 10. Spicular crystal inside a loop mounted on the goniometer at the X06DA beamline. The 
shape of the crystal allowed recording a highly redundant data set at various positions of the crystal, 
preventing radiation damage. This data set allowed for a structure solution with P-SAD. 
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Table 3. Data collection and refinement statistics of the octameric palindrome duplex 
5´-UCGUACGA-3´. 
Data collection     
Data set High resolution 
λ (Å) 0.9999 
Space group R3 
Unit cell parameters a = b = 46.671 Å, c = 51.885 Å, α = β = 90°, γ = 120° 
Resolution range (Å) 32.3-1. 48 
Number of reflections  
total 39034 
unique 7297 
Completeness (%)a 99.84 (99.45) 
<I/σI>a 25.82 (3.47) 
Average multiplicitya 5.3 (4.9) 
Rmrgd-Fa,b 3.36 (41.6) 
Refinement  
Rfactor (free Rfactor)c 18.7 (21.2) 
r.m.s. deviations from target values 
Bond lengths (Å) 0.005 
Bond angle distances (Å) 0.89 
Average B-factors (Å2) 
ligands 24.5 
RNA 22.9 
Solvent 27.1 
Number of RNA atomsd 334 
Number of  solvent moleculesd 29 
a Outermost resolution shell values in parentheses.b For definition of Rmrgd-F see 
reference [15]. cRfactor = {Σhkl ||Fo| - k |Fc || / Σhkl |Fo|} x100, with Fo and Fc as the observed and 
calculated structure factor. d Per asymmetric unit.  
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4 Co-crystallization trials of naturally occurring RNA with Fe2L3 
Three constructs derived from domain 1 (D1) of the group II intron ai5γ residing in the 
mitochondrial cox1 gene in yeast (Figure 11) were used in crystallization trials with the 
iron(II) cylinder Fe2L3. The three constructs are depicted in Figure 12. These short RNA 
sequences were chosen because either purified RNA or template DNA was available. 
Additionally the whole intron is one of the main focuses in the working group. The DNA 
templates were transcribed and purified using established methods.[18] The constructs D1-49 
and D1-47i bear a 3WJ and the d3’-EBS1 was used to investigate whether binding of the 
cylinder to duplex RNA would occur as well. 
 
Figure 11. Secondary structure of the ribozyme derived from the ai5γ intron of the mitochondrial cox1 
gene in yeast. A 3WJ is located in the κ−ζ region of D1. Derivatives of D1 were used in crystallization 
trials. Furthermore a modified version of the EBS1 site was also used for crystallization attempts 
(Figure 12).  
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Figure 12. Three constructs derived from the group II intron ai5γ of the mitochondrial cox1 gene in 
yeast. Co-crystallization attempts with Fe2L3 remained unsuccessful. 
 
However, no crystals ever grew from the various standard nucleic acid screens used for 
crystallization. Heavy precipitation was always visible when mixing the RNA solutions with 
the cylinder solutions. Possibly, the decreased solubility and mobility in solution prevented 
nucleation of crystals. 
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5 Crystallization trials of elongated artificial RNA three-way junctions. 
In order to further explore the binding of iron(II), nickel(II), and cobalt(II) cylinders, longer 
artificial palindromic RNA strands were used in crystallization trials. The octameric RNA 
5´-UCGUACGA-3´ yielded purple crystals with the iron(II) cylinder after remaining months 
inside the crystallization drops. However, the structure of one of these crystals showed only 
the Fe2L3 complex together with some degraded cylinder ligands. The only solved crystal 
structure resulted from co-crystallization with the Co2L3 cylinder. However, only duplex 
RNA with no cylinder attached was found in the crystals, yet at very high resolution (see 
Section 3). Co-crystallization of the decameric 5´-CUCGUACGAG-3´ with the iron cylinder 
yielded purple crystals. However, the diffraction was too weak to solve a structure at a 
resolution weaker than 5 Å. The dodecameric 5´-UAUGGUACCAUA-3´ never produced any 
crystals. 
6 Competition crystallization trials with DNA and RNA three-way junctions 
The DNA and RNA oligomers 5´-CGTACG-3´ and 5´-CGUACG-3´ were used to co-
crystallize with the iron(II), nickel(II), and cobalt(II) cylinder. The goal was to find 
preferences of crystallization or hybrid crystals of the DNA or RNA. However, crystals never 
grew in the standard screens used (Natrix, Nucleix, and Doudna). 
7 Modified ligands of the cylinder complexes in co-crystallization attempts 
Modifications of the ligand L of the metallo-cylinders by introducing additional groups 
(provided by Ariel Mucha) or amino acids (provided by Lucia Cardo) were used to investigate 
potential crystal growth with the 5´-CGUACG-3´ RNA hexamer (Figure 2). Again, crystal 
growth was never observed with either of these cylinders. 
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Introduction Part II 
 
The role of RNA goes way beyond that of a mere carrier of genetic information. Correctly 
folded, RNA can perform a variety of tasks inside the cell. Aptameric regions of mRNAs, 
so-called riboswitches, for example can sense metal ions or small molecules in order to 
regulate their concentrations.[1] Another example are ribozymes, catalytically active RNAs, 
that can, like protein enzymes, perform chemical reactions.[2] The largest known ribozyme is 
the ribosome which synthesizes proteins from mRNA templates in all living organisms. The 
needed amino acids for protein synthesis are carried by tRNAs, another example of functional 
RNA molecules.[3] In order to fulfill all these versatile tasks, RNA molecules are dependent 
on a correct folding to reach their native three-dimensional structure. Folding could not occur 
without cationic cofactors, since the negatively charged backbone would not allow a packing 
of the structure because of electrostatic repulsion.  Loosely bound mono- and divalent cations 
such as Na+, K+, Mg2+, or Ca2+ are mainly involved in charge compensation. In contrast, 
mostly divalent cations are prevalently bound site-specifically. These metal ions coordinate to 
non-bridging phosphate oxygens or hydrogen bond donors of the nucleosides. Binding occurs 
in an innersphere (direct) or an outersphere (water mediated) manner with high specificity.[4] 
Furthermore, most ribozymes require divalent metal ions for catalysis.[5] Mg2+ is the most 
abundant divalent cation inside the cell and it is therefore also the cation found most often 
bound at specific locations in RNAs. In order to verify, encompass and categorize these metal 
ion binding sites, we created the MINAS database (Metal Ions in Nucleic AcidS, 
www.minas.uzh.ch) where all metal ions ever discovered and mapped in structures are 
stored.[6] Nearly 100'000 (and counting) metals are now inside the database containing metal 
ions from structure files deposited in an ever growing resource, the Protein Data Bank 
(PDB).[7] MINAS has various search functions, e.g. the kind of metal ion, metal-ligand 
distance, innersphere and outersphere ligands defined by element, functional group or 
residues, as well as PDB entry-related information. The MINAS database thus offers a 
unique way to explore the coordination geometries and ligands of metal ions together with the 
respective binding pockets in nucleic acids. 
Another structure stabilizing aspect in RNA that remained scarcely investigated until now is 
the interaction of the π-systems of the aromatic nucleobases with charged species. The first 
focus was on metal ions stored in the MINAS database to determine the extent of cation-π 
interactions.[8] We expanded this view onto any charged species, anionic or cationic, to 
encompass the frequency of occurrence of all ion-π interactions in RNA and DNA.[9] Metal 
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ions are rather the exception than the rule in cation-π interactions. The largest part is 
accounted for by arginine side chains of proteins.[10] Anion-π interactions are mostly found in 
an intramolecular fashion between the aromatic nucleobases and phosphate oxygens of the 
backbone. 
 
Aims of the second part of this thesis 
 
Chapter 3 describes the buildup of the MINAS database and is a user’s guide to the web 
interface at www.minas.uzh.ch.[6] In Chapter 4 the trends of the binding environments of the 
metal ions are analyzed and outlined as statistical data of the most prominent binding sites 
such as the phosphate oxygens of the nucleic acid backbone and the Hoogsteen face of 
guanine. Chapter 5 is a study on the cation-π and anion-π interactions found in all nucleic acid 
structures in the PDB. Arginine side-chains of nucleic acid-binding proteins and phosphate 
oxygens of RNA and DNA backbones are the most frequent charged species found in 
interaction distance to the π-systems of the nucleobases. The ion-π study supplements the 
results from the MINAS database by adding the extent of charged π-interactions drawing a 
more complete picture of structure stabilization in nucleic acids. 
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ABSTRACT 
Correctly folded into the respective native three-dimensional structure, RNA and DNA are 
responsible for uncountable key functions in any viable organism. In order to exert their 
function, metal ion cofactors are always closely involved in folding, structure formation and, 
e.g. in ribozymes, also the catalytic mechanism. The database MINAS, Metal Ions in Nucleic 
AcidS (www.minas.uzh.ch), compiles the detailed information on innersphere, outersphere 
and larger coordination environment of >70'000 metal ions of 36 elements found in all > 
2'000 structures of nucleic acids contained today in the PDB and NDB. MINAS is monthly 
updated with new structures and offers a multitude of search functions, e.g. the kind of metal 
ion, metal-ligand distance, innersphere and outersphere ligands defined by element or 
functional group, residue, experimental method, as well as PDB entry-related information. 
The results of each search can be saved individually for later use together with so-called 
miniPDB files containing the respective metal ion together with the coordination environment 
within a 15 Å radius. MINAS thus offers a unique way to explore the coordination geometries 
and ligands of metal ions together with the respective binding pockets in nucleic acids. 
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INTRODUCTION  
RNA is not only an information carrier for the primary proteins structure, but is also actively 
involved in numerous processes within living cells (1). The RNA world hypothesis suggests 
that at early stages of evolution solely RNA acted as both information carrier and cellular 
catalyst (2). The existence of ribozymes discovered in the beginning of the 1980s (3,4) 
support this hypothesis and ever since interest in native RNA structures has grown. Today, 
RNA molecules with manifold tasks are known. For example so-called riboswitches are 
aptameric regions of mRNAs involved in self-regulation of genes in metabolic pathways (5). 
All RNA functions depend on a correct fold. Since nucleic acids in general contain a 
polyanionic phosphate-sugar backbone, this electrostatic repulsion has to be overcome to 
allow a close neighborhood of the negatively charged sites. Alkaline and earth alkaline metal 
ions are ideal for general charge screening due to their high abundance, their localized charge, 
and relatively weak general affinity towards any ligand. Aside from the negatively charged 
phosphate oxygens, each nucleotide comprises several potential coordinating atoms all of 
which may be important for 3D structure and catalysis. If these coordinating atoms are 
arranged ideally, metal ions can be recognized specifically and tightly bound through an 
intricate network of innersphere and outersphere interactions. The 2006 established MeRNA 
database categorizes eight such metal ion binding motifs together with their inner 
coordination environment within 6 Å within 389 PDB files (6). Specifically bound metal ions 
are most crucial for structure and function of complex nucleic acid structures in general (7,8). 
For example, the necessity of divalent cations becomes obvious by the fact that the Mg2+ 
concentration can be reduced from ~50mM to physiological 3 mM in the group II intron 
ribozyme Sc.ai5γ upon addition of the naturally associated protein Mss116, but cannot be 
completely replaced by other factors (9). A detailed knowledge on the coordination 
environment and the preferences of each metal ion for specific binding atoms is thus essential 
to understand structure and function of nucleic acids. 
The most abundant divalent metal ion in living cells, Mg2+, has the same number of 
electrons as H2O and Na+ and is mostly spectroscopically silent. Consequently, it is difficult 
to localize Mg2+ and to differentiate single Mg2+ ions from H2O or Na+ by X-ray, NMR, or 
other spectroscopic methods. High resolution X-Ray data is essential together with a correct 
interpretation of the electron density maps to assign the defined places of Mg2+ and other 
metal ions. A detailed knowledge on the most preferred coordinating atoms would thus be of 
great help to identify possible Mg2+ ions in electron density maps. Of the >5'500 structures of 
nucleic acids deposited in the Protein Data Bank (PDB) (10,11), more than half contain metal 
ions that are bound to nucleic acids. Until today there has been no possibility to directly 
explore all these metal ions with regard to their first and second shell ligand environment, 
except for going through these PDB files individually. 
The here described database MINAS, Metal Ions in Nucleic AcidS 
(www.minas.uzh.ch), now enables the detailed search for information on all metal ions and 
their wider coordination environment stored in the PDB. MINAS is monthly updated and 
offers a large variety of intuitive search functions to explore all metal ions and their first and 
second shell coordination sphere identified in nucleic acid structures deposited in the PDB. 
The matching metal ions and ligands can then be viewed and downloaded as tabular data. 
Additionally, the binding pocket of the metal ion is provided as a section of the original PDB 
file displaying the macromolecular environment within a radius of 15 Å around the central 
57
Part II   Chapter 3: NAR 2012 D434, DOI: 10.1093/nar/gkr920 
metal ion. These so-called Mini PDB files can be viewed directly in the web browser (Jmol, 
Java-plugin required) or downloaded for local display in a PDB viewer of choice. As of July 
2011, the MINAS database contains over 70'000 metal ions of 36 distinct elements. The 
majority is accounted for by Mg2+ with over 50'000 entries being the most abundant metal 
ion. Mg2+ is followed by Na+ (more than 6'000) and Sr2+ (more than 3'000). With an almost 
exponential growth rate of the Protein Data Bank, MINAS grows and more information on 
metal ions becomes available. 
 
AIMS AND SCOPE OF THE MINAS DATABASE 
Rising interest in metal binding sites in RNA requires that the existing wealth of information 
is readily accessible. To extend the knowledge about binding properties of metal ions and 
enable a direct and rapid access we created the database of Metal Ions in Nucleic AcidS 
(MINAS, www.minas.uzh.ch). MINAS contains the full structural information of all nucleic 
acid-metal ion binding sites stored in the PDB. This centralized information allows now a 
detailed search of metal ion coordination sites in RNA, DNA and PNA: (i) The kind of metal 
ion can be specified along with multiple innersphere or outersphere ligands; (ii) These ligands 
can be defined by element, residue, distance to the metal ion and ligand relations; (iii) Apart 
from the coordination sphere, a variety of structurally related search criteria such as 
experimental methods can be chosen; (iv) PDB-related search terms like authors or keywords 
can be used to filter results. The retrieved information can then be used by researchers to 
understand the specificity of metal ions binding to nucleic acids. In addition, comparison with 
other nucleic acid molecules can accelerate the process of solving new three-dimensional 
structures of nucleic acids containing metals and locate metal ions more exact in the electron 
density map.  
MeRNA and MINAS have a different focus and yield different information. The MeRNA 
database (http://merna.lbl.gov) focuses on the eight known binding motifs derived from 389 
RNA containing PDB files (6). MINAS instead lists all metal ions and focuses on the ligands 
and their combination to build up a complete coordination sphere. MINAS will prove very 
useful to identify possible further binding motifs of metal ions in nucleic acids in general. 
 
STRUCTURE OF THE DATABASE 
All structure files of the PDB containing nucleic acids (RNA, DNA, and PNA) form the basis 
of MINAS. These files were downloaded and screened for metal ions. Each metal ion was 
then screened for potential ligands (i.e. the elements nitrogen and oxygen) found in an 
appropriate distance. For innersphere ligands the cutoff distance was set to 2.5 Å, for 
outersphere ligands the maximum distance to an innersphere ligand is 3.2 Å corresponding to 
the maximum length of a typical hydrogen bond. Hence a sphere with a radius of 5.7 Å 
around each metal ion was defined as the coordination environment. The coordinates of each 
metal ion together with those of the potential ligands were then stored in the MINAS database 
along with the metadata from the PDB files such as experimental data and authors. In order to 
enable the convenient visualization of each metal ion binding site, the surrounding binding 
pocket within a radius of 15 Å around the metal ion is stored as a so-called miniPDB file. On 
a monthly basis, the PDB is searched for newly deposited PDB files containing nucleic acids 
to keep the MINAS database up-to-date.  
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ACCESS TO THE MINAS DATABASE 
The MINAS database can be easily accessed on www.minas.uzh.ch. Access and full search 
options are free and unrestricted. The user obtains the full output list including shortcuts to the 
miniPDB files, which can be downloaded as *.csv files. In addition, the user can also register 
to obtain a login and password (registration is free). This allows to save each query and its 
output on the MINAS server for later retrieval, analysis and comparison. Registration is also 
free. 
 
SEARCH AND OUTPUT OF MINAS 
The search portal of MINAS database can be found on www.minas.uzh.ch/search. The query 
(unless defined differently by the user) automatically searches the full database containing 
more than 70'000 metal ions in > 2'000 PDB files of nucleic acids. The Query Builder is 
subdivided into three sections, which are briefly explained below. For a full documentation of 
the MINAS search functions, please refer to the supplementary information or the regularly 
updated help menu on the MINAS webpage: 
i. The top part of the Query Builder allows to define the search (Figure 1). On the top level, 
the metal ion of interest is set, and in the middle level, PDB related information can be 
specified, like PDB ID, experimental method, authors and journal, and the type of 
macromolecule. In the third level, the ligands in the first and second shell coordination 
sphere can specified (or excluded) (Figure 1a). Ligands can be any coordinating atom of a 
nucleotide, water or simply the element nitrogen or oxygen. Also the relation between two 
coordinating atoms can be defined, e.g. on the same residue or two nucleotides apart. Any 
search definition needs to be confirmed with "set". 
ii. In the middle section, called Your Query, the search parameters as defined by the user in 
the Query Builder, are summarized (Figure 1b). This section is intended to provide the user 
with an overview on the search, which is important especially for more complex multi-
ligand searches. Once, the search is defined as intended, the search is executed by the 
"execute query" button. 
iii. The last section on the bottom shows the results of the query. In the top right corner of this 
section, the total number of metal ions matching the user-specified query is given. The 
metal ions are listed below together with the PDB ID as well as the method and publication 
information. In column eight, the miniPBD can be viewed directly with Jmol (12) (when 
using a Java-enabled web browser) or downloaded for local viewing. In column nine, all 
potential ligands within a distance of 5.7 Å from the metal ion can be viewed and/or 
downloaded as *.csv file. If registered, the query results can also be saved online for later 
retrieval. 
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Figure 1. Screenshot of the query and results from www.minas.uzh.ch/search. A The Query 
Builder allows the specification of metal ions, the PDB-related data as well as the detailed 
choice of (multiple) ligands.  B The section Your Query summarizes the specified parameters 
and choices for the query. C In the Results section, the metal ions found according to the set 
parameters are listed together the with number of total hits in the top right corner. Links to the 
parent PDB ID, the miniPDB for viewing in a Java-enabled web browser as well as to a list of 
all identified ligands are provided (see also Figure 2). 
A 
B 
C 
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Figure 2. Screenshot of the detailed results from www.minas.uzh.ch/search. A View of a 
miniPDB file as provided after clicking on view.  A Jmol (12) frame displays the interactive 
3D representation of the metal ion and its binding pocket.  B A click on show opens a table 
with all ligands listed. Here details on the ligands from the PDB files as well as their direct 
distance to the metal ions are shown. Those outersphere ligands, which have a direct 
connection to an innersphere ligand display a blue info symbol in the column "Connections to 
Innersphere". This information box shows the element and residue number of the innersphere 
ligand as well as the distance between innersphere and outersphere ligands. 
A 
B 
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CONCLUSIONS 
The MINAS database comprises as of July 2011 36 metallic elements counting more than 
70'000 metal ions in total. Mg2+ is by far the most abundant metal in MINAS with over 50'000 
entries coordinating to nucleic acids. Second to Mg2+ is Na+ with more than 6'000 entries in 
the MINAS database and third is Sr2+ with still more than 3'000 metals found. On the other 
end of the lane are Li+ and Lu3+ (1 entry each), as well as Sb3+ and Yb3+ (2 entries each). It is 
obvious that with increasing numbers of submitted macromolecular structures to the PDB 
each year (11), the number of metal ions increases with the same pace and the MINAS 
database will cover an even wider range of metal ions in nucleic acids.  
Its sister database MeRNA (Metals in RNA) (6), established 2007 by Brenner and 
coworkers focuses on binding motifs and thus has a different aim compared to MINAS: 
MeRNA does not include DNA and PNA and provides detailed information on the eight 
known types of metal ion binding pockets in RNA. The entries taken from 389 PDB files are 
classified together with their ligands but making no distinction between inner- and 
outersphere. MINAS has a wider information and different focus being more ligand oriented: 
MINAS makes no preset restrictions, but instead includes all metal ions found in nucleic 
acids structures within the PDB together with their coordination environment. The stored 
structural data in a 15 Å radius around the metal ions allows for a detailed search and 
comparison of inner and outersphere ligands. The provided search functions allow the user to 
define any possible combination of coordinating ligands and parameters. MINAS is thus an 
ideal complementation to other databases like MeRNA (6) or SCOR (13). Further related 
databases are the Solvation Web Server (SwS) (14), which provides detailed information on 
the first solvation shell of nucleotides, and AMIGOS II (15), which allows the definition of 
and search for RNA structural motifs. In combination with those databases and their search 
functions, MINAS will provide new ways to investigate RNA structures, metal ion binding 
motifs and the role of metal ions in nucleic acid structure and function. 
It is obvious that the data compiled in MINAS can only be as good as the initial structure, 
e.g. the resolution of an X-ray structure. In many cases the resolution does not allow for a 
rigorous search for metal ions and sometimes, the metal ions have also not been refined. In 
the future as the PDB grows and the structures generally improve in resolution with the 
always better technical possibilities, also the quality of the data compiled in MINAS will rise. 
This will lead to more results of a given query and thus statistically more meaningful data. 
Consequently our understanding of metal ion binding will increase, e.g. by finding new 
classes of metal ion binding pockets in RNA. 
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SEARCHING THE MINAS DATABASE 
www.minas.uzh.ch/search provides a detailed search function for metal ions, their 
coordination first and second shell spheres as well as PDB-related information. The search 
page is subdivided in three sections Query Builder, Your Query, and Results (Figure S1), 
which are explained in more detail below: 
QUERY BUILDER 
The top section, the Query Builder, allows the definition of various search parameters for 
metal ions, ligands, and PDB-related data. Every choice has to be confirmed by clicking on 
the respective "set" button on each tab (Figures S2-S8): 
Specify Metal Ion 
Metal ions can be chosen from a dropdown list or an interactive periodic table that appears by 
clicking on the periodic table symbol (Figure S2). The metal ions contained in the MINAS 
database are underlined and on "mouse-over" a the total number of hits in the database is 
shown. 
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Specify PDB Parameters 
Specific metadata from the PDB files is stored in the database and be searched for 
(Figures S3-S6): 
1. Basic (Figure S3) 
1. The PDB ID 
2. The experimental method (Exp. Method; X-ray, NMR, other) along with a user-
defined resolution limit if X-Ray is chosen 
ii. Authors & Journal (Figure S4) 
1. Author names and journal titles can be specified. 
iii. Keywords (Figure S5) 
1. Keywords that are contained in the PDB file can be searched by entering them in 
the textbox separated by a comma 
iv. Macromolecule Type (Figure S6) 
1. The macromolecules (RNA, DNA, PNA or Protein), which the specific query 
should cover 
Add Ligands 
Multiple ligands with different properties can be chosen here (Figures S7 and S8) 
1. Nucleotide (Figure S7) 
2. Here the user can specify whether to include or exclude specific coordinating 
ligands. Either specific functional groups on the nucleotides, the elements "N" or 
"O", H2O, or the two non-bridging oxygens on the phosphate (POx) can be 
specified. By clicking on the purine symbol the nucleotides appear as images of 
the skeletal formula of DNA or RNA monomers and the ligand can be chosen by 
clicking on the desired atom. Alternatively, ligands can be chosen from a 
dropdown list. The maximum distance of a ligand to a metal ion can be set here as 
well. 
2. Ligand Relations (Figure S8) 
3. Relations of ligands can be defined, e.g., a metal ion coordinating to two ligands 
that are (not) on the same nucleic acid chain or on the same residue. 
 
YOUR QUERY 
In the middle section Your Query all the choices made in the Query Builder are summarized 
(Figure S9 and S10). This section allows the user to see all the selections made and is 
especially useful for keeping an overview of more complex searches containing multiple 
ligands. This section is divided in two tabs, Specifications and Ligands.  
Specifications 
Here all the metal ion- or PDB file-related choices are shown (Figure S9). 
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Ligands 
The ligands, included or excluded, as well as their relations to each other in case of more than 
one ligand can be reviewed here before executing the query (Figure S10). After reviewing all 
the chosen parameters the search for matching metal ions can be started by clicking on the 
"execute query" button. To empty all search fields and choices, click the "reset query" button 
on the left side (Figure S9 & S10). 
 
RESULTS 
The bottom section Results displays the output of the query. To the top right of this section 
the Records indicate the total number of metal ions matching the user-specified query. The 
result columns show from left to right (Figure S11): 
4. The element symbol of the metal ion 
5. The PDB ID of the file containing the metal ion. The ID is directly linked to the 
original PDB file on http://www.pdb.org/ 
6. The classification of the structure according to the PDB entry 
7. The experimental method  
8. The journal title 
9. The authors 
10. A link to directly view the miniPDB file of the metal ion in the Java-enabled web 
browser (plugin available at www.java.com) (Figure S12) 
11. A link to download the miniPDB file for local viewing in a molecular visualization 
software of choice 
12. A link to view all potential ligands of the metal ion in a table (Figure S13) with 
information on how the outersphere ligands are connected to the innersphere ligands 
of the metal ion 
13. A link to download the ligands of the metal ion in the *.csv file format. This file can 
be opened in a text editor or in a spreadsheet application (e.g. Microsoft Excel or 
OpenOffice Calc) 
SEARCH HISTORY 
The Search History provides the user with the possibility to restore previous searches in the 
case of multiple queries to the MINAS database. Such, waiting times can be prevented and 
the modification of searches is facilitated by restoring and adjusting the choices made in 
previous queries (Figure S14). 
 
SAVED QUERIES 
Registered users have the possibility to save each query before executing it (Figure S15). This 
is done by typing a filename in the text field next to the execute query button. The query and 
the results can then be retrieved in the tab My Queries that appears inside the Query Builder 
(Figure S16). The saved queries can be restored or deleted. Saving and retrieving of queries is 
only possible after logging in. 
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Figure S1.  Overview of the search page on www.minas.uzh.ch/search . The three sections 
Query Builder, Your Query, and Results are shown. 
 
 
Figure S2.  In the first tab of the Query Builder, the metal ion can be specified either from a 
pull-down list, or directly by clicking on the respective symbol in the pop-up window 
showing the periodic table. 
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Figure S3.  In the second tab of the Query Builder, PDB parameters can be defined. In the 
first sub-tab, the PDB ID and/or the experimental method can be set. 
 
 
Figure S4.  In the second tab of the Query Builder, PDB parameters can be defined. In the 
second sub-tab, the authors and/or the journal can be set. 
 
 
Figure S5.  In the second tab of the Query Builder, PDB parameters can be defined. In the 
third  sub-tab, the keywords contained in the PDB files can searched. 
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Figure S6.  In the second tab of the Query Builder, PDB parameters can be defined. In the 
fourth sub-tab, the type of macromolecule can either be included, excluded, or ignored. 
 
 
Figure S7.  In the third tab of the Query Builder, the specific ligands of the metal ion can be 
defined. All, the coordination sphere, the nucleobase, and any potential ligand on the 
nucleotide can either be specifically excluded or included. Several ligands can be defined, by 
clicking on "set" each time. 
 
 
Figure S8.  In the third tab of the Query Builder and the second sub-tab of the ligand 
definition, the relationship between the various ligands defined in the first sub-tab can be set. 
For example the distance (in nucleotides) can be defined, or if two ligands should be on the 
same strand or not. 
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Figure S9.  In the Specifications tab of the Your Query section, all choices made under the 
Specify Metal Ion and Specify PDB Parameters tab of the Query Builder are summarized. 
 
 
Figure S10.  In the Ligands  tab of the Your Query section, all choices made under the Add 
Ligands tab of the Query Builder are summarized. 
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Figure S11.  After executing the query, the metal ions that match all criteria defined by the 
user, are listed in the Results section. 
 
 
Figure S12.  By clicking view in the miniPDB column in the output list, and if Java is 
enabled in the web browser, the metal ion together with its environment in a sphere of 15 Å 
radius is displayed in Jmol Viewer. Alternatively, the miniPDB can be downloaded. 
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Figure S13.  By clicking on show in the Ligands column of the Results output list, a complete 
list of innersphere and potential outersphere ligands (within 5.7 Å from the central metal ion) 
is given. Those outersphere ligands that are linked to an innersphere ligand are marked with a 
blue info button in the column to the far right. By clicking on this info button, the connection 
to the respective innersphere ligand is provided (see also Figure 2). This list can also be 
downloaded a s a *.csv file to be opened in any text editor or spreadsheet application. 
 
 
Figure S14.  The Search History provides the user to toggle between different searches. 
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Figure S15.  Upon registration, the text field My Personal Query appears, where the user can 
give a file name to the query to be executed. 
 
 
Figure S16.  As registered user, a further tab appears, where all saved queries are listed and 
can be retrieved from or deleted again. 
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ABSTRACT 
Metal ions are vital for the native state of three-dimensional nucleic acid structures. The MINAS 
database provides the tool to categorize and search for metal ions throughout all nucleic acid 
structures available in the structural databases. Innersphere and outersphere ligands of metal ions 
provide a large pool of information on binding pockets and binding preferences of the diverse metal 
ions found inside these structures. Charge neutralization is vital for folded RNA molecules, and 
many cations are found in an innersphere coordination to phosphate oxygens of the backbone. Up to 
four simultaneous innersphere phosphate coordinations are possible. The most occupied uncharged 
system in nucleic acids is provided by the Hoogsteen face of guanine. At this side, many transition 
metals show their preferences for nitrogen by preferrably coordinating to N7, whereas alkali and 
alkaline earth metals prefer O6 as a direct ligand. Mg2+ is the most abundant metal in the MINAS 
database representing over 70 % of all metal ions registered. Nontheless, over 30 different elements 
and their most frequent coordination sites are encompassed. The preferences of metal ions binding 
to nucleic acids is provided for the first time in a statistical manner representing all available 
structures as a resource for these numbers. 
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1 INTRODUCTION 
Metal ions are well known cofactors throughout the living world. Their tasks include signaling, 
catalysis, structure, or homeostasis.[1] Accordingly, in RNA and DNA, metal ions also play crucial 
roles. The polyanionic nature of nucleic acids (NAs) requires charge compensation, a task that is 
broadly fulfilled by metal ions. Metal ions allow functional NAs to fold into their native structure, 
and they are also directly involved in catalysis of ribozymes. The vast majority of metal ions 
typically binds diffusely around NAs, fulfilling the mere task of charge neutralization by 
accumulation around RNA or DNA, thereby forming a delocalized shell of counter ions. For folded 
RNAs, however, site-specifically bound metal ions are needed to prevent repelling of the closely 
packed negatively charged backbones. These sites harbor metal ions in a unique network of 
innersphere and outersphere bound ligands. In the active center of ribozymes, metal ions act as 
crucial cofactors. Their determined geometry and placement is vital for catalysis.[2] Spectroscopic 
determination of naturally occurring metal ions is often a tedious task, as most of the ions have 
either a short occupancy time or they are spectroscopically silent. Nevertheless, there are thousands 
of structures deposited in the Protein Data Bank (PDB)[3] that contain coordinates of metal ions 
bound to NAs. The almost exponential increase of number of structures published in the PDB 
during the last two decades reflects the recent advancements in spectroscopic methods. Almost 
90 % of all structures in the PDB are determined by X-Ray crystallography. Enhancement of X-Ray 
facilities with more advanced synchrotron beamlines, high-performance X-Ray detectors,[4] and 
automation of crystal screening with high-throughput crystallization have doubtless contributed 
most to many of the recently determined structures. 
In order to get the full scope of all the metal ions that are mapped in NA structures, we created 
MINAS, the database on Metal Ions in Nucleic AcidS.[5] MINAS comprises information on all metal 
ions in the context of NA structures deposited in the PDB: The geometrical data of the respective 
NA structure containing metal ions is extracted and stored in the database. The wider coordination 
environments of each metal ion is categorized in innersphere (≤ 2.5Å distance from a metal center) 
and outersphere (within a distance between 2.5Å and 5.7Å from the metal) coordination. The metal 
ions and their innersphere or outersphere ligands can be retrieved via the web interface of 
http://www.minas.uzh.ch. 
MINAS holds now almost 100’000 metal ions and is the largest library on metal ions coordinated to 
NAs. This article will for the first time numerically encompass metal ion coordination in RNA and 
DNA. The nature and amount of binding sites are explored and statistical data of binding that has 
been described in many coordination chemistry reviews involving nucleic acids is provided.[6] This 
analysis will help identifying known metal coordination sites in RNA and DNA structures as well 
as help with future experimental metal binding site determination. 
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2 METALS IN MINAS 
2.1 General Overview of the database 
35 different metal ions are found in the MINAS database as of 2013-03-08. Alkali and alkaline 
earth metal ions account for the majority of the found metal ions. But also numerous transition 
metal- and lanthanide ions are found. Many of the latter are used as crystallization aides and/or for 
creation of heavy atom derivatives enabling phase information through MAD or SAD 
experiments.[7] Tables 1 and 2 show all metal ions that have at least one innersphere or outersphere 
contact with NA structures. Many of the structures within the MINAS database contain not only 
NAs but also NA-binding proteins. Some of the metal ions found are exclusively bound to these 
proteins and hence the Tables 1 and 2 do not show the full number of metals in the MINAS 
database. Zn2+, for example, is found with over 90 % only bound in proteins. Furthermore, Au3+, 
Cd2+, Fe3+, and Hg2+, are in most cases bound to amino acids of the NA-binding proteins alone. 
Nonetheless, there are over 70’000 NA-bound metals, over 20’000 of which are connected to DNA 
or RNA through at least one innersphere contact, including the ones with contacts to both proteins 
and NAs. 
Mg2+ is the most abundant metal ion found in the MINAS database. In numbers, it represents over 
84 % of all innersphere-bound and over 76 % of all outersphere-bound metals. This comes as no 
surprise since magnesium(II) is the most abundant divalent metal ion in the cytosol and thus 
commonly used in crystallization buffers. In addition, its high charge and small ionic radius make 
Mg2+ the most suitable counter ion for stabilizing compact folds of RNA. Magnesium(II) is, 
however, not charge-neutralizes and stabilizes NAs but it can also play a role in the enzymatic 
chemistry of ribozymes.[2b, 8] Even if Mg2+ is bound specifically with a sufficient lifetime, high 
enough resolution of the X-Ray diffraction is needed for its detection. That the residence lifetimes 
of Mg2+ in specific pockets can be in the second-to-minutes regime, despite a ligand exchange rate 
in the micro- to millisecond range, has recently been shown by single molecule studies.[9] However, 
the equal amount of electrons makes it hard to distinguish Mg2+ from water molecules. Hence the 
geometry of the ligands as well as the Mg2+-H2O distance are its only direct indicators in a crystal 
structure. 
The second most abundant metal ion found in MINAS is Na+ with about 8.5 % outersphere and 6 % 
innersphere coordination. Even though Na+ is not as abundant as K+ inside cells, it is widely used in 
crystallization screens despite the identical detectability problems in X-Ray structures as with the 
isoelectronic Mg2+. Nonetheless, Na+ has been shown to stabilize tertiary structures of RNAs among 
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other monovalent ions and has been found to undergo many innersphere and outersphere 
interactions.[10] 
Aside from Mg2+ and Na+ we find among the innersphere-bound metal ions Mn2+, Ca2+, Sr2+, Pt2+ 
and K+ in decreasing number of occurrence. When considering only outersphere bound metals, the 
hierarchy after Mg2+ and Na+ changes to Sr2+, Os3+, Ca2+, K+, Mn2+, and Co2+/3+ in decreasing order. 
Next to Mg2+, K+ is considered a natural cofactor of nucleic acids as it is the most abundant metal 
ion in the cytosol and relevant for the formation of secondary structures in RNA. Nevertheless, K+ 
is not as commonly present in the X-ray structures as other metal ions, despite its ability to provide 
anomalous signals for phasing. 
Sr2+ replaces the lighter alkaline earth ions being the third abundant metal found undergoing 
outersphere contacts. Its frequent usage is mainly due to its ability to exhibit a good anomalous 
signal in high energy SAD experiments.[11] 
Ca2+, although an essential metal ion in the human body, e.g. acting as a neurotransmitter, is only 
found in sub-micromolar concentrations in intracellular fluids. In fact, Ca2+ has been found to 
inhibit some ribozymes.[12] Nevertheless, Ca2+ is still used in various crystallization screens.  
Mn2+ has distinctly differing coordination properties versus N and O ligands compared to Mg2+.[6c, 
13] Nonetheless Mn2+ is frequently used for studying Mg2+ binding sites, e.g. in rescue experiments 
because of its similar ionic radius and H2O coordination distance. Also, replacing Mg2+ with Mn2+ 
can lead to comparable or even accelerated activity of ribozymes.[13-14] 
Pt2+ is found in many structures, not only because this metal ion also shows an anomalous signal but 
it is also used in many structural studies due to its numerous complexes applied as 
chemotherapeutic agent in the clinics. [15] 
Co3+ and Os3+ are only found in outersphere coordination with DNA and RNA because they are 
applied as [Co(NH3)6]3+ and [Os(NH3)6]3+. Both are used as phasing agents, but [Co(NH3)6]3+ is in 
addition often used in, e.g., heteronuclear multidimensional NMR to mimic [Mg(H2O)6]2+.[6c, 16] 
Despite kinetically inert ammine ligands, innersphere binding of Co3+ has been observed, maybe 
due to inherent impurities.[17] The remaining innersphere-coordinated cobalt ions found in MINAS 
are as Co2+ from CoCl2 for crystallographic purposes. 
Many more metal ions, as listed in Tables 1 and 2 are found in the MINAS database; however, they 
will not be discussed here in detail. 
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Table 1. Metal ions stored in the MINAS database as of 2013-03-08 with at least one innersphere 
contact to a coordinating atom of a nucleic acid molecule (N or O). The metals are sorted by 
frequency of occurrence. Values in parentheses represent the numbers found with an X-Ray 
resolution limit of 3, 2.5, or 2 Å. Mg2+ clearly dominates, accounting for over 84% of all 
innersphere-coordinated metals. 
 
 
 
Table 2. Metal ions stored in the MINAS database as of 2013-03-08 with at least one outersphere 
contact to a coordinating atom of a nucleic acid molecule. The metals are sorted by frequency of 
occurrence. Values in parentheses represent the numbers found with an X-Ray resolution limit of 3, 
2.5, or 2 Å. Mg2+ also dominates in outersphere-coordinated metals with over 76% occurrence. 
 
Mn+ # (≤3Å, ≤2.5Å, ≤2Å) Mn+ # (≤3Å, ≤2.5Å, ≤2Å) Mn+ # (≤3Å, ≤2.5Å, ≤2Å) 
Mg 17489 (7637 , 1448 , 
245) 
V 26 (24 , 24 , 4) Os 2 (1 , - , -) 
Na 1265 (1101 , 434 , 136) Cd 24 (12 , 8 , 1) Eu 1 (1 , 1 , -) 
Mn 457 (420 , 254 , 80) Ba 21 (15 , 3 , 3) Fe 1 (1 , 1 , 1) 
Ca 427 (389 , 322 , 196) Cu 13 (13 , 13 , 12) Li 1 (1 , 1 , 1) 
Sr 333 (333 , 249 , 9) Pb 12 (3 , - , -) Lu 1 (1 , - , -) 
Pt 135 (127 , 39 , 29) Hg 5 (5 , - , -) Rb 1 (1 , 1 , -) 
K 104 (89 , 72 , 49) Ir 4 (3 , - , -) U 1 (1 , - , -) 
Co 76 (63 , 48 , 22) Ag 3 (3 , 3 , 3) Ru -  
Zn 76 (73 , 48 , 21) Cr 3 (1 , - , -) Tb -  
Ni 70 (45 , 7 , 5) Rh 3 (3 , 3 , 3) W -  
Al 43 (15 , 5 , 1) Au 2 (2 , 2 , -) Yb -  
Tl 28 (28 , 20 , 7) Cs 2 (1 , - , -) total 20629 (10412, 3006, 
828) 
Mn+ # (≤3Å, ≤2.5Å, ≤2Å) Mn+ # (≤3Å, ≤2.5Å, ≤2Å) Mn+ # (≤3Å, ≤2.5Å, ≤2Å) 
Mg 53426 (22588, 2917, 
706) 
Ir 108 (100, 39, 7) Rb 15 (15, 15, 10) 
Na 5981 (5143, 1625, 360) Ni 100 (69, 11, 7) Ru 15 (15, 12, 10) 
Sr 3420 (3200, 1117, 60) Cd 57 (35, 14, 1) Cr 7 (4, -, -) 
Os 2009 (1322, -, -) Al 45 (17, 7, 1) Hg 7 (6, -, -) 
Ca 1185 (1076, 808, 415) Cs 35 (22, 6, 6) Eu 5 (3, 3, 2) 
K 1161 (857, 513, 247) W 31 (-, -, -) Tb 5 (5, -, -) 
Mn 914 (820, 457, 137) Pb 29 (6, -, -) Ag 3 (3, 3, 3) 
Co 731 (694, 580, 372) V 28 (26, 26, 5) Au 2 (2, 2, -) 
Zn 266 (178, 97, 46) Fe 23 (23, 23, 10) Li 1 (1, 1, 1) 
Pt 192 (181, 44, 34) Rh 22 (22, 22, 22) Lu 1 (1, -, -) 
Ba 181 (139, 49, 40) U 20 (10, -, -) Yb 1 (1, 1, 1) 
Tl 109 (109, 84, 46) Cu 17 (17, 17, 13) total 70152 (36710, 8943, 
2544) 
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2.2 Innersphere Binding 
Metal ions are considered innersphere-bound, when they have at least one direct connection to a 
ligand atom of NAs. These potential ligands comprise the ring nitrogens, exocyclic keto- and amine 
groups of the nucleobases as well as phosphate oxygens and the 2’-hydroxyl group of RNA 
riboses.[6a] Tables 3 to 6 as well as Figures 1 to 4 show all innersphere bound metals to these ligands 
in DNA and RNA. The highest occurrence of innersphere coordinations is found for non-bridging 
phosphate oxygens. This is expected, as a charged ligand is generally preferred as a coordination 
site for metal ions. There are differences in the two non-bridging phosphate oxygens: In 
pyrimidines, OP1 (pro-Sp) is more occupied than OP2 (pro-Rp); in purines it is exactly the 
opposite. One exception is Ca2+, which has a preference for OP1 over OP2 in all four nucleobases. 
In the following, we will shortly discuss coordination to the individual nucleotides. 
2.2.1 Guanosine 
The most prominent binding site of all the nucleobases - apart from phosphate oxygens - is the 
Hoogsteen face of guanine (see Figure 1 and Table 3). Guanine has the second largest dipole 
moment of all nucleobases.[18] The orientation of its vector points between N7 and O6, favoring this 
site in the major groove for metal ion coordination over all other nucleobases in a double helix. This 
is nicely reflected by the numbers found in the MINAS database, N7 being the most prominent 
innersphere coordination site. The preference of alkali and alkaline earth metal ions for oxygen as 
an innersphere ligand is reflected by O6-coordination as is the nitrogen preference of the transition 
metals: Ni2+, Cd2+, Co2+, Mn2+, and Zn2+ show up to 90 % innersphere coordination towards G-N7. 
Pt2+ is found in over 90 % covalently linked to G-N7.[19] Percentages of alkali and alkaline earth 
metals coordinating to O6 are not as high as the ones of transition metals coordinating to N7, yet 
they outnumber all other non-charged binding sites. Examples of metal ions with innersphere 
coordination to guanine as well the network of other ligands including outersphere contacts are 
shown in Figure 5. Figure 5 A-D shows G-N7-bound transition metals (Cd2+, Co2+, Mn2+, and 
Zn2+). Figure 5 E-H shows G-O6-bound alkali and alkaline earth metals (K+, Mg2+, Na+, and Sr2+). 
The figure was prepared with the miniPDB files available on the MINAS homepage. MiniPDB files 
are created for each metal ion and display a clipping of the original PDB file containing the binding 
site.[5] The guanine Hoogsteen face will be further explored when discussing outersphere and 
multiple binding in the following sections. 
In guanosine 5 % of all Ca2+ atoms are innersphere bound to the 2’-OH group of the ribose. This is 
in agreement with studies on multidentate ligands containing a hydroxyl group as a secondary 
binding site. Specifically for Ca2+ a significant enhancement of the complex stabilities was 
observed.[20] 
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NH
NN
N
O
O
OH/HO
OPO
O
O NH 2
Lu:    1 (100.0)
Cs:    1 (50.00)
Ir:    1 (25.00)
Ca:   80 (18.74)
Sr:   62 (18.62)
Mg: 2218 (12.68)
Na:  119 ( 9.41)
Zn:    7 ( 9.21)
Ba:    1 ( 4.76)
Mn:   21 ( 4.60)
 K:    3 ( 2.88)
Co:    2 ( 2.63)
Pt: 126 (93.33)
Ni:  62 (88.57)
Co:  59 (77.63)
Cd:  17 (70.83)
Cu:   9 (69.23)
Mn: 217 (47.48)
Zn:  27 (35.53)
Tl:   6 (21.43)
Pb:   2 (16.67)
Ba:   2 ( 9.52)
 K:   6 ( 5.77)
Sr:  17 ( 5.11)
Na:  48 ( 3.79)
Mg: 458 ( 2.62)
Ca:   3 ( 0.70)
 K:   55 (52.88)
Tl:   10 (35.71)
Pb:    4 (33.33)
Ir:    1 (25.00)
Na:  313 (24.74)
Ba:    4 (19.05)
Sr:   44 (13.21)
Mg: 1487 ( 8.50)
Mn:   33 ( 7.22)
Co:    5 ( 6.58)
Pt:    6 ( 4.44)
Ni:    3 ( 4.29)
Ca:   17 ( 3.98) Au:  2 (100.0)
Ir:  1 (25.00)
 K: 13 (12.50)
Ba:  2 ( 9.52)
Tl:  1 ( 3.57)
Ca:  3 ( 0.70)
Na:  2 ( 0.16)
Mg: 22 ( 0.13)
Au:  2 (100.0)
Tl:  3 (10.71)
Ba:  1 ( 4.76)
Co:  1 ( 1.32)
Zn:  1 ( 1.32)
Mg: 27 ( 0.15)Tl:  2 (7.14)
Ba:  1 (4.76)
Co:  1 (1.32)
Zn:  1 (1.32)
Ca:  5 (1.17)
Sr:  1 (0.30)
Mn:  1 (0.22)
Na:  2 (0.16)
Mg: 19 (0.11)
Os:    1 (50.00)
Sr:   71 (21.32)
Mg: 3051 (17.45)
Ca:   52 (12.18)
Na:  129 (10.20)
Ba:    1 ( 4.76)
Zn:    3 ( 3.95)
Mn:   18 ( 3.94)
 K:    4 ( 3.85)
OP2
OP1
N7
Ca:  22 (5.15)
 K:   1 (0.96)
Mg: 150 (0.86)
Mn:   2 (0.44)
Na:   3 (0.24)
O2'
O6
N1
N2
N3
innersphere
 
Figure 1 Innersphere coordination to guanosine-5’-phosphate (see also Table 3). 
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2.2.2 Adenosine 
The predominant innersphere coordination sites of adenosine are the phosphate oxygens (see 
Figure 2 and Table 4). 22 % of all Mg2+ are bound to the OP2 phosphate oxygen. Interestingly, Ca2+ 
and Sr2+ prefer OP1 as their primary binding site. In comparison to guanosine, phosphate 
coordination is roughly 18 % more common. Both adenosine and guanosine have the N7 as major 
binding site. However, N7 innersphere coordination occurs ca. three times more often in guanosine. 
This is due to the neighboring adenosine-N6 being a hydrogen bond donor, which clearly 
complicates innersphere coordination to the close-by N7.  
N
NN
N
O
OH/HO
OPO
O
O
NH2
Ca:   80 (18.74)
Mg: 2919 (16.69)
Sr:   45 (13.51)
Mn:   25 ( 5.47)
Ba:    1 ( 4.76)
Na:   59 ( 4.66)
Cd:    1 ( 4.17)
Co:    2 ( 2.63)
 K:    2 ( 1.92)
Zn:    1 ( 1.32)
Cd:   5 (20.83)
Cu:   1 ( 7.69)
Pt:   7 ( 5.19)
Mn:  16 ( 3.50)
Ni:   2 ( 2.86)
Mg: 285 ( 1.63)
Zn:   1 ( 1.32)
Na:   2 ( 0.16)
Ir:  1 (25.00)
Ba:  1 ( 4.76)
Tl:  1 ( 3.57)
Zn:  1 ( 1.32)
Pt:  1 ( 0.74)
Ca:  3 ( 0.70)
Mn:  1 ( 0.22)
Mg: 21 ( 0.12)
Na:  1 ( 0.08)
Ir:  1 (25.00)
Ba:  1 ( 4.76)
Ca:  1 ( 0.23)
Mg: 24 ( 0.14)
Ir:  2 (50.00)
Ba:  2 ( 9.52)
Zn:  2 ( 2.63)
Pt:  1 ( 0.74)
Na:  7 ( 0.55)
Ca:  1 ( 0.23)
Mn:  1 ( 0.22)
Mg: 33 ( 0.19)
 U:    1 (100.0)
Mg: 3826 (21.88)
Sr:   33 ( 9.91)
Mn:   44 ( 9.63)
Cd:    2 ( 8.33)
 K:    7 ( 6.73)
Ca:   25 ( 5.85)
Co:    4 ( 5.26)
Ba:    1 ( 4.76)
Zn:    3 ( 3.95)
Tl:    1 ( 3.57)
Ni:    1 ( 1.43)
Na:   16 ( 1.26)
OP2
OP1
N7
N6
N1
N3
Cs:   1 (50.00)
 V:   3 (11.54)
Cd:   2 ( 8.33)
 K:   3 ( 2.88)
Na:  29 ( 2.29)
Mg: 159 ( 0.91)
O2'
innersphere
 
Figure 2. Innersphere coordination to adenosine-5’-phosphate (see also Table 4). 
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2.2.3 Cytidine 
Cytosine has the largest dipole moment of all four nucleobases.[18] The dipole moment’s orientation, 
however, points between O2 and N3, which is the Watson-Crick face of the base and hence almost 
inaccessible for coordination in canonical base pairs. This is reflected in the low number of 
innersphere coordinating metal ions to cytosine (see Figure 3 and Table 5). Significant coordination 
occurs only at phosphate oxygens. For example, almost 23 % of all Ca2+ atoms are bound to OP1 of 
cytosine which is the highest number in comparison to all other alkali or earth alkaline metal ions. 
NH2
O
OH/HO
OPO
O
O
N
N O
Eu:    1 (100.0)
Rh:    2 (66.67)
Ca:   98 (22.95)
Zn:   12 (15.79)
Mg: 2137 (12.22)
Tl:    3 (10.71)
Sr:   35 (10.51)
Mn:   32 ( 7.00)
Ba:    1 ( 4.76)
Na:   52 ( 4.11)
Tl:  1 ( 3.57)
Sr:  3 ( 0.90)
Pt:  1 ( 0.74)
Ca:  2 ( 0.47)
Mn:  2 ( 0.44)
Na:  5 ( 0.40)
Mg: 35 ( 0.20)
Au:  2 (100.0)
Hg:  1 (20.00)
Ba:  1 ( 4.76)
Na: 32 ( 2.53)
Co:  1 ( 1.32)
Zn:  1 ( 1.32)
Ca:  1 ( 0.23)
Mn:  1 ( 0.22)
Mg: 14 ( 0.08)
Hg:   1 (20.00)
Pb:   2 (16.67)
Na:  94 ( 7.43)
Tl:   2 ( 7.14)
Sr:  18 ( 5.41)
Ba:   1 ( 4.76)
Co:   1 ( 1.32)
 K:   1 ( 0.96)
Mg: 117 ( 0.67)
Ca:   2 ( 0.47)
Mn:   2 ( 0.44)
Mg: 1861 (10.64)
Sr:   32 ( 9.61)
Ca:   37 ( 8.67)
Tl:    2 ( 7.14)
Zn:    4 ( 5.26)
Na:   54 ( 4.27)
 K:    3 ( 2.88)
Mn:   11 ( 2.41)
OP2
OP1
N4
N3
O2
Pb:  1 (8.33)
Tl:  1 (3.57)
Na: 18 (1.42)
Ca:  3 (0.70)
Mg: 73 (0.42)
Mn:  1 (0.22)
O2'
innersphere
 
Figure 3 Innersphere coordination to cytidine-5’-phosphate. (see also Table 5). 
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2.2.4 Uridine (Thymidine) 
Similar to cytosine, uracil and also thymidine have only few innersphere coordinating ligands 
(Figure 4 and Table 6). U-O4, however, catches the eye: when canonically base paired, the oxygen 
is not very well accessible, in the frequent GU wobble pair, however, it is exposed into the major 
groove like O6 of guanine. Alkali and earth alkaline metals are therefore frequently found in 
innersphere contact to U-O4. Nonetheless, GU wobble pairs harbor metal ions mostly via 
outersphere connections. For crystallography the GU wobble pair is introduced into RNA sequences 
to provide a metal ion binding site for phasing purposes.[21] 
O
OH/HO
OPO
O
O
NH
N
O
O
CH /H3
Cr:    2 (66.67)
Ca:   50 (11.71)
Mg: 1777 (10.16)
Ba:    2 ( 9.52)
Zn:    5 ( 6.58)
Sr:   20 ( 6.01)
 K:    6 ( 5.77)
Na:   51 ( 4.03)
Tl:    1 ( 3.57)
Ni:    2 ( 2.86)
Mn:   13 ( 2.84)
Co:    2 ( 2.63)
 K:  22 (21.15)
Pb:   2 (16.67)
Na: 193 (15.26)
Ba:   3 (14.29)
Sr:  17 ( 5.11)
Mg: 827 ( 4.73)
Co:   3 ( 3.95)
Tl:   1 ( 3.57)
Mn:   5 ( 1.09)
Pt:   1 ( 0.74)
Ca:   3 ( 0.70) Hg:  3 (60.00)
 K:  6 ( 5.77)
Zn:  2 ( 2.63)
Co:  1 ( 1.32)
Sr:  1 ( 0.30)
Ca:  1 ( 0.23)
Mn:  1 ( 0.22)
Mg: 10 ( 0.06)
Rb:  1 (100.0)
Cs:  1 (50.00)
Na: 78 ( 6.17)
Tl:  1 ( 3.57)
 K:  3 ( 2.88)
Zn:  1 ( 1.32)
Co:  1 ( 1.32)
Ca:  3 ( 0.70)
Mg: 58 ( 0.33)
Sr:  1 ( 0.30)
Mn:  1 ( 0.22)
Os:    1 (50.00)
Sr:   41 (12.31)
Ba:    2 ( 9.52)
Ca:   36 ( 8.43)
Mg: 1445 ( 8.26)
Cd:    1 ( 4.17)
Zn:    3 ( 3.95)
Mn:   12 ( 2.63)
 K:    2 ( 1.92)
Ni:    1 ( 1.43)
Na:   18 ( 1.42)
Co:    1 ( 1.32)
OP2
OP1
O4
N3
O2
Tl:  1 (3.57)
Na: 41 (3.24)
Co:  1 (1.32)
 K:  1 (0.96)
Mg: 84 (0.48)
Mn:  2 (0.44)
Ca:  1 (0.23)
O2'
innersphere
 
Figure 4 Innersphere coordination to thymidine- and uridine-5’-phosphate (see also Table 6). 
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Figure 5. Innersphere coordination to guanine N7 (A-D) and O6 (E-H). Outersphere coordinations 
are shown as colored spheres of the surrounding residues and water molecules. In the here shown 
examples, innersphere N7 connections are always combined with an outersphere connection to the 
O6 of the same nucleobase. All images were prepared from miniPDB files of the corresponding 
PDBs provided by the MINAS web interface. 
A.  Cd2+ (yellow) in innersphere coordination to N7 of G1087 (blue) of rRNA (PDB ID: 1MMS). 
The Cd2+ ion is also in innersphere distance to the 2’-OH of the adjacent A1068. B.  Co2+ (blue) 
innersphere coordination to N7 of DG7 (blue) of a hexameric DNA duplex (PDB ID: 1P24). The 
outersphere-bound phosphate oxygens on the left are part of a lattice interaction and belong to the 
neighboring asymmetric unit. C.  Mn2+ (purple) innersphere coordination to N7 of G126 (blue) of a 
Mg2+-dependent  riboswitch (PDB ID: 3PDR). The two outersphere phosphate oxygens in the front 
are linked to the Mn2+ ion via its second innersphere coordination, the 2’-OH group of A46. D.  
Zn2+ (grey) innersphere coordination to N7 of DG18 (blue) of a DNA duplex sequence used in a 
transcription factor study (PDB ID: 1BC8). E. A “chain of pearls” of K+ ions (pink) in a DNA 
quadruplex, all coordinated O6 atoms of the involved guanines (blue) are shown as red spheres 
(PDB ID: 1JRN). F. Mg2+ coordination to O6 of G188 (blue) in a group I intron. This interaction is 
the most frequent innersphere coordination of Mg2+ to a non-charged ligand (PDB ID: 1HR2). Note 
the six outersphere contacts to nearby phosphate oxygens (two are only partially visible). G. Na+ 
coordination to O6 of DG10 (blue) in a Dickerson-Drew DNA dodoecamer (PDB ID: 2DYW). 
Note that this is one of the rare examples of Na+ ions in MINAS with a complete inner coordination 
shell. H.  Sr2+ coordinated to O6 of G2632 in the large ribosomal subunit (PDB ID: 1VQ8). The 
hydration shell is only partially filled as is the case for most Sr2+ mapped in MINAS. 
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able 4. Innersphere coordination to adenosine-5’-phosphate. N
itrogen and oxygen ligand atom
s are listed. Phosphate oxygens are the m
ost occupied 
ligands for earth alkaline m
etals that prefer oxygen over nitrogen. N
7 is far less occupied than in guanine (see Table 3). 
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itrogen and oxygen ligand atom
s are listed. Phosphate oxygens are the m
ost occupied 
ligands for earth alkaline m
etals that prefer oxygen over nitrogen. N
7 is far less occupied than in guanine (see Table 3). 
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able 6. Innersphere coordination to thym
idine-5’-phosphate and uridine-5’-phosphate. N
itrogen and oxygen ligand atom
s are listed. Significant 
coordination num
bers to non-charged ligands are only present at U
-O
4, m
any of them
 found in G
U
 w
obble pairs. 
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2.3 Multiple Ligands 
The MINAS database search tool allows specifying multiple ligands at the same time. This expands 
the picture drawn in the previous chapter which focuses only on a single coordination per metal ion. 
The majority of ligands found in MINAS are water molecules, although there are many cases where 
single H2O were not refined or the hydration shell is completely missing. Nevertheless, a significant 
number of metal ions have more than one non-water ligand in their coordination sphere. Defining 
the complete coordination sphere around each metal would generate a too great variety of 
combinations which is hard to categorize or even to display in a manageable set of tables. 
Therefore, a few examples of the most prominent ligands and coordination sites were chosen and 
combinations thereof generated. We have focused on multiple phosphate coordinations being 
important to bring the backbones of folded NAs close together. Second we characterized the above 
described innersphere coordinations for each nucleobase in combination with additional phosphate 
oxygens. Finally, combinations of O6 and N7 of the Hoogsteen face of guanine, tandem-Gs as well 
as GU wobble pairs were analyzed. 
2.3.1 Multiple phosphate coordination 
Many crystal structures of folded NAs show metal ions coordinated to multiple phosphates that are 
close in space. This can be either intramolecularly or due to crystal packing.  These specifically 
bound metals enable the proximity of negative charges and hence the three-dimensional structure 
and function of folded RNAs. In MINAS, simultaneous innersphere coordination to up to four 
phosphate oxygens is found (see Supplementary Table S5).  Mg2+ as well as Ca2+ are the metal ions 
of choice for such dense packing, allowing four phosphates to come close together. Coordination to 
three phosphate oxygens is more frequent. Here, Ca2+ and Mg2+ dominate again but also Sr2+ ions 
show such a ligand arrangement. Two simultaneous phosphate coordinations are present in every 
fourth Sr2+ or Mg2+ ion respectively, in the whole MINAS database, and in over one third of all 
Ca2+ ions. Finally, over 80 % of all metal ions in MINAS have at least one innersphere phosphate 
oxygen ligand. Ca2+ and Mg2+ show the highest number of this innersphere coordination. 
2.3.2 Innersphere coordination to an additional phosphate oxygen 
Tables 3 to 6 show innersphere coordination to a single ligand of all nucleobases. Since in many 
cases the metal ions are chelated by the NAs, we evaluated the concurrent coordination to 
nucleotide ligands and phosphate oxygens in an innersphere manner. Tables S6 to S9 show the 
numbers of such a combined coordination.  
Adenosine (Table S6) shows significant numbers of OPx (OP1 or OP2) and concurrent ribose O2’ 
coordinations by Mg2+ (inter- and intranucleotide occurrences). Here, over 22 % of all 
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coordinations are accompanied by a second innersphere coordination to a phosphate oxygen. Mg2+ 
ions that are coordinated to A-N7 are in over 42 % of the cases chelated with phosphate. Cytidine 
(Table S7) shows the same chelation with OPx of Mg2+ for O2’ (11 %), O2 (6 %) and N4 (17 %). 
For guanosine (Table S8), we find again the O2’ coordination combined with OPx this time at an 
occurrence of 36% for Mg2+ and Ca2+ each. Also, a G-O6 coordinated Mg2+ is to 41 % additionally 
innersphere phosphate-bound. The same holds for some N7 coordinations:  Na+ is in addition to 48 
% coordinated to a phosphate and Zn2+ to 22 %. In Uracil (together with thymidine in Table S9) we 
find that 44 % of all O2’ bound and > 53 % of all O4 bound Mg2+ are chelated with a phosphate 
oxygen. 
Subsequently, we summarized (Tables S10-S13) those metal ions that show an innersphere 
coordination to a nucleotide and an outersphere coordination to a phosphate. It turns out that almost 
all metals show an additional outersphere coordination to a phosphate. The large search volume 
around a metal ion encompassing all outersphere ligands leads to an enormous number of hits and 
hence the numbers for outersphere coordinations must be selectively chosen for analysis. For 
example, metal ions with an innersphere coordination to a phosphate and to a guanine ligand in an 
outersphere fashion (Table S14). 10 - 20 % of all Mg2+ ions to be considered having only an 
outersphere binding to guanine (Table S3) show an additional innersphere contact to a phosphate 
oxygen. An exception is the O2’ where about one third of all innersphere phosphate-bound Mg2+ 
are also coordinated to the sugar outersphere. The shorter distance of sugars to phosphates in the 
backbone allows for such high numbers. To cope with the complexity introduced in the evaluation 
of multiple innersphere and outersphere coordinations we enabled the function of specifically 
excluding ligands when searching the MINAS database. This helps identifying binding sites that are 
not influenced by ligands with a much higher affinity to the metal than the ligands in being searched 
for. 
 
2.3.3 Multiple coordinations involving guanine’s Hoogsteen face 
In the following section we focus on (i) the Hoogsteen site of guanine, (ii) consecutive guanine 
residues, and (iii) on GU wobble pairs. Figures S5 to S8 show simultaneous coordination to N7 and 
O6 of a single guanine base, both innersphere, outersphere, or the combination thereof. Innersphere 
contact to both N7 and O6 is extremely rare (Figure S5) although calculations show that the most 
stable arrangement for Mg2+ to a guanine is a tetrahydrated metal ion connected to O6 and N7 in an 
innersphere fashion.[22] Metal ions with innersphere coordination to N7 almost entirely show 
outersphere contacts to O6 (Figure S6). Vice versa, the same is true for an innersphere coordination 
to O6 together with an outersphere contact to N7 (Figure S7). Two simultaneous outersphere 
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connections to N7 and O6 are found for 80 – 90 % of all metals coordinated to either of the two in 
an outersphere way (Figure S8). 
Multiple coordinations to two consecutive guanosines (Table S 15 of the supplementary 
information) reveal a high chance of metal ion coordination inside such an arrangement. For 
example more than one third of all innersphere G-O6-bound Mg2+ are additionally bound 
outersphere to the neighboring guanine’s O6 (or the N7). Innersphere-bound Mn2+ to G-N7 on the 
other hand, is in over 50 % of the occurrences also coordinated innersphere or outersphere to a 
neighboring N7 (or O6). If we look at the ligands of two consecutive guanines (Table S 16) there is 
a higher probability to find a metal ion than if only one guanine is present. 
In contrast to a GC base pair, the GU wobble pair has three hydrogen-bond acceptors pointing into 
the major groove. This surface with a continuous electronegative potential creates a lunate binding 
pocket ideal for metal ions or other positively charged residues.[23] In X-Ray crystallography, GU 
wobble pairs are sometimes deliberately introduced into RNA sequences to lock heavy metal ions 
for phasing purposes. Although we don’t have direct access to motifs and base pairing arrangements 
in MINAS, we analyzed simultaneous binding of metal ions to the oxygen ligands of guanine and 
uracil. The numbers (Table S17) can therefore also contain combinations of coordinations to 
guanine and uracil that are not necessarily forming a GU wobble pair but the G and the U can also 
be offset or staggered. More than two thirds of all innersphere-bound Mg2+ to UO4 are connected to 
an outersphere GO6 and over 95 % of all GO6 innersphere bound Mg2+ are in outersphere 
connection to UO4. Even if these sites are not all GU wobble base pairs the probability of 
coordination to either of the bases rises when the other base is in proximity. Outersphere-only 
combinations have to be considered again with care but for alkali and alkaline earth metals the 
coordination numbers are between 20 % and 30 % to both, guanine O6 and uracil O4. 
2.3.4 Cisplatin 
In the MINAS database, a total of 214 platinum ions (without considering any coordination) are 
found. 157 are Pt2+ ions used for phasing purposes, 22 reside in various platinum-containing 
complexes, and 35 are part of the chemotherapeutic cisplatin.[24] Cisplatin is uniquely found in 
crosslinking two guanines in DNA with a direct connection to N7. This plays a role in part of the 
drug’s mechanism of action.[25]. Three out of the 35 crosslinks occur in an interstrand fashion as 
opposed to the remaining 32 which interconnect two consecutive guanines on the same strand. 
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3 Conclusions 
Nucleic acid contain large numbers of metal ions and new structures are deposited in the PDB 
nearly every day. An analysis of the binding environment of each metal with the help of the MINAS 
database is therefore possible with a high statistical relevance. If innersphere binding is considered, 
a manageable amount of possible ligands as well as a compact coordination volume can be 
searched.  
Nonbridging phosphate oxygens of the phospodiester backbone are the first choice as an 
innersphere binding site. The second most frequent ligands are buried in the Hoogsteen face of 
guanine. Here, the oxygen or nitrogen preferences of alkali and alkaline earth metals vs. transition 
metal ions are well represented. If looking at outersphere coordinations alone, the search distance is 
a caveat that must be considered and ligands must be chosen with care. The volume from 2.5-5-7Å 
comprising all outersphere ligands around a metal ion is almost 12 times as large as the innersphere 
(775.7 vs. 65.4 Å3) volume. The picture drawn from merely outersphere interactions with so many 
different coordination possibilities is therefore much harder to distinctively grasp from the overall 
collection of MINAS’ numbers when compared to only innersphere, multi-innersphere or 
innersphere-outersphere combinations. When querying the MINAS database for specific 
outersphere ligands, one can consider excluding specific ligands in order to refine the amount of 
metal ion hits. Over all, outersphere is preferred over innersphere in the structures searched. This 
fact represents the higher numbers of possible outersphere vs. innersphere coordination as well as 
the energy cost of dehydrating a metal ion. Nonetheless, this energy barrier is overcome when close 
phosphate packing of the structures requires metals to compensate for negative charges close in 
space. Up to four simultaneous innersphere coordinations of the most dominant metal ion in all 
structures, Mg2+, is found. Since the possible permutations of ligands are huge we limited the 
database analysis here to some examples involving combinations of  phosphate oxygens with 
innersphere ligands and guanine Hoogsteen-site coordinations as well as an approach to discover 
GU wobble binding sites. 
It is now up to the user of MINAS to take advantage of this database and explore its search 
functionalities to (i) investigate the coordination spheres of different metal ions (ii) search for new 
binding motifs, (iii) to design specific metal ion complexes or binding sites and (iv) to come up with 
new ideas and direction in the wide field of nucleic acids research, including also medicinal 
chemistry. 
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 T
able S 5. Sim
ultaneous innersphere coordinations w
ith m
ultiple non-bridging phosphate oxygens.  U
p to four coordinations to phosphate oxygens per 
m
etal can be found in M
IN
A
S. 
 
 
 
1 O
P
a 
 
2 O
Ps 
 
3 O
Ps 
 
4 O
Ps 
M
n+ 
# m
etals 
# 
%
 
# 
%
 
# 
%
 
# 
%
 
A
g 
3 
  
  
  
  
  
  
  
  
A
l 
43 
  
  
  
  
  
  
  
  
A
u 
2 
  
  
  
  
  
  
  
  
B
a 
21 
7 
33.33 
1 
4.76 
1 
4.76 
  
  
C
a 
427 
356 
83.37 
145 
33.96 
27 
6.32 
8 
1.87 
C
d 
24 
4 
16.67 
  
  
  
  
  
  
C
o 
76 
11 
14.47 
2 
2.63 
  
  
  
  
C
r 
3 
2 
66.67 
  
  
  
  
  
  
C
s 
2 
1 
50 
  
  
  
  
  
  
C
u 
13 
  
  
  
  
  
  
  
  
Eu 
1 
1 
100 
  
  
  
  
  
  
Fe 
1 
  
  
  
  
  
  
  
  
H
g 
5 
  
  
  
  
  
  
  
  
Ir 
4 
1 
25 
  
  
  
  
  
  
K
 
104 
26 
25 
1 
0.96 
  
  
  
  
Li 
1 
  
  
  
  
  
  
  
  
Lu 
1 
1 
100 
  
  
  
  
  
  
M
g 
17489 
14635 
83.68 
4757 
27.2 
1132 
6.47 
74 
0.42 
M
n 
457 
145 
31.73 
51 
11.16 
11 
2.41 
1 
0.22 
N
a 
1265 
489 
38.66 
23 
1.82 
  
  
  
  
N
i 
70 
4 
5.71 
  
  
  
  
  
  
O
s 
2 
2 
100 
  
  
  
  
  
  
Pb 
12 
  
  
  
  
  
  
  
  
Pt 
135 
  
  
  
  
  
  
  
  
R
b 
1 
  
  
  
  
  
  
  
  
R
h 
3 
2 
66.67 
  
  
  
  
  
  
R
u 
0 
  
  
  
  
  
  
  
  
Sr 
333 
244 
73.27 
79 
23.72 
20 
6.01 
  
  
Tb 
0 
  
  
  
  
  
  
  
  
Tl 
28 
5 
17.86 
2 
7.14 
  
  
  
  
U
 
1 
1 
100 
  
  
  
  
  
  
V
 
26 
  
  
  
  
  
  
  
  
W
 
0 
828 
  
54 
  
  
  
  
  
Y
b 
0 
  
  
  
  
  
  
  
  
Zn 
76 
44 
57.89 
3 
3.95 
1 
1.32 
1 
1.32 
T
otal b 
20629 
16809 
81.48 
5118 
24.81 
1192 
5.78 
84 
0.41 
a O
P = phosphate oxygen. 
b The percentage of the total am
ount of phosphate ligands is relative to the total am
ount of innersphere bound m
etals in the first colum
n. 
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B
a 
21
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
C
a 
42
7 
1 
0.
23
 
1 
0.
23
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0.
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66
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63
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44
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41
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U
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b 
0 
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76
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
T
ot
al
c  
20
62
9 
2 
0.
01
 
1 
0 
7 
0.
03
 
12
4 
0.
6 
18
32
 
8.
88
 
15
56
 
7.
54
 
38
 
0.
18
 
a  T
he
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N
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id
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y.
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able S 5. Sim
ultaneous innersphere coordinations w
ith m
ultiple non-bridging phosphate oxygens.  U
p to four coordinations to phosphate oxygens per 
m
etal can be found in M
IN
A
S. 
 
 
 
1 O
P
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2 O
Ps 
 
3 O
Ps 
 
4 O
Ps 
M
n+ 
# m
etals 
# 
%
 
# 
%
 
# 
%
 
# 
%
 
A
g 
3 
  
  
  
  
  
  
  
  
A
l 
43 
  
  
  
  
  
  
  
  
A
u 
2 
  
  
  
  
  
  
  
  
B
a 
21 
7 
33.33 
1 
4.76 
1 
4.76 
  
  
C
a 
427 
356 
83.37 
145 
33.96 
27 
6.32 
8 
1.87 
C
d 
24 
4 
16.67 
  
  
  
  
  
  
C
o 
76 
11 
14.47 
2 
2.63 
  
  
  
  
C
r 
3 
2 
66.67 
  
  
  
  
  
  
C
s 
2 
1 
50 
  
  
  
  
  
  
C
u 
13 
  
  
  
  
  
  
  
  
Eu 
1 
1 
100 
  
  
  
  
  
  
Fe 
1 
  
  
  
  
  
  
  
  
H
g 
5 
  
  
  
  
  
  
  
  
Ir 
4 
1 
25 
  
  
  
  
  
  
K
 
104 
26 
25 
1 
0.96 
  
  
  
  
Li 
1 
  
  
  
  
  
  
  
  
Lu 
1 
1 
100 
  
  
  
  
  
  
M
g 
17489 
14635 
83.68 
4757 
27.2 
1132 
6.47 
74 
0.42 
M
n 
457 
145 
31.73 
51 
11.16 
11 
2.41 
1 
0.22 
N
a 
1265 
489 
38.66 
23 
1.82 
  
  
  
  
N
i 
70 
4 
5.71 
  
  
  
  
  
  
O
s 
2 
2 
100 
  
  
  
  
  
  
Pb 
12 
  
  
  
  
  
  
  
  
Pt 
135 
  
  
  
  
  
  
  
  
R
b 
1 
  
  
  
  
  
  
  
  
R
h 
3 
2 
66.67 
  
  
  
  
  
  
R
u 
0 
  
  
  
  
  
  
  
  
Sr 
333 
244 
73.27 
79 
23.72 
20 
6.01 
  
  
Tb 
0 
  
  
  
  
  
  
  
  
Tl 
28 
5 
17.86 
2 
7.14 
  
  
  
  
U
 
1 
1 
100 
  
  
  
  
  
  
V
 
26 
  
  
  
  
  
  
  
  
W
 
0 
828 
  
54 
  
  
  
  
  
Y
b 
0 
  
  
  
  
  
  
  
  
Zn 
76 
44 
57.89 
3 
3.95 
1 
1.32 
1 
1.32 
T
otal b 
20629 
16809 
81.48 
5118 
24.81 
1192 
5.78 
84 
0.41 
a O
P = phosphate oxygen. 
b The percentage of the total am
ount of phosphate ligands is relative to the total am
ount of innersphere bound m
etals in the first colum
n. 
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 T
able S 7. Sim
ultaneous innersphere coordination to a ligand of cytidine-5’-phosphate and a phosphate oxygen. 
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M
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0.03 
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0.04 
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M
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1.53 
1 
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T
otal c 
20629 
2 
0.01 
7 
0.03 
9 
0.04 
1169 
5.67 
1058 
5.13 
11 
0.05 
 a The second phosphate oxygen is on a different residue. 
b R
N
A
 nucleotides only. 
c The percentage of the total am
ount of phosphate ligands is relative to the total am
ount of innersphere bound m
etals in the first colum
n. 
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able S 7. Sim
ultaneous innersphere coordination to a ligand of cytidine-5’-phosphate and a phosphate oxygen. 
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 T
able S 9. Sim
ultaneous innersphere coordination to a ligand of thym
idine-5’-phosphate or uridine-5’-phosphate and a phosphate oxygen. 
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 T
able S 9. Sim
ultaneous innersphere coordination to a ligand of thym
idine-5’-phosphate or uridine-5’-phosphate and a phosphate oxygen. 
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 T
able S 11. Sim
ultaneous coordination to an innersphere ligand of cytidine-5’-phosphate and an outersphere phosphate oxygen. 
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able S 11. Sim
ultaneous coordination to an innersphere ligand of cytidine-5’-phosphate and an outersphere phosphate oxygen. 
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able S 13. Sim
ultaneous coordination to an innersphere ligand of thym
idine-5’-phosphate or uridine-5’-phosphate and an outersphere phosphate 
oxygen. 
 
 
 
N
3+1 O
P 
 
O
2+1 O
P 
 
O
4+1 O
P 
 
O
P1 
+1 O
P
a 
 
O
P2 
+1 O
P
a 
 
O
2' b 
M
n+ 
# m
etals 
# 
%
 
# 
%
 
# 
%
 
# 
%
 
# 
%
 
# 
%
 
A
g 
3 
  
  
  
  
  
  
  
  
  
  
  
  
A
l 
43 
  
  
  
  
  
  
  
  
  
  
  
  
A
u 
2 
  
  
  
  
  
  
  
  
  
  
  
  
B
a 
21 
  
  
  
  
1 
4.76 
1 
4.76 
2 
9.52 
  
  
C
a 
427 
  
  
3 
0.7 
  
  
40 
9.37 
33 
7.73 
1 
0.23 
C
d 
24 
  
  
  
  
  
  
  
  
1 
4.17 
  
  
C
o 
76 
1 
1.32 
1 
1.32 
2 
2.63 
  
  
1 
1.32 
1 
1.32 
C
r 
3 
  
  
  
  
  
  
  
  
  
  
  
  
C
s 
2 
  
  
  
  
  
  
  
  
  
  
  
  
C
u 
13 
  
  
  
  
  
  
  
  
  
  
  
  
Eu 
1 
  
  
  
  
  
  
  
  
  
  
  
  
Fe 
1 
  
  
  
  
  
  
  
  
  
  
  
  
H
g 
5 
3 
60 
  
  
  
  
  
  
  
  
  
  
Ir 
4 
  
  
  
  
  
  
  
  
  
  
  
  
K
 
104 
  
  
  
  
3 
2.88 
2 
1.92 
1 
0.96 
1 
0.96 
Li 
1 
  
  
  
  
  
  
  
  
  
  
  
  
Lu 
1 
  
  
  
  
  
  
  
  
  
  
  
  
M
g 
17489 
6 
0.03 
15 
0.09 
702 
4.01 
1733 
9.91 
1437 
8.22 
80 
0.46 
M
n 
457 
1 
0.22 
1 
0.22 
5 
1.09 
8 
1.75 
12 
2.63 
2 
0.44 
N
a 
1265 
  
  
71 
5.61 
132 
10.43 
5 
0.4 
17 
1.34 
41 
3.24 
N
i 
70 
  
  
  
  
  
  
  
  
1 
1.43 
  
  
O
s 
2 
  
  
  
  
  
  
  
  
1 
50 
  
  
Pb 
12 
  
  
  
  
2 
16.67 
  
  
  
  
  
  
Pt 
135 
  
  
  
  
  
  
  
  
  
  
  
  
R
b 
1 
  
  
  
  
  
  
  
  
  
  
  
  
R
h 
3 
  
  
  
  
  
  
  
  
  
  
  
  
R
u 
0 
  
  
  
  
  
  
  
  
  
  
  
  
Sr 
333 
1 
0.3 
1 
0.3 
17 
5.11 
20 
6.01 
41 
12.31 
  
  
Tb 
0 
  
  
  
  
  
  
  
  
  
  
  
  
Tl 
28 
  
  
1 
3.57 
1 
3.57 
1 
3.57 
  
  
1 
3.57 
U
 
1 
  
  
  
  
  
  
  
  
  
  
  
  
V
 
26 
  
  
  
  
  
  
  
  
  
  
  
  
W
 
0 
  
  
  
  
  
  
  
  
  
  
  
  
Y
b 
0 
  
  
  
  
  
  
  
  
  
  
  
  
Zn 
76 
1 
1.32 
  
  
  
  
1 
1.32 
1 
1.32 
  
  
T
otal c 
20629 
13 
0.06 
93 
0.45 
865 
4.19 
1811 
8.78 
1548 
7.5 
127 
0.62 
a The second phosphate oxygen is on a different residue. 
b R
N
A
 nucleotides only. 
c The percentage of the total am
ount of phosphate ligands is relative to the total am
ount of innersphere bound m
etals in the first colum
n. 
 T
ab
le
 S
 1
4.
 S
im
ul
ta
ne
ou
s c
oo
rd
in
at
io
n 
to
 a
n 
in
ne
rs
ph
er
e 
ph
os
ph
at
e 
ox
yg
en
 (a
ny
 b
as
e)
 a
nd
 a
nd
 a
n 
ou
te
rs
ph
er
e 
lig
an
d 
in
 g
ua
no
si
ne
-5
’-
ph
os
ph
at
e.
 
 
 
 
(i)
 O
P 
+ 
(o
)G
N
1 
 
 
(i)
 O
P 
+ 
(o
)G
N
2 
 
 
(i)
 O
P 
+ 
(o
)G
N
3 
 
 
(i)
 O
P 
+ 
(o
)G
N
7 
 
 
(i)
 O
P 
+ 
(o
)G
O
6 
 
 
(i)
 O
P 
+ 
(o
)O
P1
 
 
(i)
 O
P 
+ 
(o
)O
P2
 
 
(i)
 O
P+
 
(o
)G
O
2'
 a
 
M
n+
 
# 
m
et
al
s 
# 
%
 
# 
%
 
# 
%
 
# 
%
 
# 
%
 
# 
%
 
# 
%
 
# 
%
 
A
g 
3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
l 
45
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
u 
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B
a 
18
1 
2 
1.
1 
2 
1.
1 
1 
0.
55
 
4 
2.
21
 
3 
1.
66
 
3 
1.
66
 
4 
2.
21
 
 
 
C
a 
11
85
 
18
 
1.
52
 
14
 
1.
18
 
6 
0.
51
 
52
 
4.
39
 
32
 
2.
7 
10
9 
9.
2 
13
6 
11
.4
8 
22
 
1.
86
 
C
d 
57
 
2 
3.
51
 
1 
1.
75
 
1 
1.
75
 
3 
5.
26
 
3 
5.
26
 
 
 
1 
1.
75
 
1 
1.
75
 
C
o 
73
1 
4 
0.
55
 
2 
0.
27
 
4 
0.
55
 
5 
0.
68
 
4 
0.
55
 
2 
0.
27
 
6 
0.
82
 
5 
0.
68
 
C
r 
7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
s 
35
 
 
 
1 
2.
86
 
 
 
 
 
 
 
1 
2.
86
 
1 
2.
86
 
 
 
C
u 
17
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eu
 
5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fe
 
23
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H
g 
7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ir 
10
8 
 
 
 
 
 
 
 
 
 
 
1 
0.
93
 
1 
0.
93
 
 
 
K
 
11
61
 
7 
0.
6 
6 
0.
52
 
4 
0.
34
 
10
 
0.
86
 
7 
0.
6 
9 
0.
78
 
14
 
1.
21
 
9 
0.
78
 
Li
 
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lu
 
1 
 
 
 
 
 
 
 
 
 
 
 
 
1 
10
0 
 
 
M
g 
53
42
6 
17
21
 
3.
22
 
11
88
 
2.
22
 
87
8 
1.
64
 
59
95
 
11
.2
2 
43
02
 
8.
05
 
69
04
 
12
.9
2 
70
81
 
13
.2
5 
37
46
 
7.
01
 
M
n 
91
4 
17
 
1.
86
 
7 
0.
77
 
4 
0.
44
 
32
 
3.
5 
31
 
3.
39
 
39
 
4.
27
 
51
 
5.
58
 
7 
0.
77
 
N
a 
59
81
 
96
 
1.
61
 
77
 
1.
29
 
54
 
0.
9 
12
9 
2.
16
 
12
3 
2.
06
 
18
5 
3.
09
 
18
6 
3.
11
 
33
 
0.
55
 
N
i 
10
0 
1 
1 
 
 
1 
1 
1 
1 
2 
2 
 
 
2 
2 
 
 
O
s 
20
09
 
 
 
 
 
 
 
1 
0.
05
 
 
 
1 
0.
05
 
1 
0.
05
 
 
 
Pb
 
29
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pt
 
19
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R
b 
15
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R
h 
22
 
 
 
 
 
2 
9.
09
 
 
 
 
 
 
 
 
 
2 
9.
09
 
R
u 
15
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sr
 
34
20
 
18
 
0.
53
 
21
 
0.
61
 
3 
0.
09
 
96
 
2.
81
 
80
 
2.
34
 
13
7 
4.
01
 
13
3 
3.
89
 
19
 
0.
56
 
Tb
 
5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tl
 
10
9 
3 
2.
75
 
 
 
1 
0.
92
 
3 
2.
75
 
3 
2.
75
 
1 
0.
92
 
5 
4.
59
 
 
 
U
 
20
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V
 
28
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
W
 
31
 
 
 
 
 
 
 
 
 
 
 
6 
19
.3
5 
 
 
 
 
Y
b 
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Zn
 
26
6 
7 
2.
63
 
5 
1.
88
 
5 
1.
88
 
2 
0.
75
 
7 
2.
63
 
7 
2.
63
 
12
 
4.
51
 
2 
0.
75
 
T
ot
al
b  
70
15
2 
18
96
 
2.
7 
13
24
 
1.
89
 
96
4 
1.
37
 
63
33
 
9.
03
 
45
97
 
6.
55
 
74
05
 
10
.5
6 
76
35
 
10
.8
8 
38
46
 
5.
48
 
a  R
N
A
 n
uc
le
ot
id
es
 o
nl
y.
 
b  T
he
 p
er
ce
nt
ag
e 
of
 th
e 
to
ta
l a
m
ou
nt
 o
f m
et
al
s i
s r
el
at
iv
e 
to
 th
e 
to
ta
l a
m
ou
nt
 o
f o
ut
er
sp
he
re
 b
ou
nd
 m
et
al
s i
n 
th
e 
fir
st
 c
ol
um
n.
 
 
111
 T
able S 13. Sim
ultaneous coordination to an innersphere ligand of thym
idine-5’-phosphate or uridine-5’-phosphate and an outersphere phosphate 
oxygen. 
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 nucleotides only. 
c The percentage of the total am
ount of phosphate ligands is relative to the total am
ount of innersphere bound m
etals in the first colum
n. 
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able S 15. Sim
ultaneous coordinations to the H
oogsteen face of tw
o consecutive guanosine-5’-phosphates. 
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ount of m
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etals in the first colum
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ultaneous coordinations to the H
oogsteen face of tw
o consecutive guanosine-5’-phosphates. 
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Figure S 5. Metal ion coordination to the Hoogsteen face of guanosine-5’-phosphate. Innersphere 
N7 and concurrent innersphere O6 coordination of the same metal.  
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Figure S 6. Metal ion coordination to the Hoogsteen face of guanosine-5’-phosphate. Innersphere 
N7 and concurrent outersphere O6 coordination of the same metal. 
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Figure S 7. Metal ion coordination to the Hoogsteen face of guanosine-5’-phosphate. Outersphere 
N7 and concurrent innersphere O6 coordination of the same metal. 
 
 
122
Part II Chapter 4: Supp. Info  MINAS – A Closer Look on Metal Binding Sites in Nucleic Acids 
 
 
 
 
 
 
 
NH
NN
N
O
O
O
OPO
O
O NH2
OH/H
Au:     2 (100.0)
Tl:    83 (76.15)
Ba:   127 (70.17)
 K:   738 (63.57)
Co:   426 (58.28)
Ir:    62 (57.41)
Os:   916 (45.59)
Rh:    10 (45.45)
Na:  2696 (45.08)
Mn:   402 (43.98)
Pb:    12 (41.38)
Mg: 22035 (41.24)
Cu:     7 (41.18)
Cs:    14 (40.00)
Ni:    40 (40.00)
Rb:     6 (40.00)
Sr:  1318 (38.54)
Pt:    70 (36.46)
Cd:    15 (26.32)
Ru:     3 (20.00)
Ca:   171 (14.43)
Zn:    24 (9.02)
 U:     1 (5.00)
 V:     1 (3.57)
outersphere N7
outersphere O6
 
 
 
Figure S 8. Metal ion coordination to the Hoogsteen face of guanosine-5’-phosphate. Outersphere 
N7 and concurrent outersphere O6 coordination of the same metal. 
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ABSTRACT 
Among the various noncovalent interactions, ion-π interactions are found in many biolocigal 
contexts. Recognition, transport,  binding events, or structure stability depend on these interactions 
to be highly specific. To comprehend the extent of ionic-π-interactions with nucleic acids, we 
screened all non-redundant DNA and RNA sequences deposited in the PDB for this kind of 
interaction. Predominantly found were interactions of positively charged side chains -mostly 
arginine- of proteins binding to nucleobases through ion-π-interactions. Negatively charged 
interactions between the phosphate oxygens of backbones have been identified to be the most 
frequent anion-π-interaction. Additionally, metal-ion-π-stacking is found more often in RNA than 
in DNA. Visualizations of these findings are overlays of the various types of interactions to 
illustrate the three-dimensional distribution of the ionic groups in contact around the individual 
nucleobases. This view on cation- and anion-π-interactions elucidates the extent of this interface 
throughout nucleic acid structures and will be useful in understanding structure and binding events 
involving charged species and aromatic systems in biomolecules. 
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INTRODUCTION 
To completely understand the structure, function and recognition mechanism of nucleic 
acids, it is essential to apprehend the full scope of the involved noncovalent forces. Among 
hydrogen bonding, π-stacking and electrostatic interactions, to name some, the interaction between 
charged species and a π-system, so-called anion- and cation-π-stacking has awoken increased 
interest during the past two decades.[1] Database analyses of crystal structures within the Cambridge 
Structural Database (CSD)[2]  show that this kind of interactions are widespread in small molecules. 
Additionally, the analysis of small subsets of structures from the Protein Data Bank (PDB)[3] 
revealed that ion-π interactions exist also in protein or nucleic acid structures. Ligand recognition or 
protein inhibition through cation-π interfaces also play an important role in the investigations on 
drug-receptor interactions.[4] For the study presented here, binding events of proteins to nucleic 
acids as well as intramolecular interactions through ion-π-stacking in RNA or DNA were of 
fundamental interest.[1a, 1g, 5] 
Experimental and theoretical results support the stabilizing nature of an interaction between a 
properly localized charged species and a suitable π-system.[1f, 1j-l] Anion-π-interactions of small 
molecules for instance, are found between an electron-deficient aromatic system and a negatively 
charged species. [1d, 1m] Calculated π-stacking energies between small anions and N-heteroaromatic 
compounds range from -5 to -20 kcal/mol.[1m] In biological systems this kind of stacking occurs for 
example at the protein-base interface of an RNA-bound protein involving the stacking of the 
carboxylate group of an aspartic acid onto the π-system of a nucleobase.[6] Anion-π-stacking in 
nucleic acids can also be exhibited through the negatively charged sugar-phosphate backbone, 
where a phosphate oxygen is present in stacking distance of a nucleobase.[7] Cations, on the other 
hand, including metal ions, small molecules, or positively charged amino acids can interact with 
electron-rich aromatic systems. Investigations within the biomolecular context show that there are 
various examples of cation-π-interactions between charged side chains of proteins and DNA.[1b, 1c, 
1e, 1g, 1h] Average cation-π stacking energies are within the range of -1 and -5 kcal/mol.[1h]  
With the knowledge of the occurrence of ion-π interactions in the context of DNA and RNA, as 
well as their stabilizing effect, our goal was to investigate the full scope of cations and anions in 
proximity of the π−planar bases of nucleic acids. Being able to conceive a whole library of all 
occurring stacking interactions between nucleobases and charged species will help with 
understanding of highly specific recognition or binding events and even facilitate future structure 
determination. To investigate these thoroughly present interactions, we searched the environment of 
every nucleobase within DNA and RNA structures found in the PDB. A non-redundant set of 
nucleic acid structures was screened for bases in close stacking distance with any anionic or 
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cationic species. In focus were any charged species such as metal ions, side chains of proteins, 
oxygens of the sugar-phosphate backbone, or charged small molecules. This allows quantifying for 
the first time all anion- or cation-π-stacking within nucleic acids found in the PDB. 
 
METHODS 
PDB structure files containing RNA and/or DNA were downloaded from the Protein Data 
Bank.[3b] In order to analyze only non-redundant structures, the sequences of all files were 
compared using the clustering tool CD-HIT-EST of the CD-HIT Suite.[8] This sequence alignment- 
and comparison-tool was used to find clusters of similar sequences like, e.g., various homologs of 
the same ribosomal subunit. From highly redundant clusters, only the sequences with the highest X-
Ray resolution were considered unique and subsequently searched for charged π-ligands. Possible 
cationic and anionic π-stacking ligands were found in an automated manner from this reduced 
dataset using a Perl script.[9] The neigborhood of each nucleobase was searched in a space 
incorporating the potential stacking environment. This space is defined by a cuboid whose center is 
represented by the centroid of a purine or a pyrimidine base. For both, the maximum distance 
parallel to the plane of a nucleobase is 4 Å, which allows consideration of charged stacking partners 
that are involved in hydrogen bonding with neighboring bases. The distance perpendicular to the 
sides towards and away from the sugar moiety is 2.5 Å with respect to the base centroid. The final 
parameter leading to the predefined volume is defined by the length of a base and encompasses 2.5 
Å in pyrimidines, whereas this distance is 3 Å in purines because of their bicyclic structure. These 
dimensions cover parallel- and parallel-displaced stacking as well as ionic ligands that are in 
secondary interaction with neighboring residues. The searched surrounding cuboids of purines and 
pyrimidines are depicted in Figure 1. If anything but another nucleotide is present within a given 
cuboid, its  coordinates are strored for further examination. These hits are then categorized by 
species, charge and residue type, such as “anionic protein side chain”, or “metal ion”. Each ion-π 
stacking situation is then visualized by overlaying each nucleotide to create images of scattered 
clouds of charged ligands above and below a particular base (one example is Figure 2 where all 
guanines with a cation-π-interaction involving arginine are shown). 
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Figure 1 
Cuboids define the surrounding of each purine (left) or pyrimidine (right) that is searched in order to find 
possible π-stacking ligands. The dimensions of the cuboids are a = 5 Å, b = 6 Å, c = 8 Å. A volume of  1 Å 
above and below the plane of the bases is excluded from the search. Every residue or ion found within this 
volume is stored, including backbone-phosphates and water molecules but no other nucleobase. The 
centroids of the nucleobases are represented by a black dot. 
 
After a first evaluation of these generated overlais we came to the conclusion that in a general 
discrimination between DNA and RNA is necessary upon evaluating ionic stacking (Figure 2). In 
single stranded RNA, which contains not only helical parts but also bulges, loops and turns, the 
residues have larger degrees of freedom compared to the mostly double stranded DNA. Therefore, 
more contact surface for ion-π interactions is available in RNA yielding in more versatile stacking 
possibilities. Figure 3 shows an example displaying the reason for the clustering found in DNA of 
cationic species involved in these interactions. Overlays of π stacking ligands display the 
aforementioned lack of degrees of freedom: Interaction with proteins mainly via the major groove 
produces a cluster of arginines that form a stair motif in the overlay.[5] Table 1 shows the relative 
numbers of all bases found in all PDB files used in this study with a resolution of 3Å or better and 
whose sequences are free of redundant structures. These values are used to compare the found ionic 
stacking hits for every nucleobase relative to its occurrence in the searched structures.  
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Figure 2 
Side (1), top (2, from 5’-end) and bottom (3, from 3’-end) view of guanines overlaid where arginines within 
the predefined search volume were found. (A1-A3: RNA, B1-B3: DNA). Magenta spheres represent CZ, the 
central carbon of the arginine’s guanidinium moiety. The higher degrees of freedom in RNA (A1-A3) are 
clearly visible by the more disordered sugar-phosphate backbone in the overlay. Also, in the case of RNA, 
the arginines are more equally distributed over the whole space, whereas in DNA the stacking guanidiniums 
are more clustered in the major and minor groove. For numerical values, please refer to Table S4 (RNA) and 
Table S10 (DNA). 
 
 
Figure 3 
A: Overlay of arginine stacking onto deoxyguanine. Clustering of the guanidinium residues is especially 
visible on the lower left of the base. B: The results of A are now overlaid with one of the original PDB files 
(PDB ID: 3QMG).[14] The reason for the clustering is clearly visible: most of the arginines are located in the 
major groove of a DNA double helix. In this case the arginine (magenta) of the protein (cyan) binding to this 
DNA additionally forms a hydrogen bond to the neighboring guanine (green) in a so-called stair motif.[5] For 
numerical values of the overlaid guanines, please refer to Table S10. 
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Table 1 
Amount (#) and percentage of nucleobases found in the Protein Data Bank within DNA and RNA structures 
with a resolution of 3 Å or better. Sequence redundancies were flattened as described in the text. These all 
the bases used in this study for the search for ion-π-interactions. 
 Nucleobase DNA&RNA  RNA  DNA 
 # %  # %  # % 
Cytosine 25570 25.91  13135 25.33  12435 26.55 
Guanine 29286 29.68  16278 31.39  13008 27.78 
Adenine 21895 22.19  11666 22.5  10229 21.84 
Thymine 10845 10.99  40
[a] 0.08  10805 23.07 
Uracil 10936 11.08  10693 20.62  243
[b] 0.52 
Non-Standard[c] 154 0.16  41 0.08  113 0.24 
Total 98686 100  51853 100  46833 100 
         
Purines 51181 51.86  27944 53.89  23237 49.62 
Pyrimidines 47351 47.98  23868 46.03  23483 50.14 
[a] The small presence of thymines in RNA derives mostly from tRNA strucures. 
[b] Uracils in DNA are mostly halogeno-derivatives replacing thymine, used for phasing in X-Ray 
experiments. 
[c] Non-standard residues are not derived from purines or pyrimidines. 
 
RESULTS 
RNA-sequences: 
Before focusing on charged residues, some short remarks on other molecules and residues found 
around the nucleobases: 48 % of all species found in the described vicinity of RNA nucleobases are 
H2O; 10 % are neutral aromatic amino acid side chains of binding proteins, the majority consists of 
tryptophan, phenylalanine and tyrosine; 3 % are charged aromatic ligands, dominated by histidine; 
18 % are non-charged side chains or small molecules; and the remaining 21 % are the charged 
species that were kept for further examination. Out of these, 90 % of all negatively charged residues 
are phosphate oxygens from the sugar-phosphate backbone, the rest are mostly aspartate and 
glutamate; less than 2% are small anions such as bromide, sulfate or nitrate. The cationic species 
around RNA purines and pyrimidines are dominated by arginine which accounts for 73% of all 
positively charged residues. 18 % are metal ions, 8 % lysines and 1 % cationic small molecules. The 
summary and numerical values are found in Table 2. 
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DNA-sequences: 
The presence of water shows a similar picture: here, 51% of all residues within the searched 
distances are water molecules. 12 % are again neutral aromatic ligands, mainly tryptophan, 
phenylalanine and tyrosine; 4 % are charged aromatic species dominated by histidine, and 22 % are 
non-charged non-aromatic species. From the remaining total of 13 % (10 % positive and 3 % 
negative) charged species the positive ones are arginines with 84 % presence, 10 % are lysines, 4 % 
small molecules and 2 % metal ions. 78 % of the few anionic species found are to a large extent 
phosphate oxygens of the DNA backbone, 10 % are glutamates, 8 % aspartates and 4 % negatively 
charged small molecules. Detailed numbers are shown in Table 3. The individual evaluations for 
purines, pyrimidines and each type of nucleobase are listed separately in Tables S1-S12 of the 
supplementary information. 
 
Table 2 
RNA nucleotides and their stacking environment: The first row shows the total amount of affected 
nucleobases found in RNA structures with a resolution of 3 Å or better. Sequence redundancies 
were flattened as described in the text. Included in the table are interactions with water to get an 
overview of all interactions and the relative numbers. Arginines dominate the cation-π interactions 
with over 70 % presence. The majority of anion-π interactions with over 90 % are phosphate 
oxygens.  
      Nucleobases undergoing ion-π-interaction 
  # bases % bases[a] % total[b] % cationic % anionic % ionic 
Total RNA nucleobases 51853 100         
Stacking interaction[c] 10907 21.03     
H2O 5207 10.04 (47.74)    
Total cations 948 1.83 8.69 100  41.8 
Arginine 691 1.33 6.34 72.89  30.47 
Lysine 75 0.14 0.69 7.91  3.31 
Small molecules 11 0.02 0.1 1.16  0.49 
Metal ions 171 0.33 1.57 18.04   7.54 
Total anions 1320 2.55 12.1  100 58.2 
Aspartate 48 0.09 0.44  3.64 2.12 
Glutamate 59 0.11 0.54  4.47 2.6 
Small molecules 19 0.04 0.17  1.44 0.84 
Phosphates 1194 2.3 10.95   90.45 52.65 
[a] The values are relative to the total amount of nucleobases. 
[b] These numbers are relative to nucleobases with charged, uncharged or water ligands. 
[c] The stacking species is anything else but another nucleobase (see [b]). 
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Table 3 
DNA nucleotides and their stacking environment: The first row shows the total amount of affected 
nucleobases found in DNA structures with a resolution of 3 Å or better. Sequence redundancies were 
flattened as described in the text. Included in the table are also non-charged π interactions to get an overview 
over all interactions and the relative numbers. Again, arginines dominate the cationic π interactions with over 
84 % presence. Also, phosphate oxygens account for most anions with over 78 %, however, in DNA there 
are almost five times less anion-π interactions than in RNA. 
      Nucleobases undergoing ion-π-interaction 
  # bases % bases[a] % total[b] % cationic % anionic % ionic 
Total DNA nucleobases 46833 100         
Stacking interaction[c] 11039 23.57     
H2O 5667 12.1 (51.34)    
Total cations 887 1.89 8.04 100  76.27 
Arginine 750 1.6 6.79 84.55  64.49 
Lysine 90 0.19 0.82 10.15  7.74 
Small molecules 31 0.07 0.28 3.49  2.67 
Metal ions 16 0.03 0.14 1.8   1.38 
Total anions 276 0.59 2.5  100 23.73 
Aspartate 22 0.05 0.2  7.97 1.89 
Glutamate 26 0.06 0.24  9.42 2.24 
Small molecules 12 0.03 0.11  4.35 1.03 
Phosphates 216 0.46 1.96   78.26 18.57 
[a] The values are relative to the total amount of nucleobases. 
[b] These numbers are relative to nucleobases with charged, uncharged or water ligands. 
[c] The stacking species is anything else but another nucleobase (see [b]). 
 
Two trends catch the eye immediately: First, there are almost twice as many ionic stacking 
interactions found in RNA than in DNA. Second, in RNA the anionic interactions outnumber the 
cationic ones. Phosphate oxygens are responsible for both of these observations; they account for 
half of all ionic stacking interactions in RNA which is due to its single-stranded and hence more 
flexible nature. Figure 4 shows four examples, where most phosphate stacking in DNA and RNA is 
found. Especially in DNA intranucleotide stacking is observed, i.e. the phosphate of a nucleotide 
stacks onto its own base. Leaving the phosphates out of consideration, the situation of ionic 
stacking for RNA and DNA looks similar: mostly cationic stacking with arginine is found. In RNA, 
most arginine stacking occurs with adenine whereas in DNA thymine is favored for this interaction 
(Figure 5). Similar to the situation shown in Figure 3, a clustering of arginine guanidinium moieties 
in the major groove can be clearly seen for the interaction with thymine. Stacking of the π-planar 
guanidinium group can be considered a combination of π-π stacking and cation-π-stacking. 
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Figure 4 
Examples of phosphate stacking on RNA (A&B)  and DNA (C&D). A: Guanine, B: Uracil C: 
Deoxyguanine, D: Deoxycytosine. The phosphorus atoms and negatively-charged oxygen atoms are only 
colored orange and red when they belong to a different nucleotide than the base they are stacking onto. Most 
phosphate stacking in RNA occurs to guanine (A1-A3). Less intranucleotide stacking is observed, however, 
custering is visible especially to the bottom (at the 3’-end (3)) of the base. In uracil (B1-B3) most of the 
stacking is as well observed at the 3’-end of the base. In deoxyguanine (C1-C3) most stacking is 
intranucleotide and strong clustering on both sides of the base is visible. Deoxycytosine (D1-D3) shows also 
a lot of intranucleotide phosphate stacking, however, less clustering than in deoxyguanine is observed. 1: 
Side view, 2: view from 5’-end, 3: view from 3’-end. 
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The dihedral angles between the plane of the nucleobase and the plane defined by the guanidinium 
group have been analyzed as well. Dihedral angles were calculated for each arginine-nucleobase 
pair to display the deviation from planar stacking (Figure 6). Most of the arginines (50-75 %) are 
within a 0 - 30 ° interplanar angle, making this interaction clearly parallel π-π stacking. These 
numbers are not surprising since arginine is frequently involved in intermolecular hydrogen bonds 
to neighboring bases with the same parallel orientation as the base involved in the cation-π-
interaction. Fewer arginines have guanidinium groups tilted with an oblique angle (30 ° - 60 °)[1i] or 
angles close to orthogonal; the latter ranges from 2.2 % (U) to as high as 7.8 % (dG). Here, a 
perpendicular or “T-shaped” cationic-π-π interaction occurs.[10] The remaining non-aromatic 
charged amino acids; lysine, aspartate and glutamate; are not as numerously present as arginine. 
More examples of phosphate and lysine stacking are shown in the supplementary information. 
 
 
 
Figure 5 
Most abundant arginine stacking in RNA (A) and DNA (B). A1-A3 shows adenine and the almost equally 
distributed guanidinium moieties of arginine. In thymine (B1-B3) the clustering of the guanindinums due to 
major groove binding is clearly visible. 1: Side view, 2: view from 5’-end, 3: view from 3’-end. 
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Figure 6 
Interplanar angles 
between the guanidinium 
group of the arginine side 
chains and the individual 
nucleobases. For RNA 
(a-d) as well as for DNA 
(e-h), most of the angles 
are between 0 and 30 ° 
(darker columns). This 
interaction can therefore 
predominately be 
considered parallel 
cation π-π. 
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Metal ions are the last focus in the context of cationic stacking. Especially alkali and alkaline-earth 
metals are essential companions of nucleic acids and are used in many standard crystallization 
screens. Despite their indispensability for backbone charge compensation, structure or function of 
folded RNAs, their spectroscopic determination remains challenging because of short occupancy 
times or their isoelectronic nature to H2O (for Mg2+ and Na+). Nonetheless, some metals were found 
in the searched structures within the cation-π-distance of RNA, but only a handful in DNA. The 
amount of DNA containing structures found in the PDB is almost double the amount of RNA but 
again the more conserved double helical structure in DNA is responsible for the fewer metal ion 
hits. Most charge compensation of the DNA backbone occurs through loosely bound metal ions that 
are normally not seen in X-Ray structures. RNA on the other hand, which is often folded to a native 
three-dimensional structure, requires specifically bound metal ions for charge compensation of 
otherwise repelling sugar-phosphate backbones; this is represented by their relative number of 
occurrences found in this study. 
By far, most metal ions found are Mg2+, followed by Na+, K+ and Ca2+. An overview of the total 
less than 200 metal ion-π-interactions found is given in Table 4. The relative numbers of the 
different metal ions is related to their total amount mapped in the MINAS database (Metal Ions in 
Nucleic Acid Structures, www.minas.uzh.ch) where all metal ions including their coordination 
sphere found in DNA and RNA structures are stored.[11] Many of the metal ions in stacking distance 
are, like arginine, coordinated directly to neighboring bases or phosphate oxygens. Figure 7 shows 
the distribution of all metal ions together around the four RNA nucleobases. Clearly visible here is 
clustering of metal ions, especially at the major groove site, however, not directly above the purine 
or pyrimidine rings. From a stabilizing point of view this is in agreement with calculations from 
Wintjens and coworkers: Na+ ions have their most stable position for a cation-π complex more 
likely outside the area above the rings especially in regions where exocyclic oxygens and ring 
nitrogens are close.[1c] A remarkable example of metal ion-π-interactions in RNA is the PDB 
structure of the eukaryotic ribosome (3U5D).[12] Several locations with mismatched, flipped-out, or 
unpaired nucleobases were identified containing a Mg2+ ion stacking to them (Figure 8). 
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Figure 7 
Metal ion stacking in RNA. A1-A3: Side, top and bottom view of adenine where mostly Mg2+ (green) are 
found.  Na+ (light blue) and K+ (pink) ions are the exception, as well as Ba2+ (orange) and Sr2+ (yellow, 
visible best in the lower left of A2, next to Ba2+). Clustering in the major groove is visible. B1-B3: Side, top 
and bottom view of cytosine. Again, Mg2+ (green) dominates the metal ions along with some Ca2+ (black), 
Cu+ (red), Na+ (light blue), and K+ (pink) ions. C1-C3: Side, top and bottom view of guanine. Mg2+ (green) 
is the most abundant metal ion followed by Na+ (light blue) and K+ (pink). The remaining ones are one Mn2+ 
(red, best visible at the bottom of C2), one Co3+ (orange, with its six ammine ligands) one Sr2+ (yellow, next 
to [Co (NH3)6 ]3+), and one Zn2+ (black, next to [Co (NH3)6 ]3+). D1-D3: Side, top and bottom view of uracil. 
Also in the case of uracil, Mg2+ (green) is mostly found. The rest are two Na+ (light blue), two K+ (pink), one 
Co2+ (orange) and an [Os (NH3)6 ]3+ complex (light blue). 
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Table 4 
Stacking interactions with metal ions found 
in RNA and DNA. The hits found in RNA 
are shown in Figure 7, for the sake of 
statistical relevance no figures were created 
for the interactions of metal-ions and DNA. 
RNA DNA 
Metal Ion #Hits Metal Ion #Hits 
Mg 130 Cu 6 
Na 16 Mn 3 
K 8 Mg 2 
Ca 6 Ni 2 
Zn 3 Zn 2 
Co 2 Na 1 
Sr 2 Pt 1 
Ba 1 Tl 1 
Cu 1 
  Mn 1 
  Os 1     
total: 171 total: 18 
 
 
Figure 8 
Mg2+ stacking to the RNA of the 60S subunit of the 
eukaryotic ribosome (PDB ID: 3U5D). A: Unpaired 
C3278 (blue) stacks itself on a flipped-out adenine. 
Mg2+ (green) in π−interaction with the cytosine has 
outersphere contacts to OP2 and O2’ of U3277. 
B: Flipped-out A2401 (blue) in a sharp turn of the 
RNA backbone with a Mg2+ π−stacking (green). 
Neighboring phosphate oxygens as well as an 
additional adenine in the background are in 
outersphere coordination distance to the magnesium. 
C: G33 (blue) from a GA sheared base pair has a Mg2+ 
(green) π−stacking and in various outersphere 
interactions with surrounding bases and sugars. 
D: U2140 (blue) of a UU base pair before branching 
of the strand. The Mg2+ (green) is mainly π−stacking 
on U2140 but also coordinated in an outersphere 
fashion with the U2978 above. 
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CONCLUSIONS 
By defining a cuboid volume around each nucleobase and calculating distances to charged 
species that are potential stacking to the π-systems, we could display the full ionic stacking 
environment of each RNA and DNA nucleobase deposited in the PDB. This collection of visual and 
numerical findings is in agreement with previous studies and calculations that were performed on, 
e.g., small sets of structure files containing protein-DNA interactions.[1c] The most prominent 
interactions are arginines for cationic species and phosphates for anions, the latter dominate in 
RNA. Clustering of the cations and anions is very often found because of the double stranded nature 
of nucleic acids, especially for DNA. The herein presented summarization of existing ion-π 
interactions may be helpful for structure predictions or solving structures from ambiguous 
experimental data. Calculated energies show that these noncovalent interactions are within the 
range of the strength of a hydrogen bond which of course depends on the geometry, distance and 
environment of the contact.[1h] This makes the ion-π interaction a subtle but non-negligible force for 
the accomplishment of recognition or dead-on binding geometry.[1h, 13]  
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Table S 1. RNA purines 
   RNA purines with π interaction 
 # bases % bases[a] % purines % total[b] % cationic % anionic % ionic 
Total RNA purines 27944 53.89          
Stacking interaction[c] 5548 10.7 19.85     
H2O 2491 4.8 8.91 (44.9)    
Total cations 555 1.07 1.99 10 100  45.72 
Arginine 409 0.79 1.46 7.37 73.69  33.69 
Lysine 45 0.09 0.16 0.81 8.11  3.71 
Small molecules 7 0.01 0.03 0.13 1.26  0.58 
Metal ions 94 0.18 0.34 1.69 16.94   7.74 
Total anions 659 1.27 2.36 11.88  100 54.28 
Aspartate 13 0.03 0.05 0.23  1.97 1.07 
Glutamate 25 0.05 0.09 0.45  3.79 2.06 
Small molecules 9 0.02 0.03 0.16  1.37 0.74 
Phosphates 612 1.18 2.19 11.03   92.87 50.41 
[a] The values are relative to the total amount of RNA nucleobases (purines and pyrimidines). [b] 
These numbers are relative to nucleobases with charged, uncharged or water ligands. [c] The stacking 
species is anything else but another nucleobase (see [b]). 
 
Table S 2. RNA pyrimidines. 
   RNA pyrimidines with π interaction 
 # bases % bases[a] % pyrimidines % total
[b] % cationic % anionic % ionic 
Total RNA pyrimidines 23868 46.03          
Stacking interaction[c] 5359 10.33 22.45     
H2O 2716 5.24 11.38 (50.68)    
Total cations 393 0.76 1.65 7.33 100  37.29 
Arginine 282 0.54 1.18 5.26 71.76  26.76 
Lysine 30 0.06 0.13 0.56 7.63  2.85 
Small molecules 4 0.01 0.02 0.07 1.02  0.38 
Metal ions 77 0.15 0.32 1.44 19.59   7.31 
Total anions 661 1.27 2.77 12.33  100 62.71 
Aspartate 35 0.07 0.15 0.65  5.3 3.32 
Glutamate 34 0.07 0.14 0.63  5.14 3.23 
Small molecules 10 0.02 0.04 0.19  1.51 0.95 
Phosphates 582 1.12 2.44 10.86   88.05 55.22 
[a] The values are relative to the total amount of RNA nucleobases (purines and pyrimidines). [b] 
These numbers are relative to nucleobases with charged, uncharged or water ligands. [c] The stacking 
species is anything else but another nucleobase (see [b]). 
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Table S 3. RNA adenines. 
   Adenines with π interaction 
 # bases % bases[a] % adenines % total[b] % cationic % anionic % ionic 
Total RNA adenines 11666 22.5          
Stacking interaction[c] 2328 4.49 19.96     
H2O 817 1.58 7 (35.09)    
Total cations 338 0.65 2.9 14.52 100  64.02 
Arginine 278 0.54 2.38 11.94 82.25  52.65 
Lysine 26 0.05 0.22 1.12 7.69  4.92 
Small molecules 3 0.01 0.03 0.13 0.89  0.57 
Metal ions 31 0.06 0.27 1.33 9.17   5.87 
Total anions 190 0.37 1.63 8.16  100 35.98 
Aspartate 8 0.02 0.07 0.34  4.21 1.52 
Glutamate 11 0.02 0.09 0.47  5.79 2.08 
Small molecules 5 0.01 0.04 0.21  2.63 0.95 
Phosphates 166 0.32 1.42 7.13   87.37 31.44 
[a] The values are relative to the total amount of RNA nucleobases (purines and pyrimidines). [b] 
These numbers are relative to nucleobases with charged, uncharged or water ligands. [c] The stacking 
species is anything else but another nucleobase (see [b]). 
 
Table S 4.RNA guanines. 
   Guanines with π interaction 
 # bases % bases[a] % guanines % total[b] % cationic % anionic % ionic 
Total RNA guanines 16278 31.39           
Stacking interaction[c] 3191 6.15 19.6     
H2O 1656 3.19 10.17 (51.9)    
Total cations 217 0.42 1.33 6.8 100    31.63 
Arginine 128 0.25 0.79 4.01 58.99  18.66 
Lysine 19 0.04 0.12 0.6 8.76  2.77 
Small molecules 7 0.01 0.04 0.22 3.23  1.02 
Metal ions 63 0.12 0.39 1.97 29.03   9.18 
Total anions 469 0.9 2.88 14.7   100  68.37 
Aspartate 5 0.01 0.03 0.16  1.07 0.73 
Glutamate 14 0.03 0.09 0.44  2.99 2.04 
Small molecules 4 0.01 0.02 0.13  0.85 0.58 
Phosphates 446 0.86 2.74 13.98   95.1 65.01 
[a] The values are relative to the total amount of RNA nucleobases (purines and pyrimidines). [b] 
These numbers are relative to nucleobases with charged, uncharged or water ligands. [c] The stacking 
species is anything else but another nucleobase (see [b]). 
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Table S 5. RNA cytosines. 
   Cytosines with π interaction 
 # bases % bases[a] % cytosines % total
[b] % cationic % anionic % ionic 
Total RNA cytosines 13135 25.33           
Stacking interaction[c] 2103 4.06 16.01     
H2O 1259 2.43 9.59 (59.87)    
Total cations 156 0.3 1.19 7.42 100    42.28 
Arginine 105 0.2 0.8 4.99 67.31  28.46 
Lysine 16 0.03 0.12 0.76 10.26  4.34 
Small molecules 1 0 0.01 0.05 0.64  0.27 
Metal ions 34 0.07 0.26 1.62 21.79   9.21 
Total anions 213 0.41 1.62 10.13   100  57.72 
Aspartate 32 0.06 0.24 1.52  15.02 8.67 
Glutamate 7 0.01 0.05 0.33  3.29 1.9 
Small molecules 2 0 0.02 0.1  0.94 0.54 
Phosphates 172 0.33 1.31 8.18   80.75 46.61 
[a] The values are relative to the total amount of RNA nucleobases (purines and pyrimidines). [b] 
These numbers are relative to nucleobases with charged, uncharged or water ligands. [c] The stacking 
species is anything else but another nucleobase (see [b]). 
Table S 6. RNA uracils. 
   Uracils with π interaction 
 # bases % bases[a] % uracils % total[b] % cationic % anionic % ionic 
Total RNA uracils 10693 20.62           
Stacking interaction[c] 3174 6.12 29.68     
H2O 1385 2.67 12.95 (43.64)    
Total cations 237 0.46 2.22 7.47 100    34.96 
Arginine 177 0.34 1.66 5.58 74.68  26.11 
Lysine 14 0.03 0.13 0.44 5.91  2.06 
Small molecules 3 0.01 0.03 0.09 1.27  0.44 
Metal ions 43 0.08 0.4 1.35 18.14   6.34 
Total anions 441 0.85 4.12 13.89   100  65.04 
Aspartate 3 0.01 0.03 0.09  0.68 0.44 
Glutamate 27 0.05 0.25 0.85  6.12 3.98 
Small molecules 6 0.01 0.06 0.19  1.36 0.88 
Phosphates 405 0.78 3.79 12.76   91.84 59.73 
[a] The values are relative to the total amount of RNA nucleobases (purines and pyrimidines). 
[b] These numbers are relative to nucleobases with charged, uncharged or water ligands. [c] 
The stacking species is anything else but another nucleobase (see [b]). 
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Table S 7. DNA purines.  
   DNA purines with π interaction 
 # bases % bases[a] % purines % total[b] % cationic % anionic % ionic 
Total DNA purines 23237 49.62           
Stacking interaction[c] 5372 11.47 23.12     
H2O 2697 5.76 11.61 (50.2)    
Total cations 418 0.89 1.8 7.78  100   74.38 
Arginine 310 0.66 1.33 5.77 74.16  55.16 
Lysine 72 0.15 0.31 1.34 17.22  12.81 
Small molecules 26 0.06 0.11 0.48 6.22  4.63 
Metal ions 10 0.02 0.04 0.19 2.39   1.78 
Total anions 144 0.31 0.62 2.68   100  25.62 
Aspartate 10 0.02 0.04 0.19  6.94 1.78 
Glutamate 5 0.01 0.02 0.09  3.47 0.89 
Small molecules 7 0.01 0.03 0.13  4.86 1.25 
Phosphates 122 0.26 0.53 2.27   84.72 21.71 
[a] The values are relative to the total amount of  DNA nucleobases (purines and 
pyrimidines). [b] These numbers are relative to nucleobases with charged, uncharged or water 
ligands. [c] The stacking species is anything else but another nucleobase (see [b]). 
 
Table S 8. DNA pyrimidines. 
   DNA pyrimidines with π interaction 
 # bases % bases[a] % pyrimidines % total
[b] % cationic % anionic % ionic 
Total DNA pyrimidines 23483 50.14           
Stacking interaction[c] 5667 12.1 24.13     
H2O 2970 6.34 12.65 (52.41)    
Total cations 469 1 2 8.28 100    78.04 
Arginine 440 0.94 1.87 7.76 93.82  73.21 
Lysine 18 0.04 0.08 0.32 3.84  3 
Small molecules 5 0.01 0.02 0.09 1.07  0.83 
Metal ions 6 0.01 0.03 0.11 1.28   1 
Total anions 132 0.28 0.56 2.33   100  21.96 
Aspartate 12 0.03 0.05 0.21  9.09 2 
Glutamate 21 0.04 0.09 0.37  15.91 3.49 
Small molecules 5 0.01 0.02 0.09  3.79 0.83 
Phosphates 94 0.2 0.4 1.66   71.21 15.64 
[a] The values are relative to the total amount of  DNA nucleobases (purines and 
pyrimidines). [b] These numbers are relative to nucleobases with charged, uncharged or water 
ligands. [c] The stacking species is anything else but another nucleobase (see [b]). 
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Table S 9. DNA adenines. 
   Adenines with π interaction 
 # bases % bases[a] % adenines % total[b] % cationic % anionic % ionic 
Total DNA adenines 10229 21.84           
Stacking interaction[c] 1947 4.16 19.03     
H2O 873 1.86 8.53 (44.84)    
Total cations 168 0.36 1.64 8.63  100   83.17 
Arginine 137 0.29 1.34 7.04 81.55  67.82 
Lysine 24 0.05 0.23 1.23 14.29  11.88 
Small molecules 6 0.01 0.06 0.31 3.57  2.97 
Metal ions 1 0 0.01 0.05 0.6   0.5 
Total anions 34 0.07 0.33 1.75   100  16.83 
Aspartate 6 0.01 0.06 0.31  17.65 2.97 
Glutamate 3 0.01 0.03 0.15  8.82 1.49 
Small molecules 3 0.01 0.03 0.15  8.82 1.49 
Phosphates 22 0.05 0.22 1.13   64.71 10.89 
[a] The values are relative to the total amount of  DNA nucleobases (purines and 
pyrimidines). [b] These numbers are relative to nucleobases with charged, uncharged or water 
ligands. [c] The stacking species is anything else but another nucleobase (see [b]). 
 
Table S 10. DNA guanines. 
   Guanines with π interaction 
 # bases % bases[a] % guanines % total[b] % cationic % anionic % ionic 
Total DNA guanines 13008 27.78           
Stacking interaction[c] 3357 7.17 25.81     
H2O 1796 3.83 13.81 (53.5)    
Total cations 250 0.53 1.92 7.45 100    69.06 
Arginine 173 0.37 1.33 5.15 69.2  47.79 
Lysine 48 0.1 0.37 1.43 19.2  13.26 
Small molecules 20 0.04 0.15 0.6 8  5.52 
Metal ions 9 0.02 0.07 0.27 3.6   2.49 
Total anions 112 0.24 0.86 3.34   100  30.94 
Aspartate 4 0.01 0.03 0.12  3.57 1.1 
Glutamate 2 0 0.02 0.06  1.79 0.55 
Small molecules 6 0.01 0.05 0.18  5.36 1.66 
Phosphates 100 0.21 0.77 2.98   89.29 27.62 
[a] The values are relative to the total amount of  DNA nucleobases (purines and 
pyrimidines). [b] These numbers are relative to nucleobases with charged, uncharged or water 
ligands. [c] The stacking species is anything else but another nucleobase (see [b]). 
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Table S 11. DNA cytosines. 
   Cytosines with π interaction 
 # bases % bases[a] % cytosines % total
[b] % cationic % anionic % ionic 
Total DNA cytosines 12435 26.55           
Stacking interaction[c] 3046 6.5 24.5     
H2O 1724 3.68 13.86 (56.6)    
Total cations 190 0.41 1.53 6.24 100    75.4 
Arginine 175 0.37 1.41 5.75 92.11  69.44 
Lysine 10 0.02 0.08 0.33 5.26  3.97 
Small molecules 2 0 0.02 0.07 1.05  0.79 
Metal ions 3 0.01 0.02 0.1 1.58   1.19 
Total anions 62 0.13 0.5 2.04   100  24.6 
Aspartate 8 0.02 0.06 0.26  12.9 3.17 
Glutamate 9 0.02 0.07 0.3  14.52 3.57 
Small molecules 2 0 0.02 0.07  3.23 0.79 
Phosphates 43 0.09 0.35 1.41   69.35 17.06 
[a] The values are relative to the total amount of  DNA nucleobases (purines and 
pyrimidines). [b] These numbers are relative to nucleobases with charged, uncharged or water 
ligands. [c] The stacking species is anything else but another nucleobase (see [b]). 
 
Table S 12. DNA thymines. 
   Thymies with π interaction 
 # bases % bases[a] % thymines % total[b] % cationic % anionic % ionic 
Total DNA thymines 10805 23.07           
Stacking interaction[c] 2470 5.27 22.86     
H2O 1151 2.46 10.65 (46.6)    
Total cations 273 0.58 2.53 11.05 100    80.53 
Arginine 260 0.56 2.41 10.53 95.24  76.7 
Lysine 7 0.01 0.06 0.28 2.56  2.06 
Small molecules 3 0.01 0.03 0.12 1.1  0.88 
Metal ions 3 0.01 0.03 0.12 1.1   0.88 
Total anions 66 0.14 0.61 2.67   100  19.47 
Aspartate 4 0.01 0.04 0.16  6.06 1.18 
Glutamate 11 0.02 0.1 0.45  16.67 3.24 
Small molecules 3 0.01 0.03 0.12  4.55 0.88 
Phosphates 48 0.1 0.44 1.94   72.73 14.16 
[a] The values are relative to the total amount of  DNA nucleobases (purines and 
pyrimidines). [b] These numbers are relative to nucleobases with charged, uncharged or water 
ligands. [c] The stacking species is anything else but another nucleobase (see [b]). 
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SUPPLEMENTARY FIGURES 
 
 
Figure S 1 
Side (1), top (2, from 5’-end) and bottom (3, from 3’-end) view of phosphate stacking on 
RNA (A&B) and DNA (C&D). A1-A3: Adenine, B1-B3: Cytosine,  C1-C3: Deoxyadenine, 
D1-D3: Thymine. The phosphorus atoms and negatively-charged oxygen atoms are colored 
orange and red, respectively, when they belong to a different nucleotide than the base they are 
stacking onto. 
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Figure S 2 
Side (1), top (2, from 5’-end) and bottom (3, from 3’-end) view of lysine stacking in RNA. 
A1-A3: Adenine, B1-B3: Cytosine, C1-C3: Guanine, D1-D3: Uracil. 
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Figure S 3 
Side (1), top (2, from 5’-end) and bottom (3, from 3’-end) view of lysine stacking in DNA. 
A1-A3: Adenine, B1-B3: Cytosine, C1-C3: Guanine, D1-D3: Thymine. 
 
149
Summary 
 
Summary 
Part I 
Supramolecular dinuclear iron(II) complexes [Fe2L3]4+ are helical cylinders that are known to 
bind in an extraordinary fashion to DNA. These features make them potential anticancer 
drugs. The cylinders can target Y-shaped DNA three-way junctions specifically but also 
binding in the major groove of double-stranded DNA could be shown. The appropriate size 
and shape of the helicates as well as their high electrostatic charge allow all these non-
covalent interactions. Treatment of tumor cell lines with the cylinder results in increased cell 
death by a non-genotoxic activity. This alternative mechanism of action, based on the 
cylinder’s non-covalent mode of three-way junction recognition, could be a promising step 
towards the treatment of cancer cells that are resistant to chemotherapeutics. RNA is involved 
in various regulatory functions inside the cell. Since DNA and RNA are very similar in 
structure, the question arose whether the cylinder would also bind to RNA. RNA occurs 
mostly as a single stranded molecule and contains a high abundance of natural three-way 
junctions that could potentially be targeted. Affection of RNA in living cells might be a key 
element in the cylinder’s discovered antitumor activity. 
In the first study of this thesis, we therefore used various RNA constructs of artificial or 
natural origin as the target for the iron(II) cylinders. The RNA analog of the recently 
discovered DNA three-way junction could be successfully crystallized and the structure 
characterized. Furthermore, two more crystal structures of RNA three-way junctions 
containing cobalt(II) and nickel(II) cylinder complexes could be solved. These three crystal 
structures are identical in topology. The metallo-cylinder is found buried inside the center of 
the RNA three-way junction. The inner rings of the cylinder’s aromatic ligands are in 
π-stacking interaction with the central base pairs of the RNA which radiates as three double 
helices from the heart of the three-way junction. Comparing the known crystal structure of the 
DNA three-way junction with the RNA three-way junction shows an inherent structural 
difference: The narrow opening on one side of the DNA three-way junction restricts the 
cylinders position to a certain depth of penetration. However, inside the RNA three-way 
junction, the cylinder can interact with a maximal π-stacking surface because both openings 
of the junction are wide enough to allow a free movement and hence an energetically optimal 
position. This is the first characterization of an induced RNA three-way junction that is 
specifically recognized by a supramolecular cylinder.   
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Part II 
Tertiary structures of large polyanions such as DNA and especially RNA (e.g. ribozymes) 
imply a highly complex three-dimensional architecture containing hairpins, loops and many 
other local structures. For charge compensation and to enable the nucleic acids to fold into 
their native structure, mono- and divalent metal ions like Na+, K+, Mg2+, or Ca2+ are a 
prerequisite. Specifically bound metal ions thereby coordinate with high selectivity to the 
phosphate oxygens as well as to the various functionalities on the nucleoside moieties, such as 
carbonyl oxygens, ring nitrogens or hydroxyl groups. In addition to innersphere interactions, 
an extensive network of hydrogen bonds via outersphere coordination is crucial to achieve a 
tight binding. 
In order to elucidate the origin of this selectivity, we have built a new database MINAS – 
Metal Ions in Nucleic AcidS that contains the exact geometric information on the first 
(innersphere) and second-shell (outersphere) coordinating ligands of every metal ion present 
in all nucleic acid structures deposited in the PDB. The inclusion of the second coordination 
sphere in the MINAS database thereby allows for the first time to evaluate also the effect of 
indirect liganding atoms on metal ion binding. This is important because metal ions can e.g. 
influence catalysis over a distance of up to 20 Å within RNA. Additionally, the information of 
the binding pocket-proximal nucleotides enables a detailed search of all potential ligand 
combinations and all possible coordination spaces of metal ions. MINAS is therefore a perfect 
new tool to statistically classify metal ion binding pockets in nucleic acids, to draw general 
conclusions about the different coordination properties of these ions, and to compare the 
different binding modes of metal ions in nucleic acids. 
The second study of this thesis comprises the buildup of the MINAS database as well as the 
evaluation of binding sites of nearly 100'000 metal ions from various nucleic acid structures. 
This global structure analysis shows the preferred binding sites for various metal ions. The 
data show expected ligand preferences that differ for alkali, alkaline earth as well as for 
transition metals. The anionic phosphate backbone is the most frequent binding site for metals 
in nucleic acids, especially for Mg2+, the most abundant metal ion in the MINAS database 
with over 70'000 entries. Up to four simultaneous connections to phosphate oxygens are 
found. Furthermore, the Hoogsteen face of guanine with its N7 and O6 makes a perfect 
binding site for metal ion coordination and therewith stands out as the most frequent non-
charged binding site. 
Additionally, cation-π and anion-π interactions in nucleic acids were investigated as the final 
study of this thesis. These noncovalent molecular interactions have been observed, e.g., in 
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small aromatic molecules interacting with metal ions and in crystal packing. In terms of in the 
biomolecular context, ion-π binding plays an important role in the transport of metal ions 
through ion channels or in contribution to successful ligand-receptor recognition. Charged 
side chains of proteins have also been discovered to recognize nucleic acids through cation-π 
interactions. A search over all nucleic acid structures deposited in the PDB was therefore 
preformed in order to investigate the extent of cation-π and anion-π interactions in DNA and 
RNA systems. The automated analysis of over thousands of nucleobases showed that of all 
negatively charges species the most common anion-π binding occurs through phosphate 
oxygens that interact with the π-systems of nucleobases in an intramolecular fashion. 
Cation-π interactions on the other hand are also found for various species including a few 
metal ions. Arginine accounts for the most frequent cation-π contact when its side chain 
interacts with a nucleobase in an event of protein-DNA or protein-RNA binding. 
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Teil I 
Supramolekulare zweikernige Eisen(II)-Komplexe [Fe2L3]4+ sind helikale Zylinder die dank 
ihren ausserordentlichen DNS Bindungseigenschaften potentielle Antikrebsmittel sind. Die 
Zylinder können einerseits spezifisch an Y-förmige dreiarmige DNS Kreuzungen binden. Es 
wurde aber auch eine Anlagerung an die grosse Furche doppelsträngiger DNS gezeigt. Die 
geeignete Grösse und Form der Helikate sowie ihre hohe elektrostatische Ladung sind 
verantwortlich für diese nichtkovalenten Wechselwirkungen. Behandlung von Krebszelllinien 
mit den zylinderförmigen Komplexen resultierten in erhöhten Zellsterblichkeitsraten ohne das 
Erbgut der Zellen zu schädigen. Dieser alternative Mechanismus des Eisen(II) Supramoleküls 
könnte ein vielversprechender Schritt in Richtung Behandlung von Krebs sein, welcher schon 
Resitenzen gegen andere Chemotherapeutika aufweist. Die nichtkovalente Art der Erkennung 
von dreiarmigen Kreuzungen könnte somit die Entwicklung neuartiger Medikamente 
ermöglichen. RNS erfüllt verschiedene regulatorische Funktionen in einer Zelle. Da DNS und 
RNS eine sehr ähnliche Struktur aufweisen, stellte sich die Frage ob der Zylinder auch an 
RNS binden würde. RNS kommt meist als einzelsträngiges Molekül vor welches ein hohes 
natürliches Vorkommen an dreiarmigen Kreuzungen als potentielle Zielbindungsstellen 
enthält Die Beeinflussung der RNS in lebenden Zellen könnte ein Schlüsselelement in der 
Antitumoraktivität des Zylinders sein. 
In der ersten Studie dieser Dissertation wurden deshalb verschiedene RNS Konstrukte 
künstlichem oder natürlichem Ursprungs als Ziel für die Eisen(II) Zylinder verwendet. Das 
RNS Analogon der kürzlich entdeckten dreiarmigen DNS Kreuzung konnten erfolgreich 
kristallisiert und die Struktur mittels Röntgenkristallografie charakterisiert werden. Ferner 
wurden zwei weitere Kristallstrukturen der dreiarmigen RNS Kreuzung mit Kobalt(II) und 
Nickel(II) Zylindern gelöst. Diese drei Kristallstrukturen haben eine identische Topologie. 
Der Metallzylinder befindet sich im Zentrum der dreiarmigen RNS Kreuzung. Die inneren 
Ringe der aromatischen Liganden des Zylinders sind in π-Stapelwechselwirkung mit den 
zentralen Basenpaaren der RNS, die als drei Doppelhelices vom Inneren der dreiarmigen 
Kreuzung wegführt. Ein Vergleich der bekannten Kristallstruktur der dreiarmige DNS 
Kreuzung mit der dreiarmige RNS Kreuzung zeigt einen strukturellen Unteschied: Die enge 
Öffnung an der einen Seite der dreiarmigen DNS Kreuzung beschränkt die innere Platzierung 
des Zylinders auf eine gewisse Tiefe. Der Zylinder kann aber mit der dreiarmigen RNS 
Kreuzung eine maximale π-Stapeloberfläche einnehmen: beide Öffnungen der Kreuzung sind 
weit genug für eine freie Beweglichkeit des Zylinders und ermöglichen somit eine energetisch 
optimale Geometrie. Dies ist die erste Charakterisierung einer induzierten dreiarmigen RNS 
Kreuzung, die spezifisch durch einen supramolekularen Zylinder erkannt wurde.  
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Teil II 
Tertiärstrukturen grosser Polyanionen wie DNS oder gerade RNS (z.B. Ribozyme) schliessen 
eine hochkomplexe dreidimensionale Architektur ein, die Haarnadelstrukturen, Schlaufen und 
viele andere lokale Strukturen beinhalten. Zur Ladungskompensation und um den 
Nukleinsäuren eine Faltung in die native Struktur zu ermöglichen, sind mono- und divalente 
Metallionen wie Na+, K+, Mg2+, or Ca2+ eine Grundvoraussetzung. Spezifisch gebundene 
Metallionen koordinieren dabei mit hoher Selektivität an die Phosphatsauerstoffatome sowie 
an die verschiedenen funktionellen Gruppen der Nukleosidreste, wie Carbonylgruppen, 
Ringstickstoffe oder Hydroxylgruppen. Nebst innersphere (direkt gebunden) Interaktionen ist 
ein weitreichendes Netzwerk an Wasserstoffbrücken durch outersphere (via ein Ligandatom) 
Koordination entscheidend um eine starke Bindung zu erreichen. 
Um den Ursprung dieser Selektivität aufzuklären erstellten wir eine neue Datenbank: MINAS 
- Metal Ions in Nucleic AcidS (Metallionen in Nukleinsäurestrukturen) beinhaltet die exakten 
geometrischen Informationen über Liganden der ersten (innersphere) und zweiten 
(outersphere) Koordinationssphäre jedes Metallions in Nukleinsäurestrukturen, die in der 
PDB abgelegt sind. Das Einschliessen der zweiten Koordinationssphäre in der MINAS 
Datenbank erlaubt somit ein erstes Mal auch den Effekt weiter entfernter Liganden auf die 
Metallionenbindung zu beurteilen: Dies ist zum Beispiel wichtig, da in RNS Metallionen 
Katalyse über Distanzen von bis zu 20 Å beeinflussen können. Zusätzlich ermöglichen die 
Informationen über Nukletoide, die sich in der Nähe der Bindungstaschen befinden, eine 
detailierte Suche aller potentieller Ligandenkombinationen und aller möglichen 
Koordinationsbereiche von Metallionen. MINAS ist deshalb ein ideales neues Instrument um 
Metallionenbindungstaschen in Nukleinsäuren statistisch zu klassifizieren, allgemeine 
Schlussfolgerung über die verschiedenen Koordinationseigenschaften dieser Ionen zu ziehen 
und verschiedene Bindungsarten von Metallionen in Nukleinsäuren zu vergleichen.  
Die zweite Studie dieser Dissertation beinhaltet die Erstellung der MINAS Datenbank sowie 
die Auswertung der Bindungsstellen von nahezu 100'000 Metallionen verschiedener 
Nukleinsäurestrukturen. Diese globale Strukturenanalyse zeigt die bevorzugten 
Bindungsstellen für verschiedene Metallionen. Die Daten zeigen erwartete Präferenzen für 
Liganden, die sich für Alkali-, Erdalkali- und Übergangsmetalle unterscheiden. Das 
anionische Phosphatrückgrat ist die häufigste Bindungsstelle für Metalle in Nukleinsäuren, 
besonders für Mg2+, dem häufigsten Metallion in der MINAS Datenbank mit über 70'000 
Einträgen. Bis zu vier gleichzeitige Koordinationen zu Phosphatsauerstoffatomen wurden 
gefunden. Des Weiteren zeichnet sich die Hoogsteen Seite von Guanin als die häufigste 
ungeladene Bindungsstelle aus. Ihre Wasserstoffbrücken-Donor-Eigenschaft macht N7 und 
O6 zu perfekten Liganden für Metallionenkoordination. 
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In der letzten Studie dieser Dissertation wurden Kationen-π und Anionen-π 
Wechselwirkungen innerhalb von Nukleinsäuren untersucht. Diese nichtkovalenten 
molekularen Wechselwirkungen wurden z.B in kleinen aromatischen Molekülen, die mit 
Metallionen interagieren, sowie in der Anordnung von Kristallstrukturen beobachtet. Im 
biomolekularen Kontext spielen Ionen-π Bindungen eine wichtige Rolle indem sie den 
Transport von Metallionen durch Ionenkanäle ermöglichen oder zu einer erfolgreichen 
Ligand-Rezeptorerkennung beitragen. Erkennung von Nukleinsäuren durch geladene 
Seitenketten von Proteinen kann ebenfalls durch Kationen-π Wechselwirkungen stattfinden. 
Um das Ausmass der Kationen-π und Anionen-π Wechselwirkungen in DNS-und 
RNS-Systemen zu untersuchen, wurde eine Suche durch alle Nukleinsäurestrukturen die in 
der PDB abgelegt sind durchgeführt. Die automatisierte Analyse von tausenden von 
Nukleobasen zeigte, dass von allen negativ geladenen Spezies, die häufigste Anionen-π 
Wechselwirkung durch eine intramolekulare Interaktion von Phosphatsauerstoffatomen mit 
den π-Systemen von Nukleobasen auftritt. Kationen-π Interaktionen werden ebenfalls durch 
verschiedene Spezies eingegangen, einschliesslich einiger Metallionen. Den grössten Teil der 
Kationen-π Wechselwirkungen macht Arginin aus, dessen positiv geladene Seitenkette mit 
den Nukleobasen interagieren kann, wenn ein Protein an DNS oder an RNS bindet. 
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  # KEY `idAtom` (`idAtom`) 
# ) ENGINE=InnoDB AUTO_INCREMENT=71215957 DEFAULT CHARSET=latin1$$ 
############################################################################# 
# The tables on the server (database minasschatten)": 
# first the components table to insert all the resnames from the huge cif file downloaded at the PDB: 
############################################################################# 
# CREATE TABLE `components` ( 
  # `ID` int(11) unsigned NOT NULL auto_increment, 
  # `formula` text, 
  # `resName` char(3) default NULL, 
  # `rna` tinyint(1) unsigned NOT NULL default '0', 
  # `dna` tinyint(1) unsigned NOT NULL default '0', 
  # `purine` tinyint(1) unsigned NOT NULL default '0', 
  # `pyrimidine` tinyint(1) unsigned NOT NULL default '0', 
  # `adenine` tinyint(1) unsigned NOT NULL default '0', 
  # `cytosine` tinyint(1) unsigned NOT NULL default '0', 
  # `guanine` tinyint(1) unsigned NOT NULL default '0', 
  # `inosine` tinyint(1) unsigned NOT NULL default '0', 
  # `thymine` tinyint(1) unsigned NOT NULL default '0', 
  # `uracil` tinyint(1) unsigned NOT NULL default '0', 
  # `terminal` tinyint(1) unsigned NOT NULL default '0', 
  # `name` text, 
  # `parentRes` char(3) default NULL, 
  # PRIMARY KEY  (`ID`) 
# ) ENGINE=InnoDB AUTO_INCREMENT=13537 DEFAULT CHARSET=latin1$$ 
############################################################################# 
############################################################################# 
# "CREATE TABLE `pi_header` ( 
  # `idCode` varchar(4) NOT NULL, 
  # `classification` text, 
  # `depDate` varchar(9) default NULL, 
  # `creation_date` timestamp NOT NULL default CURRENT_TIMESTAMP, 
  # `start_stacksearch` datetime default NULL, 
  # `calctime` double default NULL, 
  # `purineplanedist` double default NULL, 
  # `purinesugardist` double default NULL, 
  # `purineperpendiculardist` double default NULL, 
  # `pyrimidineplanedist` double default NULL, 
  # `pyrimidinesugardist` double default NULL, 
  # `pyrimidineperpendiculardist` double default NULL, 
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  # KEY `idAtom` (`idAtom`) 
# ) ENGINE=InnoDB AUTO_INCREMENT=71215957 DEFAULT CHARSET=latin1$$ 
############################################################################# 
# The tables on the server (database minasschatten)": 
# first the components table to insert all the resnames from the huge cif file downloaded at the PDB: 
############################################################################# 
# CREATE TABLE `components` ( 
  # `ID` int(11) unsigned NOT NULL auto_increment, 
  # `formula` text, 
  # `resName` char(3) default NULL, 
  # `rna` tinyint(1) unsigned NOT NULL default '0', 
  # `dna` tinyint(1) unsigned NOT NULL default '0', 
  # `purine` tinyint(1) unsigned NOT NULL default '0', 
  # `pyrimidine` tinyint(1) unsigned NOT NULL default '0', 
  # `adenine` tinyint(1) unsigned NOT NULL default '0', 
  # `cytosine` tinyint(1) unsigned NOT NULL default '0', 
  # `guanine` tinyint(1) unsigned NOT NULL default '0', 
  # `inosine` tinyint(1) unsigned NOT NULL default '0', 
  # `thymine` tinyint(1) unsigned NOT NULL default '0', 
  # `uracil` tinyint(1) unsigned NOT NULL default '0', 
  # `terminal` tinyint(1) unsigned NOT NULL default '0', 
  # `name` text, 
  # `parentRes` char(3) default NULL, 
  # PRIMARY KEY  (`ID`) 
# ) ENGINE=InnoDB AUTO_INCREMENT=13537 DEFAULT CHARSET=latin1$$ 
############################################################################# 
############################################################################# 
# "CREATE TABLE `pi_header` ( 
  # `idCode` varchar(4) NOT NULL, 
  # `classification` text, 
  # `depDate` varchar(9) default NULL, 
  # `creation_date` timestamp NOT NULL default CURRENT_TIMESTAMP, 
  # `start_stacksearch` datetime default NULL, 
  # `calctime` double default NULL, 
  # `purineplanedist` double default NULL, 
  # `purinesugardist` double default NULL, 
  # `purineperpendiculardist` double default NULL, 
  # `pyrimidineplanedist` double default NULL, 
  # `pyrimidinesugardist` double default NULL, 
  # `pyrimidineperpendiculardist` double default NULL, 
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  # `inosine` tinyint(1) unsigned default NULL, 
  # `thymine` tinyint(1) unsigned default NULL, 
  # `uracil` tinyint(1) unsigned default NULL, 
  # `normalvector_x` double default NULL, 
  # `sugarvector_x` double default NULL, 
  # `perpendicularvector_x` double default NULL, 
  # `centroid_x` double default NULL, 
  # `centroid_y` double default NULL, 
  # `centroid_z` double default NULL, 
  # `perpendicularvector_y` double default NULL, 
  # `perpendicularvector_z` double default NULL, 
  # `normalvector_y` double default NULL, 
  # `normalvector_z` double default NULL, 
  # `sugarvector_z` double default NULL, 
  # `sugarvector_y` double default NULL, 
  # `iCode` char(1) default '', 
  # PRIMARY KEY  (`ID`), 
  # KEY `idCode` (`idCode`), 
  # CONSTRAINT `FK_pi_bases` FOREIGN KEY (`idCode`) REFERENCES `pi_header` (`idCode`) ON DELETE CASCADE 
# ) ENGINE=InnoDB AUTO_INCREMENT=1099236 DEFAULT CHARSET=latin1$$ 
############################################################################# 
 #pi_clusters and pi_sequences for redundancies (calculated with CD HIT-EST) 
############################################################################# 
# CREATE TABLE `pi_clusters` ( 
  # `ID` int(10) unsigned NOT NULL auto_increment, 
  # `idCode` varchar(4) NOT NULL, 
  # `ChainID` char(1) default NULL, 
  # `clusterno` smallint(7) unsigned default '0', 
  # `clustersize` smallint(7) unsigned default '0', 
  # `is_parent` tinyint(1) unsigned default NULL, 
  # `similarity` tinyint(3) unsigned default '0', 
  # `chainlength` mediumint(7) unsigned default '0', 
  # `resolution` double default '0', 
  # `minas_ExpData` text, 
  # `dominant` tinyint(1) unsigned default NULL, 
  # PRIMARY KEY  (`ID`), 
  # KEY `pi_bases_index` (`idCode`) 
# ) ENGINE=InnoDB AUTO_INCREMENT=98111 DEFAULT CHARSET=latin1$$ 
############################################################################ 
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  # `inosine` tinyint(1) unsigned default NULL, 
  # `thymine` tinyint(1) unsigned default NULL, 
  # `uracil` tinyint(1) unsigned default NULL, 
  # `normalvector_x` double default NULL, 
  # `sugarvector_x` double default NULL, 
  # `perpendicularvector_x` double default NULL, 
  # `centroid_x` double default NULL, 
  # `centroid_y` double default NULL, 
  # `centroid_z` double default NULL, 
  # `perpendicularvector_y` double default NULL, 
  # `perpendicularvector_z` double default NULL, 
  # `normalvector_y` double default NULL, 
  # `normalvector_z` double default NULL, 
  # `sugarvector_z` double default NULL, 
  # `sugarvector_y` double default NULL, 
  # `iCode` char(1) default '', 
  # PRIMARY KEY  (`ID`), 
  # KEY `idCode` (`idCode`), 
  # CONSTRAINT `FK_pi_bases` FOREIGN KEY (`idCode`) REFERENCES `pi_header` (`idCode`) ON DELETE CASCADE 
# ) ENGINE=InnoDB AUTO_INCREMENT=1099236 DEFAULT CHARSET=latin1$$ 
############################################################################# 
 #pi_clusters and pi_sequences for redundancies (calculated with CD HIT-EST) 
############################################################################# 
# CREATE TABLE `pi_clusters` ( 
  # `ID` int(10) unsigned NOT NULL auto_increment, 
  # `idCode` varchar(4) NOT NULL, 
  # `ChainID` char(1) default NULL, 
  # `clusterno` smallint(7) unsigned default '0', 
  # `clustersize` smallint(7) unsigned default '0', 
  # `is_parent` tinyint(1) unsigned default NULL, 
  # `similarity` tinyint(3) unsigned default '0', 
  # `chainlength` mediumint(7) unsigned default '0', 
  # `resolution` double default '0', 
  # `minas_ExpData` text, 
  # `dominant` tinyint(1) unsigned default NULL, 
  # PRIMARY KEY  (`ID`), 
  # KEY `pi_bases_index` (`idCode`) 
# ) ENGINE=InnoDB AUTO_INCREMENT=98111 DEFAULT CHARSET=latin1$$ 
############################################################################ 
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  # KEY `idCode` (`idCode`), 
  # KEY `IDRes` (`IDRes`), 
  # CONSTRAINT `FK_pi_stackatom` FOREIGN KEY (`IDRes`) REFERENCES `pi_stackresidue` (`ID`) ON DELETE CASCADE 
# ) ENGINE=InnoDB AUTO_INCREMENT=7668775 DEFAULT CHARSET=latin1$$ 
############################################################################# 
 ############################################################################# 
# CREATE TABLE `pi_stackresidue` ( 
  # `ID` int(10) unsigned NOT NULL auto_increment, 
  # `IDBase` int(10) unsigned NOT NULL, 
  # `idCode` varchar(4) NOT NULL default '', 
  # `resName` char(3) default NULL, 
  # `ChainID` char(1) default NULL, 
  # `resSeq` bigint(8) default NULL, 
  # `isclone` int(10) unsigned NOT NULL default '0', 
  # `positive` tinyint(1) unsigned default NULL, 
  # `negative` tinyint(1) unsigned default NULL, 
  # `neutral` tinyint(1) unsigned default NULL, 
  # `normalvector_x` double default NULL, 
  # `normalvector_y` double default NULL, 
  # `normalvector_z` double default NULL, 
  # `tilt_angle` double default NULL, 
  # PRIMARY KEY  (`ID`), 
  # KEY `idCode` (`idCode`), 
  # KEY `FK_pi_stackresidue` (`IDBase`), 
  # CONSTRAINT `FK_pi_stackresidue` FOREIGN KEY (`IDBase`) REFERENCES `pi_bases` (`ID`) ON DELETE CASCADE 
# ) ENGINE=InnoDB AUTO_INCREMENT=5002738 DEFAULT CHARSET=latin1$$ 
############################################################################# 
 use strict; 
use warnings; 
use File::Copy; 
use Term::ANSIColor qw(:constants); 
 # PERL MODULE WE WILL BE USING for the whole mysql stuff 
#con.ConnectionString = "server=" & "localhost" & ";" & "user id=" & "********" & ";" & "password=" & "********" & ";" 
& "database=minas_pi" 
use DBI; #install DBI through cpan (linux shell: type (sudo) cpan, then when able to enter a command, type install 
"DBI") 
us
e 
DB
D:
:m
ys
ql
; 
#i
ns
ta
ll
 a
ls
o 
DB
D 
(i
f 
cp
an
 f
ai
ls
, 
us
e 
th
e 
se
ar
ch
: 
 "
su
do
 a
pt
-c
ac
he
 s
ea
rc
h 
pe
rl
 D
BD
::
my
sq
l"
 a
nd
 t
he
n 
in
st
al
l 
th
e 
fo
un
d 
mo
du
le
 "
su
do
 a
pt
-g
et
 i
ns
ta
ll
 l
ib
db
d-
my
sq
l-
pe
rl
")
 
us
e 
Sw
it
ch
; 
us
e 
Lo
g:
:L
og
4p
er
l;
 #
#i
ns
ta
ll
l 
wi
th
 u
bu
nt
u:
 "
su
do
 a
pt
-g
et
 i
ns
ta
ll
 l
ib
lo
g-
lo
g4
pe
rl
-p
er
l"
 
us
e 
Ti
me
::
Hi
Re
s 
qw
/ 
ti
me
 s
le
ep
 /
; 
 my
 $
PD
B_
fi
le
_c
ou
nt
er
=0
; 
ST
AR
T:
 
 my
 $
st
ar
t;
 
my
 $
en
d;
 
$s
ta
rt
 =
 t
im
e;
 
my
 $
ha
s_
an
y_
st
ac
ke
rs
_i
n_
PD
B=
0;
 
 ##
fo
rg
et
 a
bo
ut
 c
re
at
in
g 
th
e 
ti
me
 h
er
e:
 j
us
t 
sa
y 
in
 S
QL
: 
UP
DA
TE
 *
**
**
**
*.
pi
_h
ea
de
r 
SE
T 
st
ar
t_
st
ac
ks
ea
rc
h 
= 
NO
W(
) 
#m
y 
($
se
c,
$m
in
,$
ho
ur
,$
md
ay
,$
mo
n,
$y
ea
r,
$w
da
y,
$y
da
y,
$i
sd
st
)=
lo
ca
lt
im
e(
ti
me
);
 
#$
ye
ar
=$
ye
ar
+1
90
0;
 
#$
mo
n=
$m
on
+1
; 
#m
y 
$u
pl
oa
dt
im
e 
=$
ye
ar
."
-"
.$
mo
n.
"-
".
$m
da
y.
" 
".
$h
ou
r.
":
".
$m
in
."
:"
.$
se
c;
 
#p
ri
nt
 $
up
lo
ad
ti
me
; 
  ##
lo
gf
il
e 
pr
ep
ar
at
io
ns
m 
wi
th
 s
cr
ee
n 
ou
tp
ut
, 
lo
gf
il
e 
ou
tp
ut
 a
nd
 t
od
b.
lo
g 
a 
sp
ec
ia
l 
fi
le
 o
nl
y 
re
ce
iv
in
g 
li
ne
s 
th
at
 g
o 
to
 
th
e 
db
 e
ve
nt
ua
ll
y.
 
my
 $
lo
gf
il
en
am
e 
= 
"$
0.
lo
g"
; 
my
 $
db
lo
gf
il
en
am
e 
= 
"t
od
b.
lo
g"
; 
my
 $
lo
g_
co
nf
 =
 q
q(
  
  
  
lo
g4
pe
rl
.c
at
eg
or
y 
= 
DE
BU
G,
 L
og
fi
le
, 
Sc
re
en
 
  
  
lo
g4
pe
rl
.l
og
ge
r.
db
 =
 D
EB
UG
, 
db
Ap
pe
nd
er
 
  
  
  
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Lo
gf
il
e 
= 
Lo
g:
:L
og
4p
er
l:
:A
pp
en
de
r:
:F
il
e 
 
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Lo
gf
il
e.
fi
le
na
me
 =
 $
lo
gf
il
en
am
e 
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Lo
gf
il
e.
mo
de
 =
 a
pp
en
d 
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Lo
gf
il
e.
st
de
rr
 =
 0
 
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Lo
gf
il
e.
la
yo
ut
 =
 L
og
::
Lo
g4
pe
rl
::
La
yo
ut
::
Pa
tt
er
nL
ay
ou
t 
 
lo
g4
pe
rl
.a
pp
en
de
r.
Lo
gf
il
e.
la
yo
ut
.C
on
ve
rs
io
nP
at
te
rn
 =
 %
d 
%p
> 
%m
%n
 
   
  
  
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Sc
re
en
  
  
  
  
= 
Lo
g:
:L
og
4p
er
l:
:A
pp
en
de
r:
:S
cr
ee
n 
 
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Sc
re
en
.l
ay
ou
t 
= 
Lo
g:
:L
og
4p
er
l:
:L
ay
ou
t:
:P
at
te
rn
La
yo
ut
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  # KEY `idCode` (`idCode`), 
  # KEY `IDRes` (`IDRes`), 
  # CONSTRAINT `FK_pi_stackatom` FOREIGN KEY (`IDRes`) REFERENCES `pi_stackresidue` (`ID`) ON DELETE CASCADE 
# ) ENGINE=InnoDB AUTO_INCREMENT=7668775 DEFAULT CHARSET=latin1$$ 
############################################################################# 
 ############################################################################# 
# CREATE TABLE `pi_stackresidue` ( 
  # `ID` int(10) unsigned NOT NULL auto_increment, 
  # `IDBase` int(10) unsigned NOT NULL, 
  # `idCode` varchar(4) NOT NULL default '', 
  # `resName` char(3) default NULL, 
  # `ChainID` char(1) default NULL, 
  # `resSeq` bigint(8) default NULL, 
  # `isclone` int(10) unsigned NOT NULL default '0', 
  # `positive` tinyint(1) unsigned default NULL, 
  # `negative` tinyint(1) unsigned default NULL, 
  # `neutral` tinyint(1) unsigned default NULL, 
  # `normalvector_x` double default NULL, 
  # `normalvector_y` double default NULL, 
  # `normalvector_z` double default NULL, 
  # `tilt_angle` double default NULL, 
  # PRIMARY KEY  (`ID`), 
  # KEY `idCode` (`idCode`), 
  # KEY `FK_pi_stackresidue` (`IDBase`), 
  # CONSTRAINT `FK_pi_stackresidue` FOREIGN KEY (`IDBase`) REFERENCES `pi_bases` (`ID`) ON DELETE CASCADE 
# ) ENGINE=InnoDB AUTO_INCREMENT=5002738 DEFAULT CHARSET=latin1$$ 
############################################################################# 
 use strict; 
use warnings; 
use File::Copy; 
use Term::ANSIColor qw(:constants); 
 # PERL MODULE WE WILL BE USING for the whole mysql stuff 
#con.ConnectionString = "server=" & "localhost" & ";" & "user id=" & "********" & ";" & "password=" & "********" & ";" 
& "database=minas_pi" 
use DBI; #install DBI through cpan (linux shell: type (sudo) cpan, then when able to enter a command, type install 
"DBI") 
us
e 
DB
D:
:m
ys
ql
; 
#i
ns
ta
ll
 a
ls
o 
DB
D 
(i
f 
cp
an
 f
ai
ls
, 
us
e 
th
e 
se
ar
ch
: 
 "
su
do
 a
pt
-c
ac
he
 s
ea
rc
h 
pe
rl
 D
BD
::
my
sq
l"
 a
nd
 t
he
n 
in
st
al
l 
th
e 
fo
un
d 
mo
du
le
 "
su
do
 a
pt
-g
et
 i
ns
ta
ll
 l
ib
db
d-
my
sq
l-
pe
rl
")
 
us
e 
Sw
it
ch
; 
us
e 
Lo
g:
:L
og
4p
er
l;
 #
#i
ns
ta
ll
l 
wi
th
 u
bu
nt
u:
 "
su
do
 a
pt
-g
et
 i
ns
ta
ll
 l
ib
lo
g-
lo
g4
pe
rl
-p
er
l"
 
us
e 
Ti
me
::
Hi
Re
s 
qw
/ 
ti
me
 s
le
ep
 /
; 
 my
 $
PD
B_
fi
le
_c
ou
nt
er
=0
; 
ST
AR
T:
 
 my
 $
st
ar
t;
 
my
 $
en
d;
 
$s
ta
rt
 =
 t
im
e;
 
my
 $
ha
s_
an
y_
st
ac
ke
rs
_i
n_
PD
B=
0;
 
 ##
fo
rg
et
 a
bo
ut
 c
re
at
in
g 
th
e 
ti
me
 h
er
e:
 j
us
t 
sa
y 
in
 S
QL
: 
UP
DA
TE
 *
**
**
**
*.
pi
_h
ea
de
r 
SE
T 
st
ar
t_
st
ac
ks
ea
rc
h 
= 
NO
W(
) 
#m
y 
($
se
c,
$m
in
,$
ho
ur
,$
md
ay
,$
mo
n,
$y
ea
r,
$w
da
y,
$y
da
y,
$i
sd
st
)=
lo
ca
lt
im
e(
ti
me
);
 
#$
ye
ar
=$
ye
ar
+1
90
0;
 
#$
mo
n=
$m
on
+1
; 
#m
y 
$u
pl
oa
dt
im
e 
=$
ye
ar
."
-"
.$
mo
n.
"-
".
$m
da
y.
" 
".
$h
ou
r.
":
".
$m
in
."
:"
.$
se
c;
 
#p
ri
nt
 $
up
lo
ad
ti
me
; 
  ##
lo
gf
il
e 
pr
ep
ar
at
io
ns
m 
wi
th
 s
cr
ee
n 
ou
tp
ut
, 
lo
gf
il
e 
ou
tp
ut
 a
nd
 t
od
b.
lo
g 
a 
sp
ec
ia
l 
fi
le
 o
nl
y 
re
ce
iv
in
g 
li
ne
s 
th
at
 g
o 
to
 
th
e 
db
 e
ve
nt
ua
ll
y.
 
my
 $
lo
gf
il
en
am
e 
= 
"$
0.
lo
g"
; 
my
 $
db
lo
gf
il
en
am
e 
= 
"t
od
b.
lo
g"
; 
my
 $
lo
g_
co
nf
 =
 q
q(
  
  
  
lo
g4
pe
rl
.c
at
eg
or
y 
= 
DE
BU
G,
 L
og
fi
le
, 
Sc
re
en
 
  
  
lo
g4
pe
rl
.l
og
ge
r.
db
 =
 D
EB
UG
, 
db
Ap
pe
nd
er
 
  
  
  
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Lo
gf
il
e 
= 
Lo
g:
:L
og
4p
er
l:
:A
pp
en
de
r:
:F
il
e 
 
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Lo
gf
il
e.
fi
le
na
me
 =
 $
lo
gf
il
en
am
e 
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Lo
gf
il
e.
mo
de
 =
 a
pp
en
d 
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Lo
gf
il
e.
st
de
rr
 =
 0
 
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Lo
gf
il
e.
la
yo
ut
 =
 L
og
::
Lo
g4
pe
rl
::
La
yo
ut
::
Pa
tt
er
nL
ay
ou
t 
 
lo
g4
pe
rl
.a
pp
en
de
r.
Lo
gf
il
e.
la
yo
ut
.C
on
ve
rs
io
nP
at
te
rn
 =
 %
d 
%p
> 
%m
%n
 
   
  
  
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Sc
re
en
  
  
  
  
= 
Lo
g:
:L
og
4p
er
l:
:A
pp
en
de
r:
:S
cr
ee
n 
 
  
  
lo
g4
pe
rl
.a
pp
en
de
r.
Sc
re
en
.l
ay
ou
t 
= 
Lo
g:
:L
og
4p
er
l:
:L
ay
ou
t:
:P
at
te
rn
La
yo
ut
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    log4perl.appender.Screen.stderr = 0 
 
log4perl.appender.Screen.layout.ConversionPattern = %d %p> %m%n 
 
 
 
 log4perl.appender.dbAppender = Log::Log4perl::Appender::File 
 
 log4perl.appender.dbAppender.mode = write 
     log4perl.appender.dbAppender.filename = $dblogfilename 
     log4perl.appender.dbAppender.layout = Log::Log4perl::Layout::PatternLayout 
 
 log4perl.appender.dbAppender.layout.ConversionPattern = %d %p> %m%n 
 ); 
# MySQL CONFIG VARIABLES (plaintext of course) 
 my $purinebasedistance=4; 
my $purinesugardistance=2.5; 
my $purineperpendiculardistance=2; 
my $pyrimidinebasedistance=4; 
my $pyrimidinesugardistance=2; 
my $pyrimidineperpendiculardistance=2; 
 my $uzh_host = "mysql.uzh.ch"; 
my $uzh_database = "********"; 
my $uzh_tablename = "pi_header"; 
my $uzh_user = "********"; 
my $uzh_pw = "********"; 
 my $PDB_ID; 
 my $host = "130.60.152.28"; 
my $database = "minas_pi"; 
my $tablename = "atom"; 
my $user = "********"; 
my $pw = "********"; 
  Log::Log4perl::init( \$log_conf ); 
my $logger = Log::Log4perl::get_logger(); 
my $dblogger = Log::Log4perl::get_logger("db"); 
sub logfile {    
    open LOGFILE, ">>$logfilename" or die "cannot open logfile $logfilename for append:$!"; 
print LOGFILE "$_[0]", "\n"; 
cl
os
e 
LO
GF
IL
E;
 
} &l
og
fi
le
("
In
it
ia
li
zi
ng
 M
in
as
_p
i 
ca
lc
ul
at
io
ns
")
; 
&l
og
fi
le
("
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
")
; 
##
lo
gg
in
g 
go
es
 l
ik
e 
th
is
: 
 
 
 
 
 
 
 
 
 
--
--
--
--
--
--
in
si
de
 t
he
 l
og
fi
le
:-
--
--
--
--
--
--
--
--
 
##
# 
#$
lo
gg
er
->
in
fo
("
St
ar
ti
ng
 $
0"
);
 -
--
->
  
  
  
  
  
  
  
  
  
  
  
  
20
12
/0
1/
26
 1
3:
36
:3
9 
IN
FO
> 
St
ar
ti
ng
 l
og
ge
rt
es
t.
pl
 
#$
lo
gg
er
->
er
ro
r(
"B
ad
 t
hi
ng
 h
ap
pe
ne
d"
);
 -
--
->
  
  
  
  
  
  
  
  
20
12
/0
1/
26
 1
3:
36
:4
0 
ER
RO
R>
 B
ad
 t
hi
ng
 h
ap
pe
ne
d 
  
  
  
  
 
##
#p
ri
nt
s 
to
 l
og
fi
le
 w
it
ho
ut
 t
he
 t
im
e 
an
d 
da
te
: 
  
  
  
  
  
  
  
  
  
  
  
 
#&
lo
gf
il
e(
"n
ot
hi
ng
 h
ap
pe
ne
d 
he
re
!"
);
 -
--
->
  
  
  
  
  
  
  
  
  
  
  
 n
ot
hi
ng
 h
ap
pe
ne
d 
he
re
! 
  
  
#$
db
lo
gg
er
->
fa
ta
l(
"t
o 
to
db
.l
og
 &
 s
ta
nd
ar
d 
lo
g!
 "
);
 -
--
->
  
  
20
12
/0
1/
26
 1
3:
36
:4
0 
FA
TA
L>
 t
o 
to
db
.l
og
 &
 s
ta
nd
ar
d 
lo
g!
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
#&
lo
gf
il
e(
"-
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-
--
--
--
--
--
--
")
; 
 su
b 
er
ro
r_
to
_p
i_
he
ad
er
 
{  my
 $
er
ro
r_
db
h 
= 
DB
I-
>c
on
ne
ct
("
db
i:
my
sq
l:
$u
zh
_d
at
ab
as
e:
$u
zh
_h
os
t"
, 
$u
zh
_u
se
r,
 $
uz
h_
pw
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Oh
 n
o!
!!
 
co
ul
d 
no
t 
co
nn
ec
t 
to
 $
uz
h_
da
ta
ba
se
: 
$D
BI
::
er
rs
tr
")
; 
 
 
 
my
 $
er
ro
r_
up
da
te
 =
 "
UP
DA
TE
 "
.$
uz
h_
da
ta
ba
se
."
.p
i_
he
ad
er
 S
ET
 S
av
eO
k 
= 
2 
WH
ER
E 
id
Co
de
 =
 '
$P
DB
_I
D'
";
 
my
 $
st
h_
er
ro
r 
= 
$e
rr
or
_d
bh
->
pr
ep
ar
e(
$e
rr
or
_u
pd
at
e)
 |
| 
$l
og
ge
r-
>l
og
di
e(
"P
re
pa
ri
ng
 M
yS
QL
 u
pd
at
e 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
$s
th
_e
rr
or
->
ex
ec
ut
e(
);
 
 $s
th
_e
rr
or
->
fi
ni
sh
()
; 
$e
rr
or
_d
bh
->
di
sc
on
ne
ct
()
; 
  
 
$l
og
ge
r-
>e
rr
or
("
$P
DB
_I
D 
is
 e
rr
on
eo
us
 o
r 
a 
di
ff
er
en
t 
pr
ob
le
m 
oc
cu
re
d,
 a
 S
av
eO
K=
2 
en
tr
y 
wa
s 
ma
de
 t
o 
th
e 
pi
_h
ea
de
r"
);
 
##
no
w 
le
ts
 r
es
ta
rt
 w
it
h 
th
e 
ne
xt
 P
DB
 F
il
e 
go
to
 S
TA
RT
; 
 
}  ##
##
##
##
##
##
##
##
##
 
  
  
# 
PE
RL
 M
YS
QL
 C
ON
NE
CT
 
##
##
HE
AD
ER
 o
f 
**
**
**
**
.p
i_
he
ad
er
 c
he
ck
 f
or
 n
ot
 y
et
 p
ro
ce
ss
ed
 f
il
es
: 
 
   m
y 
$p
i_
he
ad
er
_o
pe
n_
db
h 
= 
DB
I-
>c
on
ne
ct
("
db
i:
my
sq
l:
$u
zh
_d
at
ab
as
e:
$u
zh
_h
os
t"
, 
$u
zh
_u
se
r,
 $
uz
h_
pw
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Oh
 
no
!!
! 
co
ul
d 
no
t 
co
nn
ec
t 
to
 $
uz
h_
da
ta
ba
se
: 
$D
BI
::
er
rs
tr
")
; 
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    log4perl.appender.Screen.stderr = 0 
 
log4perl.appender.Screen.layout.ConversionPattern = %d %p> %m%n 
 
 
 
 log4perl.appender.dbAppender = Log::Log4perl::Appender::File 
 
 log4perl.appender.dbAppender.mode = write 
     log4perl.appender.dbAppender.filename = $dblogfilename 
     log4perl.appender.dbAppender.layout = Log::Log4perl::Layout::PatternLayout 
 
 log4perl.appender.dbAppender.layout.ConversionPattern = %d %p> %m%n 
 ); 
# MySQL CONFIG VARIABLES (plaintext of course) 
 my $purinebasedistance=4; 
my $purinesugardistance=2.5; 
my $purineperpendiculardistance=2; 
my $pyrimidinebasedistance=4; 
my $pyrimidinesugardistance=2; 
my $pyrimidineperpendiculardistance=2; 
 my $uzh_host = "mysql.uzh.ch"; 
my $uzh_database = "********"; 
my $uzh_tablename = "pi_header"; 
my $uzh_user = "********"; 
my $uzh_pw = "********"; 
 my $PDB_ID; 
 my $host = "130.60.152.28"; 
my $database = "minas_pi"; 
my $tablename = "atom"; 
my $user = "********"; 
my $pw = "********"; 
  Log::Log4perl::init( \$log_conf ); 
my $logger = Log::Log4perl::get_logger(); 
my $dblogger = Log::Log4perl::get_logger("db"); 
sub logfile {    
    open LOGFILE, ">>$logfilename" or die "cannot open logfile $logfilename for append:$!"; 
print LOGFILE "$_[0]", "\n"; 
cl
os
e 
LO
GF
IL
E;
 
} &l
og
fi
le
("
In
it
ia
li
zi
ng
 M
in
as
_p
i 
ca
lc
ul
at
io
ns
")
; 
&l
og
fi
le
("
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
")
; 
##
lo
gg
in
g 
go
es
 l
ik
e 
th
is
: 
 
 
 
 
 
 
 
 
 
--
--
--
--
--
--
in
si
de
 t
he
 l
og
fi
le
:-
--
--
--
--
--
--
--
--
 
##
# 
#$
lo
gg
er
->
in
fo
("
St
ar
ti
ng
 $
0"
);
 -
--
->
  
  
  
  
  
  
  
  
  
  
  
  
20
12
/0
1/
26
 1
3:
36
:3
9 
IN
FO
> 
St
ar
ti
ng
 l
og
ge
rt
es
t.
pl
 
#$
lo
gg
er
->
er
ro
r(
"B
ad
 t
hi
ng
 h
ap
pe
ne
d"
);
 -
--
->
  
  
  
  
  
  
  
  
20
12
/0
1/
26
 1
3:
36
:4
0 
ER
RO
R>
 B
ad
 t
hi
ng
 h
ap
pe
ne
d 
  
  
  
  
 
##
#p
ri
nt
s 
to
 l
og
fi
le
 w
it
ho
ut
 t
he
 t
im
e 
an
d 
da
te
: 
  
  
  
  
  
  
  
  
  
  
  
 
#&
lo
gf
il
e(
"n
ot
hi
ng
 h
ap
pe
ne
d 
he
re
!"
);
 -
--
->
  
  
  
  
  
  
  
  
  
  
  
 n
ot
hi
ng
 h
ap
pe
ne
d 
he
re
! 
  
  
#$
db
lo
gg
er
->
fa
ta
l(
"t
o 
to
db
.l
og
 &
 s
ta
nd
ar
d 
lo
g!
 "
);
 -
--
->
  
  
20
12
/0
1/
26
 1
3:
36
:4
0 
FA
TA
L>
 t
o 
to
db
.l
og
 &
 s
ta
nd
ar
d 
lo
g!
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
#&
lo
gf
il
e(
"-
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-
--
--
--
--
--
--
")
; 
 su
b 
er
ro
r_
to
_p
i_
he
ad
er
 
{  my
 $
er
ro
r_
db
h 
= 
DB
I-
>c
on
ne
ct
("
db
i:
my
sq
l:
$u
zh
_d
at
ab
as
e:
$u
zh
_h
os
t"
, 
$u
zh
_u
se
r,
 $
uz
h_
pw
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Oh
 n
o!
!!
 
co
ul
d 
no
t 
co
nn
ec
t 
to
 $
uz
h_
da
ta
ba
se
: 
$D
BI
::
er
rs
tr
")
; 
 
 
 
my
 $
er
ro
r_
up
da
te
 =
 "
UP
DA
TE
 "
.$
uz
h_
da
ta
ba
se
."
.p
i_
he
ad
er
 S
ET
 S
av
eO
k 
= 
2 
WH
ER
E 
id
Co
de
 =
 '
$P
DB
_I
D'
";
 
my
 $
st
h_
er
ro
r 
= 
$e
rr
or
_d
bh
->
pr
ep
ar
e(
$e
rr
or
_u
pd
at
e)
 |
| 
$l
og
ge
r-
>l
og
di
e(
"P
re
pa
ri
ng
 M
yS
QL
 u
pd
at
e 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
$s
th
_e
rr
or
->
ex
ec
ut
e(
);
 
 $s
th
_e
rr
or
->
fi
ni
sh
()
; 
$e
rr
or
_d
bh
->
di
sc
on
ne
ct
()
; 
  
 
$l
og
ge
r-
>e
rr
or
("
$P
DB
_I
D 
is
 e
rr
on
eo
us
 o
r 
a 
di
ff
er
en
t 
pr
ob
le
m 
oc
cu
re
d,
 a
 S
av
eO
K=
2 
en
tr
y 
wa
s 
ma
de
 t
o 
th
e 
pi
_h
ea
de
r"
);
 
##
no
w 
le
ts
 r
es
ta
rt
 w
it
h 
th
e 
ne
xt
 P
DB
 F
il
e 
go
to
 S
TA
RT
; 
 
}  ##
##
##
##
##
##
##
##
##
 
  
  
# 
PE
RL
 M
YS
QL
 C
ON
NE
CT
 
##
##
HE
AD
ER
 o
f 
**
**
**
**
.p
i_
he
ad
er
 c
he
ck
 f
or
 n
ot
 y
et
 p
ro
ce
ss
ed
 f
il
es
: 
 
   m
y 
$p
i_
he
ad
er
_o
pe
n_
db
h 
= 
DB
I-
>c
on
ne
ct
("
db
i:
my
sq
l:
$u
zh
_d
at
ab
as
e:
$u
zh
_h
os
t"
, 
$u
zh
_u
se
r,
 $
uz
h_
pw
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Oh
 
no
!!
! 
co
ul
d 
no
t 
co
nn
ec
t 
to
 $
uz
h_
da
ta
ba
se
: 
$D
BI
::
er
rs
tr
")
; 
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 my $pi_header_open_query = "SELECT idCode FROM ".$uzh_database.".".$uzh_tablename." WHERE in_progress = 0 AND SaveOk = 
0 limit 0,1"; 
  my $sth_pi_header_open = $pi_header_open_dbh->prepare($pi_header_open_query) || $logger->logdie("Preparing MySQL 
query failed: $DBI::errstr"); 
  $sth_pi_header_open->execute() || $logger->logdie("The execution of the MySQL query \"$pi_header_open_query\" failed: 
$DBI::errstr"); 
my $uzh_countrows;   
$uzh_countrows = $sth_pi_header_open->rows; 
  $logger->info("number of rows found: $uzh_countrows");     
if ($uzh_countrows == 0) 
{ $logger->info("The last PDB ID has been processed...");  
 
$logger->info("now shutting down, $PDB_file_counter Files have been processed. Bye."); 
exit;     
} my @affected_PDBs=$sth_pi_header_open->fetchrow(); 
 $PDB_ID =  $affected_PDBs[0]; 
 print $uzh_countrows; 
print "\n"; 
print $PDB_ID; 
print "\n"; 
my $pi_header_in_progress_update = "UPDATE ".$uzh_database.".".$uzh_tablename." SET in_progress = 1,purineplanedist = 
".$purinebasedistance.", 
purinesugardist = ".$purinesugardistance.", purineperpendiculardist = 
".$purineperpendiculardistance.",pyrimidineplanedist = ".$pyrimidinebasedistance.", 
pyrimidinesugardist = ".$pyrimidinesugardistance.", pyrimidineperpendiculardist = 
".$pyrimidineperpendiculardistance.",start_stacksearch = NOW() WHERE idCode = '$PDB_ID'"; 
$sth_pi_header_open = $pi_header_open_dbh->prepare($pi_header_in_progress_update) || $logger->logdie("Preparing MySQL 
update failed: $DBI::errstr"); 
$sth_pi_header_open->execute(); 
 $logger->info("header temporary update finished, ".$sth_pi_header_open->rows." row(s) changed in the pi_header 
table."); 
  $sth_pi_header_open->finish(); 
$p
i_
he
ad
er
_o
pe
n_
db
h-
>d
is
co
nn
ec
t(
);
  
  
  
  
  
   m
y 
$d
bh
 =
 D
BI
->
co
nn
ec
t(
"d
bi
:m
ys
ql
:$
da
ta
ba
se
:$
ho
st
",
 $
us
er
, 
$p
w)
 |
| 
$l
og
ge
r-
>l
og
di
e(
"O
h 
no
!!
! 
co
ul
d 
no
t 
co
nn
ec
t 
to
 
da
ta
ba
se
: 
$D
BI
::
er
rs
tr
")
; 
 #
ch
ec
k 
we
th
er
 P
DB
 f
il
e 
al
re
ad
y 
in
 d
at
ab
as
e,
 i
f 
ye
s,
 d
el
et
e 
it
 f
ro
m 
da
ta
ba
se
 
  
my
 $
qu
er
y_
fo
r_
PD
B_
ID
 =
 "
SE
LE
CT
 i
dC
od
e,
se
ri
al
,n
am
e,
re
sN
am
e,
Ch
ai
nI
D,
re
sS
eq
,x
,y
,z
,e
le
me
nt
,I
D,
at
om
,a
lt
Lo
c,
 i
Co
de
, 
oc
cu
pa
nc
y,
 t
em
pF
ac
to
r,
 s
eg
ID
, 
ch
ar
ge
 
  
 
 
 
 
 
 
  
fr
om
 "
.$
da
ta
ba
se
."
."
.$
ta
bl
en
am
e.
" 
WH
ER
E 
id
Co
de
 =
 '
".
$P
DB
_I
D.
"'
";
 
  
my
 $
st
h_
PD
B_
ID
 =
 $
db
h-
>p
re
pa
re
($
qu
er
y_
fo
r_
PD
B_
ID
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Pr
ep
ar
in
g 
My
SQ
L 
qu
er
y 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
  
$s
th
_P
DB
_I
D-
>e
xe
cu
te
()
 |
| 
$l
og
ge
r-
>l
og
di
e(
"T
he
 e
xe
cu
ti
on
 o
f 
th
e 
My
SQ
L 
qu
er
y 
\"
$q
ue
ry
_f
or
_P
DB
_I
D\
" 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
my
 $
co
un
tr
ow
s;
  
 
$c
ou
nt
ro
ws
 =
 $
st
h_
PD
B_
ID
->
ro
ws
; 
$l
og
ge
r-
>i
nf
o(
"n
um
be
r 
of
 r
ow
s 
fo
r 
$P
DB
_I
D 
fo
un
d:
 $
co
un
tr
ow
s"
);
 
 if
 (
$c
ou
nt
ro
ws
 =
= 
0)
 
{  
##
#e
rr
or
 a
nd
 n
ex
t 
PD
B 
ID
!!
! 
 
$l
og
ge
r-
>e
rr
or
("
no
 a
to
ms
 f
ou
nd
 f
or
 t
he
 P
DB
 f
il
e 
$P
DB
_I
D.
 M
ak
in
g 
an
 e
rr
or
 e
nt
ry
 a
nd
 t
ak
in
g 
ne
xt
 f
il
e!
")
; 
 
 
&e
rr
or
_t
o_
pi
_h
ea
de
r;
 
 
$s
th
_P
DB
_I
D-
>f
in
is
h(
);
 
 
$d
bh
->
di
sc
on
ne
ct
()
; 
 
 
go
to
 S
TA
RT
; 
} my
 $
re
f 
= 
$s
th
_P
DB
_I
D-
>f
et
ch
al
l_
ar
ra
yr
ef
; 
 $s
th
_P
DB
_I
D-
>f
in
is
h(
);
 
  m
y 
$s
th
_p
ur
in
es
; 
 
 
 
  
my
 $
qu
er
yr
na
_p
ur
in
es
 =
 "
SE
LE
CT
 *
 F
RO
M 
".
$d
at
ab
as
e.
".
co
mp
on
en
ts
 W
HE
RE
 (
rn
a 
= 
1 
or
 d
na
 =
 1
) 
an
d 
pu
ri
ne
 =
 1
";
 
 
 
 
  
$s
th
_p
ur
in
es
 =
 $
db
h-
>p
re
pa
re
($
qu
er
yr
na
_p
ur
in
es
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Pr
ep
ar
in
g 
My
SQ
L 
qu
er
y 
wi
th
 
\"
$q
ue
ry
rn
a_
pu
ri
ne
s\
" 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
 
 
 
  
$s
th
_p
ur
in
es
->
ex
ec
ut
e(
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Th
e 
ex
ec
ut
io
n 
of
 t
he
 M
yS
QL
 q
ue
ry
 \
"$
qu
er
yr
na
_p
ur
in
es
\"
 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
 
 
 
my
 $
co
un
tr
na
_p
ur
in
es
 =
 $
st
h_
pu
ri
ne
s-
>r
ow
s;
 
# 
 
 
pr
in
t 
GR
EE
N,
 "
to
ta
l 
di
ff
er
en
t 
na
me
s 
fo
r 
pu
ri
ne
s 
in
 t
he
 w
ho
le
 P
DB
:"
.$
co
un
tr
na
_p
ur
in
es
."
\n
",
 R
ES
ET
; 
# 
 
 
pr
in
t 
"\
n"
; 
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 my $pi_header_open_query = "SELECT idCode FROM ".$uzh_database.".".$uzh_tablename." WHERE in_progress = 0 AND SaveOk = 
0 limit 0,1"; 
  my $sth_pi_header_open = $pi_header_open_dbh->prepare($pi_header_open_query) || $logger->logdie("Preparing MySQL 
query failed: $DBI::errstr"); 
  $sth_pi_header_open->execute() || $logger->logdie("The execution of the MySQL query \"$pi_header_open_query\" failed: 
$DBI::errstr"); 
my $uzh_countrows;   
$uzh_countrows = $sth_pi_header_open->rows; 
  $logger->info("number of rows found: $uzh_countrows");     
if ($uzh_countrows == 0) 
{ $logger->info("The last PDB ID has been processed...");  
 
$logger->info("now shutting down, $PDB_file_counter Files have been processed. Bye."); 
exit;     
} my @affected_PDBs=$sth_pi_header_open->fetchrow(); 
 $PDB_ID =  $affected_PDBs[0]; 
 print $uzh_countrows; 
print "\n"; 
print $PDB_ID; 
print "\n"; 
my $pi_header_in_progress_update = "UPDATE ".$uzh_database.".".$uzh_tablename." SET in_progress = 1,purineplanedist = 
".$purinebasedistance.", 
purinesugardist = ".$purinesugardistance.", purineperpendiculardist = 
".$purineperpendiculardistance.",pyrimidineplanedist = ".$pyrimidinebasedistance.", 
pyrimidinesugardist = ".$pyrimidinesugardistance.", pyrimidineperpendiculardist = 
".$pyrimidineperpendiculardistance.",start_stacksearch = NOW() WHERE idCode = '$PDB_ID'"; 
$sth_pi_header_open = $pi_header_open_dbh->prepare($pi_header_in_progress_update) || $logger->logdie("Preparing MySQL 
update failed: $DBI::errstr"); 
$sth_pi_header_open->execute(); 
 $logger->info("header temporary update finished, ".$sth_pi_header_open->rows." row(s) changed in the pi_header 
table."); 
  $sth_pi_header_open->finish(); 
$p
i_
he
ad
er
_o
pe
n_
db
h-
>d
is
co
nn
ec
t(
);
  
  
  
  
  
   m
y 
$d
bh
 =
 D
BI
->
co
nn
ec
t(
"d
bi
:m
ys
ql
:$
da
ta
ba
se
:$
ho
st
",
 $
us
er
, 
$p
w)
 |
| 
$l
og
ge
r-
>l
og
di
e(
"O
h 
no
!!
! 
co
ul
d 
no
t 
co
nn
ec
t 
to
 
da
ta
ba
se
: 
$D
BI
::
er
rs
tr
")
; 
 #
ch
ec
k 
we
th
er
 P
DB
 f
il
e 
al
re
ad
y 
in
 d
at
ab
as
e,
 i
f 
ye
s,
 d
el
et
e 
it
 f
ro
m 
da
ta
ba
se
 
  
my
 $
qu
er
y_
fo
r_
PD
B_
ID
 =
 "
SE
LE
CT
 i
dC
od
e,
se
ri
al
,n
am
e,
re
sN
am
e,
Ch
ai
nI
D,
re
sS
eq
,x
,y
,z
,e
le
me
nt
,I
D,
at
om
,a
lt
Lo
c,
 i
Co
de
, 
oc
cu
pa
nc
y,
 t
em
pF
ac
to
r,
 s
eg
ID
, 
ch
ar
ge
 
  
 
 
 
 
 
 
  
fr
om
 "
.$
da
ta
ba
se
."
."
.$
ta
bl
en
am
e.
" 
WH
ER
E 
id
Co
de
 =
 '
".
$P
DB
_I
D.
"'
";
 
  
my
 $
st
h_
PD
B_
ID
 =
 $
db
h-
>p
re
pa
re
($
qu
er
y_
fo
r_
PD
B_
ID
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Pr
ep
ar
in
g 
My
SQ
L 
qu
er
y 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
  
$s
th
_P
DB
_I
D-
>e
xe
cu
te
()
 |
| 
$l
og
ge
r-
>l
og
di
e(
"T
he
 e
xe
cu
ti
on
 o
f 
th
e 
My
SQ
L 
qu
er
y 
\"
$q
ue
ry
_f
or
_P
DB
_I
D\
" 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
my
 $
co
un
tr
ow
s;
  
 
$c
ou
nt
ro
ws
 =
 $
st
h_
PD
B_
ID
->
ro
ws
; 
$l
og
ge
r-
>i
nf
o(
"n
um
be
r 
of
 r
ow
s 
fo
r 
$P
DB
_I
D 
fo
un
d:
 $
co
un
tr
ow
s"
);
 
 if
 (
$c
ou
nt
ro
ws
 =
= 
0)
 
{  
##
#e
rr
or
 a
nd
 n
ex
t 
PD
B 
ID
!!
! 
 
$l
og
ge
r-
>e
rr
or
("
no
 a
to
ms
 f
ou
nd
 f
or
 t
he
 P
DB
 f
il
e 
$P
DB
_I
D.
 M
ak
in
g 
an
 e
rr
or
 e
nt
ry
 a
nd
 t
ak
in
g 
ne
xt
 f
il
e!
")
; 
 
 
&e
rr
or
_t
o_
pi
_h
ea
de
r;
 
 
$s
th
_P
DB
_I
D-
>f
in
is
h(
);
 
 
$d
bh
->
di
sc
on
ne
ct
()
; 
 
 
go
to
 S
TA
RT
; 
} my
 $
re
f 
= 
$s
th
_P
DB
_I
D-
>f
et
ch
al
l_
ar
ra
yr
ef
; 
 $s
th
_P
DB
_I
D-
>f
in
is
h(
);
 
  m
y 
$s
th
_p
ur
in
es
; 
 
 
 
  
my
 $
qu
er
yr
na
_p
ur
in
es
 =
 "
SE
LE
CT
 *
 F
RO
M 
".
$d
at
ab
as
e.
".
co
mp
on
en
ts
 W
HE
RE
 (
rn
a 
= 
1 
or
 d
na
 =
 1
) 
an
d 
pu
ri
ne
 =
 1
";
 
 
 
 
  
$s
th
_p
ur
in
es
 =
 $
db
h-
>p
re
pa
re
($
qu
er
yr
na
_p
ur
in
es
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Pr
ep
ar
in
g 
My
SQ
L 
qu
er
y 
wi
th
 
\"
$q
ue
ry
rn
a_
pu
ri
ne
s\
" 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
 
 
 
  
$s
th
_p
ur
in
es
->
ex
ec
ut
e(
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Th
e 
ex
ec
ut
io
n 
of
 t
he
 M
yS
QL
 q
ue
ry
 \
"$
qu
er
yr
na
_p
ur
in
es
\"
 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
 
 
 
my
 $
co
un
tr
na
_p
ur
in
es
 =
 $
st
h_
pu
ri
ne
s-
>r
ow
s;
 
# 
 
 
pr
in
t 
GR
EE
N,
 "
to
ta
l 
di
ff
er
en
t 
na
me
s 
fo
r 
pu
ri
ne
s 
in
 t
he
 w
ho
le
 P
DB
:"
.$
co
un
tr
na
_p
ur
in
es
."
\n
",
 R
ES
ET
; 
# 
 
 
pr
in
t 
"\
n"
; 
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my $purineref = $sth_purines->fetchall_arrayref; #  $purineref is a reference to an array holding 
REFERENCES TO EACH MySQL Record, R_E_F_E_R_E_N_C_E_S!!! 
 
 
 
$sth_purines->finish(); 
  my $sth_pyrimidines; 
 
 
 
  my $queryrna_pyrimidines = "SELECT * FROM ".$database.".components WHERE (rna = 1 or dna = 1) and 
pyrimidine = 1"; 
 
 
 
  $sth_pyrimidines = $dbh->prepare($queryrna_pyrimidines) || $logger->logdie("Preparing MySQL query 
with \"$queryrna_pyrimidines\" failed: $DBI::errstr"); 
 
 
 
  $sth_pyrimidines->execute() || $logger->logdie("The execution of the MySQL query 
\"$queryrna_pyrimidines\" failed: $DBI::errstr"); 
 
 
 
my $countrna_pyrimidines = $sth_pyrimidines->rows; 
# 
 
 
print GREEN, "total different names for pyrimidines in the whole PDB:".$countrna_pyrimidines."\n", 
RESET; 
# 
 
 
print "\n"; 
 
 
 
my $pyrimidineref = $sth_pyrimidines->fetchall_arrayref; #  $pyrimidineref is a reference to an array 
holding REFERENCES TO EACH MySQL Record, R_E_F_E_R_E_N_C_E_S!!! 
 
 
 
$sth_pyrimidines->finish(); 
$logger->info("different 3-letter codes for purines: $countrna_purines, for pyrimidines: $countrna_pyrimidines"); 
 $dbh->disconnect(); 
##empty the purines array 
 my @purines=(); 
my $i; 
for ($i = 0; $i<=$#{$purineref};$i++) 
{ push (@purines, ${${$purineref}[$i]}[2]); 
}  my @pyrimidines=(); 
for ($i = 0; $i<=$#{$pyrimidineref};$i++) 
{ push (@pyrimidines, ${${$pyrimidineref}[$i]}[2]); 
}  sub is_purine                      
{                                                   
 
my $residuename  = $_[0];       
 
foreach (0..$#purines)                     
 
{ 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
if
 (
$r
es
id
ue
na
me
 e
q 
$p
ur
in
es
[$
_]
) 
 
 
 
{ 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
re
tu
rn
 1
; 
# 
re
tu
rn
 e
ar
ly
 o
nc
e 
fo
un
d 
  
  
  
 
 
 
} 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
} 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
0;
 #
 e
le
me
nt
 n
ot
 f
ou
nd
 (
re
tu
rn
 i
s 
op
ti
on
al
 h
er
e)
  
 
} su
b 
is
_p
yr
im
id
in
e 
  
  
  
  
  
  
  
  
  
  
 
{ 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
my
 $
re
si
du
en
am
e 
= 
$_
[0
];
  
  
  
 
 
fo
re
ac
h 
(0
..
$#
py
ri
mi
di
ne
s)
  
  
  
  
  
  
  
  
  
  
 
 
{ 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
if
 (
$r
es
id
ue
na
me
 e
q 
$p
yr
im
id
in
es
[$
_]
) 
 
 
 
{ 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
re
tu
rn
 1
; 
# 
re
tu
rn
 e
ar
ly
 o
nc
e 
fo
un
d 
  
  
  
 
 
 
} 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
} 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
0;
 #
 e
le
me
nt
 n
ot
 f
ou
nd
 
}   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
my
 $
ro
w;
 
my
 (
@C
4,
@C
6,
@N
1)
; 
my
 (
@C
2,
@C
8,
@p
uN
1,
@N
7,
@N
9)
; 
my
 $
x;
 
my
 $
y;
 
my
 $
z;
 
my
 $
j=
0;
 
my
 $
cu
rr
en
t_
re
si
du
e=
""
; 
my
 $
py
ri
mi
di
ne
_c
ou
nt
er
=0
; 
my
 $
pu
ri
ne
_c
ou
nt
er
=0
; 
my
 $
ki
ll
sw
it
ch
=0
; 
my
 $
re
si
du
e_
to
_s
ki
p=
""
; 
my
 $
py
ri
mi
di
ne
=0
; 
my
 $
pu
ri
ne
=0
; 
my
 @
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
=(
);
 
my
 @
pu
ri
ne
_p
la
ne
_a
rr
ay
=(
);
 
my
 $
pu
ri
ne
re
si
du
ec
ou
nt
er
=0
; 
my
 $
py
ri
mi
di
ne
re
si
du
ec
ou
nt
er
=0
; 
my
 $
fa
ul
ty
_p
yr
im
id
in
e_
co
un
te
r=
0;
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my $purineref = $sth_purines->fetchall_arrayref; #  $purineref is a reference to an array holding 
REFERENCES TO EACH MySQL Record, R_E_F_E_R_E_N_C_E_S!!! 
 
 
 
$sth_purines->finish(); 
  my $sth_pyrimidines; 
 
 
 
  my $queryrna_pyrimidines = "SELECT * FROM ".$database.".components WHERE (rna = 1 or dna = 1) and 
pyrimidine = 1"; 
 
 
 
  $sth_pyrimidines = $dbh->prepare($queryrna_pyrimidines) || $logger->logdie("Preparing MySQL query 
with \"$queryrna_pyrimidines\" failed: $DBI::errstr"); 
 
 
 
  $sth_pyrimidines->execute() || $logger->logdie("The execution of the MySQL query 
\"$queryrna_pyrimidines\" failed: $DBI::errstr"); 
 
 
 
my $countrna_pyrimidines = $sth_pyrimidines->rows; 
# 
 
 
print GREEN, "total different names for pyrimidines in the whole PDB:".$countrna_pyrimidines."\n", 
RESET; 
# 
 
 
print "\n"; 
 
 
 
my $pyrimidineref = $sth_pyrimidines->fetchall_arrayref; #  $pyrimidineref is a reference to an array 
holding REFERENCES TO EACH MySQL Record, R_E_F_E_R_E_N_C_E_S!!! 
 
 
 
$sth_pyrimidines->finish(); 
$logger->info("different 3-letter codes for purines: $countrna_purines, for pyrimidines: $countrna_pyrimidines"); 
 $dbh->disconnect(); 
##empty the purines array 
 my @purines=(); 
my $i; 
for ($i = 0; $i<=$#{$purineref};$i++) 
{ push (@purines, ${${$purineref}[$i]}[2]); 
}  my @pyrimidines=(); 
for ($i = 0; $i<=$#{$pyrimidineref};$i++) 
{ push (@pyrimidines, ${${$pyrimidineref}[$i]}[2]); 
}  sub is_purine                      
{                                                   
 
my $residuename  = $_[0];       
 
foreach (0..$#purines)                     
 
{ 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
if
 (
$r
es
id
ue
na
me
 e
q 
$p
ur
in
es
[$
_]
) 
 
 
 
{ 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
re
tu
rn
 1
; 
# 
re
tu
rn
 e
ar
ly
 o
nc
e 
fo
un
d 
  
  
  
 
 
 
} 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
} 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
0;
 #
 e
le
me
nt
 n
ot
 f
ou
nd
 (
re
tu
rn
 i
s 
op
ti
on
al
 h
er
e)
  
 
} su
b 
is
_p
yr
im
id
in
e 
  
  
  
  
  
  
  
  
  
  
 
{ 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
my
 $
re
si
du
en
am
e 
= 
$_
[0
];
  
  
  
 
 
fo
re
ac
h 
(0
..
$#
py
ri
mi
di
ne
s)
  
  
  
  
  
  
  
  
  
  
 
 
{ 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
if
 (
$r
es
id
ue
na
me
 e
q 
$p
yr
im
id
in
es
[$
_]
) 
 
 
 
{ 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
re
tu
rn
 1
; 
# 
re
tu
rn
 e
ar
ly
 o
nc
e 
fo
un
d 
  
  
  
 
 
 
} 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
} 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
0;
 #
 e
le
me
nt
 n
ot
 f
ou
nd
 
}   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
my
 $
ro
w;
 
my
 (
@C
4,
@C
6,
@N
1)
; 
my
 (
@C
2,
@C
8,
@p
uN
1,
@N
7,
@N
9)
; 
my
 $
x;
 
my
 $
y;
 
my
 $
z;
 
my
 $
j=
0;
 
my
 $
cu
rr
en
t_
re
si
du
e=
""
; 
my
 $
py
ri
mi
di
ne
_c
ou
nt
er
=0
; 
my
 $
pu
ri
ne
_c
ou
nt
er
=0
; 
my
 $
ki
ll
sw
it
ch
=0
; 
my
 $
re
si
du
e_
to
_s
ki
p=
""
; 
my
 $
py
ri
mi
di
ne
=0
; 
my
 $
pu
ri
ne
=0
; 
my
 @
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
=(
);
 
my
 @
pu
ri
ne
_p
la
ne
_a
rr
ay
=(
);
 
my
 $
pu
ri
ne
re
si
du
ec
ou
nt
er
=0
; 
my
 $
py
ri
mi
di
ne
re
si
du
ec
ou
nt
er
=0
; 
my
 $
fa
ul
ty
_p
yr
im
id
in
e_
co
un
te
r=
0;
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my $faulty_purine_counter=0; 
my @faulty_pyrimidine_array=(); 
my @faulty_purine_array=(); 
my $residuecounter=0; 
my @residuecheckarray=(); 
my $residuestart=""; 
my $residueend=""; 
my $residue; 
my $baseresidueswitch=0; 
 RESIDUECHECK: 
##walk the PDB file first do determine all bases and their positions in the array 
foreach my $residuerow (0..$#{$ref}) 
{  
if ($current_residue ne ${${$ref}[$residuerow]}[3].${${$ref}[$residuerow]}[4].${${$ref}[$residuerow]}[5]) 
 
{ 
 
 
if ($baseresidueswitch == 1) 
 
 
{ 
 
 
$residueend= $residuerow-1; 
 
 
#print "-".$residueend."\n"; 
 
 
##fill the endvalue to see where the residue ends 
 
 
${${residuecheckarray}[$residuecounter-1]}[4]= $residueend; 
 
 
} 
 
 
$residuestart = $residuerow; 
 
 
$current_residue = ${${$ref}[$residuerow]}[3].${${$ref}[$residuerow]}[4].${${$ref}[$residuerow]}[5]; 
 
 
if (&is_purine(${${$ref}[$residuerow]}[3]) != 1 && &is_pyrimidine(${${$ref}[$residuerow]}[3]) != 1) 
 
 
{ 
 
 
$baseresidueswitch =0; 
 
 
next RESIDUECHECK; 
 
 
} 
 
 
 
 
else 
 
 
{ 
 
 
#print $current_residue. ":  " .$residuestart; 
 
 
##let's save this into an array... 
 
 
push 
(@residuecheckarray,[${${$ref}[$residuerow]}[3],${${$ref}[$residuerow]}[4],${${$ref}[$residuerow]}[5],$residuestart]); 
 
 
$residuecounter+=1; 
 
 
$baseresidueswitch =1; 
 
 
 
} 
 
} 
 
##
th
is
 i
s 
if
 w
e'
re
 d
ea
li
ng
 w
it
h 
th
e 
ve
ry
 l
as
t 
re
si
du
e 
 
if
 (
$b
as
er
es
id
ue
sw
it
ch
 =
= 
1 
&&
 $
re
si
du
er
ow
 =
= 
$#
{$
re
f}
) 
 
{ 
 
  
 #
pr
in
t 
"-
".
$r
es
id
ue
ro
w.
"\
n"
; 
 
  
${
${
re
si
du
ec
he
ck
ar
ra
y}
[$
re
si
du
ec
ou
nt
er
-1
]}
[4
]=
 $
re
si
du
er
ow
; 
 
} 
  
 
}  $l
og
ge
r-
>i
nf
o(
"$
re
si
du
ec
ou
nt
er
 n
uc
le
ob
as
es
 i
n 
th
e 
PD
B 
fi
le
 $
PD
B_
ID
")
; 
   fo
re
ac
h 
$r
ow
 (
 0
..
$#
re
si
du
ec
he
ck
ar
ra
y)
 
{  
#p
ri
nt
 $
re
si
du
ec
he
ck
ar
ra
y[
$r
ow
][
0]
."
\t
".
$r
es
id
ue
ch
ec
ka
rr
ay
[$
ro
w]
[1
].
"\
t"
.$
re
si
du
ec
he
ck
ar
ra
y[
$r
ow
][
2]
."
\n
";
 
 
$j
=0
; 
 
if
 (
&i
s_
py
ri
mi
di
ne
($
re
si
du
ec
he
ck
ar
ra
y[
$r
ow
][
0]
)=
=1
) 
 
{ 
 
 
fo
re
ac
h 
my
 $
re
si
du
eb
as
e 
($
re
si
du
ec
he
ck
ar
ra
y[
$r
ow
][
3]
..
 $
re
si
du
ec
he
ck
ar
ra
y[
$r
ow
][
4]
) 
 
 
{ 
 
 
my
 (
$i
dC
od
e,
 $
se
ri
al
, 
$n
am
e,
 $
re
sN
am
e,
 $
Ch
ai
nI
D,
 $
re
sS
eq
, 
$x
, 
$y
, 
$z
, 
$e
le
me
nt
) 
= 
@{
${
$r
ef
}[
$r
es
id
ue
ba
se
]}
;
 
 
 
 
##
ex
tr
ac
t 
th
e 
pl
an
e 
at
om
s 
of
 p
yr
im
id
in
es
  
 
 
 
 
 
 
sw
it
ch
 (
$n
am
e)
  
 
 
 
{ 
 
 
 
 
  
  
  
  
  
  
  
  
 
 
 
 
 
 
ca
se
 "
C4
" 
{@
C4
=(
$x
,$
y,
$z
);
$j
+=
1;
}  
 
 
 
 
 
ca
se
 "
C6
" 
{@
C6
=(
$x
,$
y,
$z
);
$j
+=
1;
}  
 
 
 
 
 
ca
se
 "
N1
" 
{@
N1
=(
$x
,$
y,
$z
);
$j
+=
1;
}  
 
 
 
 
 
} 
 
 
 
if
 (
$r
es
id
ue
ba
se
 =
= 
$r
es
id
ue
ch
ec
ka
rr
ay
[$
ro
w]
[4
])
 
 
 
 
{ 
 
 
 
 
if
 (
$j
==
3)
 
 
 
 
 
{ 
 
 
 
 
##
st
or
in
g 
al
l 
pl
an
e-
re
le
va
nt
 a
to
ms
 i
n 
th
e 
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
. 
no
te
 t
ha
t 
it
's
 a
ll
 s
to
re
d 
by
 
re
fe
re
nc
e.
 t
he
 @
C4
,.
..
 a
rr
ay
s 
ca
nn
ot
 b
e 
st
or
ed
 d
ir
ec
tl
y 
by
 r
ef
er
en
ce
, 
be
ca
us
e 
th
ei
r 
re
fe
re
nc
e 
ge
ts
 o
ve
rw
ri
tt
en
 i
n 
ea
ch
 
cy
cl
e 
ov
er
 t
he
 r
es
id
ue
ch
ec
ka
rr
ay
 l
oo
p.
 
 
 
 
 
##
 t
he
 p
yr
im
id
in
e_
pl
an
e_
ar
ra
y 
no
w 
lo
ok
s 
as
 f
ol
lo
ws
 [
0]
 i
s 
$r
es
Na
me
, 
[1
] 
is
 C
ha
in
ID
, 
[2
] 
is
 
re
sS
eq
, 
[3
] 
is
 t
he
 C
4 
ar
ra
y,
 [
4]
 i
s 
th
e 
C6
 a
rr
ay
, 
[5
] 
is
 t
he
 N
1 
ar
ra
y.
 
 
 
 
 
pu
sh
 (
@p
yr
im
id
in
e_
pl
an
e_
ar
ra
y,
 
[$
re
sN
am
e,
$C
ha
in
ID
,$
re
sS
eq
,[
$C
4[
0]
,$
C4
[1
],
$C
4[
2]
],
[$
C6
[0
],
$C
6[
1]
,$
C6
[2
]]
,[
$N
1[
0]
,$
N1
[1
],
$N
1[
2]
]]
);
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my $faulty_purine_counter=0; 
my @faulty_pyrimidine_array=(); 
my @faulty_purine_array=(); 
my $residuecounter=0; 
my @residuecheckarray=(); 
my $residuestart=""; 
my $residueend=""; 
my $residue; 
my $baseresidueswitch=0; 
 RESIDUECHECK: 
##walk the PDB file first do determine all bases and their positions in the array 
foreach my $residuerow (0..$#{$ref}) 
{  
if ($current_residue ne ${${$ref}[$residuerow]}[3].${${$ref}[$residuerow]}[4].${${$ref}[$residuerow]}[5]) 
 
{ 
 
 
if ($baseresidueswitch == 1) 
 
 
{ 
 
 
$residueend= $residuerow-1; 
 
 
#print "-".$residueend."\n"; 
 
 
##fill the endvalue to see where the residue ends 
 
 
${${residuecheckarray}[$residuecounter-1]}[4]= $residueend; 
 
 
} 
 
 
$residuestart = $residuerow; 
 
 
$current_residue = ${${$ref}[$residuerow]}[3].${${$ref}[$residuerow]}[4].${${$ref}[$residuerow]}[5]; 
 
 
if (&is_purine(${${$ref}[$residuerow]}[3]) != 1 && &is_pyrimidine(${${$ref}[$residuerow]}[3]) != 1) 
 
 
{ 
 
 
$baseresidueswitch =0; 
 
 
next RESIDUECHECK; 
 
 
} 
 
 
 
 
else 
 
 
{ 
 
 
#print $current_residue. ":  " .$residuestart; 
 
 
##let's save this into an array... 
 
 
push 
(@residuecheckarray,[${${$ref}[$residuerow]}[3],${${$ref}[$residuerow]}[4],${${$ref}[$residuerow]}[5],$residuestart]); 
 
 
$residuecounter+=1; 
 
 
$baseresidueswitch =1; 
 
 
 
} 
 
} 
 
##
th
is
 i
s 
if
 w
e'
re
 d
ea
li
ng
 w
it
h 
th
e 
ve
ry
 l
as
t 
re
si
du
e 
 
if
 (
$b
as
er
es
id
ue
sw
it
ch
 =
= 
1 
&&
 $
re
si
du
er
ow
 =
= 
$#
{$
re
f}
) 
 
{ 
 
  
 #
pr
in
t 
"-
".
$r
es
id
ue
ro
w.
"\
n"
; 
 
  
${
${
re
si
du
ec
he
ck
ar
ra
y}
[$
re
si
du
ec
ou
nt
er
-1
]}
[4
]=
 $
re
si
du
er
ow
; 
 
} 
  
 
}  $l
og
ge
r-
>i
nf
o(
"$
re
si
du
ec
ou
nt
er
 n
uc
le
ob
as
es
 i
n 
th
e 
PD
B 
fi
le
 $
PD
B_
ID
")
; 
   fo
re
ac
h 
$r
ow
 (
 0
..
$#
re
si
du
ec
he
ck
ar
ra
y)
 
{  
#p
ri
nt
 $
re
si
du
ec
he
ck
ar
ra
y[
$r
ow
][
0]
."
\t
".
$r
es
id
ue
ch
ec
ka
rr
ay
[$
ro
w]
[1
].
"\
t"
.$
re
si
du
ec
he
ck
ar
ra
y[
$r
ow
][
2]
."
\n
";
 
 
$j
=0
; 
 
if
 (
&i
s_
py
ri
mi
di
ne
($
re
si
du
ec
he
ck
ar
ra
y[
$r
ow
][
0]
)=
=1
) 
 
{ 
 
 
fo
re
ac
h 
my
 $
re
si
du
eb
as
e 
($
re
si
du
ec
he
ck
ar
ra
y[
$r
ow
][
3]
..
 $
re
si
du
ec
he
ck
ar
ra
y[
$r
ow
][
4]
) 
 
 
{ 
 
 
my
 (
$i
dC
od
e,
 $
se
ri
al
, 
$n
am
e,
 $
re
sN
am
e,
 $
Ch
ai
nI
D,
 $
re
sS
eq
, 
$x
, 
$y
, 
$z
, 
$e
le
me
nt
) 
= 
@{
${
$r
ef
}[
$r
es
id
ue
ba
se
]}
;
 
 
 
 
##
ex
tr
ac
t 
th
e 
pl
an
e 
at
om
s 
of
 p
yr
im
id
in
es
  
 
 
 
 
 
 
sw
it
ch
 (
$n
am
e)
  
 
 
 
{ 
 
 
 
 
  
  
  
  
  
  
  
  
 
 
 
 
 
 
ca
se
 "
C4
" 
{@
C4
=(
$x
,$
y,
$z
);
$j
+=
1;
}  
 
 
 
 
 
ca
se
 "
C6
" 
{@
C6
=(
$x
,$
y,
$z
);
$j
+=
1;
}  
 
 
 
 
 
ca
se
 "
N1
" 
{@
N1
=(
$x
,$
y,
$z
);
$j
+=
1;
}  
 
 
 
 
 
} 
 
 
 
if
 (
$r
es
id
ue
ba
se
 =
= 
$r
es
id
ue
ch
ec
ka
rr
ay
[$
ro
w]
[4
])
 
 
 
 
{ 
 
 
 
 
if
 (
$j
==
3)
 
 
 
 
 
{ 
 
 
 
 
##
st
or
in
g 
al
l 
pl
an
e-
re
le
va
nt
 a
to
ms
 i
n 
th
e 
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
. 
no
te
 t
ha
t 
it
's
 a
ll
 s
to
re
d 
by
 
re
fe
re
nc
e.
 t
he
 @
C4
,.
..
 a
rr
ay
s 
ca
nn
ot
 b
e 
st
or
ed
 d
ir
ec
tl
y 
by
 r
ef
er
en
ce
, 
be
ca
us
e 
th
ei
r 
re
fe
re
nc
e 
ge
ts
 o
ve
rw
ri
tt
en
 i
n 
ea
ch
 
cy
cl
e 
ov
er
 t
he
 r
es
id
ue
ch
ec
ka
rr
ay
 l
oo
p.
 
 
 
 
 
##
 t
he
 p
yr
im
id
in
e_
pl
an
e_
ar
ra
y 
no
w 
lo
ok
s 
as
 f
ol
lo
ws
 [
0]
 i
s 
$r
es
Na
me
, 
[1
] 
is
 C
ha
in
ID
, 
[2
] 
is
 
re
sS
eq
, 
[3
] 
is
 t
he
 C
4 
ar
ra
y,
 [
4]
 i
s 
th
e 
C6
 a
rr
ay
, 
[5
] 
is
 t
he
 N
1 
ar
ra
y.
 
 
 
 
 
pu
sh
 (
@p
yr
im
id
in
e_
pl
an
e_
ar
ra
y,
 
[$
re
sN
am
e,
$C
ha
in
ID
,$
re
sS
eq
,[
$C
4[
0]
,$
C4
[1
],
$C
4[
2]
],
[$
C6
[0
],
$C
6[
1]
,$
C6
[2
]]
,[
$N
1[
0]
,$
N1
[1
],
$N
1[
2]
]]
);
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$j=0; 
 
 
 
 
$pyrimidineresiduecounter+=1; 
 
 
 
 
} 
 
 
 
 
else 
 
 
 
 
{ 
 
 
 
 
$logger->info("something wrong with the pyrimidine: $resName $ChainID $resSeq!!!"); 
 
 
 
 
$faulty_pyrimidine_counter+=1; 
 
 
 
 
push (@faulty_pyrimidine_array,[$idCode,$resName,$ChainID,$resSeq]); 
 
 
 
 
} 
 
 
 
}                                 
 
 
 
 
} 
 
} 
 
if (&is_purine($residuecheckarray[$row][0])==1) 
 
{ 
 
 
foreach my $residuebase ($residuecheckarray[$row][3].. $residuecheckarray[$row][4]) 
 
 
{ 
 
 
my ($idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element) = @{${$ref}[$residuebase]};
 
 
 
 
##extract the plane atoms of purines 
 
 
 
 
 
 
 
switch ($name)  
 
 
 
{ 
 
 
 
 
                
 
 
 
 
 
 
case "C2" 
{@C2=($x,$y,$z);$j+=1;}  
 
 
 
 
 
case "C8" 
{@C8=($x,$y,$z);$j+=1;}  
 
 
 
 
 
case "N1" 
{@puN1=($x,$y,$z);$j+=1;} 
 
 
 
case "N7" 
{@N7=($x,$y,$z);$j+=1;} 
 
 
 
case "N9" 
{@N9=($x,$y,$z);$j+=1;}  
 
 
 
 
 
} 
 
 
 
if ($residuebase == $residuecheckarray[$row][4]) 
 
 
 
{ 
 
 
 
 
if ($j==5) 
 
 
 
 
{  
 
 
 
 
##storing all plane-relevant atoms in the purine_plane_array. note that it's all stored by 
reference. the @C4,... arrays cannot be stored directly by reference, because their reference gets overwritten in each 
cycle over the residuecheckarray loop. 
 
 
 
 
## the purine_plane_array now looks as follows [0] is $resName, [1] is ChainID, [2] is resSeq, 
[3] is the C2 array, [4] is the C8 array, [5] is the N1 array, [6] is the N7 array, [7] is the N9 array. 
 
 
 
 
push (@purine_plane_array, 
[$resName,$ChainID,$resSeq,[$C2[0],$C2[1],$C2[2]],[$C8[0],$C8[1],$C8[2]],[$puN1[0],$puN1[1],$puN1[2]],[$N7[0],$N7[1],$N
7[2]],[$N9[0],$N9[1],$N9[2]]]); 
 
 
 
 
$j=0; 
 
 
 
 
$p
ur
in
er
es
id
ue
co
un
te
r+
=1
; 
 
 
 
 
} 
 
 
 
 
el
se
 
 
 
 
 
{ 
 
 
 
 
$l
og
ge
r-
>i
nf
o(
"s
om
et
hi
ng
 w
ro
ng
 w
it
h 
th
e 
pu
ri
ne
 $
re
sN
am
e 
$C
ha
in
ID
 $
re
sS
eq
!!
!"
);
 
 
 
 
 
$f
au
lt
y_
pu
ri
ne
_c
ou
nt
er
+=
1;
 
 
 
 
 
pu
sh
 (
@f
au
lt
y_
pu
ri
ne
_a
rr
ay
,[
$i
dC
od
e,
$r
es
Na
me
,$
Ch
ai
nI
D,
$r
es
Se
q]
);
 
 
 
 
 
} 
 
 
 
} 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
 
 
} 
 
} 
 
} $l
og
ge
r-
>i
nf
o(
"$
PD
B_
ID
 h
as
 $
pu
ri
ne
re
si
du
ec
ou
nt
er
 p
ur
in
es
 a
nd
 $
py
ri
mi
di
ne
re
si
du
ec
ou
nt
er
 p
yr
im
id
in
es
 t
ha
t 
ar
e 
us
ef
ul
 f
or
 
Pi
 i
nt
er
ac
ti
on
 s
ea
rc
h 
in
si
de
")
; 
&l
og
fi
le
("
--
--
--
--
-"
);
 
 ##
de
te
ct
io
n 
of
 "
fa
ul
ty
 p
ur
in
es
 o
r 
py
ri
mi
di
ne
s.
 N
ow
 p
ri
nt
 t
o 
ou
tp
ut
, 
la
te
r 
pr
in
t 
to
 l
og
fi
le
 a
nd
 a
dd
 t
o 
da
ta
ba
se
! 
if
 (
$f
au
lt
y_
py
ri
mi
di
ne
_c
ou
nt
er
>0
) 
{  
$l
og
ge
r-
>i
nf
o(
"F
au
lt
y 
Py
ri
mi
di
ne
s:
 $
fa
ul
ty
_p
yr
im
id
in
e_
co
un
te
r"
);
 
 
 
 
fo
re
ac
h 
my
 $
fa
ul
ty
py
ri
mi
di
ne
 (
0.
.$
#f
au
lt
y_
py
ri
mi
di
ne
_a
rr
ay
) 
 
{ 
 
$d
bl
og
ge
r-
>d
eb
ug
($
fa
ul
ty
_p
yr
im
id
in
e_
ar
ra
y[
$f
au
lt
yp
yr
im
id
in
e]
[0
].
"\
t"
.$
fa
ul
ty
_p
yr
im
id
in
e_
ar
ra
y[
$f
au
lt
yp
yr
im
id
in
e]
[1
].
"\
t"
.$
fa
ul
ty
_
py
ri
mi
di
ne
_a
rr
ay
[$
fa
ul
ty
py
ri
mi
di
ne
][
2]
."
\t
".
$f
au
lt
y_
py
ri
mi
di
ne
_a
rr
ay
[$
fa
ul
ty
py
ri
mi
di
ne
][
3]
);
 
 
 
} 
 
&l
og
fi
le
("
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
")
; 
} 
 
 if
 (
$f
au
lt
y_
pu
ri
ne
_c
ou
nt
er
>0
) 
{  
$l
og
ge
r-
>i
nf
o(
"F
au
lt
y 
Pu
ri
ne
s:
 $
fa
ul
ty
_p
ur
in
e_
co
un
te
r"
);
 
 
fo
re
ac
h 
my
 $
fa
ul
ty
pu
ri
ne
 (
0.
.$
#f
au
lt
y_
pu
ri
ne
_a
rr
ay
) 
 
{ 
 
$d
bl
og
ge
r-
>d
eb
ug
($
fa
ul
ty
_p
ur
in
e_
ar
ra
y[
$f
au
lt
yp
ur
in
e]
[0
].
"\
t"
.$
fa
ul
ty
_p
ur
in
e_
ar
ra
y[
$f
au
lt
yp
ur
in
e]
[1
].
"\
t"
.$
fa
ul
ty
_p
ur
in
e_
ar
ra
y[
$f
a
ul
ty
pu
ri
ne
][
2]
."
\t
".
$f
au
lt
y_
pu
ri
ne
_a
rr
ay
[$
fa
ul
ty
pu
ri
ne
][
3]
);
 
 
 
 
} 
 
&l
og
fi
le
("
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
")
; 
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$j=0; 
 
 
 
 
$pyrimidineresiduecounter+=1; 
 
 
 
 
} 
 
 
 
 
else 
 
 
 
 
{ 
 
 
 
 
$logger->info("something wrong with the pyrimidine: $resName $ChainID $resSeq!!!"); 
 
 
 
 
$faulty_pyrimidine_counter+=1; 
 
 
 
 
push (@faulty_pyrimidine_array,[$idCode,$resName,$ChainID,$resSeq]); 
 
 
 
 
} 
 
 
 
}                                 
 
 
 
 
} 
 
} 
 
if (&is_purine($residuecheckarray[$row][0])==1) 
 
{ 
 
 
foreach my $residuebase ($residuecheckarray[$row][3].. $residuecheckarray[$row][4]) 
 
 
{ 
 
 
my ($idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element) = @{${$ref}[$residuebase]};
 
 
 
 
##extract the plane atoms of purines 
 
 
 
 
 
 
 
switch ($name)  
 
 
 
{ 
 
 
 
 
                
 
 
 
 
 
 
case "C2" 
{@C2=($x,$y,$z);$j+=1;}  
 
 
 
 
 
case "C8" 
{@C8=($x,$y,$z);$j+=1;}  
 
 
 
 
 
case "N1" 
{@puN1=($x,$y,$z);$j+=1;} 
 
 
 
case "N7" 
{@N7=($x,$y,$z);$j+=1;} 
 
 
 
case "N9" 
{@N9=($x,$y,$z);$j+=1;}  
 
 
 
 
 
} 
 
 
 
if ($residuebase == $residuecheckarray[$row][4]) 
 
 
 
{ 
 
 
 
 
if ($j==5) 
 
 
 
 
{  
 
 
 
 
##storing all plane-relevant atoms in the purine_plane_array. note that it's all stored by 
reference. the @C4,... arrays cannot be stored directly by reference, because their reference gets overwritten in each 
cycle over the residuecheckarray loop. 
 
 
 
 
## the purine_plane_array now looks as follows [0] is $resName, [1] is ChainID, [2] is resSeq, 
[3] is the C2 array, [4] is the C8 array, [5] is the N1 array, [6] is the N7 array, [7] is the N9 array. 
 
 
 
 
push (@purine_plane_array, 
[$resName,$ChainID,$resSeq,[$C2[0],$C2[1],$C2[2]],[$C8[0],$C8[1],$C8[2]],[$puN1[0],$puN1[1],$puN1[2]],[$N7[0],$N7[1],$N
7[2]],[$N9[0],$N9[1],$N9[2]]]); 
 
 
 
 
$j=0; 
 
 
 
 
$p
ur
in
er
es
id
ue
co
un
te
r+
=1
; 
 
 
 
 
} 
 
 
 
 
el
se
 
 
 
 
 
{ 
 
 
 
 
$l
og
ge
r-
>i
nf
o(
"s
om
et
hi
ng
 w
ro
ng
 w
it
h 
th
e 
pu
ri
ne
 $
re
sN
am
e 
$C
ha
in
ID
 $
re
sS
eq
!!
!"
);
 
 
 
 
 
$f
au
lt
y_
pu
ri
ne
_c
ou
nt
er
+=
1;
 
 
 
 
 
pu
sh
 (
@f
au
lt
y_
pu
ri
ne
_a
rr
ay
,[
$i
dC
od
e,
$r
es
Na
me
,$
Ch
ai
nI
D,
$r
es
Se
q]
);
 
 
 
 
 
} 
 
 
 
} 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
 
 
} 
 
} 
 
} $l
og
ge
r-
>i
nf
o(
"$
PD
B_
ID
 h
as
 $
pu
ri
ne
re
si
du
ec
ou
nt
er
 p
ur
in
es
 a
nd
 $
py
ri
mi
di
ne
re
si
du
ec
ou
nt
er
 p
yr
im
id
in
es
 t
ha
t 
ar
e 
us
ef
ul
 f
or
 
Pi
 i
nt
er
ac
ti
on
 s
ea
rc
h 
in
si
de
")
; 
&l
og
fi
le
("
--
--
--
--
-"
);
 
 ##
de
te
ct
io
n 
of
 "
fa
ul
ty
 p
ur
in
es
 o
r 
py
ri
mi
di
ne
s.
 N
ow
 p
ri
nt
 t
o 
ou
tp
ut
, 
la
te
r 
pr
in
t 
to
 l
og
fi
le
 a
nd
 a
dd
 t
o 
da
ta
ba
se
! 
if
 (
$f
au
lt
y_
py
ri
mi
di
ne
_c
ou
nt
er
>0
) 
{  
$l
og
ge
r-
>i
nf
o(
"F
au
lt
y 
Py
ri
mi
di
ne
s:
 $
fa
ul
ty
_p
yr
im
id
in
e_
co
un
te
r"
);
 
 
 
 
fo
re
ac
h 
my
 $
fa
ul
ty
py
ri
mi
di
ne
 (
0.
.$
#f
au
lt
y_
py
ri
mi
di
ne
_a
rr
ay
) 
 
{ 
 
$d
bl
og
ge
r-
>d
eb
ug
($
fa
ul
ty
_p
yr
im
id
in
e_
ar
ra
y[
$f
au
lt
yp
yr
im
id
in
e]
[0
].
"\
t"
.$
fa
ul
ty
_p
yr
im
id
in
e_
ar
ra
y[
$f
au
lt
yp
yr
im
id
in
e]
[1
].
"\
t"
.$
fa
ul
ty
_
py
ri
mi
di
ne
_a
rr
ay
[$
fa
ul
ty
py
ri
mi
di
ne
][
2]
."
\t
".
$f
au
lt
y_
py
ri
mi
di
ne
_a
rr
ay
[$
fa
ul
ty
py
ri
mi
di
ne
][
3]
);
 
 
 
} 
 
&l
og
fi
le
("
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
")
; 
} 
 
 if
 (
$f
au
lt
y_
pu
ri
ne
_c
ou
nt
er
>0
) 
{  
$l
og
ge
r-
>i
nf
o(
"F
au
lt
y 
Pu
ri
ne
s:
 $
fa
ul
ty
_p
ur
in
e_
co
un
te
r"
);
 
 
fo
re
ac
h 
my
 $
fa
ul
ty
pu
ri
ne
 (
0.
.$
#f
au
lt
y_
pu
ri
ne
_a
rr
ay
) 
 
{ 
 
$d
bl
og
ge
r-
>d
eb
ug
($
fa
ul
ty
_p
ur
in
e_
ar
ra
y[
$f
au
lt
yp
ur
in
e]
[0
].
"\
t"
.$
fa
ul
ty
_p
ur
in
e_
ar
ra
y[
$f
au
lt
yp
ur
in
e]
[1
].
"\
t"
.$
fa
ul
ty
_p
ur
in
e_
ar
ra
y[
$f
a
ul
ty
pu
ri
ne
][
2]
."
\t
".
$f
au
lt
y_
pu
ri
ne
_a
rr
ay
[$
fa
ul
ty
pu
ri
ne
][
3]
);
 
 
 
 
} 
 
&l
og
fi
le
("
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
")
; 
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}  ##now to resize the @{$ref} array to potential stacking ligands only (remove bases except OPxes,) 
my $watercounter=0; 
my @potential_ligands=(); 
LIGANDBYLIGAND: 
 
foreach $row ( @{$ref} ) 
 
{# 
  idCode,  serial,  name,  resName,  ChainID,  resSeq,  x,  y,  z,  element,  ID,  atom,  altLoc,  iCode,  
occupancy,  tempFactor,  segID, charge 
 
 my ($idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element,  $ID,  $atom,  $altLoc,  $iCode,  
$occupancy,  $tempFactor,  $segID, $charge) = @{$row}; 
 
  
  
 
  if (&is_purine($resName)==1 || &is_pyrimidine($resName)==1) 
 
 
  { 
 
 
 
  
if ($name =~ m/^O[1-3]\w$/ || $name =~ m/^OP\d$/) 
 
 
 
  
{ 
 
 
 
  
push (@potential_ligands, [$idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, 
$element,  $ID,  $atom,  $altLoc,  $iCode,  $occupancy,  $tempFactor,  $segID, $charge]); 
 
 
 
  
next LIGANDBYLIGAND; 
 
 
 
 
  
} 
 
 
 
  
else 
 
 
 
  
{ 
 
 
 
  
 
 next LIGANDBYLIGAND; 
 
 
 
 
 
  
} 
 
 
 } 
 
 
  
 
 
 if ($resName eq "HOH") 
 
 
 { 
 
 
  
 
 $watercounter+=1; 
 
 
 
 } 
 
 
 push (@potential_ligands, [$idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element,  
$ID,  $atom,  $altLoc,  $iCode,  $occupancy,  $tempFactor,  $segID, $charge]); 
 
 
}  
$logger->info("Water molecules found inside $PDB_ID: $watercounter"); 
 
  #foreach my $potential_ligand (@potential_ligands) 
#{  
# 
 my ($idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element) = @{$potential_ligand}; 
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}  ##now to resize the @{$ref} array to potential stacking ligands only (remove bases except OPxes,) 
my $watercounter=0; 
my @potential_ligands=(); 
LIGANDBYLIGAND: 
 
foreach $row ( @{$ref} ) 
 
{# 
  idCode,  serial,  name,  resName,  ChainID,  resSeq,  x,  y,  z,  element,  ID,  atom,  altLoc,  iCode,  
occupancy,  tempFactor,  segID, charge 
 
 my ($idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element,  $ID,  $atom,  $altLoc,  $iCode,  
$occupancy,  $tempFactor,  $segID, $charge) = @{$row}; 
 
  
  
 
  if (&is_purine($resName)==1 || &is_pyrimidine($resName)==1) 
 
 
  { 
 
 
 
  
if ($name =~ m/^O[1-3]\w$/ || $name =~ m/^OP\d$/) 
 
 
 
  
{ 
 
 
 
  
push (@potential_ligands, [$idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, 
$element,  $ID,  $atom,  $altLoc,  $iCode,  $occupancy,  $tempFactor,  $segID, $charge]); 
 
 
 
  
next LIGANDBYLIGAND; 
 
 
 
 
  
} 
 
 
 
  
else 
 
 
 
  
{ 
 
 
 
  
 
 next LIGANDBYLIGAND; 
 
 
 
 
 
  
} 
 
 
 } 
 
 
  
 
 
 if ($resName eq "HOH") 
 
 
 { 
 
 
  
 
 $watercounter+=1; 
 
 
 
 } 
 
 
 push (@potential_ligands, [$idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element,  
$ID,  $atom,  $altLoc,  $iCode,  $occupancy,  $tempFactor,  $segID, $charge]); 
 
 
}  
$logger->info("Water molecules found inside $PDB_ID: $watercounter"); 
 
  #foreach my $potential_ligand (@potential_ligands) 
#{  
# 
 my ($idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element) = @{$potential_ligand}; 
# 
 p
ri
nt
 $
na
me
."
\t
".
 $
re
sN
am
e.
"\
t"
. 
$C
ha
in
ID
."
\n
";
 
#}
 
 ##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
py
ri
mi
di
ne
s 
to
 d
b#
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
# 
 $l
og
ge
r-
>i
nf
o(
"N
ow
 c
al
cu
la
ti
ng
 a
ll
 p
la
ne
s 
of
 t
he
 b
as
es
 a
nd
 d
is
ta
nc
es
 t
o 
po
te
nt
ia
l 
st
ac
ki
ng
 a
to
ms
")
; 
$l
og
ge
r-
>i
nf
o(
"F
ir
st
 t
he
 p
yr
im
id
in
es
:"
);
 
$l
og
ge
r-
>i
nf
o(
"-
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-
--
")
; 
 
 
fo
re
ac
h 
my
 $
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
 (
0.
. 
$#
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
) 
{ ##
 t
he
 p
yr
im
id
in
e_
pl
an
e_
ar
ra
y 
no
w 
lo
ok
s 
as
 f
ol
lo
ws
 [
0]
 i
s 
$r
es
Na
me
, 
[1
] 
is
 C
ha
in
ID
, 
[2
] 
is
 r
es
Se
q,
 [
3]
 i
s 
th
e 
C4
 a
rr
ay
, 
[4
] 
is
 t
he
 C
6 
ar
ra
y,
 [
5]
 i
s 
th
e 
N1
 a
rr
ay
. 
#p
ri
nt
 "
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
0]
 
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
1]
 
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
2]
\t
 C
4:
 
@{
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
3]
}\
t 
C6
: 
@{
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
4]
}\
tN
1:
 
@{
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
5]
}\
n"
; 
#p
ri
nt
 "
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
0]
 
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
1]
 
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
2]
\n
";
 
my
 $
ba
se
wi
th
st
ac
ke
rs
 =
 $
{$
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
[$
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[0
].
" 
".
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
1]
."
 
".
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
2]
; 
 
my
 $
ba
se
_r
es
Na
me
 =
 $
{$
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
[$
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[0
];
 
 
my
 $
ba
se
_C
ha
in
ID
 =
 $
{$
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
[$
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[1
];
 
 
my
 $
ba
se
_r
es
Se
q 
= 
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
2]
; 
my
 @
ba
se
no
rm
al
 =
 
&c
re
at
e_
ba
se
no
rm
al
($
{$
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
[$
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[5
],
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[3
],
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
4]
);
 
my
 $
bn
_a
bs
=s
qr
t(
$b
as
en
or
ma
l[
0]
*$
ba
se
no
rm
al
[0
] 
+ 
$b
as
en
or
ma
l[
1]
*$
ba
se
no
rm
al
[1
] 
+ 
$b
as
en
or
ma
l[
2]
*$
ba
se
no
rm
al
[2
])
; 
#p
ri
nt
 "
no
rm
al
iz
ed
 b
as
en
or
ma
l:
 "
. 
$b
as
en
or
ma
l[
0]
/$
bn
_a
bs
 .
 "
 "
 .
 $
ba
se
no
rm
al
[1
]/
$b
n_
ab
s 
. 
" 
" 
. 
$b
as
en
or
ma
l[
2]
/$
bn
_a
bs
 
. 
"\
n"
; 
 
my
 $
ba
se
no
rm
al
_x
 =
 $
ba
se
no
rm
al
[0
]/
$b
n_
ab
s;
 
 
my
 $
ba
se
no
rm
al
_y
 =
 $
ba
se
no
rm
al
[1
]/
$b
n_
ab
s;
 
 
my
 $
ba
se
no
rm
al
_z
 =
 $
ba
se
no
rm
al
[2
]/
$b
n_
ab
s;
 
my
 (
$s
ug
ar
no
rm
al
re
f,
$p
yr
im
id
in
ec
en
tr
oi
dr
ef
) 
= 
&c
re
at
e_
su
ga
rn
or
ma
l(
${
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y[
$p
yr
im
id
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
5]
,$
{$
py
ri
mi
di
ne
_p
la
ne
_a
rr
ay
[$
py
ri
mi
di
n
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
3]
,\
@b
as
en
or
ma
l)
; 
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my @sugarnormal=@{$sugarnormalref}; 
my @pyrimidinecentroid=@{$pyrimidinecentroidref}; 
 
my $pyrimidinecentroid_x = $pyrimidinecentroid[0]; 
 
my $pyrimidinecentroid_y = $pyrimidinecentroid[1]; 
 
my $pyrimidinecentroid_z = $pyrimidinecentroid[2]; 
 
 
#print "pyrimidinecentroid= @pyrimidinecentroid\n"; 
my $sn_abs=sqrt($sugarnormal[0]*$sugarnormal[0] + $sugarnormal[1]*$sugarnormal[1] + $sugarnormal[2]*$sugarnormal[2]); 
#print "normalized sugarnormal: ". $sugarnormal[0]/$sn_abs . " " . $sugarnormal[1]/$sn_abs . " " . 
$sugarnormal[2]/$sn_abs . "\n"; 
 
my $sugarnormal_x = $sugarnormal[0]/$sn_abs; 
 
my $sugarnormal_y = $sugarnormal[1]/$sn_abs; 
 
my $sugarnormal_z = $sugarnormal[2]/$sn_abs; 
my @perpendicularnormal = &create_perpendicularnormal(\@sugarnormal,\@basenormal); 
##to compare the plane normals with Mercury (Mercury: click on More Info > Planes) 
my $pn_abs=sqrt($perpendicularnormal[0]*$perpendicularnormal[0] + $perpendicularnormal[1]*$perpendicularnormal[1] + 
$perpendicularnormal[2]*$perpendicularnormal[2]); 
#print "normalized perpendicularnormal: ". $perpendicularnormal[0]/$pn_abs . " " . $perpendicularnormal[1]/$pn_abs . " 
" . $perpendicularnormal[2]/$pn_abs . "\n"; 
my $perpendicularnormal_x = $perpendicularnormal[0]/$pn_abs; 
my $perpendicularnormal_y = $perpendicularnormal[1]/$pn_abs; 
my $perpendicularnormal_z = $perpendicularnormal[2]/$pn_abs; 
 my @stackingresults = 
&distance_to_all_pyrimidines(\@basenormal,\@sugarnormal,\@perpendicularnormal,\@pyrimidinecentroid); 
 
if (@stackingresults) #if there is a stacking hit... 
 
{ 
 
$has_any_stackers_in_PDB+=1; 
 
$logger->info("-----------------------------------------------------"); 
 
 
$logger->info("$basewithstackers has atoms stacking.");  
 
my $pi_dbh 
= DBI->connect("dbi:mysql:$uzh_database:$uzh_host", $uzh_user, $uzh_pw) || $logger->logdie("Oh no!!! 
could not connect to $uzh_database: $DBI::errstr"); 
 
 
my $insertbasesql = "INSERT INTO ".$uzh_database.".pi_bases (idCode, resName, ChainID, resSeq, normalvector_x, 
normalvector_y, normalvector_z, sugarvector_x, sugarvector_y, sugarvector_z, 
 
perpendicularvector_x, perpendicularvector_y, perpendicularvector_z, centroid_x, centroid_y, centroid_z)  
 
VALUES ('$PDB_ID', '$base_resName', '$base_ChainID', '$base_resSeq', '$basenormal_x', '$basenormal_y', 
'$basenormal_z', '$sugarnormal_x', '$sugarnormal_y', '$sugarnormal_z',  
 
'$perpendicularnormal_x', '$perpendicularnormal_y', '$perpendicularnormal_z', '$pyrimidinecentroid_x', 
'$pyrimidinecentroid_y', '$pyrimidinecentroid_z')"; 
 
my $pi_sth = $pi_dbh->prepare($insertbasesql) || $logger->logdie("Preparing MySQL update failed: $DBI::errstr");   
$p
i_
st
h-
>e
xe
cu
te
()
; 
 
my
 $
ba
se
_I
D 
= 
$p
i_
st
h-
>{
my
sq
l_
in
se
rt
id
};
 
 
$p
i_
st
h-
>f
in
is
h(
);
 
 
 
 
$l
og
ge
r-
>i
nf
o(
"$
ba
se
wi
th
st
ac
ke
rs
 e
nt
er
ed
 i
nt
o 
th
e 
da
ta
ba
se
, 
it
s 
DB
 I
D 
is
: 
$b
as
e_
ID
")
; 
 
$l
og
ge
r-
>i
nf
o(
"-
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
")
; 
 
 
$l
og
ge
r-
>i
nf
o(
"n
ow
 e
nt
er
in
g 
th
e 
fi
rs
t 
st
ac
ki
ng
 r
es
id
ue
:"
);
  
 
##
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k 
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 c
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 F
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H 
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W 
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!!
 i
f 
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 i
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##
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op
 t
hr
og
h 
st
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ke
rs
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rr
ay
 t
o 
fi
nd
 m
ul
ti
pl
e 
at
om
s 
fr
om
 t
he
 s
am
e 
re
si
du
e.
 A
ft
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 i
ns
er
ti
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 t
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e 
to
 
pi
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ck
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du
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 g
et
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t'
s 
ID
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nd
 e
nt
er
 a
ll
 s
ta
ck
in
g 
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om
s 
to
 p
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st
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to
m 
 
##
is
me
ta
l 
->
 a
dd
 i
t 
no
w 
or
 i
n 
a 
co
sm
et
ic
 u
pd
at
e 
la
te
r.
..
.l
at
er
! 
 
my
 $
cu
rr
en
t_
re
sN
am
e=
""
; 
 
my
 $
cu
rr
en
t_
Ch
ai
nI
D=
""
; 
 
my
 $
cu
rr
en
t_
re
sS
eq
="
";
 
 
my
 $
cu
rr
en
t_
pi
_s
ta
ck
re
si
du
e_
ID
="
";
 
 
my
 $
in
se
rt
_s
ta
ck
re
s=
""
; 
 
my
 $
in
se
rt
_s
ta
ck
at
om
="
";
 
 
my
 $
st
ac
kr
es
_I
D=
""
; 
 
 
fo
re
ac
h 
my
 $
st
ac
ke
rs
 (
@s
ta
ck
in
gr
es
ul
ts
) 
 
 
{ 
 
 
my
 (
$i
dC
od
e,
 $
se
ri
al
, 
$n
am
e,
 $
re
sN
am
e,
 $
Ch
ai
nI
D,
 $
re
sS
eq
, 
$x
, 
$y
, 
$z
, 
$e
le
me
nt
, 
 $
ID
, 
 $
at
om
, 
 $
al
tL
oc
, 
 
$i
Co
de
, 
 $
oc
cu
pa
nc
y,
  
$t
em
pF
ac
to
r,
  
$s
eg
ID
, 
$c
ha
rg
e,
$b
as
ed
is
t,
 $
su
ga
rd
is
t,
 $
pe
rp
en
di
cu
la
rd
is
t)
 =
 @
{$
st
ac
ke
rs
};
 
 
 
 
##
if
 e
it
he
r 
of
 t
he
 3
 u
ni
qu
e 
re
si
du
e 
id
en
ti
fi
er
s 
ch
an
ge
, 
th
is
 m
us
t 
be
 a
 n
ew
 r
es
id
ue
 
 
 
 
if
 (
$r
es
Na
me
 n
e 
$c
ur
re
nt
_r
es
Na
me
 |
| 
$C
ha
in
ID
 n
e 
$c
ur
re
nt
_C
ha
in
ID
 |
| 
$r
es
Se
q 
ne
 $
cu
rr
en
t_
re
sS
eq
) 
 
 
 
{ 
 
 
 
my
 $
ch
ec
k_
fo
r_
st
ac
kr
es
cl
on
es
 =
 "
SE
LE
CT
 *
 F
RO
M 
pi
_s
ta
ck
re
si
du
e 
wh
er
e 
id
Co
de
 =
 '
".
$P
DB
_I
D.
"'
 a
nd
  
re
sN
am
e 
= 
'"
.$
re
sN
am
e.
"'
 a
nd
 C
ha
in
ID
 =
 '
".
$C
ha
in
ID
."
' 
an
d 
re
sS
eq
 =
 '
".
$r
es
Se
q.
"'
";
 
 
 
 
$p
i_
st
h 
= 
$p
i_
db
h-
>p
re
pa
re
($
ch
ec
k_
fo
r_
st
ac
kr
es
cl
on
es
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Pr
ep
ar
in
g 
My
SQ
L 
up
da
te
 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
 
 
 
$p
i_
st
h-
>e
xe
cu
te
()
; 
 
 
 
my
 $
co
un
tc
lo
ne
s;
  
 
 
 
 
$c
ou
nt
cl
on
es
 =
 $
pi
_s
th
->
ro
ws
; 
 
 
 
$p
i_
st
h-
>f
in
is
h(
);
 
 
 
 
 
if
 (
$c
ou
nt
cl
on
es
 >
 0
) 
 
 
 
 
{ 
 
 
 
 
$i
ns
er
t_
st
ac
kr
es
="
IN
SE
RT
 I
NT
O 
pi
_s
ta
ck
re
si
du
e 
(I
DB
as
e,
 i
dC
od
e,
 r
es
Na
me
, 
Ch
ai
nI
D,
 r
es
Se
q,
 
is
cl
on
e)
  
 
 
 
 
 
 
 
 
 
VA
LU
ES
 (
'$
ba
se
_I
D'
, 
'$
PD
B_
ID
',
 '
$r
es
Na
me
',
 '
$C
ha
in
ID
',
 '
$r
es
Se
q'
, 
'$
co
un
tc
lo
ne
s'
)"
; 
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my @sugarnormal=@{$sugarnormalref}; 
my @pyrimidinecentroid=@{$pyrimidinecentroidref}; 
 
my $pyrimidinecentroid_x = $pyrimidinecentroid[0]; 
 
my $pyrimidinecentroid_y = $pyrimidinecentroid[1]; 
 
my $pyrimidinecentroid_z = $pyrimidinecentroid[2]; 
 
 
#print "pyrimidinecentroid= @pyrimidinecentroid\n"; 
my $sn_abs=sqrt($sugarnormal[0]*$sugarnormal[0] + $sugarnormal[1]*$sugarnormal[1] + $sugarnormal[2]*$sugarnormal[2]); 
#print "normalized sugarnormal: ". $sugarnormal[0]/$sn_abs . " " . $sugarnormal[1]/$sn_abs . " " . 
$sugarnormal[2]/$sn_abs . "\n"; 
 
my $sugarnormal_x = $sugarnormal[0]/$sn_abs; 
 
my $sugarnormal_y = $sugarnormal[1]/$sn_abs; 
 
my $sugarnormal_z = $sugarnormal[2]/$sn_abs; 
my @perpendicularnormal = &create_perpendicularnormal(\@sugarnormal,\@basenormal); 
##to compare the plane normals with Mercury (Mercury: click on More Info > Planes) 
my $pn_abs=sqrt($perpendicularnormal[0]*$perpendicularnormal[0] + $perpendicularnormal[1]*$perpendicularnormal[1] + 
$perpendicularnormal[2]*$perpendicularnormal[2]); 
#print "normalized perpendicularnormal: ". $perpendicularnormal[0]/$pn_abs . " " . $perpendicularnormal[1]/$pn_abs . " 
" . $perpendicularnormal[2]/$pn_abs . "\n"; 
my $perpendicularnormal_x = $perpendicularnormal[0]/$pn_abs; 
my $perpendicularnormal_y = $perpendicularnormal[1]/$pn_abs; 
my $perpendicularnormal_z = $perpendicularnormal[2]/$pn_abs; 
 my @stackingresults = 
&distance_to_all_pyrimidines(\@basenormal,\@sugarnormal,\@perpendicularnormal,\@pyrimidinecentroid); 
 
if (@stackingresults) #if there is a stacking hit... 
 
{ 
 
$has_any_stackers_in_PDB+=1; 
 
$logger->info("-----------------------------------------------------"); 
 
 
$logger->info("$basewithstackers has atoms stacking.");  
 
my $pi_dbh 
= DBI->connect("dbi:mysql:$uzh_database:$uzh_host", $uzh_user, $uzh_pw) || $logger->logdie("Oh no!!! 
could not connect to $uzh_database: $DBI::errstr"); 
 
 
my $insertbasesql = "INSERT INTO ".$uzh_database.".pi_bases (idCode, resName, ChainID, resSeq, normalvector_x, 
normalvector_y, normalvector_z, sugarvector_x, sugarvector_y, sugarvector_z, 
 
perpendicularvector_x, perpendicularvector_y, perpendicularvector_z, centroid_x, centroid_y, centroid_z)  
 
VALUES ('$PDB_ID', '$base_resName', '$base_ChainID', '$base_resSeq', '$basenormal_x', '$basenormal_y', 
'$basenormal_z', '$sugarnormal_x', '$sugarnormal_y', '$sugarnormal_z',  
 
'$perpendicularnormal_x', '$perpendicularnormal_y', '$perpendicularnormal_z', '$pyrimidinecentroid_x', 
'$pyrimidinecentroid_y', '$pyrimidinecentroid_z')"; 
 
my $pi_sth = $pi_dbh->prepare($insertbasesql) || $logger->logdie("Preparing MySQL update failed: $DBI::errstr");   
$p
i_
st
h-
>e
xe
cu
te
()
; 
 
my
 $
ba
se
_I
D 
= 
$p
i_
st
h-
>{
my
sq
l_
in
se
rt
id
};
 
 
$p
i_
st
h-
>f
in
is
h(
);
 
 
 
 
$l
og
ge
r-
>i
nf
o(
"$
ba
se
wi
th
st
ac
ke
rs
 e
nt
er
ed
 i
nt
o 
th
e 
da
ta
ba
se
, 
it
s 
DB
 I
D 
is
: 
$b
as
e_
ID
")
; 
 
$l
og
ge
r-
>i
nf
o(
"-
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
")
; 
 
 
$l
og
ge
r-
>i
nf
o(
"n
ow
 e
nt
er
in
g 
th
e 
fi
rs
t 
st
ac
ki
ng
 r
es
id
ue
:"
);
  
 
##
ch
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k 
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 c
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H 
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!!
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f 
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##
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op
 t
hr
og
h 
st
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ke
rs
 a
rr
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 t
o 
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 m
ul
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pl
e 
at
om
s 
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om
 t
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 s
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e.
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ft
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 i
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er
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e 
to
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ta
ck
re
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du
e,
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t'
s 
ID
 a
nd
 e
nt
er
 a
ll
 s
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in
g 
at
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s 
to
 p
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st
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to
m 
 
##
is
me
ta
l 
->
 a
dd
 i
t 
no
w 
or
 i
n 
a 
co
sm
et
ic
 u
pd
at
e 
la
te
r.
..
.l
at
er
! 
 
my
 $
cu
rr
en
t_
re
sN
am
e=
""
; 
 
my
 $
cu
rr
en
t_
Ch
ai
nI
D=
""
; 
 
my
 $
cu
rr
en
t_
re
sS
eq
="
";
 
 
my
 $
cu
rr
en
t_
pi
_s
ta
ck
re
si
du
e_
ID
="
";
 
 
my
 $
in
se
rt
_s
ta
ck
re
s=
""
; 
 
my
 $
in
se
rt
_s
ta
ck
at
om
="
";
 
 
my
 $
st
ac
kr
es
_I
D=
""
; 
 
 
fo
re
ac
h 
my
 $
st
ac
ke
rs
 (
@s
ta
ck
in
gr
es
ul
ts
) 
 
 
{ 
 
 
my
 (
$i
dC
od
e,
 $
se
ri
al
, 
$n
am
e,
 $
re
sN
am
e,
 $
Ch
ai
nI
D,
 $
re
sS
eq
, 
$x
, 
$y
, 
$z
, 
$e
le
me
nt
, 
 $
ID
, 
 $
at
om
, 
 $
al
tL
oc
, 
 
$i
Co
de
, 
 $
oc
cu
pa
nc
y,
  
$t
em
pF
ac
to
r,
  
$s
eg
ID
, 
$c
ha
rg
e,
$b
as
ed
is
t,
 $
su
ga
rd
is
t,
 $
pe
rp
en
di
cu
la
rd
is
t)
 =
 @
{$
st
ac
ke
rs
};
 
 
 
 
##
if
 e
it
he
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of
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he
 3
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qu
e 
re
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du
e 
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en
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er
s 
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, 
th
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 m
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t 
be
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ue
 
 
 
 
if
 (
$r
es
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me
 n
e 
$c
ur
re
nt
_r
es
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me
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| 
$C
ha
in
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 n
e 
$c
ur
re
nt
_C
ha
in
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 |
| 
$r
es
Se
q 
ne
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rr
en
t_
re
sS
eq
) 
 
 
 
{ 
 
 
 
my
 $
ch
ec
k_
fo
r_
st
ac
kr
es
cl
on
es
 =
 "
SE
LE
CT
 *
 F
RO
M 
pi
_s
ta
ck
re
si
du
e 
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er
e 
id
Co
de
 =
 '
".
$P
DB
_I
D.
"'
 a
nd
  
re
sN
am
e 
= 
'"
.$
re
sN
am
e.
"'
 a
nd
 C
ha
in
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 =
 '
".
$C
ha
in
ID
."
' 
an
d 
re
sS
eq
 =
 '
".
$r
es
Se
q.
"'
";
 
 
 
 
$p
i_
st
h 
= 
$p
i_
db
h-
>p
re
pa
re
($
ch
ec
k_
fo
r_
st
ac
kr
es
cl
on
es
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Pr
ep
ar
in
g 
My
SQ
L 
up
da
te
 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
 
 
 
$p
i_
st
h-
>e
xe
cu
te
()
; 
 
 
 
my
 $
co
un
tc
lo
ne
s;
  
 
 
 
 
$c
ou
nt
cl
on
es
 =
 $
pi
_s
th
->
ro
ws
; 
 
 
 
$p
i_
st
h-
>f
in
is
h(
);
 
 
 
 
 
if
 (
$c
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nt
cl
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es
 >
 0
) 
 
 
 
 
{ 
 
 
 
 
$i
ns
er
t_
st
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kr
es
="
IN
SE
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O 
pi
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ck
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du
e 
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D,
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VA
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ES
 (
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D'
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 '
$C
ha
in
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',
 '
$r
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, 
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lo
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)"
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$logger->info("$PDB_ID $resName  $ChainID  $resSeq is already 
$countclones time(s) a stacking base, for  $PDB_ID $resName  $ChainID  $resSeq isclone = $countclones"); 
 
 
 
 
 
} 
 
 
 
 
else 
 
 
 
 
{ 
 
 
 
 
$insert_stackres="INSERT INTO pi_stackresidue (IDBase, idCode, resName, ChainID, resSeq, 
isclone)  
 
 
 
 
 
 
 
 
 
VALUES ('$base_ID', '$PDB_ID', '$resName', '$ChainID', 
'$resSeq','0')"; 
 
 
 
 
 
} 
 
 
 
$current_resName = $resName; 
 
 
 
$current_ChainID = $ChainID; 
 
 
 
$current_resSeq = $resSeq; 
 
 
 
 
 
#whether clone or not, enter the residue into the pi_stackresidue table, extract the ID of course 
 
 
 
$pi_sth = $pi_dbh->prepare($insert_stackres) || $logger->logdie("Preparing MySQL update failed: 
$DBI::errstr"); 
 
 
 
$pi_sth->execute(); 
 
 
 
$stackres_ID = $pi_sth->{mysql_insertid}; 
 
 
 
$pi_sth->finish(); 
 
 
 
$logger->info("$PDB_ID $resName  $ChainID  $resSeq entered into the pi_stackresidue table. Insertion 
ID is: $stackres_ID"); 
 
 
 
} 
 
 
$insert_stackatom="INSERT INTO ".$uzh_database.".pi_stackatom (IDRes, idCode, atom, serial, 
name,altLoc,resName,ChainID,resSeq,iCode,x,y,z,occupancy, 
 
 
tempFactor, segID,element,charge,normaldist,sugardist,perpendiculardist) 
 
 
VALUES ('$stackres_ID', '$PDB_ID', '$atom', '$serial', '$name', '$altLoc', '$resName', '$ChainID', 
'$resSeq', '$iCode', '$x','$y','$z', '$occupancy', 
 
 
'$tempFactor', '$segID','$element','$charge','$basedist', '$sugardist','$perpendiculardist')";  
 
 
$pi_sth = $pi_dbh->prepare($insert_stackatom) || $logger->logdie("Preparing MySQL update failed: 
$DBI::errstr"); 
 
 
$pi_sth->execute(); 
 
 
my $stackatom_ID = $pi_sth->{mysql_insertid}; #this is for debugging only, not needed anymore in the 
future. 
 
 
$pi_sth->finish(); 
 
 
$logger->info("$PDB_ID $resName  $ChainID  $resSeq $name entered into the pi_stackatom table. Insertion ID 
$stackatom_ID "); 
 
 
$logger->info("stackingdistances: basedist = $basedist Å, sugardist = $sugardist Å, perpendiculardist = 
$perpendiculardist Å.") 
 
 
} 
 
 
$logger->info("-----------------------------------------------------"); 
 
 
 
$p
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is
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} 
 } ##
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##
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##
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; 
 
$l
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nd
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] 
is
 C
ha
in
ID
, 
[2
] 
is
 r
es
Se
q,
 [
3]
 i
s 
th
e 
C2
 a
rr
ay
, 
[4
] 
is
 t
he
 C
8 
ar
ra
y,
 [
5]
 i
s 
th
e 
N1
 a
rr
ay
, 
[6
] 
is
 t
he
 N
7 
ar
ra
y,
 [
7]
 i
s 
th
e 
N9
 a
rr
ay
. 
 
#p
ri
nt
 "
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
0]
 $
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[1
] 
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
2]
\t
 C
2:
 
@{
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
3]
}\
t 
C8
: 
@{
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
4]
}\
tN
1:
 
@{
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
5]
}\
tN
7:
 
@{
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
6]
}\
tN
9:
 
@{
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
7]
}\
n"
; 
#p
ri
nt
 "
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
0]
 $
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[1
] 
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
2]
\n
";
 
my
 $
ba
se
wi
th
st
ac
ke
rs
 =
 $
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[0
].
" 
".
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
1]
."
 "
.$
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[2
];
 
 
my
 $
ba
se
_r
es
Na
me
 =
 $
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[0
];
 
 
my
 $
ba
se
_C
ha
in
ID
 =
 $
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[1
];
 
 
my
 $
ba
se
_r
es
Se
q 
= 
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
2]
; 
my
 @
ba
se
no
rm
al
 =
 
&c
re
at
e_
ba
se
no
rm
al
($
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[7
],
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
e
me
nt
]}
[3
],
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
4]
);
 
my
 $
bn
_a
bs
=s
qr
t(
$b
as
en
or
ma
l[
0]
*$
ba
se
no
rm
al
[0
] 
+ 
$b
as
en
or
ma
l[
1]
*$
ba
se
no
rm
al
[1
] 
+ 
$b
as
en
or
ma
l[
2]
*$
ba
se
no
rm
al
[2
])
; 
#p
ri
nt
 "
no
rm
al
iz
ed
 b
as
en
or
ma
l:
 "
. 
$b
as
en
or
ma
l[
0]
/$
ab
s 
. 
" 
" 
. 
$b
as
en
or
ma
l[
1]
/$
ab
s 
. 
" 
" 
. 
$b
as
en
or
ma
l[
2]
/$
ab
s 
. 
"\
n"
; 
 
my
 $
ba
se
no
rm
al
_x
 =
 $
ba
se
no
rm
al
[0
]/
$b
n_
ab
s;
 
 
my
 $
ba
se
no
rm
al
_y
 =
 $
ba
se
no
rm
al
[1
]/
$b
n_
ab
s;
 
 
my
 $
ba
se
no
rm
al
_z
 =
 $
ba
se
no
rm
al
[2
]/
$b
n_
ab
s;
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$logger->info("$PDB_ID $resName  $ChainID  $resSeq is already 
$countclones time(s) a stacking base, for  $PDB_ID $resName  $ChainID  $resSeq isclone = $countclones"); 
 
 
 
 
 
} 
 
 
 
 
else 
 
 
 
 
{ 
 
 
 
 
$insert_stackres="INSERT INTO pi_stackresidue (IDBase, idCode, resName, ChainID, resSeq, 
isclone)  
 
 
 
 
 
 
 
 
 
VALUES ('$base_ID', '$PDB_ID', '$resName', '$ChainID', 
'$resSeq','0')"; 
 
 
 
 
 
} 
 
 
 
$current_resName = $resName; 
 
 
 
$current_ChainID = $ChainID; 
 
 
 
$current_resSeq = $resSeq; 
 
 
 
 
 
#whether clone or not, enter the residue into the pi_stackresidue table, extract the ID of course 
 
 
 
$pi_sth = $pi_dbh->prepare($insert_stackres) || $logger->logdie("Preparing MySQL update failed: 
$DBI::errstr"); 
 
 
 
$pi_sth->execute(); 
 
 
 
$stackres_ID = $pi_sth->{mysql_insertid}; 
 
 
 
$pi_sth->finish(); 
 
 
 
$logger->info("$PDB_ID $resName  $ChainID  $resSeq entered into the pi_stackresidue table. Insertion 
ID is: $stackres_ID"); 
 
 
 
} 
 
 
$insert_stackatom="INSERT INTO ".$uzh_database.".pi_stackatom (IDRes, idCode, atom, serial, 
name,altLoc,resName,ChainID,resSeq,iCode,x,y,z,occupancy, 
 
 
tempFactor, segID,element,charge,normaldist,sugardist,perpendiculardist) 
 
 
VALUES ('$stackres_ID', '$PDB_ID', '$atom', '$serial', '$name', '$altLoc', '$resName', '$ChainID', 
'$resSeq', '$iCode', '$x','$y','$z', '$occupancy', 
 
 
'$tempFactor', '$segID','$element','$charge','$basedist', '$sugardist','$perpendiculardist')";  
 
 
$pi_sth = $pi_dbh->prepare($insert_stackatom) || $logger->logdie("Preparing MySQL update failed: 
$DBI::errstr"); 
 
 
$pi_sth->execute(); 
 
 
my $stackatom_ID = $pi_sth->{mysql_insertid}; #this is for debugging only, not needed anymore in the 
future. 
 
 
$pi_sth->finish(); 
 
 
$logger->info("$PDB_ID $resName  $ChainID  $resSeq $name entered into the pi_stackatom table. Insertion ID 
$stackatom_ID "); 
 
 
$logger->info("stackingdistances: basedist = $basedist Å, sugardist = $sugardist Å, perpendiculardist = 
$perpendiculardist Å.") 
 
 
} 
 
 
$logger->info("-----------------------------------------------------"); 
 
 
 
$p
i_
db
h-
>d
is
co
nn
ec
t(
);
  
 
 
 
} 
 } ##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
#e
nd
 o
f:
 p
yr
im
id
in
es
 t
o 
db
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
# 
 ##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
pu
ri
ne
s 
to
 d
b#
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
# 
 $l
og
ge
r-
>i
nf
o(
"-
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-
--
")
; 
 
$l
og
ge
r-
>i
nf
o(
"A
nd
 l
as
t 
bu
t 
no
t 
le
as
t:
 t
he
 p
ur
in
es
!"
);
 
$l
og
ge
r-
>i
nf
o(
"-
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-
--
")
; 
 
fo
re
ac
h 
my
 $
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
 (
0.
. 
$#
pu
ri
ne
_p
la
ne
_a
rr
ay
) 
{ ##
 t
he
 p
ur
in
e_
pl
an
e_
ar
ra
y 
no
w 
lo
ok
s 
as
 f
ol
lo
ws
 [
0]
 i
s 
$r
es
Na
me
, 
[1
] 
is
 C
ha
in
ID
, 
[2
] 
is
 r
es
Se
q,
 [
3]
 i
s 
th
e 
C2
 a
rr
ay
, 
[4
] 
is
 t
he
 C
8 
ar
ra
y,
 [
5]
 i
s 
th
e 
N1
 a
rr
ay
, 
[6
] 
is
 t
he
 N
7 
ar
ra
y,
 [
7]
 i
s 
th
e 
N9
 a
rr
ay
. 
 
#p
ri
nt
 "
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
0]
 $
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[1
] 
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
2]
\t
 C
2:
 
@{
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
3]
}\
t 
C8
: 
@{
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
4]
}\
tN
1:
 
@{
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
5]
}\
tN
7:
 
@{
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
6]
}\
tN
9:
 
@{
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
7]
}\
n"
; 
#p
ri
nt
 "
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
0]
 $
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[1
] 
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
2]
\n
";
 
my
 $
ba
se
wi
th
st
ac
ke
rs
 =
 $
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[0
].
" 
".
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
1]
."
 "
.$
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[2
];
 
 
my
 $
ba
se
_r
es
Na
me
 =
 $
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[0
];
 
 
my
 $
ba
se
_C
ha
in
ID
 =
 $
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[1
];
 
 
my
 $
ba
se
_r
es
Se
q 
= 
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
2]
; 
my
 @
ba
se
no
rm
al
 =
 
&c
re
at
e_
ba
se
no
rm
al
($
{$
pu
ri
ne
_p
la
ne
_a
rr
ay
[$
pu
ri
ne
_p
la
ne
_a
rr
ay
_e
le
me
nt
]}
[7
],
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
e
me
nt
]}
[3
],
${
$p
ur
in
e_
pl
an
e_
ar
ra
y[
$p
ur
in
e_
pl
an
e_
ar
ra
y_
el
em
en
t]
}[
4]
);
 
my
 $
bn
_a
bs
=s
qr
t(
$b
as
en
or
ma
l[
0]
*$
ba
se
no
rm
al
[0
] 
+ 
$b
as
en
or
ma
l[
1]
*$
ba
se
no
rm
al
[1
] 
+ 
$b
as
en
or
ma
l[
2]
*$
ba
se
no
rm
al
[2
])
; 
#p
ri
nt
 "
no
rm
al
iz
ed
 b
as
en
or
ma
l:
 "
. 
$b
as
en
or
ma
l[
0]
/$
ab
s 
. 
" 
" 
. 
$b
as
en
or
ma
l[
1]
/$
ab
s 
. 
" 
" 
. 
$b
as
en
or
ma
l[
2]
/$
ab
s 
. 
"\
n"
; 
 
my
 $
ba
se
no
rm
al
_x
 =
 $
ba
se
no
rm
al
[0
]/
$b
n_
ab
s;
 
 
my
 $
ba
se
no
rm
al
_y
 =
 $
ba
se
no
rm
al
[1
]/
$b
n_
ab
s;
 
 
my
 $
ba
se
no
rm
al
_z
 =
 $
ba
se
no
rm
al
[2
]/
$b
n_
ab
s;
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my ($sugarnormalref,$purinecentroidref) = 
&create_purine_sugarnormal(${$purine_plane_array[$purine_plane_array_element]}[5],${$purine_plane_array[$purine_plane_a
rray_element]}[3],${$purine_plane_array[$purine_plane_array_element]}[4],\@basenormal); 
my @sugarnormal=@{$sugarnormalref}; 
my @purinecentroid=@{$purinecentroidref}; 
 
my $purinecentroid_x = $purinecentroid[0]; 
 
my $purinecentroid_y = $purinecentroid[1]; 
 
my $purinecentroid_z = $purinecentroid[2]; 
#print "purinecentroid= @purinecentroid\n"; 
my $sn_abs=sqrt($sugarnormal[0]*$sugarnormal[0] + $sugarnormal[1]*$sugarnormal[1] + $sugarnormal[2]*$sugarnormal[2]); 
#print "normalized sugarnormal: ". $sugarnormal[0]/$abs . " " . $sugarnormal[1]/$abs . " " . $sugarnormal[2]/$abs . 
"\n"; 
 
my $sugarnormal_x = $sugarnormal[0]/$sn_abs; 
 
my $sugarnormal_y = $sugarnormal[1]/$sn_abs; 
 
my $sugarnormal_z = $sugarnormal[2]/$sn_abs; 
my @perpendicularnormal = &create_perpendicularnormal(\@sugarnormal,\@basenormal); 
##to compare the plane normals with Mercury (Mercury: click on More Info > Planes) 
my $pn_abs=sqrt($perpendicularnormal[0]*$perpendicularnormal[0] + $perpendicularnormal[1]*$perpendicularnormal[1] + 
$perpendicularnormal[2]*$perpendicularnormal[2]); 
#print "normalized perpendicularnormal: ". $perpendicularnormal[0]/$abs . " " . $perpendicularnormal[1]/$abs . " " . 
$perpendicularnormal[2]/$abs . "\n"; 
 
my $perpendicularnormal_x = $perpendicularnormal[0]/$pn_abs; 
 
my $perpendicularnormal_y = $perpendicularnormal[1]/$pn_abs; 
 
my $perpendicularnormal_z = $perpendicularnormal[2]/$pn_abs; 
 my @stackingresults = &distance_to_all_purines(\@basenormal,\@sugarnormal,\@perpendicularnormal,\@purinecentroid); 
 
if (@stackingresults) 
 
{ 
 
$has_any_stackers_in_PDB+=1; 
 
 
$logger->info("-----------------------------------------------------"); 
 
 
$logger->info("$basewithstackers has atoms stacking."); 
 
 
my $pi_dbh 
= DBI->connect("dbi:mysql:$uzh_database:$uzh_host", $uzh_user, $uzh_pw) || $logger->logdie("Oh no!!! 
could not connect to $uzh_database: $DBI::errstr"); 
 
 
my $insertbasesql = "INSERT INTO ".$uzh_database.".pi_bases (idCode, resName, ChainID, resSeq, normalvector_x, 
normalvector_y, normalvector_z, sugarvector_x, sugarvector_y, sugarvector_z, 
 
perpendicularvector_x, perpendicularvector_y, perpendicularvector_z, centroid_x, centroid_y, centroid_z)  
 
VALUES ('$PDB_ID', '$base_resName', '$base_ChainID', '$base_resSeq', '$basenormal_x', '$basenormal_y', 
'$basenormal_z', '$sugarnormal_x', '$sugarnormal_y', '$sugarnormal_z',  
 
'$perpendicularnormal_x', '$perpendicularnormal_y', '$perpendicularnormal_z', '$purinecentroid_x', 
'$purinecentroid_y', '$purinecentroid_z')"; 
 
my
 $
pi
_s
th
 =
 $
pi
_d
bh
->
pr
ep
ar
e(
$i
ns
er
tb
as
es
ql
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Pr
ep
ar
in
g 
My
SQ
L 
up
da
te
 f
ai
le
d:
 $
DB
I:
:e
rr
st
r"
);
  
 
$p
i_
st
h-
>e
xe
cu
te
()
; 
 
my
 $
ba
se
_I
D 
= 
$p
i_
st
h-
>{
my
sq
l_
in
se
rt
id
};
 
 
$p
i_
st
h-
>f
in
is
h(
);
 
 
 
 
$l
og
ge
r-
>i
nf
o(
"$
ba
se
wi
th
st
ac
ke
rs
 e
nt
er
ed
 i
nt
o 
th
e 
da
ta
ba
se
, 
it
s 
DB
 I
D 
is
: 
$b
as
e_
ID
")
; 
 
$l
og
ge
r-
>i
nf
o(
"-
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
")
; 
 
 
$l
og
ge
r-
>i
nf
o(
"n
ow
 e
nt
er
in
g 
th
e 
fi
rs
t 
st
ac
ki
ng
 r
es
id
ue
:"
);
  
 
##
ch
ec
k 
if
 h
as
 c
lo
ne
 F
OR
 E
AC
H 
NE
W 
RE
SI
DU
E!
!!
 i
f 
ye
s,
 s
et
 i
sc
lo
ne
 t
o 
co
un
tr
ow
s+
1 
 
##
lo
op
 t
hr
og
h 
st
ac
ke
rs
 a
rr
ay
 t
o 
fi
nd
 m
ul
ti
pl
e 
at
om
s 
fr
om
 t
he
 s
am
e 
re
si
du
e.
 A
ft
er
 i
ns
er
ti
ng
 t
he
  
re
si
du
e 
to
 
pi
_s
ta
ck
re
si
du
e,
 g
et
 i
t'
s 
ID
 a
nd
 e
nt
er
 a
ll
 s
ta
ck
in
g 
at
om
s 
to
 p
i_
st
ac
ka
to
m 
 
##
is
me
ta
l 
->
 a
dd
 i
t 
no
w 
or
 i
n 
a 
co
sm
et
ic
 u
pd
at
e 
la
te
r.
..
.l
at
er
! 
 
my
 $
cu
rr
en
t_
re
sN
am
e=
""
; 
 
my
 $
cu
rr
en
t_
Ch
ai
nI
D=
""
; 
 
my
 $
cu
rr
en
t_
re
sS
eq
="
";
 
 
my
 $
cu
rr
en
t_
pi
_s
ta
ck
re
si
du
e_
ID
="
";
 
 
my
 $
in
se
rt
_s
ta
ck
re
s=
""
; 
 
my
 $
in
se
rt
_s
ta
ck
at
om
="
";
 
 
my
 $
st
ac
kr
es
_I
D=
""
; 
 
 
fo
re
ac
h 
my
 $
st
ac
ke
rs
 (
@s
ta
ck
in
gr
es
ul
ts
) 
 
 
{ 
 
 
my
 (
$i
dC
od
e,
 $
se
ri
al
, 
$n
am
e,
 $
re
sN
am
e,
 $
Ch
ai
nI
D,
 $
re
sS
eq
, 
$x
, 
$y
, 
$z
, 
$e
le
me
nt
, 
 $
ID
, 
 $
at
om
, 
 $
al
tL
oc
, 
 
$i
Co
de
, 
 $
oc
cu
pa
nc
y,
  
$t
em
pF
ac
to
r,
  
$s
eg
ID
, 
$c
ha
rg
e,
$b
as
ed
is
t,
 $
su
ga
rd
is
t,
 $
pe
rp
en
di
cu
la
rd
is
t)
 =
 @
{$
st
ac
ke
rs
};
 
 
 
 
##
if
 e
it
he
r 
of
 t
he
 3
 u
ni
qu
e 
re
si
du
e 
id
en
ti
fi
er
s 
ch
an
ge
, 
th
is
 m
us
t 
be
 a
 n
ew
 r
es
id
ue
 
 
 
 
if
 (
$r
es
Na
me
 n
e 
$c
ur
re
nt
_r
es
Na
me
 |
| 
$C
ha
in
ID
 n
e 
$c
ur
re
nt
_C
ha
in
ID
 |
| 
$r
es
Se
q 
ne
 $
cu
rr
en
t_
re
sS
eq
) 
 
 
 
{ 
 
 
 
my
 $
ch
ec
k_
fo
r_
st
ac
kr
es
cl
on
es
 =
 "
SE
LE
CT
 *
 F
RO
M 
pi
_s
ta
ck
re
si
du
e 
wh
er
e 
id
Co
de
 =
 '
".
$P
DB
_I
D.
"'
 a
nd
  
re
sN
am
e 
= 
'"
.$
re
sN
am
e.
"'
 a
nd
 C
ha
in
ID
 =
 '
".
$C
ha
in
ID
."
' 
an
d 
re
sS
eq
 =
 '
".
$r
es
Se
q.
"'
";
 
 
 
 
$p
i_
st
h 
= 
$p
i_
db
h-
>p
re
pa
re
($
ch
ec
k_
fo
r_
st
ac
kr
es
cl
on
es
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Pr
ep
ar
in
g 
My
SQ
L 
up
da
te
 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
 
 
 
$p
i_
st
h-
>e
xe
cu
te
()
; 
 
 
 
my
 $
co
un
tc
lo
ne
s;
  
 
 
 
 
$c
ou
nt
cl
on
es
 =
 $
pi
_s
th
->
ro
ws
; 
 
 
 
$p
i_
st
h-
>f
in
is
h(
);
 
 
 
 
 
if
 (
$c
ou
nt
cl
on
es
 >
 0
) 
 
 
 
 
{ 
 
 
 
 
$i
ns
er
t_
st
ac
kr
es
="
IN
SE
RT
 I
NT
O 
pi
_s
ta
ck
re
si
du
e 
(I
DB
as
e,
 i
dC
od
e,
 r
es
Na
me
, 
Ch
ai
nI
D,
 r
es
Se
q,
 
is
cl
on
e)
  
 
 
 
 
 
 
 
 
 
VA
LU
ES
 (
'$
ba
se
_I
D'
, 
'$
PD
B_
ID
',
 '
$r
es
Na
me
',
 '
$C
ha
in
ID
',
 '
$r
es
Se
q'
, 
'$
co
un
tc
lo
ne
s'
)"
; 
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my ($sugarnormalref,$purinecentroidref) = 
&create_purine_sugarnormal(${$purine_plane_array[$purine_plane_array_element]}[5],${$purine_plane_array[$purine_plane_a
rray_element]}[3],${$purine_plane_array[$purine_plane_array_element]}[4],\@basenormal); 
my @sugarnormal=@{$sugarnormalref}; 
my @purinecentroid=@{$purinecentroidref}; 
 
my $purinecentroid_x = $purinecentroid[0]; 
 
my $purinecentroid_y = $purinecentroid[1]; 
 
my $purinecentroid_z = $purinecentroid[2]; 
#print "purinecentroid= @purinecentroid\n"; 
my $sn_abs=sqrt($sugarnormal[0]*$sugarnormal[0] + $sugarnormal[1]*$sugarnormal[1] + $sugarnormal[2]*$sugarnormal[2]); 
#print "normalized sugarnormal: ". $sugarnormal[0]/$abs . " " . $sugarnormal[1]/$abs . " " . $sugarnormal[2]/$abs . 
"\n"; 
 
my $sugarnormal_x = $sugarnormal[0]/$sn_abs; 
 
my $sugarnormal_y = $sugarnormal[1]/$sn_abs; 
 
my $sugarnormal_z = $sugarnormal[2]/$sn_abs; 
my @perpendicularnormal = &create_perpendicularnormal(\@sugarnormal,\@basenormal); 
##to compare the plane normals with Mercury (Mercury: click on More Info > Planes) 
my $pn_abs=sqrt($perpendicularnormal[0]*$perpendicularnormal[0] + $perpendicularnormal[1]*$perpendicularnormal[1] + 
$perpendicularnormal[2]*$perpendicularnormal[2]); 
#print "normalized perpendicularnormal: ". $perpendicularnormal[0]/$abs . " " . $perpendicularnormal[1]/$abs . " " . 
$perpendicularnormal[2]/$abs . "\n"; 
 
my $perpendicularnormal_x = $perpendicularnormal[0]/$pn_abs; 
 
my $perpendicularnormal_y = $perpendicularnormal[1]/$pn_abs; 
 
my $perpendicularnormal_z = $perpendicularnormal[2]/$pn_abs; 
 my @stackingresults = &distance_to_all_purines(\@basenormal,\@sugarnormal,\@perpendicularnormal,\@purinecentroid); 
 
if (@stackingresults) 
 
{ 
 
$has_any_stackers_in_PDB+=1; 
 
 
$logger->info("-----------------------------------------------------"); 
 
 
$logger->info("$basewithstackers has atoms stacking."); 
 
 
my $pi_dbh 
= DBI->connect("dbi:mysql:$uzh_database:$uzh_host", $uzh_user, $uzh_pw) || $logger->logdie("Oh no!!! 
could not connect to $uzh_database: $DBI::errstr"); 
 
 
my $insertbasesql = "INSERT INTO ".$uzh_database.".pi_bases (idCode, resName, ChainID, resSeq, normalvector_x, 
normalvector_y, normalvector_z, sugarvector_x, sugarvector_y, sugarvector_z, 
 
perpendicularvector_x, perpendicularvector_y, perpendicularvector_z, centroid_x, centroid_y, centroid_z)  
 
VALUES ('$PDB_ID', '$base_resName', '$base_ChainID', '$base_resSeq', '$basenormal_x', '$basenormal_y', 
'$basenormal_z', '$sugarnormal_x', '$sugarnormal_y', '$sugarnormal_z',  
 
'$perpendicularnormal_x', '$perpendicularnormal_y', '$perpendicularnormal_z', '$purinecentroid_x', 
'$purinecentroid_y', '$purinecentroid_z')"; 
 
my
 $
pi
_s
th
 =
 $
pi
_d
bh
->
pr
ep
ar
e(
$i
ns
er
tb
as
es
ql
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Pr
ep
ar
in
g 
My
SQ
L 
up
da
te
 f
ai
le
d:
 $
DB
I:
:e
rr
st
r"
);
  
 
$p
i_
st
h-
>e
xe
cu
te
()
; 
 
my
 $
ba
se
_I
D 
= 
$p
i_
st
h-
>{
my
sq
l_
in
se
rt
id
};
 
 
$p
i_
st
h-
>f
in
is
h(
);
 
 
 
 
$l
og
ge
r-
>i
nf
o(
"$
ba
se
wi
th
st
ac
ke
rs
 e
nt
er
ed
 i
nt
o 
th
e 
da
ta
ba
se
, 
it
s 
DB
 I
D 
is
: 
$b
as
e_
ID
")
; 
 
$l
og
ge
r-
>i
nf
o(
"-
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
")
; 
 
 
$l
og
ge
r-
>i
nf
o(
"n
ow
 e
nt
er
in
g 
th
e 
fi
rs
t 
st
ac
ki
ng
 r
es
id
ue
:"
);
  
 
##
ch
ec
k 
if
 h
as
 c
lo
ne
 F
OR
 E
AC
H 
NE
W 
RE
SI
DU
E!
!!
 i
f 
ye
s,
 s
et
 i
sc
lo
ne
 t
o 
co
un
tr
ow
s+
1 
 
##
lo
op
 t
hr
og
h 
st
ac
ke
rs
 a
rr
ay
 t
o 
fi
nd
 m
ul
ti
pl
e 
at
om
s 
fr
om
 t
he
 s
am
e 
re
si
du
e.
 A
ft
er
 i
ns
er
ti
ng
 t
he
  
re
si
du
e 
to
 
pi
_s
ta
ck
re
si
du
e,
 g
et
 i
t'
s 
ID
 a
nd
 e
nt
er
 a
ll
 s
ta
ck
in
g 
at
om
s 
to
 p
i_
st
ac
ka
to
m 
 
##
is
me
ta
l 
->
 a
dd
 i
t 
no
w 
or
 i
n 
a 
co
sm
et
ic
 u
pd
at
e 
la
te
r.
..
.l
at
er
! 
 
my
 $
cu
rr
en
t_
re
sN
am
e=
""
; 
 
my
 $
cu
rr
en
t_
Ch
ai
nI
D=
""
; 
 
my
 $
cu
rr
en
t_
re
sS
eq
="
";
 
 
my
 $
cu
rr
en
t_
pi
_s
ta
ck
re
si
du
e_
ID
="
";
 
 
my
 $
in
se
rt
_s
ta
ck
re
s=
""
; 
 
my
 $
in
se
rt
_s
ta
ck
at
om
="
";
 
 
my
 $
st
ac
kr
es
_I
D=
""
; 
 
 
fo
re
ac
h 
my
 $
st
ac
ke
rs
 (
@s
ta
ck
in
gr
es
ul
ts
) 
 
 
{ 
 
 
my
 (
$i
dC
od
e,
 $
se
ri
al
, 
$n
am
e,
 $
re
sN
am
e,
 $
Ch
ai
nI
D,
 $
re
sS
eq
, 
$x
, 
$y
, 
$z
, 
$e
le
me
nt
, 
 $
ID
, 
 $
at
om
, 
 $
al
tL
oc
, 
 
$i
Co
de
, 
 $
oc
cu
pa
nc
y,
  
$t
em
pF
ac
to
r,
  
$s
eg
ID
, 
$c
ha
rg
e,
$b
as
ed
is
t,
 $
su
ga
rd
is
t,
 $
pe
rp
en
di
cu
la
rd
is
t)
 =
 @
{$
st
ac
ke
rs
};
 
 
 
 
##
if
 e
it
he
r 
of
 t
he
 3
 u
ni
qu
e 
re
si
du
e 
id
en
ti
fi
er
s 
ch
an
ge
, 
th
is
 m
us
t 
be
 a
 n
ew
 r
es
id
ue
 
 
 
 
if
 (
$r
es
Na
me
 n
e 
$c
ur
re
nt
_r
es
Na
me
 |
| 
$C
ha
in
ID
 n
e 
$c
ur
re
nt
_C
ha
in
ID
 |
| 
$r
es
Se
q 
ne
 $
cu
rr
en
t_
re
sS
eq
) 
 
 
 
{ 
 
 
 
my
 $
ch
ec
k_
fo
r_
st
ac
kr
es
cl
on
es
 =
 "
SE
LE
CT
 *
 F
RO
M 
pi
_s
ta
ck
re
si
du
e 
wh
er
e 
id
Co
de
 =
 '
".
$P
DB
_I
D.
"'
 a
nd
  
re
sN
am
e 
= 
'"
.$
re
sN
am
e.
"'
 a
nd
 C
ha
in
ID
 =
 '
".
$C
ha
in
ID
."
' 
an
d 
re
sS
eq
 =
 '
".
$r
es
Se
q.
"'
";
 
 
 
 
$p
i_
st
h 
= 
$p
i_
db
h-
>p
re
pa
re
($
ch
ec
k_
fo
r_
st
ac
kr
es
cl
on
es
) 
||
 $
lo
gg
er
->
lo
gd
ie
("
Pr
ep
ar
in
g 
My
SQ
L 
up
da
te
 
fa
il
ed
: 
$D
BI
::
er
rs
tr
")
; 
 
 
 
$p
i_
st
h-
>e
xe
cu
te
()
; 
 
 
 
my
 $
co
un
tc
lo
ne
s;
  
 
 
 
 
$c
ou
nt
cl
on
es
 =
 $
pi
_s
th
->
ro
ws
; 
 
 
 
$p
i_
st
h-
>f
in
is
h(
);
 
 
 
 
 
if
 (
$c
ou
nt
cl
on
es
 >
 0
) 
 
 
 
 
{ 
 
 
 
 
$i
ns
er
t_
st
ac
kr
es
="
IN
SE
RT
 I
NT
O 
pi
_s
ta
ck
re
si
du
e 
(I
DB
as
e,
 i
dC
od
e,
 r
es
Na
me
, 
Ch
ai
nI
D,
 r
es
Se
q,
 
is
cl
on
e)
  
 
 
 
 
 
 
 
 
 
VA
LU
ES
 (
'$
ba
se
_I
D'
, 
'$
PD
B_
ID
',
 '
$r
es
Na
me
',
 '
$C
ha
in
ID
',
 '
$r
es
Se
q'
, 
'$
co
un
tc
lo
ne
s'
)"
; 
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$logger->info("$PDB_ID $resName  $ChainID  $resSeq is already 
$countclones time(s) a stacking base, for  $PDB_ID $resName  $ChainID  $resSeq isclone = $countclones"); 
 
 
 
 
 
} 
 
 
 
 
else 
 
 
 
 
{ 
 
 
 
 
$insert_stackres="INSERT INTO pi_stackresidue (IDBase, idCode, resName, ChainID, resSeq, 
isclone)  
 
 
 
 
 
 
 
 
 
VALUES ('$base_ID', '$PDB_ID', '$resName', '$ChainID', 
'$resSeq','0')"; 
 
 
 
 
 
} 
 
 
 
$current_resName = $resName; 
 
 
 
$current_ChainID = $ChainID; 
 
 
 
$current_resSeq = $resSeq; 
 
 
 
 
 
#whether clone or not, enter the residue into the pi_stackresidue table, extract the ID of course 
 
 
 
$pi_sth = $pi_dbh->prepare($insert_stackres) || $logger->logdie("Preparing MySQL update failed: 
$DBI::errstr"); 
 
 
 
$pi_sth->execute(); 
 
 
 
$stackres_ID = $pi_sth->{mysql_insertid}; 
 
 
 
$pi_sth->finish(); 
 
 
 
$logger->info("$PDB_ID $resName  $ChainID  $resSeq entered into the pi_stackresidue table. Insertion 
ID is: $stackres_ID"); 
 
 
 
} 
 
 
$insert_stackatom="INSERT INTO ".$uzh_database.".pi_stackatom (IDRes, idCode, atom, serial, 
name,altLoc,resName,ChainID,resSeq,iCode,x,y,z,occupancy, 
 
 
tempFactor, segID,element,charge,normaldist,sugardist,perpendiculardist) 
 
 
VALUES ('$stackres_ID', '$PDB_ID', '$atom', '$serial', '$name', '$altLoc', '$resName', '$ChainID', 
'$resSeq', '$iCode', '$x','$y','$z', '$occupancy', 
 
 
'$tempFactor', '$segID','$element','$charge','$basedist', '$sugardist','$perpendiculardist')";  
 
 
$pi_sth = $pi_dbh->prepare($insert_stackatom) || $logger->logdie("Preparing MySQL update failed: 
$DBI::errstr"); 
 
 
$pi_sth->execute(); 
 
 
my $stackatom_ID = $pi_sth->{mysql_insertid}; #this is for debugging only, not needed anymore in the 
future. 
 
 
$pi_sth->finish(); 
 
 
$logger->info("$PDB_ID $resName  $ChainID  $resSeq $name entered into the pi_stackatom table. Insertion ID 
$stackatom_ID "); 
 
 
$logger->info("stackingdistances: basedist = $basedist Å, sugardist = $sugardist Å, perpendiculardist = 
$perpendiculardist Å.") 
 
 
} 
 
 
$logger->info("-----------------------------------------------------"); 
 
 
 
$p
i_
db
h-
>d
is
co
nn
ec
t(
);
  
 
 
} 
} ##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
en
d 
of
: 
pu
ri
ne
s 
to
 
db
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
 
 ##
#w
ri
te
 t
hi
ng
s 
to
 h
ea
de
r:
 s
ta
ck
in
g 
(0
/1
),
 #
ba
se
s 
to
ta
l,
 s
av
eo
k 
= 
1,
 i
n 
pr
og
re
ss
 b
ac
k 
to
 0
, 
ca
lc
ti
me
, 
fa
ul
ty
 p
ur
in
es
, 
py
ri
mi
di
ne
s 
$e
nd
 =
 t
im
e;
 
my
 $
du
ra
ti
on
 =
 $
en
d 
- 
$s
ta
rt
; 
$l
og
ge
r-
>i
nf
o(
"T
im
e 
ta
ke
n 
wa
s 
",
 (
$e
nd
 -
 $
st
ar
t)
, 
" 
se
co
nd
s"
);
 
my
 $
ha
ss
ta
ck
in
g;
 
 
if
 (
$h
as
_a
ny
_s
ta
ck
er
s_
in
_P
DB
 >
 0
) 
{ $h
as
st
ac
ki
ng
 =
 1
; 
 
} el
se
 
{ $h
as
st
ac
ki
ng
 =
 0
; 
 
 
}   m
y 
$p
i_
he
ad
er
_c
lo
se
_d
bh
 =
 D
BI
->
co
nn
ec
t(
"d
bi
:m
ys
ql
:$
uz
h_
da
ta
ba
se
:$
uz
h_
ho
st
",
 $
uz
h_
us
er
, 
$u
zh
_p
w)
 |
| 
$l
og
ge
r-
>l
og
di
e(
"O
h 
no
!!
! 
co
ul
d 
no
t 
co
nn
ec
t 
to
 $
uz
h_
da
ta
ba
se
: 
$D
BI
::
er
rs
tr
")
; 
 
my
 $
pi
_h
ea
de
r_
cl
os
e_
up
da
te
 =
 "
UP
DA
TE
 "
.$
uz
h_
da
ta
ba
se
."
."
.$
uz
h_
ta
bl
en
am
e.
" 
SE
T 
in
_p
ro
gr
es
s 
= 
0,
Sa
ve
Ok
 =
 1
, 
ba
se
_q
ua
nt
it
y 
= 
'$
re
si
du
ec
ou
nt
er
',
 
ca
lc
ti
me
 =
 '
$d
ur
at
io
n'
, 
fa
ul
ty
_p
yr
im
id
in
es
 =
 '
$f
au
lt
y_
py
ri
mi
di
ne
_c
ou
nt
er
',
 f
au
lt
y_
pu
ri
ne
s 
= 
'$
fa
ul
ty
_p
ur
in
e_
co
un
te
r'
, 
pi
_s
ta
ck
in
g 
= 
'$
ha
ss
ta
ck
in
g'
 W
HE
RE
 i
dC
od
e 
= 
'$
PD
B_
ID
'"
; 
my
 $
st
h_
pi
_h
ea
de
r_
cl
os
e 
= 
$p
i_
he
ad
er
_c
lo
se
_d
bh
->
pr
ep
ar
e(
$p
i_
he
ad
er
_c
lo
se
_u
pd
at
e)
 |
| 
$l
og
ge
r-
>l
og
di
e(
"P
re
pa
ri
ng
 M
yS
QL
 
up
da
te
 f
ai
le
d:
 $
DB
I:
:e
rr
st
r"
);
 
$s
th
_p
i_
he
ad
er
_c
lo
se
->
ex
ec
ut
e(
);
 
 $s
th
_p
i_
he
ad
er
_c
lo
se
->
fi
ni
sh
()
; 
$p
i_
he
ad
er
_c
lo
se
_d
bh
->
di
sc
on
ne
ct
()
; 
  
 
 &l
og
fi
le
("
No
w 
ta
ki
ng
 n
ex
t 
PD
B 
Fi
le
")
; 
&l
og
fi
le
("
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
")
; 
 ##
#t
ak
e 
ne
xt
 b
as
e 
ak
a 
go
to
 s
ta
rt
 
#i
f 
no
 m
or
e 
PD
B 
ID
s 
ar
e 
fo
un
d,
 e
xi
t.
 
#s
ea
rc
h:
 f
or
 P
DB
 I
D 
wh
er
e 
sa
ve
OK
 =
 0
 A
ND
 i
n_
pr
og
re
ss
= 
0 
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$logger->info("$PDB_ID $resName  $ChainID  $resSeq is already 
$countclones time(s) a stacking base, for  $PDB_ID $resName  $ChainID  $resSeq isclone = $countclones"); 
 
 
 
 
 
} 
 
 
 
 
else 
 
 
 
 
{ 
 
 
 
 
$insert_stackres="INSERT INTO pi_stackresidue (IDBase, idCode, resName, ChainID, resSeq, 
isclone)  
 
 
 
 
 
 
 
 
 
VALUES ('$base_ID', '$PDB_ID', '$resName', '$ChainID', 
'$resSeq','0')"; 
 
 
 
 
 
} 
 
 
 
$current_resName = $resName; 
 
 
 
$current_ChainID = $ChainID; 
 
 
 
$current_resSeq = $resSeq; 
 
 
 
 
 
#whether clone or not, enter the residue into the pi_stackresidue table, extract the ID of course 
 
 
 
$pi_sth = $pi_dbh->prepare($insert_stackres) || $logger->logdie("Preparing MySQL update failed: 
$DBI::errstr"); 
 
 
 
$pi_sth->execute(); 
 
 
 
$stackres_ID = $pi_sth->{mysql_insertid}; 
 
 
 
$pi_sth->finish(); 
 
 
 
$logger->info("$PDB_ID $resName  $ChainID  $resSeq entered into the pi_stackresidue table. Insertion 
ID is: $stackres_ID"); 
 
 
 
} 
 
 
$insert_stackatom="INSERT INTO ".$uzh_database.".pi_stackatom (IDRes, idCode, atom, serial, 
name,altLoc,resName,ChainID,resSeq,iCode,x,y,z,occupancy, 
 
 
tempFactor, segID,element,charge,normaldist,sugardist,perpendiculardist) 
 
 
VALUES ('$stackres_ID', '$PDB_ID', '$atom', '$serial', '$name', '$altLoc', '$resName', '$ChainID', 
'$resSeq', '$iCode', '$x','$y','$z', '$occupancy', 
 
 
'$tempFactor', '$segID','$element','$charge','$basedist', '$sugardist','$perpendiculardist')";  
 
 
$pi_sth = $pi_dbh->prepare($insert_stackatom) || $logger->logdie("Preparing MySQL update failed: 
$DBI::errstr"); 
 
 
$pi_sth->execute(); 
 
 
my $stackatom_ID = $pi_sth->{mysql_insertid}; #this is for debugging only, not needed anymore in the 
future. 
 
 
$pi_sth->finish(); 
 
 
$logger->info("$PDB_ID $resName  $ChainID  $resSeq $name entered into the pi_stackatom table. Insertion ID 
$stackatom_ID "); 
 
 
$logger->info("stackingdistances: basedist = $basedist Å, sugardist = $sugardist Å, perpendiculardist = 
$perpendiculardist Å.") 
 
 
} 
 
 
$logger->info("-----------------------------------------------------"); 
 
 
 
$p
i_
db
h-
>d
is
co
nn
ec
t(
);
  
 
 
} 
} ##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
en
d 
of
: 
pu
ri
ne
s 
to
 
db
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
 
 ##
#w
ri
te
 t
hi
ng
s 
to
 h
ea
de
r:
 s
ta
ck
in
g 
(0
/1
),
 #
ba
se
s 
to
ta
l,
 s
av
eo
k 
= 
1,
 i
n 
pr
og
re
ss
 b
ac
k 
to
 0
, 
ca
lc
ti
me
, 
fa
ul
ty
 p
ur
in
es
, 
py
ri
mi
di
ne
s 
$e
nd
 =
 t
im
e;
 
my
 $
du
ra
ti
on
 =
 $
en
d 
- 
$s
ta
rt
; 
$l
og
ge
r-
>i
nf
o(
"T
im
e 
ta
ke
n 
wa
s 
",
 (
$e
nd
 -
 $
st
ar
t)
, 
" 
se
co
nd
s"
);
 
my
 $
ha
ss
ta
ck
in
g;
 
 
if
 (
$h
as
_a
ny
_s
ta
ck
er
s_
in
_P
DB
 >
 0
) 
{ $h
as
st
ac
ki
ng
 =
 1
; 
 
} el
se
 
{ $h
as
st
ac
ki
ng
 =
 0
; 
 
 
}   m
y 
$p
i_
he
ad
er
_c
lo
se
_d
bh
 =
 D
BI
->
co
nn
ec
t(
"d
bi
:m
ys
ql
:$
uz
h_
da
ta
ba
se
:$
uz
h_
ho
st
",
 $
uz
h_
us
er
, 
$u
zh
_p
w)
 |
| 
$l
og
ge
r-
>l
og
di
e(
"O
h 
no
!!
! 
co
ul
d 
no
t 
co
nn
ec
t 
to
 $
uz
h_
da
ta
ba
se
: 
$D
BI
::
er
rs
tr
")
; 
 
my
 $
pi
_h
ea
de
r_
cl
os
e_
up
da
te
 =
 "
UP
DA
TE
 "
.$
uz
h_
da
ta
ba
se
."
."
.$
uz
h_
ta
bl
en
am
e.
" 
SE
T 
in
_p
ro
gr
es
s 
= 
0,
Sa
ve
Ok
 =
 1
, 
ba
se
_q
ua
nt
it
y 
= 
'$
re
si
du
ec
ou
nt
er
',
 
ca
lc
ti
me
 =
 '
$d
ur
at
io
n'
, 
fa
ul
ty
_p
yr
im
id
in
es
 =
 '
$f
au
lt
y_
py
ri
mi
di
ne
_c
ou
nt
er
',
 f
au
lt
y_
pu
ri
ne
s 
= 
'$
fa
ul
ty
_p
ur
in
e_
co
un
te
r'
, 
pi
_s
ta
ck
in
g 
= 
'$
ha
ss
ta
ck
in
g'
 W
HE
RE
 i
dC
od
e 
= 
'$
PD
B_
ID
'"
; 
my
 $
st
h_
pi
_h
ea
de
r_
cl
os
e 
= 
$p
i_
he
ad
er
_c
lo
se
_d
bh
->
pr
ep
ar
e(
$p
i_
he
ad
er
_c
lo
se
_u
pd
at
e)
 |
| 
$l
og
ge
r-
>l
og
di
e(
"P
re
pa
ri
ng
 M
yS
QL
 
up
da
te
 f
ai
le
d:
 $
DB
I:
:e
rr
st
r"
);
 
$s
th
_p
i_
he
ad
er
_c
lo
se
->
ex
ec
ut
e(
);
 
 $s
th
_p
i_
he
ad
er
_c
lo
se
->
fi
ni
sh
()
; 
$p
i_
he
ad
er
_c
lo
se
_d
bh
->
di
sc
on
ne
ct
()
; 
  
 
 &l
og
fi
le
("
No
w 
ta
ki
ng
 n
ex
t 
PD
B 
Fi
le
")
; 
&l
og
fi
le
("
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
")
; 
 ##
#t
ak
e 
ne
xt
 b
as
e 
ak
a 
go
to
 s
ta
rt
 
#i
f 
no
 m
or
e 
PD
B 
ID
s 
ar
e 
fo
un
d,
 e
xi
t.
 
#s
ea
rc
h:
 f
or
 P
DB
 I
D 
wh
er
e 
sa
ve
OK
 =
 0
 A
ND
 i
n_
pr
og
re
ss
= 
0 
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$PDB_file_counter+=1; 
goto START; 
 sub create_basenormal 
{ my $vN1C4x=(${$_[1]}[0]-${$_[0]}[0]); 
my $vN1C4y=(${$_[1]}[1]-${$_[0]}[1]); 
my $vN1C4z=(${$_[1]}[2]-${$_[0]}[2]); 
# my $vN1C6x=(${$_[2]}[0]-${$_[0]}[0]); 
my $vN1C6y=(${$_[2]}[1]-${$_[0]}[1]); 
my $vN1C6z=(${$_[2]}[2]-${$_[0]}[2]); 
# my $bNormx=(($vN1C4y*$vN1C6z)-($vN1C4z*$vN1C6y)); 
my $bNormy=(($vN1C4z*$vN1C6x)-($vN1C4x*$vN1C6z)); 
my $bNormz=(($vN1C4x*$vN1C6y)-($vN1C4y*$vN1C6x)); 
 
 
return ($bNormx,$bNormy,$bNormz); 
} sub create_sugarnormal 
{ my $vN1C4x=(${$_[1]}[0]-${$_[0]}[0]); 
my $vN1C4y=(${$_[1]}[1]-${$_[0]}[1]); 
my $vN1C4z=(${$_[1]}[2]-${$_[0]}[2]); 
 my $centerBasex=(${$_[0]}[0]+($vN1C4x*0.5)); 
my $centerBasey=(${$_[0]}[1]+($vN1C4y*0.5)); 
my $centerBasez=(${$_[0]}[2]+($vN1C4z*0.5)); 
 ##tobedeleted??? 
my $upperBasex=($centerBasex+${$_[2]}[0]); 
my $upperBasey=($centerBasey+${$_[2]}[1]); 
my $upperBasez=($centerBasez+${$_[2]}[2]); 
 my $sNormx=(($vN1C4y*${$_[2]}[2])-($vN1C4z*${$_[2]}[1])); 
my $sNormy=(($vN1C4z*${$_[2]}[0])-($vN1C4x*${$_[2]}[2])); 
my $sNormz=(($vN1C4x*${$_[2]}[1])-($vN1C4y*${$_[2]}[0])); 
my @sugarnormalarray=($sNormx,$sNormy,$sNormz); 
my @pyrimidinecentroidarray = ($centerBasex,$centerBasey,$centerBasez); 
##now return the two arrays (by reference!!) 
 
re
tu
rn
 (
\@
su
ga
rn
or
ma
la
rr
ay
,\
@p
yr
im
id
in
ec
en
tr
oi
da
rr
ay
);
 
} su
b 
cr
ea
te
_p
ur
in
e_
su
ga
rn
or
ma
l 
##
re
ce
iv
e 
N1
, 
C2
, 
C8
, 
ba
se
no
rm
al
 (
=0
,1
,2
,3
) 
{ my
 $
vN
1C
2x
=(
${
$_
[0
]}
[0
]-
${
$_
[1
]}
[0
])
; 
my
 $
vN
1C
2y
=(
${
$_
[0
]}
[1
]-
${
$_
[1
]}
[1
])
; 
my
 $
vN
1C
2z
=(
${
$_
[0
]}
[2
]-
${
$_
[1
]}
[2
])
; 
 my
 $
ce
nt
er
C2
N1
x=
($
{$
_[
1]
}[
0]
+(
$v
N1
C2
x*
0.
5)
);
 
my
 $
ce
nt
er
C2
N1
y=
($
{$
_[
1]
}[
1]
+(
$v
N1
C2
y*
0.
5)
);
 
my
 $
ce
nt
er
C2
N1
z=
($
{$
_[
1]
}[
2]
+(
$v
N1
C2
z*
0.
5)
);
 
 my
 $
vc
en
te
rC
2N
1_
C8
x=
($
{$
_[
2]
}[
0]
-$
ce
nt
er
C2
N1
x)
; 
my
 $
vc
en
te
rC
2N
1_
C8
y=
($
{$
_[
2]
}[
1]
-$
ce
nt
er
C2
N1
y)
; 
my
 $
vc
en
te
rC
2N
1_
C8
z=
($
{$
_[
2]
}[
2]
-$
ce
nt
er
C2
N1
z)
; 
 my
 $
ce
nt
er
Pu
ri
nx
=(
$c
en
te
rC
2N
1x
+(
$v
ce
nt
er
C2
N1
_C
8x
*0
.5
))
; 
my
 $
ce
nt
er
Pu
ri
ny
=(
$c
en
te
rC
2N
1y
+(
$v
ce
nt
er
C2
N1
_C
8y
*0
.5
))
; 
my
 $
ce
nt
er
Pu
ri
nz
=(
$c
en
te
rC
2N
1z
+(
$v
ce
nt
er
C2
N1
_C
8z
*0
.5
))
; 
 my
 $
sN
or
mx
=(
($
vN
1C
2y
*$
{$
_[
3]
}[
2]
)-
($
vN
1C
2z
*$
{$
_[
3]
}[
1]
))
; 
my
 $
sN
or
my
=(
($
vN
1C
2z
*$
{$
_[
3]
}[
0]
)-
($
vN
1C
2x
*$
{$
_[
3]
}[
2]
))
; 
my
 $
sN
or
mz
=(
($
vN
1C
2x
*$
{$
_[
3]
}[
1]
)-
($
vN
1C
2y
*$
{$
_[
3]
}[
0]
))
; 
my
 @
su
ga
rp
ur
in
no
rm
al
ar
ra
y=
($
sN
or
mx
,$
sN
or
my
,$
sN
or
mz
);
 
my
 @
pu
ri
ne
ce
nt
ro
id
ar
ra
y 
= 
($
ce
nt
er
Pu
ri
nx
,$
ce
nt
er
Pu
ri
ny
,$
ce
nt
er
Pu
ri
nz
);
 
##
no
w 
re
tu
rn
 t
he
 t
wo
 a
rr
ay
s 
(b
y 
re
fe
re
nc
e!
!)
 
 
re
tu
rn
 (
\@
su
ga
rp
ur
in
no
rm
al
ar
ra
y,
\@
pu
ri
ne
ce
nt
ro
id
ar
ra
y)
; 
} su
b 
cr
ea
te
_p
er
pe
nd
ic
ul
ar
no
rm
al
 
{ my
 $
sN
or
mx
=(
($
{$
_[
0]
}[
1]
*$
{$
_[
1]
}[
2]
)-
($
{$
_[
0]
}[
2]
*$
{$
_[
1]
}[
1]
))
; 
my
 $
sN
or
my
=(
($
{$
_[
0]
}[
2]
*$
{$
_[
1]
}[
0]
)-
($
{$
_[
0]
}[
0]
*$
{$
_[
1]
}[
2]
))
; 
my
 $
sN
or
mz
=(
($
{$
_[
0]
}[
0]
*$
{$
_[
1]
}[
1]
)-
($
{$
_[
0]
}[
1]
*$
{$
_[
1]
}[
0]
))
; 
 
 
re
tu
rn
 (
$s
No
rm
x,
$s
No
rm
y,
$s
No
rm
z)
; 
}    
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$PDB_file_counter+=1; 
goto START; 
 sub create_basenormal 
{ my $vN1C4x=(${$_[1]}[0]-${$_[0]}[0]); 
my $vN1C4y=(${$_[1]}[1]-${$_[0]}[1]); 
my $vN1C4z=(${$_[1]}[2]-${$_[0]}[2]); 
# my $vN1C6x=(${$_[2]}[0]-${$_[0]}[0]); 
my $vN1C6y=(${$_[2]}[1]-${$_[0]}[1]); 
my $vN1C6z=(${$_[2]}[2]-${$_[0]}[2]); 
# my $bNormx=(($vN1C4y*$vN1C6z)-($vN1C4z*$vN1C6y)); 
my $bNormy=(($vN1C4z*$vN1C6x)-($vN1C4x*$vN1C6z)); 
my $bNormz=(($vN1C4x*$vN1C6y)-($vN1C4y*$vN1C6x)); 
 
 
return ($bNormx,$bNormy,$bNormz); 
} sub create_sugarnormal 
{ my $vN1C4x=(${$_[1]}[0]-${$_[0]}[0]); 
my $vN1C4y=(${$_[1]}[1]-${$_[0]}[1]); 
my $vN1C4z=(${$_[1]}[2]-${$_[0]}[2]); 
 my $centerBasex=(${$_[0]}[0]+($vN1C4x*0.5)); 
my $centerBasey=(${$_[0]}[1]+($vN1C4y*0.5)); 
my $centerBasez=(${$_[0]}[2]+($vN1C4z*0.5)); 
 ##tobedeleted??? 
my $upperBasex=($centerBasex+${$_[2]}[0]); 
my $upperBasey=($centerBasey+${$_[2]}[1]); 
my $upperBasez=($centerBasez+${$_[2]}[2]); 
 my $sNormx=(($vN1C4y*${$_[2]}[2])-($vN1C4z*${$_[2]}[1])); 
my $sNormy=(($vN1C4z*${$_[2]}[0])-($vN1C4x*${$_[2]}[2])); 
my $sNormz=(($vN1C4x*${$_[2]}[1])-($vN1C4y*${$_[2]}[0])); 
my @sugarnormalarray=($sNormx,$sNormy,$sNormz); 
my @pyrimidinecentroidarray = ($centerBasex,$centerBasey,$centerBasez); 
##now return the two arrays (by reference!!) 
 
re
tu
rn
 (
\@
su
ga
rn
or
ma
la
rr
ay
,\
@p
yr
im
id
in
ec
en
tr
oi
da
rr
ay
);
 
} su
b 
cr
ea
te
_p
ur
in
e_
su
ga
rn
or
ma
l 
##
re
ce
iv
e 
N1
, 
C2
, 
C8
, 
ba
se
no
rm
al
 (
=0
,1
,2
,3
) 
{ my
 $
vN
1C
2x
=(
${
$_
[0
]}
[0
]-
${
$_
[1
]}
[0
])
; 
my
 $
vN
1C
2y
=(
${
$_
[0
]}
[1
]-
${
$_
[1
]}
[1
])
; 
my
 $
vN
1C
2z
=(
${
$_
[0
]}
[2
]-
${
$_
[1
]}
[2
])
; 
 my
 $
ce
nt
er
C2
N1
x=
($
{$
_[
1]
}[
0]
+(
$v
N1
C2
x*
0.
5)
);
 
my
 $
ce
nt
er
C2
N1
y=
($
{$
_[
1]
}[
1]
+(
$v
N1
C2
y*
0.
5)
);
 
my
 $
ce
nt
er
C2
N1
z=
($
{$
_[
1]
}[
2]
+(
$v
N1
C2
z*
0.
5)
);
 
 my
 $
vc
en
te
rC
2N
1_
C8
x=
($
{$
_[
2]
}[
0]
-$
ce
nt
er
C2
N1
x)
; 
my
 $
vc
en
te
rC
2N
1_
C8
y=
($
{$
_[
2]
}[
1]
-$
ce
nt
er
C2
N1
y)
; 
my
 $
vc
en
te
rC
2N
1_
C8
z=
($
{$
_[
2]
}[
2]
-$
ce
nt
er
C2
N1
z)
; 
 my
 $
ce
nt
er
Pu
ri
nx
=(
$c
en
te
rC
2N
1x
+(
$v
ce
nt
er
C2
N1
_C
8x
*0
.5
))
; 
my
 $
ce
nt
er
Pu
ri
ny
=(
$c
en
te
rC
2N
1y
+(
$v
ce
nt
er
C2
N1
_C
8y
*0
.5
))
; 
my
 $
ce
nt
er
Pu
ri
nz
=(
$c
en
te
rC
2N
1z
+(
$v
ce
nt
er
C2
N1
_C
8z
*0
.5
))
; 
 my
 $
sN
or
mx
=(
($
vN
1C
2y
*$
{$
_[
3]
}[
2]
)-
($
vN
1C
2z
*$
{$
_[
3]
}[
1]
))
; 
my
 $
sN
or
my
=(
($
vN
1C
2z
*$
{$
_[
3]
}[
0]
)-
($
vN
1C
2x
*$
{$
_[
3]
}[
2]
))
; 
my
 $
sN
or
mz
=(
($
vN
1C
2x
*$
{$
_[
3]
}[
1]
)-
($
vN
1C
2y
*$
{$
_[
3]
}[
0]
))
; 
my
 @
su
ga
rp
ur
in
no
rm
al
ar
ra
y=
($
sN
or
mx
,$
sN
or
my
,$
sN
or
mz
);
 
my
 @
pu
ri
ne
ce
nt
ro
id
ar
ra
y 
= 
($
ce
nt
er
Pu
ri
nx
,$
ce
nt
er
Pu
ri
ny
,$
ce
nt
er
Pu
ri
nz
);
 
##
no
w 
re
tu
rn
 t
he
 t
wo
 a
rr
ay
s 
(b
y 
re
fe
re
nc
e!
!)
 
 
re
tu
rn
 (
\@
su
ga
rp
ur
in
no
rm
al
ar
ra
y,
\@
pu
ri
ne
ce
nt
ro
id
ar
ra
y)
; 
} su
b 
cr
ea
te
_p
er
pe
nd
ic
ul
ar
no
rm
al
 
{ my
 $
sN
or
mx
=(
($
{$
_[
0]
}[
1]
*$
{$
_[
1]
}[
2]
)-
($
{$
_[
0]
}[
2]
*$
{$
_[
1]
}[
1]
))
; 
my
 $
sN
or
my
=(
($
{$
_[
0]
}[
2]
*$
{$
_[
1]
}[
0]
)-
($
{$
_[
0]
}[
0]
*$
{$
_[
1]
}[
2]
))
; 
my
 $
sN
or
mz
=(
($
{$
_[
0]
}[
0]
*$
{$
_[
1]
}[
1]
)-
($
{$
_[
0]
}[
1]
*$
{$
_[
1]
}[
0]
))
; 
 
 
re
tu
rn
 (
$s
No
rm
x,
$s
No
rm
y,
$s
No
rm
z)
; 
}    
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#give this routine the three normal vectors, the N1 and the point P! 
  
sub calculate_distance #with hesse normal form 
 
{ 
 
my @Point= (${$_[1]}[0],${$_[1]}[1],${$_[1]}[2]); 
 
my @normalvector = (${$_[0]}[0],${$_[0]}[1],${$_[0]}[2]); 
 
#distance of point P to N1 of the centroid of the pyrimidine: 
 
my $hx = $Point[0] -${$_[2]}[0]; 
 
my $hy = $Point[1]- ${$_[2]}[1]; 
 
my $hz = $Point[2]- ${$_[2]}[2]; 
 
 
 
#scalar product of normal vector and P to Centroid distance 
 
my $sp = $hx*${$_[0]}[0] + $hy*${$_[0]}[1] + $hz*${$_[0]}[2]; 
 
 
 
#length of normal vector 
 
my $length = sqrt($normalvector[0]*$normalvector[0] + $normalvector[1]*$normalvector[1] + 
$normalvector[2]*$normalvector[2]); 
 
my $distance = abs($sp/$length); 
 
return $distance; 
 
} 
###--------------------------------------------------------------------------------------------------------------------
-------------- 
#now test the plane distance with a point and all three normal vectors (verify in Mercury!) 
 sub distance_to_all_purines 
{  
my $bnormalref = $_[0]; 
 
my $snormalref = $_[1]; 
 
my $pnormalref = $_[2]; 
 
my $centroidref = $_[3]; 
 
my @stackarray=(); 
 
ATOMBYATOM: 
 
foreach $row (@potential_ligands) 
 
{ 
 
 my ($idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element,  $ID,  $atom,  $altLoc,  $iCode,  
$occupancy,  $tempFactor,  $segID, $charge) = @{$row}; 
 
my @P=($x,$y,$z); 
 
my $stackbool =0; 
 
my $basedistance= &calculate_distance($bnormalref,\@P,$centroidref); 
 
 
if ($basedistance <= $purinebasedistance) 
 
 
{ 
 
 
$s
ta
ck
bo
ol
 +
=1
; 
 
 
} 
 
my
 $
su
ga
rd
is
ta
nc
e=
 &
ca
lc
ul
at
e_
di
st
an
ce
($
sn
or
ma
lr
ef
,\
@P
,$
ce
nt
ro
id
re
f)
; 
 
 
if
 (
$s
ug
ar
di
st
an
ce
 <
= 
$p
ur
in
es
ug
ar
di
st
an
ce
) 
 
 
{ 
 
 
$s
ta
ck
bo
ol
 +
=1
; 
 
 
} 
 
my
 $
pe
rp
en
di
cu
la
rd
is
ta
nc
e=
 &
ca
lc
ul
at
e_
di
st
an
ce
($
pn
or
ma
lr
ef
,\
@P
,$
ce
nt
ro
id
re
f)
; 
 
 
if
 (
$p
er
pe
nd
ic
ul
ar
di
st
an
ce
 <
= 
$p
ur
in
ep
er
pe
nd
ic
ul
ar
di
st
an
ce
) 
 
 
{ 
 
 
$s
ta
ck
bo
ol
 +
=1
; 
 
 
 
} 
 
 
if
 (
$s
ta
ck
bo
ol
 =
= 
3)
 
 
 
{ 
 
 
pu
sh
 (
@s
ta
ck
ar
ra
y,
 [
$i
dC
od
e,
 $
se
ri
al
, 
$n
am
e,
 $
re
sN
am
e,
 $
Ch
ai
nI
D,
 $
re
sS
eq
, 
$x
, 
$y
, 
$z
, 
$e
le
me
nt
, 
 $
ID
, 
 
$a
to
m,
  
$a
lt
Lo
c,
  
$i
Co
de
, 
 
 
 $
oc
cu
pa
nc
y,
  
$t
em
pF
ac
to
r,
  
$s
eg
ID
, 
$c
ha
rg
e,
 $
ba
se
di
st
an
ce
, 
$s
ug
ar
di
st
an
ce
, 
$p
er
pe
nd
ic
ul
ar
di
st
an
ce
])
; 
 
 
 
 
} 
 
 
} 
 
 
 
if
 (
$#
st
ac
ka
rr
ay
 !
= 
0)
 
 
{ 
 
re
tu
rn
 @
st
ac
ka
rr
ay
; 
 
 
} 
 
el
se
 
 
{ 
 
re
tu
rn
 (
);
 
 
 
} 
}  su
b 
di
st
an
ce
_t
o_
al
l_
py
ri
mi
di
ne
s 
{  
my
 $
bn
or
ma
lr
ef
 =
 $
_[
0]
; 
 
my
 $
sn
or
ma
lr
ef
 =
 $
_[
1]
; 
 
my
 $
pn
or
ma
lr
ef
 =
 $
_[
2]
; 
 
my
 $
ce
nt
ro
id
re
f 
= 
$_
[3
];
 
 
my
 @
st
ac
ka
rr
ay
=(
);
 
 
AT
OM
BY
AT
OM
: 
 
fo
re
ac
h 
$r
ow
 (
@p
ot
en
ti
al
_l
ig
an
ds
) 
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#give this routine the three normal vectors, the N1 and the point P! 
  
sub calculate_distance #with hesse normal form 
 
{ 
 
my @Point= (${$_[1]}[0],${$_[1]}[1],${$_[1]}[2]); 
 
my @normalvector = (${$_[0]}[0],${$_[0]}[1],${$_[0]}[2]); 
 
#distance of point P to N1 of the centroid of the pyrimidine: 
 
my $hx = $Point[0] -${$_[2]}[0]; 
 
my $hy = $Point[1]- ${$_[2]}[1]; 
 
my $hz = $Point[2]- ${$_[2]}[2]; 
 
 
 
#scalar product of normal vector and P to Centroid distance 
 
my $sp = $hx*${$_[0]}[0] + $hy*${$_[0]}[1] + $hz*${$_[0]}[2]; 
 
 
 
#length of normal vector 
 
my $length = sqrt($normalvector[0]*$normalvector[0] + $normalvector[1]*$normalvector[1] + 
$normalvector[2]*$normalvector[2]); 
 
my $distance = abs($sp/$length); 
 
return $distance; 
 
} 
###--------------------------------------------------------------------------------------------------------------------
-------------- 
#now test the plane distance with a point and all three normal vectors (verify in Mercury!) 
 sub distance_to_all_purines 
{  
my $bnormalref = $_[0]; 
 
my $snormalref = $_[1]; 
 
my $pnormalref = $_[2]; 
 
my $centroidref = $_[3]; 
 
my @stackarray=(); 
 
ATOMBYATOM: 
 
foreach $row (@potential_ligands) 
 
{ 
 
 my ($idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element,  $ID,  $atom,  $altLoc,  $iCode,  
$occupancy,  $tempFactor,  $segID, $charge) = @{$row}; 
 
my @P=($x,$y,$z); 
 
my $stackbool =0; 
 
my $basedistance= &calculate_distance($bnormalref,\@P,$centroidref); 
 
 
if ($basedistance <= $purinebasedistance) 
 
 
{ 
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{ 
 
 my ($idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element,  $ID,  $atom,  $altLoc,  $iCode,  
$occupancy,  $tempFactor,  $segID, $charge) = @{$row}; 
 
  
 
my @P=($x,$y,$z); 
 
my $stackbool =0; 
 
my $basedistance= &calculate_distance($bnormalref,\@P,$centroidref); 
 
 
if ($basedistance <= $pyrimidinebasedistance) 
 
 
{ 
 
 
$stackbool +=1; 
 
 
} 
 
my $sugardistance= &calculate_distance($snormalref,\@P,$centroidref); 
 
 
if ($sugardistance <= $pyrimidinesugardistance) 
 
 
{ 
 
 
$stackbool +=1; 
 
 
} 
 
my $perpendiculardistance= &calculate_distance($pnormalref,\@P,$centroidref); 
 
 
if ($perpendiculardistance <= $pyrimidineperpendiculardistance) 
 
 
{ 
 
 
$stackbool +=1; 
 
 
 
} 
 
 
if ($stackbool == 3) 
 
 
{ 
 
 
push (@stackarray, [$idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element,  $ID,  
$atom, 
 
 
 $altLoc,  $iCode,  $occupancy,  $tempFactor,  $segID, $charge,$basedistance, $sugardistance, 
$perpendiculardistance]);  
 
 
 
} 
 
 
} 
 
if ($#stackarray != 0) 
 
{ 
 
return @stackarray; 
 
 
} 
 
else 
 
{ 
 
return (); 
 
 
} 
}  exit 0; 
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{ 
 
 my ($idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element,  $ID,  $atom,  $altLoc,  $iCode,  
$occupancy,  $tempFactor,  $segID, $charge) = @{$row}; 
 
  
 
my @P=($x,$y,$z); 
 
my $stackbool =0; 
 
my $basedistance= &calculate_distance($bnormalref,\@P,$centroidref); 
 
 
if ($basedistance <= $pyrimidinebasedistance) 
 
 
{ 
 
 
$stackbool +=1; 
 
 
} 
 
my $sugardistance= &calculate_distance($snormalref,\@P,$centroidref); 
 
 
if ($sugardistance <= $pyrimidinesugardistance) 
 
 
{ 
 
 
$stackbool +=1; 
 
 
} 
 
my $perpendiculardistance= &calculate_distance($pnormalref,\@P,$centroidref); 
 
 
if ($perpendiculardistance <= $pyrimidineperpendiculardistance) 
 
 
{ 
 
 
$stackbool +=1; 
 
 
 
} 
 
 
if ($stackbool == 3) 
 
 
{ 
 
 
push (@stackarray, [$idCode, $serial, $name, $resName, $ChainID, $resSeq, $x, $y, $z, $element,  $ID,  
$atom, 
 
 
 $altLoc,  $iCode,  $occupancy,  $tempFactor,  $segID, $charge,$basedistance, $sugardistance, 
$perpendiculardistance]);  
 
 
 
} 
 
 
} 
 
if ($#stackarray != 0) 
 
{ 
 
return @stackarray; 
 
 
} 
 
else 
 
{ 
 
return (); 
 
 
} 
}  exit 0; 
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1. Introduction
Nucleotides and nucleic acids do not only 
carry out a multitude of functions in liv-
ing organisms[1] but are at the same time 
also inevitably linked to metal ions.[2] The 
most simple cases are mononucleotides 
like the energy carriers and neurotransmit-
ters ATP4– and GTP4–.[3,4] Both of them are 
believed to carry two Mg2+ ions in solution, 
one of them being rather tightly bound.[4] 
In the case of larger nucleic acids, like 
catalytic RNAs (ribozymes), also posi-
tively charged proteins and polyamines 
play an important role. However, their 
accumulated intrinsic negative charge of 
the bridging phosphates cannot be com-
pensated for solely by positively charged 
amino acid side chains or polyamines, but 
in addition high amounts of monovalent 
and divalent metal ions are needed. In liv-
ing systems, the natural metal ion cofac-
tors usually considered to be involved 
with nucleic acids are Na+ and Mg2+.[5] 
The vast majority of these ions is used 
for gross charge compensation, i.e. is dif-
fusely bound, allowing large nucleic acids 
to fold to a compact three-dimensional ar-
chitecture. Such diffuse metal ion–nucleic 
acid interactions are often described with a 
nonlinear Poisson-Boltzmann equation.[6,7] 
Much more interesting in terms of local 
structure and possible function are those 
metal ions that are site-specifically bound 
and account for the compensation of about 
10% of the negative charge.[5,8] These ions 
occupy key sites in the three-dimensional 
architecture and play a direct role in, e.g. 
domain assembly by coordinating to the 
domain junctions and stabilizing local 
structures like a strong kink in the phos-
phate sugar backbone.[9] In addition, they 
can be directly involved in the catalytic 
mechanism of DNAzymes and ribozymes. 
Thereby it should be taken into account that 
such a ‘directly’ involved metal ion can also 
affect catalysis from a distance, i.e. in a 
structural or an electrostatic manner.[2]
Evidently, it is of great interest to local-
ize such metal ions and to characterize their 
binding sites, as only with this knowledge 
can we understand the functioning of cata-
lytic RNAs and DNAs. This is already a 
challenging task, because Mg2+ is not only 
spectroscopically silent, but also displays 
a rather high ligand exchange rate, i.e. is 
kinetically labile. What makes this story 
even more interesting (and at the same time 
also more challenging) is that many more 
metal ions than just Na+ and Mg2+ can be 
involved with nucleic acids: 
i)  Redox active metal ions are used in 
combination with specific sequences or 
modified oligonucleotides to build up 
electronic molecular devices for nano-
technology.[10–12] 
ii)  Other metal ions than Mg2+ are used for 
in vitro studies of, e.g. ribozymes, to 
localize binding sites and elucidate the 
functional roles of these ions.[13–17] 
iii)  DNAzymes are known that function 
with a whole battery of different diva-
lent ions, although being usually most 
active with one specific kind.[18,19] 
It is obvious that the different coor-
dination properties of metal ions will be 
the basis for their discriminating effect 
on structure and function of nucleic ac-
ids. Very recently, the first hints started 
to evolve that also naturally occurring ri-
bozymes might control their activity by 
switching the metal ion. The two most 
prominent examples are the hammerhead 
ribozyme, which is accelerated by many 
transition metal ions,[20,21] and the self-
splicing group II intron ribozyme Sc.ai5γ, 
that is severely hampered by small con-
centrations of Ca2+.[22,23]
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In this review, we will now briefly dis-
cuss the different NMR methods applied 
over the past years to investigate the inter-
action of metal ions with nucleic acids. As 
will be evident to the reader, we are only 
at the very beginning of understanding the 
manifold ways of these interactions and 
certainly many unprecedented and fasci-
nating results will evolve in the future.
2. General Aspects of Metal Ion 
Binding to Nucleic Acids
2.1 Metal Ion Binding in Natural 
Systems
Nucleic acids and their building blocks 
offer a multitude of donor atoms to coordi-
nate metal ions.[2,5] The phosphate chain of 
5’-nucleoside mono-, di- and triphosphates 
is well known to bind one, if not two Mg2+ 
ions in solution (Fig. 1A).[4,24–26] Along the 
same lines, also in the case of longer nucle-
ic acids, the most prominent sites for metal 
ions are the two non-bridging oxygen at-
oms of the negatively charged phosphate-
sugar backbone (Fig. 1A). However, aside 
from these negatively charged residues, 
also the nucleoside moieties offer coordi-
nating atoms: The ring nitrogens, the car-
bonyl oxygens and in some cases even the 
sugar oxygens. The purine N(7) position is 
thereby certainly the most prominent one 
due to the well-known coordination of cis-
platin to this site.[28]
Metal ions associated with nucleic ac-
ids in natural systems are usually consid-
ered the alkaline and earth alkaline ions 
Na+ and Mg2+, and potentially also K+ 
and Ca2+, which partly can occur in high 
millimolar amounts in living organisms 
(Table).[5] All of these metal ions show 
a higher affinity towards oxygen com-
pared to nitrogen ligands. Nevertheless, 
also Mg2+ binding to N(7) is well known, 
although it is weaker than phosphate co-
ordination. In natural systems, metal ion 
coordination takes place via several in-
teractions, as only such a strong enough 
binding can be achieved to hold these 
ions in place. Metal ions associated with 
RNA and DNA molecules are usually ki-
netically labile, meaning that their ligand 
exchange rate is fast, ranging in the order 
of 105 (Mg2+) to 109 s–1 (Ca2+).[5] At the 
same time, these divalent ions are present 
in their solvated form in water, i.e. wa-
ter ligands have to be replaced in order 
for the metal ion to coordinate directly to 
the nucleic acids: a so-called inner sphere 
coordination takes place (Fig. 1C–E). 
However, interactions between Mn+ ions 
and the nucleic acid can also take place 
mediated through the coordinated water 
molecules, i.e. in an outer sphere fashion 
(Fig. 1B). Such interactions are by no 
means weaker than inner sphere, as each 
of such a hydrogen bond accounts for 
about 20 kJmol–1. As a consequence, one 
can imagine that site-specifically bound 
Mg2+ ions are held tightly in place through 
an extensive network of inner- and outer 
sphere coordinations. 
2.2 The Use of Mimics 
The high ligand exchange rate of the 
metal ions commonly associated with nu-
cleic acids makes it difficult to investigate 
these ions in solution.[5] This task is further 
hampered by the fact that alkaline and earth 
Fig. 1. Nucleotides and their metal ion coordinating atoms (in bold). (A) Chemical structures and 
numbering schemes of the most common nucleobases in RNA and DNA. The structure of a (d)
NTP4– is shown at the top left. On the top right a nucleotide within a DNA or RNA strand is depicted 
together with the bridging phosphate groups. At the bottom the nucleobases guanine, cytosine, 
uracil (only in RNA), thymine (only in DNA) and adenine are shown from left to right. (B) Outer sphere 
binding of a hexahydrated Mg2+ ion to RNA. (C) Two Mg2+-ions coordinating in a partially inner sphere 
manner to either one (left) or two (right) phosphate oxygens. Additionally the Mg2+ ions exhibit outer 
sphere contacts to purine N(7) and O(6) positions. (D) Three inner sphere contacts of a half-dehydra-
ted Mg2+ ion to phosphate oxygens bridging two strands are shown. (E) Cis-inner sphere coordinati-
on of a Mg2+ ion to two N(7) guanine atoms of two different strands. Panels (B)–(E) have been prepa-
red with MOLMOL[27] based on the PDB file 1S72 of the large ribosomal subunit of H.marismortui.[8] 
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stabilized by an Ag+ ion. The cytosine–
Ag+–cytosine (C–Ag+–C) base pair was 
reported recently to be stabilizing C–C 
mismatched DNA duplexes.[54] 
The possibilities to incorporate metal-
mediated base pairs into DNA are dra-
matically increased by the use of artificial 
nucleosides.[11] New nucleobase analogues 
can not only be designed to specifically bind 
certain metal ions, but the modified DNA 
can also serve as a scaffold for one-dimen-
sional arrays of metal ions by the incorpo-
ration of several consecutive artificial base 
pairs. These arrays can then be used as self-
assembling nanowires or nanomagnets.[55] 
There are also examples where catalysis 
of enantioselective reactions is realized 
through the metal ions of base-modified 
DNA helices.[56] Fig. 2A–C shows a few 
examples of artificial nucleosides within 
a DNA helix that exhibit specific binding 
properties towards different metal ions. The 
base pairs can also be covalently linked, 
as for example in a metal-salen base pair 
(Fig. 2C). With these artificial nucleosides 
a metal-modified DNA double helix with 
ten consecutive Mn3+-salen base pairs was 
synthesized.[50] Constructs like this will al-
low the synthesis of more complex DNA 
molecules containing different metal bind-
ing sites in specific positions. 
This expansion beyond the genetic four 
letter code by the introduction of new met-
al-modified artificial base pairs leads to 
the development of new metal ion sensors, 
novel molecular electronics, or possible 
multi-metal enzyme analogues.
3. NMR Strategies to Investigate 
Mn+ Binding to Nucleic Acids
Various NMR methods are known to 
study metal ion binding to nucleic acids 
alkaline metal ions are basically spectro-
scopically silent. Hence, other metal ions 
are commonly applied to mimic, e.g. Mg2+. 
These ions are either directly detectable 
by NMR or other spectroscopic methods, 
or have a higher affinity towards nucleic 
acids. For example, inner sphere binding 
of Mg2+ towards oxygen ligands can be 
studied using Cd2+ in so-called thio-rescue 
studies:[13,32] Thereby, one or more specific 
carbonyl or phosphate oxygen atoms in a 
nucleotide are replaced with sulphur atoms. 
Mg2+ has an intrinsic lower affinity towards 
sulphur compared to oxygen ligands and 
will thus bind weaker. In contrast, metal 
ion binding can be ‘rescued’ by applying a 
more thiophilic ion like Cd2+ or Zn2+.[33–36] 
The introduction of a sulphur atom has the 
positive side effect that the chemical shift 
of the attached carbon or phosphorous atom 
is strongly affected: e.g. in a thiophosphate 
group, the 31P resonance is shifted down-
field to about 55 ppm, compared to about 
0 ppm of a regular phosphodiester bridge 
in nucleic acids, making such a position 
well distinguishable.[37] 
A further mimic for the diamagnetic 
Mg2+ is the paramagnetic Mn2+ ion. The 
latter is used for EPR[38,39] and also NMR 
studies, where the resonances are severely 
broadened upon binding of Mn2+ in the vi-
cinity.[26,40,41] Outer sphere binding of Mg2+ 
can be probed with [Co(NH3)6]3+ (see also 
Section 3). The ammonia ligands in this 
kinetically inert complex do not exchange 
with solvent molecules, allowing them to 
mimic the [Mg(H2O)6]2+ ion. Binding of 
this cobalt(iii) complex can then be ob-
served by NOE cross peaks between the 
ammonia and protons of the nucleic ac-
ids[42–44] or even by solid state 59Co NMR 
experiments.[45] 
Also mimics for monovalent metal ions, 
in particular K+, are known. Potassium 
binding to nucleic acids can be mimicked 
and observed by applying NH4+, allowing 
the detection of NOE cross peaks simi-
lar to the situation with [Co(NH3)6]3+.[46] 
Another mimic specific for K+ is the Tl+ 
ion, which has a similar ionic radius and 
metal–ligand bond length, but is very toxic 
already at low concentrations. Neverthe-
less, direct detection is possible using 205Tl 
NMR.[47] 
2.3 Artificial Metal Ions–Nucleic 
Acids Systems
The self-assembling properties of DNA 
have prompted the development and stud-
ies of DNA duplexes of specific sequences 
or containing modified nucleobases that 
are able to tightly bind metal ions in the 
inner core of the helix. The base pairing 
properties of DNA can be altered by in-
corporating metal ions in the center of two 
opposite nucleobases, allowing the double 
strand to implement non-natural base pairs 
held together through coordinative forces 
rather than hydrogen bonds.[10,11] For ex-
ample a thymine–thymine (T–T) mismatch 
base pair is stabilized by addition of Hg2+, 
which replaces the H(3) protons of the two 
opposite pyrimidine bases (Fig. 2D). In-
corporation of 15N labeled thymine nucle-
obases allowed the first direct spectroscop-
ic proof of such T–Hg2+–T base pairs: 15N 
NMR studies revealed a 15N–15N J-coupling 
across the Hg2+ ion (see Section 5).[51] A 
highly selective oligodeoxyribonucleotide 
Hg2+ sensor could be created based on this 
specific interaction.[52,53] Recent studies 
showed that also an RNA duplex synthe-
sized by in vitro transcription can incorpo-
rate Hg2+ ions to form uracil–Hg2+–uracil 
base pairs.[12] In vitro transcription thereby 
has the advantage that large amounts of 
nucleic acid (RNA) can be made easily. 
Another pyrimidine mismatch pair was 
Table. Ion concentrations inside and outside a 
typical mammalian cell.[29] The concentrations 
of M2+ ions total about 20 mM, but most of 
these ions are bound to proteins, nucleic acids 
and other molecules. Ca2+ is mostly stored 
in various organelles.[30,31] The intracellular 
chloride concentration is much lower than the 
total metal ion concentration: Other anions, 
like phosphate and carboxylate groups of 
nucleic acids and proteins as wells as further 
functional groups make up for the difference to 
reach charge neutrality.
Ion Concintracell. [mM] Concextracell. [mM]
Na+ 5–15 145
K+ 140 5
Mg2+ 0.5 1–2
Ca2+ 10–4 1–2
Cl– 5– 15 110
Fig. 2. Metal-modified base pairs in a DNA double helix. (A) A cytosine-derived base pair selec-
tively binds Ni2+ compared to other divalent ions.[48] (B) Artificial triazole nucleosides complex 
linearly coordinated Ag+ ions with high affinity.[49] (C) An ethylenediamine-crosslinked salen base 
pair chelates a Cu2+ ion.[50] (D) Two thymines of a T–T mismatch base pair are deprotonated at the 
N(3) position thus coordinating a Hg2+ ion in between. The stability of this Hg2+ mediated base pair 
is comparable to a normal Watson-Crick base pair.[51]
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using different probes and mimics. These 
methods range from the observation of 
chemical shift changes, which can be done 
with basically any metal ion, over paramag-
netic line broadening studies, to the most 
direct way of the detection of NOE con-
tacts between the nucleic acid and probes 
like cobalt(iii)hexammine or the ammo-
nium ion. The most important experiments 
are discussed in more detail below.
3.1 Magnesium(ii) Coordination
The detection of the metal ions that are 
naturally associated with nucleic acids (i.e. 
Na+, K+ and Mg2+), is a challenging task as 
they are spectroscopically silent and can thus 
not be observed directly in an NMR experi-
ment. Mg2+ binding is kinetically labile and 
therefore the metal ion does not necessarily 
have only one fixed coordination site within 
the nucleic acid structure.[5] Furthermore, the 
interaction with the nucleic acid is not always 
direct (inner sphere coordination) but can 
also be mediated through the water ligands 
of the solvated metal ion (outer sphere coor-
dination) (Fig. 1). However, it is possible to 
observe Mg2+ coordination by NMR because 
the chemical shifts as well as the resonance 
line widths of the nucleic acid protons are 
affected by a coordinating Mg2+. A change 
of the chemical shift can be due to either a 
Mn+-coordination in close vicinity of the ob-
served proton or to a long-range structural 
change that is induced by the metal ion. The 
broadening of resonance lines is observed 
due to the relatively fast ligand exchange rate 
of Mg2+, which is in the order of the NMR 
time scale.[34] This effect is limited specifi-
cally to the binding site thus allowing a more 
precise localization of the metal ion within 
the structure. [1H,1H]-NOESY titrations of 
RNA hairpins with MgCl2 recorded in D2O 
reveal chemical shift changes and line broad-
ening at specific sugar and nucleobase resi-
dues (Fig. 3A).[26,41,57,58] For example, a large 
chemical shift change is observed for the 
U19H1’–A20H8 crosspeak within domain 6 of 
a group II intron ribozyme but the line width 
is unvaried, arguing against a direct coordi-
nation of Mg2+ at the A20 N7 position.[26,60] 
At the G1DP, on the other hand, the chemical 
shift change is accompanied by a significant 
broadening effect indicating a direct bind-
ing of Mg2+ at the 5’-terminal diphosphate 
(DP) group.[41] The combination of chemical 
shift mapping and line broadening studies 
with Mg2+ thus yields a rather detailed pic-
ture about Mg2+ binding and accompanying 
structural changes of the nucleic acid. How-
ever, to precisely localize the binding sites as 
well as the liganding atoms and to determine 
the geometry of the coordination by NMR, 
much more information is necessary. To 
the best of our knowledge, at the moment, 
no study exists where this has been accom-
plished for kinetically labile metal ions. The 
closest system to achieve this goal is the use 
of a inert complex like [Co(NH3)6]3+, which 
mimics the hexahydrated Mg2+. By recording 
NOE contacts between the amine and nucleic 
acid protons direct distance information can 
be obtained.
3.2 Cobalt(iii)hexammine: A Probe 
for Outer Sphere Coordination
Cobalt(III)hexammine is used as a 
probe for outer sphere complexation by 
[Mg(H2O)6]2+ with RNA. The reason is 
mainly based on geometric similarities but 
this complex has also been shown to activate 
magnesium(ii)-dependent enzymes.[61,62] 
Due to its higher charge, [Co(NH3)6]3+ in-
teractions with the nucleic acid are about 
ten times stronger than is observed for 
[Mg(H2O)6]2+.[63] With respect to DNA, [Co(NH3)6]3+ has been shown to stabilize Z 
form DNA, as well as to promote the con-
version from B to A form, which is also 
driven by naturally occurring cations and 
polyamines.[64,65]
[Co(NH3)6]3+ coordination to nucleic ac-
ids is usually studied either by chemical shift 
mapping or by observation of NOE contacts 
between the ammonia protons of the Co(iii) 
complex and the imino protons or aromatic 
protons of the nucleic acid. For example, in 
their studies on the stabilization of DNA iso-
mers by [Co(NH3)6]3+ and polyamines, Rob-
inson and Wang used such NOEs between 
the ammonia ligands and guanosine H(8), 
imino, and cytosine amino protons of DNA 
to determine the exact geometry of the inter-
action.[65] Similarly Tinoco et al. employed 
[Co(NH3)6]3+ as a mimic of outer sphere 
complexation of the hydrated magnesium(ii) 
ion by RNA solving the solution structures 
of [Co(NH3)6]3+ coordinated to a group I in-
tron ribozyme domain (Fig. 4), a viral RNA 
pseudoknot, a GAAA tetraloop and the P4 
element of the RNAse P ribozyme.[43,44,66,67] 
The interaction between [Co(NH3)6]3+ and 
nucleic acids is highly dynamic:[44] Only 
one resonance is observed for all 18 ligand 
protons of [Co(NH3)6]3+ at 3.65 ppm, argu-
ing for a fast rotation of the complex in its 
binding pocket. 
Despite all these above listed advantag-
es, [Co(NH3)6]3+ also has some caveats that 
Fig. 3. (A) Section of the [1H,1H]-NOESY 
spectrum of a 27-nucleotide long RNA hairpin 
(D6-27) upon addition of Mg2+ (0–12 mM, red – 
blue) (adapted from ref. [59]). Both crosspeaks 
shift upon addition of Mg2+ indicating metal 
ion binding. In the case of the G1DP resonance, 
significant line broadening is additionally ob-
served, suggesting a direct binding of Mg2+ at 
the 5’-terminal diphosphate group. (B) Plot of 
the change in chemical shift of a 1H resonance 
in D6-27 versus [Mg2+] and fit with a non-linear 
least-squares fit according to Eqn. (1). By ta-
king the other binding sites within D6-27 into 
account, the available [Mg2+] for this binding 
site gets smaller, and the logK values increase 
with every iteration round (grey to black). A 
significant improvement of the fit is observed 
from the application of the iterative procedure.
Fig. 4. NMR solution structure of the P5b stem-
loop from a group I intron ribozyme with a bound 
[Co(NH3)6]
3+. The Fig. was prepared with MOL-
MOL[27] using the PDB coordinates 1AJF.[44]
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one needs to be aware of. This Co(iii) com-
plex can only substitute for [Mg(H2O)6]2+, 
but not for partially dehydrated Mg(ii) com-
plexes, i.e. inner sphere coordinated Mg2+. 
A recent evaluation of Mg2+ binding within 
the large ribosomal subunit has shown that 
only nine out of 116 Mg2+ are bound in a 
completely outer sphere manner.[5,8] As a 
consequence the majority of Mg2+ ions is 
partially inner sphere bound and cannot be 
mimicked with [Co(NH3)6]3+. 
3.3 Paramagnetic Metal Ions 
as Probes for Inner Sphere 
Coordination
The paramagnetic Mn2+ ion is commonly 
used as a probe for inner sphere metal coor-
dination to nucleic acids. Paramagnetic ions 
induce a more rapid relaxation of the nuclei 
in their vicinity, leading to line broadening 
of the respective resonance. The broaden-
ing effect is proportional to the distance be-
tween the paramagnetic ion and the nucleus 
with a r–6 dependence.[63] Mn2+ binding usu-
ally has a short lifetime and because of the 
fast exchange between bound and unbound 
state the resonances of the nuclei in close 
proximity to the binding site are selectively 
broadened already at very low Mn2+ concen-
trations. Paramagnetic line broadening in-
duced by Mn2+ has been successfully used 
to localize divalent metal ion binding sites 
in selfsplicing ribozymes.[42,68,69] 
3.4 NH4
+: A Probe for Monovalent 
Cation Binding
The monovalent ions Na+ and K+, both 
commonly associated with nucleic acids in 
vivo and/or in vitro, are as difficult to ob-
serve as, e.g. Mg2+. In addition to their spec-
troscopic silence, the M+ ions usually bind 
even weaker than Mg2+. Well known substi-
tutes for K+ are Tl+ and NH4+. Tl+ is one of 
the most sensitive NMR nuclei, but its high 
toxicity as well as redox activity limits its 
practical use in the laboratory. Ammonium 
instead is an often used substitute for K+, 
which in the form of 15NH4+ is also observ-
able by NMR. For example, the titration of a 
DNA quadruplex with 15NH4Cl allowed the 
first direct localization of a monovalent cat-
ion binding site by recording NOEs between 
the ammonium ion and the DNA protons.[46] 
The titration studies showed however, that 
NH4+ is coordinated preferentially over Na+ 
and K+ and its tetrahedral geometry as well 
as its potential to form hydrogen bonds with 
the nucleic acid makes it distinctly different 
from the two alkali ions.
4. Determination of Affinity 
Constants of Mn+ Binding to RNA
As already described above chemical 
shift mapping and line broadening analysis 
can be used to determine metal ion binding 
sites in a qualitative way. As for large nu-
cleic acid structures, chemical shift chang-
es are easier to measure and with greater 
certainty than the line width, only the first 
effect will be discussed here in more detail. 
However, in all the formulas listed below, 
the chemical shift can be replaced by the 
line width to calculate binding constants.
To calculate affinity constant KAi of 
a metal ion towards a binding site i in a 
RNA quantitatively, the chemical shift 
changes δ
obs of the observed protons are 
plotted versus the Mn+ concentration [Mn+]
tot. The experimental data is then fit to a 
1:1 binding isoterm (Eqn. (1)) using for 
example a Levenberg-Marquardt nonlinear 
least-square regression.[58,70] [RNA]i corre-
sponds to the concentration of the RNA, 
δRNAi to the chemical shift of the unbound 
binding site, and δRNA·M to the one of the 
fully bound site.
Usually, more than only a single co-
ordination site is present in nucleic acids. 
These are thus filled up in parallel if they 
have similar affinities towards the metal 
ions. As a consequence, a metal ion bound 
to one site is not available to bind to an-
other site simultaneously. This means that 
the actual available [Mn+] for each site is 
smaller than [Mn+]tot, and that in order 
to calculate intrinsic Mn+ affinities for a 
given coordination site, the binding of 
Mn+ to all the other sites has to be taken 
into account. To automate this extensive 
calculation, we have recently developed 
ISTARv2.2, a MatLab script, that per-
forms the iterative procedure to calculate 
the intrinsic metal ion affinity for each site 
K
ai from the NMR chemical shift change 
data.[26] This program runs in two steps: 
First, the affinity constants KA,est are esti-
mated according to Eqn. (1) using [Mn+]tot 
and the chemical shift data of protons as 
obtained from NOESY titration experi-
ments. Based on these KA,est values and 
additional line broadening data the indi-
vidual binding sites are defined manually. 
The KA,est values obtained for each proton 
of a binding site are then averaged to give 
a first set of averaged affinity constants 
KA,av1 for each individual binding site. The 
KA,av1 values are then used to calculate the 
bound [Mn+]bound,i at each site by using 
Eqn. (2): 
The Mn+ concentration available for 
binding to a specific site i, is then given 
by Eqn. (3).
These corrected Mn+ concentrations 
for each individual site [Mn+]
avail,i are then 
used in the next iteration step, fitting the 
chemical shift change data again to a 1:1 
binding model. The second set of affinity 
constants KA,est2 for each evaluated proton 
are again averaged to obtain improved af-
finity constants KA,av2 for each individual 
binding site. These corrected averaged af-
finity constants serve as a basis to calcu-
late again the amount of bound Mn+ to each 
binding site. The described procedure has 
to be repeated until no change of the KA,av 
values within the error limits is observed 
(Fig. 3B). The final affinity constants KA,fin 
are obtained by plotting the average val-
ues of each site versus the number of the 
iteration round and fitting the data to an 
asymptotic function. 
Most importantly, the above described 
iteration procedure ISTARv2.2 is generally 
applicable to all systems that have multiple 
binding sites for the same ligand.
5. Artificial Systems
Besides the studies on metal ion inter-
actions with DNA and RNA in naturally 
occurring systems, investigations of artifi-
cial metal-modified nucleic acids become 
increasingly important, as these molecules 
are promising candidates for nanodevices 
and can also be employed as tools in bio-
technology. Although the development and 
investigation of such artificial systems is 
currently a popular research field,[11] only 
few NMR studies are known in which di-
rect nucleic acid–metal contacts or metal-
induced structural changes could be ob-
served.[12,51] 
(1)
(2)
(3)
(4)
(5)
(1)
(1)
(2)
(3)
(4)
(5)
(2)
(1)
(2)
(3)
(4)
(5)
(3)
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One promising way to build-up metal-
modified DNA is to use natural nucleotides 
combined with metal ions. Already in 1963 
Katz proposed that Hg2+ ions bind specifi-
cally to thymine–thymine mismatches in 
a linear fashion to form metal-ion medi-
ated base pairs. The N(3)-H protons of 
two opposite located thymine residues of 
the DNA double strand are replaced by 
one Hg2+ ion.[71] Just recently Tanaka et. 
al were able to prove the proposed bond 
formation between Hg2+ and the N(3)s of 
the two thymines by NMR.[51] They per-
formed 15N NMR experiments with DNA 
oligomers containing thymine–thymine 
mismatches in which either two labeled 
thymines (Fig. 5A and C) or one labeled 
and one unlabeled thymine were used (Fig. 
5B). In 15N experiments a splitting of the 15N 
resonances of about 2.4 Hz was observed 
for the first case, which disappeared when 
a labeled thymine was base paired with an 
unlabeled one. This clearly shows that the 
splitting of the 15N resonances is due to a 
15N–15N J-coupling across Hg (2JNN) and is 
therefore a direct evidence for the forma-
tion of thymine–Hg2+–thymine base pairs. 
Furthermore all N(3) resonances assigned 
from a [1H,15N]-HSQC spectrum show 
downfield shifts of about 30 ppm (~155 
ppm to ~185 ppm) upon complexation 
with Hg2+ ions. Such large downfield shifts 
can only be explained by a proton–metal 
exchange and therefore also give evidence 
for the formation of the linear thymine–
Hg2+–thymine base pair.
DNA strands are usually made by 
chemical synthesis, making it difficult to 
synthesize very long strands as well as high 
amounts thereof. This is especially true if 
modified nucleotides are used. As RNA 
offers the same principles in terms of se-
quence specificity and structure, we have 
set up a system to use T7 RNA polymerase 
to obtain nucleic acids in defined length and 
sequence in a fast and highly efficient way 
by in vitro transcription:[72] Several RNA 
constructs containing stretches of 2, 6, 10 
and 20 uracils in length[12] were obtained in 
relatively high yield. The incorporation of 
Hg2+ to form uracil–Hg2+–uracil base pairs 
was investigated by NMR using diffusion-
ordered spectroscopy (DOSY).[12] Three of 
the designed constructs were palindromic, 
thus the addition of Hg2+ ions induces a 
structure conversion from hairpin to double 
helix due to the uracil–Hg2+–uracil base pair 
formation. Such a conversion should not 
only result in distinct changes of chemical 
shifts but also in the size of the construct. 
DOSY experiments were used to determine 
the hydrodynamic radius rH of the molecules 
in absence and in presence of Hg2+ ions.[12] 
In addition, we compared the experimental 
values with the theoretical ones for the hair-
pin and duplex formation of the constructs. 
Depending on the theoretical ratio q (q = 
L/d) between the length L and the diameter 
d of the RNA sequences the molecules can 
be either modeled as a spherical particle (q 
< 2) or as a symmetrical cylinder (2 < q <3 
0).[73,74] The apparent hydrodynamic radius 
rH
 can then be calculated according to Eqn. 
(4) and (5), respectively.
(1)
(2)
(3)
(4)
(5)
(4)
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by one Hg2+ ion.[64] Just recently Tanaka et. al were able to prove the proposed bond
formation between Hg2+ and the N3s of the two thymines by NMR.[44] They performed 15N
NMR experiments with DNA oligomers containing thymine-thymine mismatches in which
either two labeled thymines (Fig. 5A and C) or one labeled and one unlabeled thymine were
used (Fig. 5B). In 15N experiments a splitting of the 15N resonances of about 2.4 Hz was
observed for the first case, which disappeared when a labeled thymine was base paired with
an unlabeled one. This clearly shows that the splitting of the 15N resonances is due to a 15N-
15N J-c upling across Hg (2JNN) and is therefore a direct evidence for the formation of
thymine-Hg2+-thymine base pairs. Furthermore all N3 resonances assigned from a [1H,15N]-
HSQC spectrum show downfield shifts of about 30 ppm (~155 ppm to ~185 ppm) upon
complexation with Hg2+ ions. Such large downfield shifts can only be explained by a proton-
metal exchange and th refore also give evidence for the formation of the linear thymine-Hg2+-
thymine base pair.
DNA strands are usually made by chemical synthesis, making it difficult to synthesize
very long strands as well as high amounts thereof. This is especially true if modified
nucleo ides are used. As RNA offers the same principles in terms of sequence specificity and
structure, we have set up a system to use T7 RNA polymerase to obtain nucleic acids in
defined length and sequence in a fast and highly efficient way by in vitro transcription:[65]
Several RNA constructs containing stretches of 2, 6, 10 and 20 uracils in length [12] were
obtained in relatively high yield. The incorporation of Hg2+ to form uracil-Hg2+-uracil base
pairs was investigated by NMR using diffusion-ordered spectroscopy (DOSY).[12] Three of
the designed constructs were palindromic, thus the addition of Hg2+ ions induces a structure
conversion from hairpin to double helix due to the uracil-Hg2+-uracil base pair formation.
Such a co v rsion should not only result in distinct changes of chemical shifts but also in the
size of the construct. DOSY experiments were used to determine the hydrodynamic radius rH
of the molecules in absence and in pr sence of Hg2+ ions.[12] In addition, we compared the
experimental values with the theoretical ones for the hairpin and duplex formation of the
constructs. D pen ing on the theoretical ratio q (q = L/d) between the length L and the
diameter d of the RNA sequences the molecules can be either modeled as a spherical particle
(q<2) or as a symmetrical cylinder (2<q<30).[66,67] The apparent hydrodynamic radius rH
can then be calculated according to equations 4 and 5, respectively.
Spherical model: 2
LrH = (4)
Cylinder model: ( )21 1.0565.0312.0ln2 −− −++= qqq LrH (5)
(5)
For example, the palindromic construct 
with six uracil residues in-line clearly 
adopts a hairpin structure with a hydrody-
namic radius of 1.6 nm in the absence of 
Hg2+ ions. Upon addition of Hg2+ a 30%-in-
crease to 2.1 nm is observed unambiguous-
ly arising from a hairpin-duplex transition. 
The experimental and the theoretical data 
are thereby in good agreement.[12] 
The two examples above nicely illus-
trate that NMR is a powerful tool to ex-
plore metal-ion binding sites and metal-
induced structural changes within artificial 
oligonucleotide systems.
6. Concluding Remarks
The manifold interactions of metal ions 
with natural and artificial nucleic acids is a 
highly fascinating and diverse world, rang-
ing in research fields from classical coor-
dination chemistry, via bioinorganic chem-
istry to biochemistry and nanotechnology. 
It is well known that metal ions are crucial 
for structure and function of catalytically 
active RNAs and DNAs, i.e. ribozymes 
and DNAzymes, and hence it is somewhat 
surprising to realize how little is known on 
these relations. However, aside from the 
many coordinating atoms in nucleic acids, 
the lability of the ligands of the applied and 
used metal ions make the elucidation of 
structural and thermodynamic properties 
highly challenging. Here we have shortly 
summarized the current state of solution 
NMR experiments to address these ques-
tions. It will be fascinating to see what 
novel experiments will be developed in the 
near future and what unprecedented metal 
ion binding pockets will be discovered and 
described.
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Fig. 5. 15N-NMR 
spectra of DNA 
double-helices with 
two thymine–Hg2+–
thymine base pairs. 
In (A) and (C) two 15N 
labeled thymines are 
directly base paired 
leading to a splitting 
of the 15N resonances 
of about 2.4 Hz due to 
a 15N–15N J-coupling 
across Hg2+ (2JNN). No 
splitting is observed 
when a 15N labeled 
thymine is directly 
base paired with an 
unlabeled one (B). 
Reproduced with 
permission from Ref. 
[51]
152 CHIMIA 2009, 63, No. 3 Young AcAdemics in switzerlAnd PArt ii
[1]  R. F. Gesteland, T. R. Cech, J. F. Atkins, ‘The 
RNA World’, 2nd ed., Cold Spring Harbor 
Press, 1999; Vol. 37.
[2]  R. K. O. Sigel, A. M. Pyle, Chem. Rev. 2007, 
107, 97.
[3]  F. A. Edwards, A. J. Gibb, FEBS Letters 1993, 
325, 86.
[4]  H. Sigel, Inorg. Chim. Acta 1992, 198-200, 1.
[5]  E. Freisinger, R. K. O. Sigel, Coord. Chem. Rev. 
2007, 251, 1834.
[6]  D. E. Draper, D. Grilley, A. M. Soto, Annu. Rev. 
Biophys. Biomol. Struct. 2005, 34, 221.
[7]  V. K. Misra, D. E. Draper, J. Mol. Biol. 2000, 
299, 813.
[8]  D. J. Klein, P. B. Moore, T. A. Steitz, RNA 2004, 
10, 1366.
[9]  D. Kruschel, R. K. O. Sigel, J. Inorg. Biochem. 
2008, 102, 2147.
[10]  K. Tanaka, G. H. Clever, Y. Takezawa, Y. 
Yamada, C. Kaul, M. Shionoya, T. Carell, 
Nature Nanotech. 2006, 1, 190.
[11]  J. Müller, Eur. J. Inorg. Chem. 2008, 3749.
[12]  S. Johannsen, S. Paulus, N. Düpre, J. Müller, R. 
K. O. Sigel, J. Inorg. Biochem. 2008, 1141.
[13]  P. M. Gordon, J. A. Piccirilli, Nat. Struct. Biol. 
2001, 8, 893.
[14]  M. Hertweck, M. W. Müller, Eur. J. Biochem. 
2001, 268, 4610.
[15]  R. K. O. Sigel, A. M. Pyle, Met. Ions Biol. Syst. 
2003, 40, 477.
[16]  R. K. O. Sigel, A. Vaidya, A. M. Pyle, Nat. 
Struct. Biol. 2000, 7, 1111.
[17]  M. Boudvillain, A. de Lencastre, A. M. Pyle, 
Nature 2000, 406, 315.
[18]  Y. Lu, Chem. Eur. J. 2002, 8, 4588.
[19]  Y. Lu, J. W. Liu, J. Li, P. J. Bruesehoff, C. M. B. 
Pavot, A. K. Brown, Biosens. Bioelectron. 2003, 
18, 529.
[20]  J. L. Boots, M. D. Canny, E. Azimi, A. Pardi, 
RNA 2008, 14, 2212.
[21]  M. Roychowdhury-Saha, D. H. Burke, RNA 
2006, 12, 1846.
[22]  M. C. Erat, R. K. O. Sigel, J. Biol. Inorg. Chem. 
2008, 13, 1025.
[23]  M. Steiner, D. Rueda, R. K. O. Sigel, to be 
submitted for publication.
[24]  H. Sigel, Chem. Soc. Rev. 1993, 22, 255.
[25]  A. Mucha, B. Knobloch, M. Jezowska-Bojczuk, 
H. Kozlowski, R. K. O. Sigel, Dalton Trans. 
2008, 5368.
[26]  M. C. Erat, R. K. O. Sigel, Inorg. Chem. 2007, 
46, 11224.
[27]  R. Koradi, M. Billeter, K. Wüthrich, J. Mol. 
Graphics 1996, 14, 29; R. Koradi, M. Billeter, 
K. Wüthrich, J. Mol. Graphics 1996, 14, 51.
[28]  B. Lippert, ‘Cisplatin: Chemistry and Bio-
chemistry of a Leading Anticancer Drug’, VCHA 
and Wiley-VCH, Zürich, Weinheim, 1999.
[29]  A. J. B. Alberts, J. Lewis, M. Raff, K. Roberts, 
P. Walter, ‘Molecular Biology of the Cell’, 5th 
ed., Garland Science, 2008.
[30]  D. F. Babcock, B. Hille, Curr. Op. Neurobiol. 
1998, 8, 398.
[31]  E. Carafoli, FEBS Lett. 1979, 104, 1.
[32]  S.-O. Shan, A. V. Kravchuk, J. A. Piccirilli, D. 
Herschlag, Biochemistry 2001, 40, 5161.
[33]  R. K. O. Sigel, B. Song, H. Sigel, J. Am. Chem. 
Soc. 1997, 119, 744.
[34]  V. L. Pecoraro, J. D. Hermes, W. W. Cleland, 
Biochemistry 1984, 23, 5262.
[35]  C. P. Da Costa, A. Okruszek, H. Sigel, 
ChemBioChem 2003, 4, 593.
[36]  B. Knobloch, B. Nawrot, A. Okruszek, R. K. O. 
Sigel, Chem. Eur. J. 2008, 14, 3100.
[37]  M. Maderia, L. M. Hunsicker, V. J. DeRose, 
Biochemistry 2000, 39, 12113.
[38]  S. R. Morrissey, T. E. Horton, V. J. DeRose, J. 
Am. Chem. Soc. 2000, 122, 3473.
[39]  T. E. Horton, D. R. Clardy, V. J. DeRose, 
Biochemistry 1998, 37, 18094.
[40]  R. L. Gonzalez, Jr., I. Tinoco, Jr., Methods 
Enzymol. 2001, 338, 421.
[41]  M. C. Erat, O. Zerbe, T. Fox, R. K. O. Sigel, 
ChemBioChem 2007, 8, 306.
[42]  G. Colmenarejo, I. Tinoco Jr., J. Mol. Biol. 
1999, 290, 119.
[43]  S. Rüdisser, I. Tinoco, Jr., J. Mol. Biol. 2000, 
295, 1211.
[44]  J. S. Kieft, I. Tinoco, Jr., Structure 1997, 5, 
713.
[45]  C. V. Grant, V. Frydman, J. S. Harwood, L. 
Frydman, J. Am. Chem. Soc. 2002, 124, 4458.
[46]  N. V. Hud, P. Schultze, J. Feigon, J. Am. Chem. 
Soc. 1998, 120, 6403.
[47]  S. Basu, A. A. Szewczak, M. Cocco, S. A. 
Strobel, J. Am. Chem. Soc. 2000, 122, 3240.
[48]  C. Switzer, D. Shin, Chem. Commun. 2005, 1342.
[49]  J. Müller, D. Böhme, P. Lax, M. Morell Cerdà, 
M. Roitzsch, Chem. Eur. J. 2005, 11, 6246.
[50]  G. H. Clever, T. Carell, Angew. Chem., Int. Ed. 
2007, 46, 250.
[51]  Y. Tanaka, S. Oda, H. Yamaguchi, Y. Kondo, C. 
Kojima, A. Ono, J. Am. Chem. Soc. 2007, 129, 
244.
[52]  A. Ono, H. Togashi, Angew. Chem., Int. Ed. 
2004, 43, 4300.
[53]  J. Liu, Y. Lu, Angew. Chem., Int. Ed. 2007, 119, 
7731.
[54]  A. Ono, S. Cao, H. Togashi, M. Tashiro, T. 
Fujimoto, T. Machinami, S. Oda, Y. Miyake, 
I. Okamoto, Y. Tanaka, Chem. Commun. 2008, 
4825.
[55]  T. Carell, C. Behrens, J. Gierlich, Org. Biomol. 
Chem. 2003, 1, 2221.
[56]  G. Roelfes, Mol. BioSyst. 2007, 3, 126.
[57]  R. K. O. Sigel, Eur. J. Inorg. Chem. 2005, 12, 
2281.
[58]  R. K. O. Sigel, D. G. Sashital, D. L. Abramovitz, 
A. G. Palmer III, S. E. Butcher, A. M. Pyle, Nat. 
Struct. Mol. Biol. 2004, 11, 187.
[59]  M. C. Erat, PhD Thesis, 2007, University of 
Zurich.
[60]  M. C. Erat, H. Kovacs, R. K. O. Sigel, submitted 
for publication.
[61]  J. A. Cowan, J. Inorg. Biochem. 1993, 49, 171.
[62]  R. W. Jou, J. A. Cowan, J. Am. Chem. Soc. 1991, 
113, 6685.
[63]  J. Feigon, S. E. Butcher, L. D. Finger, N. V. 
Hud, Methods Enzymol. 2001, 338, 400.
[64]  R. V. Gessner, G. J. Quigley, A. H. J. Wang, 
G. A. Vandermarel, J. H. Vanboom, A. Rich, 
Biochemistry 1985, 24, 237.
[65]  H. Robinson, A. H. J. Wang, Nucleic Acids Res. 
1996, 24, 676.
[66]  R. L. Gonzalez, Jr., I. Tinoco Jr., J. Mol. Biol. 
1999, 289, 1267.
[67]  M. Schmitz, I. Tinoco Jr., RNA 2000, 6, 1212.
[68]  F. H.-T. Allain, G. Varani, Nucleic Acids Res. 
1995, 23, 341.
[69]  S. E. Butcher, F. H.-T. Allain, J. Feigon, 
Biochemistry 2000, 39, 2174.
[70]  R. K. O. Sigel, E. Freisinger, B. Lippert, J. Biol. 
Inorg. Chem. 2000, 5, 287.
[71]  S. Katz, Biochim. Biophys. Acta 1963, 68, 240.
[72]  S. Gallo, M. Furler, R. K. O. Sigel, Chimia 
2005, 59, 812.
[73]  J. Lapham, J. P. Rife, P. B. Moore, D. M. 
Crothers, J. Biomol. NMR 1997, 10, 255.
[74]  W. Eimer, J. R. Williamson, S. G. Boxer, R. 
Pecora, Biochemistry 1990, 29, 799.

Available online at www.sciencedirect.com
Controlling ribozyme activity by metal ions
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The observed rates of ribozyme cleavage reactions are strongly
dependent on the nature of the metal ion present. Metal ions
can thereby exhibit a stronger inhibiting or accelerating effect
compared to Mg2+, which is usually considered the natural
cofactor. Alkaline, alkaline earth, transition, d10, and other
metal ions are applied either to gain a spectroscopic handle on
the metal center, and/or to elucidate the catalytic mechanism.
Here we shortly review some of themost recent publications on
the influence of different metal ions on catalysis of the
hammerhead, hepatitis delta virus, and group II intron
ribozymes. Comparison of the observed cleavage rates of
hammerhead ribozymes with the metal ion affinities of different
ligands reveals that these rates correlate perfectly with the
intrinsic phosphate affinities of the metal ions involved.
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Introduction
RNA or DNA in a living cell is always associated with
metal ions (Mn+) [1]. The intrinsic negative charge of
the phosphate sugar backbone needs to be compensated
to achieve not only regular duplex formation but also
complex three-dimensional architectures. Estimates
show that a 200-nt long RNA needs to overcome repulsive
forces of about 2100 kJ mol1 to fold in the absence of
metal ions [2]. The vast majority of Mn+ are diffusely
bound to RNA that is via unspecific interactions that can
be best described by a nonlinear Poisson–Boltzman distri-
bution [3,4]. An estimated 10% of the negative charge is
compensated by specifically bound Mn+, as has been
concluded from X-ray structures of larger RNAs [5]. In
RNA, a distinct network of inner-sphere (i.e. direct) and
outer-sphere (i.e. mediated through water molecules)
coordination is built to hold metal ions in place. A Mn+
binding pocket thereby offers an excess of possible
coordination and H-donor/acceptor sites (Figure 1).
Outer-sphere binding should thereby not be equated
with unspecific binding. As part of a tight hydrogen
bonding network, the coordinated water molecules
(and thus also the central metal ion) are strongly bound,
as is very well known from the spine of hydration of DNA
[6].
K+ and Mg2+ are most abundant in living cells and thus
believed to be the metal ion-cofactors associated with
nucleic acids. Originally used as mimics for Mg2+, other
divalent metal ions have been applied in uncountable
studies to, for example, elucidate the catalytic mechanism
or to get a spectroscopic handle on the metal ion. Thio-
rescue [7,8], related NAIM/NAIS experiments (nucleo-
tide analogue interference mapping/suppression)
[7,9,10], and EPR measurements are just three
examples [11–13]. Such metal ions include alkaline earth
ions (Ca2+, Sr2+, Ba2+), first row transition ions (Mn2+,
Co2+, Ni2+), group 12 (IIB) ions (Zn2+, Cd2+), main group
metal ions (Pb2+), all lanthanide ions, as well as com-
plexes like Co(H2O)6
3+. Changing the metal ion usually
strongly affects ribozyme activity. Classically, an inhibit-
ing effect is expected when Mg2+ is partly or fully
replaced but also tremendous rate accelerations have
been observed. These rate modifications allow to corre-
late activity with chemico-physical properties of the ions,
for example, ionic radius, pKa of coordinated water, or
general affinities, and thus help to elucidate the mech-
anism [14,15]. Unfortunately, only rarely clear corre-
lations are found.
In this short review we focus on some of the most recent
results on the influence of different metal ions on the
cleavage rates of tertiary stabilized hammerhead (HH),
hepatitis delta virus (HDV), and group II intron ribo-
zymes. We discuss and compare these data with available
results from the literature on smaller nucleic acid systems
or derivatives. Interestingly, a clear correlation of HH
ribozyme cleavage rates and the intrinsic affinities of the
respective metal ions toward phosphate groups is
revealed.
Replacing Mg2+ by monovalent ions
More than 25 years ago, a two-metal ion mechanism has
been proposed for dephosphorylation reactions [16,17]
and is now often considered as one of the favored modes
of action for ribozymes [18,19]. With the discovery that
small ribozymes are also active in the presence of mono-
valent metal ions only, for example, alkaline ions and
NH4
+, this dogma has been strongly opposed for some
time. However, given the facts that firstly, alkaline ions
are also metal ions; secondly, nonphysiological molar
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concentrations have to be applied for folding and activity;
thirdly, the catalytic activity in the presence of M+ ions
could in no case rival the one observed with M2+ ions; and
fourthly, the realization that metal ions need not to be
coordinated directly but can exert their crucial influence
also from a distance [1], it becomes again increasingly
evident that ribozymes are simply obligate metallo-ribo-
zymes.
It is well known that high Na+ concentrations can replace
Mg2+ or Zn2+ in the related hydrolysis of ATP [20,21]. 500
times higher concentrations of M+ ions are needed in this
simple system to compensate for the intrinsic much lower
affinity of M+ ions compared to M2+ ions. In larger ribo-
zymes, a larger excess ofM+ is needed.The replacement of
one Mg2+ ion by several Na+ ions has recently been
implicated by a molecular simulation study of the HH
ribozyme,where a large negatively chargedbinding pocket
has been located at the active site [22]. MD simulations in
theabsence ofdivalent ions revealed twoNa+ ions sitting in
the catalytic pocket replacing one Mg2+ ion, but not
occupying distinct coordination sites [23]. Consistently,
the Schistosoma HH ribozyme can globally fold in the
presence of M+ ions, but M2+ ions are still needed for
efficient catalysis [24]. Similar results were obtained for
the HDV ribozymes in the presence of molar concen-
trations of M+ ions, Li+ yielding 30–50 faster cleavage
rates than Na+ and NH4
+ [25]. However, additional pre-
sence of Mg2+ further accelerates cleavage by about 100
times [25]. Along the same line, crystallographic studies of
the HDV ribozyme have demonstrated that the location of
monovalent and divalent ions do not overlap completely
[26]. All these results suggest that accumulatedM+ ions can
partly substitute Mg2+ ions, but they will not reach the
equivalent electrostatic or polarizing potential because of
either their lower charge density, or their lower affinity, or
both.
Replacing Mg2+ by Ca2+
The HDV ribozyme exists in two forms, the genomic and
the antigenomic, being encoded one on each of the two
viral RNA strands. These two forms exhibit an interesting
Mg2+/Ca2+ switch. Whereas the genomic HDV ribozyme
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Figure 1
Metal ion binding pocket in the major groove of the branch site in domain
6 of the Sc.ai5g ribozyme [45,46]. A multitude of possible coordination
sites for a metal ion (oxygens in red, nitrogens in blue) and one H-bond
donor (NH2 in green) are observed. It is highly plausible that depending
on the size and coordinating properties of a given metal ion, a specific
network of hydrogen bonds and coordination patterns for each distinct
metal ion can be achieved in such a pocket. This figure was prepared
with MOLMOL (www.mol.biol.ethz.ch/groups/wuthrich_group/software)
using PDB ID 2AHT [46].
Figure 2
(a) Overlay of crystal structures of HH ribozymes in the presence of Mg2+
(green spheres, PDB ID 301D) [36], Mn2+ (blue spheres, PDB ID 300D)
[36], and Cd2+ (yellow spheres, PDB ID 488D) [37]. Mg2+ and Mn2+
occupy corresponding regions, but coordinate differently, whereas Cd2+
prefers other binding sites. (b) Close-up of the active site: the Mn2+ is
bound inner-sphere both to the pro-RP phosphate oxygen of nucleotide
A9 and N7 of G10.1 (PDB ID 2OEU) [28]. Mg2+ coordinates inner-sphere
to the same phosphate oxygen but outer-sphere to the respective N7
position as indicated by the large distance of 4.5 A˚ (PDB ID 2QUW) [47].
The panels were prepared with MOLMOL (www.mol.biol.ethz.ch/
groups/wuthrich_group/software).
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cleaves faster in the presence of Mg2+, Ca2+ is the better
cofactor for the antigenomic form [27�]. The nature of the
nucleotide 50 to the cleavage site (position �1) (U in the
genomic and C in the antigenomic HDV ribozyme) is
decisive for this specificity, as changing C! U or U! C,
respectively, reverses the Mg2+/Ca2+ preference [27�].
The reason for this switch in Mn+ preference is unknown,
but perhaps because of the different hydrogen bonding
properties of these two nucleobases the outer-sphere
coordination network of the two ions is altered.
TheHH ribozyme is one of the best investigated catalytic
RNAs. However, despite numerous crystal structures and
uncountable biochemical studies, the mechanism of
action is still far from being understood [19,28]. The
HH ribozyme is active in the presence of transition metal
ions as well as at high M+ concentrations. Since the
discovery of the much more active extended (or tertiary
stabilized) hammerhead ribozyme [29,30], several studies
dealt with the influence of metal ions on catalysis and
folding. Out of Mg2+, Ca2+, Sr2+, and Ba2+, Mg2+ works
best, the alkaline earth metal ions showing an inverse
correlation between kobs and the pKa of the hydrated ions.
Group II introns rank among the largest catalytic RNAs
and implicitly require Mg2+ for catalysis [31]. No group II
intron is known where the addition of a divalent metal ion
other thanMg2+ leads to an increase in activity. The yeast
Sc.ai5g group II intron and its derived ribozyme con-
structs are among the best investigated large ribozymes
[32]. Ca2+ has been shown to be an efficient inhibitor of
the first step of splicing of the Sc.ai5g derived D135
ribozyme. In the presence of 5% Ca2+ (95% Mg2+), the
catalytic rate kcat drops by about 50% and at 20% Ca
2+ no
activity is detectable anymore [33�]. A replacement of
Mg2+ by Ca2+ in the catalytic core cannot be excluded to
date. However, recent single molecule Fluorescence
Resonance Energy Transfer (smFRET) experiments
have provided unprecedented insights into the influence
of metal ions on folding of large RNAs [34,35��]: Firstly,
the global architecture of these RNAs is severely dis-
turbed upon addition of Ca2+. Secondly, Ca2+ induces the
formation of a second subpopulation that behaves dis-
tinctly differently, both in folding pathway and in
smFRET states. The number of these type 2 molecules
thereby increases linearly with Ca2+ concentration. Inter-
estingly, every single molecule is forced into one distinct
subpopulation and cannot switch between them. By these
experiments, for the first time a functional role for folding
heterogeneity could be demonstrated [35��]. The obser-
vation that not all molecules are evenly affected by Ca2+
hints that Ca2+ coordinates cooperatively. As the total
concentration of Ca2+ by far exceeds the one of the single
molecules, this means that cooperativity only becomes
effective after first binding events have taken place with
Ca2+.
Replacing Mg2+ with transition and d10 metal
ions
In the HH ribozyme all transition metal ions investigated
promote faster catalysis than Mg2+, with Mn2+ promoting
catalysis about 400 times more than the one reached by
Mg2+ [15]. The reason for these large differences in
reaction velocity is still unclear. Crystal structures of
hammerhead ribozymes in the presence of Mg2+, Mn2+
and Cd2+ revealed subtle differences in binding
(Figure 2) [36,37]. All three ions occupy roughly the same
regions but coordinate slightly differently. A close-up of
the active site reveals small, but possibly decisive differ-
ences of inner-sphere (Mn2+) versus outer-sphere coordi-
nation (Mg2+). Along the same line, recent molecular
dynamic simulations of five different hammerhead states
have revealed a binding pocket with a high electronega-
tive charge potential that attracts metal ions, but binds
them differently in mode and number because of the
large enough pocket and excess of possible liganding
sites present (Figure 1) [22]. However, different mech-
anisms might take place depending on the metal ions
present. For example, a single-proton transfer was
suggested to occur in the presence of Mg2+ or Mn2+,
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Figure 3
(a) Metal ion coordinating atoms (in bold) and pKa values of RNA nucleobases. The pKa values are taken from Refs. [49,42,50]. In the case of gua and
ura the effect of a single-charged phosphate group was additionally taken into account. (b) The effect of N7 substituents on the pKa of the guanine-
N1H position. The DpKa values are taken from Ref. [40] to calculate the expected values pKa,ex values based on pKa = 9.36 as given in (a).
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whereas a double-proton transfer might take place with
Cd2+ in the case of the RzBHH ribozyme [15]. As an acid,
either a solvated Mg2+ ion or a guanine-N1H, both with a
perturbed pKa value have been suggested. The origin of
perturbed pKas in complex RNAs is largely unknown.
From nucleobase studies, coordinating Mn+ are well
known to shift pKas into the physiological range as was
recently reviewed (Figure 3) [38��]. Indeed, in the VS
ribozyme it was recently reported that metal ions control a
nucleobase pKa [39
�]. The polarizing effect of Mg2+ is
expected to be similar to that of a kinetically stable Mn+
like Pt2+, if Mg2+ is held tightly in place by further
coordination. The largest effect on pKa is actually
enforced by protons, for example, guanine-N7 protona-
tion shifts the pKa of N1H to 7.22 (Figure 3) [40].
Recently, the effect of Mg2+, Ca2+, Sr2+, Mn2+, Co2+,
Zn2+, Cd2+, Na+, and NH4
+ was investigated not only
on catalysis but also on folding of the Schistosoma mansonii
HH by FRET [24�]. All Mn+ are capable of globally
folding the HH ribozyme, but 10 000-fold differences
in cleavage rates are observed, Mn2+ again being the best
cofactor [24�]. When folded in 2 M Na+, still a >4600-fold
activation of cleavage can be observed forMn2+ compared
to Mg2+. Taken together, this is a strong indication for a
direct involvement of the metal ion in optimal cleavage
activity.
The change in cleavage rate follows the
phosphate affinity of the applied metal ion
Correlations of the observed catalytic rates kobs with ionic
radii, pKa values of the hydrated metal ion complexes, the
Irving–Williams series (Figure 4a) or others have been
attempted in the past. No clear correlation was observed
for all studied metal ions, again suggesting that different
mechanisms might occur. In this regard, single- and
double-proton transfer mechanisms involving either
hydrated metal ions or ionized nucleobases are being
considered [19,28,40,41�]. Considering the intrinsic
coordination chemical properties of the metal ions
involved, it is actually very unlikely that any straight
trend is observed: Firstly, along the Irving–Williams
series not only the affinity of metal ion–ligand inter-
actions increases, but also the preference for oxygen
ligands changes to a clear preference for nitrogen sites.
Both types of liganding sites are abundant in metal ion
binding pockets within nucleic acid structures (Figures 1
and 3). Secondly, at the same time, the preference for
inner-sphere coordination often increases from left to
right along the same series of ions (which is not true
for phosphate ligands). Thirdly, the Irving–Williams
series is not strictly followed for phosphate ligands, which
are the most important coordination sites for metal ions in
nucleic acids (Figure 4) [42,43]. Most importantly, the
phosphate affinity decreases fromMn2+ toNi2+ (most likely
due to outer-sphere binding).
Indeed, when plotting the kobs values of RzB HH clea-
vage [15,24�] versus theMn+ affinities toward a phosphate
monoester, a surprisingly good correlation is observed
(Figure 4b). The kobs values observed with the alkaline
earth M2+ and Mn2+ fit well to the Irving–Williams series
as well as to the phosphate affinities. The additionally
investigated transition and d10 M2+ do clearly not follow
anymore the Irving–Williams trend but almost perfectly
the one of the phosphate affinities with Mn2+ exhibiting
both the highest kobs and affinities (Figure 4). As the
nucleotide affinities are strongly dominated by the phos-
phate–Mn+ interaction [5,42], this result shows that the
strength of the phosphate coordination dominates the
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Figure 4
Comparison of the observed rates of HH cleavage kobs in the presence
of various divalent metal ions with the affinities of these M2+ toward
different ligands. (a) Classical Irving–Williams series as observed for
metal ion binding to acetate (~), imidazole (&), and NH3 (^) [48]. No
overall correlation with the kobs values from RzB HH ( ) [15] and the
Schistosoma HH ( ) [24�] cleavage is observed. (b) The observed RzB
HH ( ) [15] and Schistosoma HH ( ) [24�] cleavage rates kobs correlate
nicely with the affinities [5,42] of the respective M2+ toward a phosphate
monoester with pKHHðR�MPÞ ¼ 6:20. This strongly suggests that the
strength of the phosphate coordination dominates the metal ion effect in
the HH ribozyme. Further properties like the pKa of coordinated water
molecules then determine, for example, the acid–base profile of
catalysis.
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effect of metal ions on catalysis at least in the HH
ribozyme.
Conclusions
The nature of divalent metal ions obviously is the deter-
mining factor how RNAs fold and what mechanism is
employed. How this is achieved is still lying mainly in the
dark — especially concerning the picture on the atomic
level. The above summarized recent results on the effect
of varying metal ions on ribozyme activity now trigger
several considerations:
(i) There is increasing evidence that ribozymes use
different mechanisms depending on the outside
conditions, for example, the kind and concentration
of metal ions employed. As a consequence this
means that the employment of mimics, for example,
Cd2+ instead of Mg2+, might not reflect the ‘real’
catalytic mechanism but rather a minor or very
different pathway. Such concerns have increasingly
been raised in the past years, for example, for HH
ribozymes [10]. The transfer of such results to the
wild-type system should thus always be performed
with care.
(ii) Complex RNA structures are surprisingly selective
for a given metal ion that is they recognize it with
high specificity and selectivity. One could argue that
such specific binding pockets exist just by chance or
based on pure statistics. On the other hand Nature is
very efficient and has had millions of years to
optimize its processes. In evolutionary terms, one
can imagine that there is hardly any chance that the
highly effective binding of various metal ions and
their considerable effects on ribozyme activity is
without any purpose. This is even more so, as such
effects are not restricted to only one specific
ribozyme, but seem to be a more widespread
phenomenon. As a consequence, a possible regula-
tion of ribozyme activity by metal ions is an
intriguing possibility [33]. Mg2+ and Ca2+ occur
solvated in the cell plasma, but others like Mn2+
could be specifically delivered by proteins.
(iii) Metal ions other than Mg2+ often bind with
considerably higher affinity than Mg2+ itself. In
the case of transition or d10 elements, this is no
surprise because of their relative positioning in the
Irving–Williams series. This is not true for Ca2+ as for
example its affinity to the RNA building block
AMP2 is 25% lower than that of Mg2+ [5,44].
Nevertheless, even at a 10-fold excess of Mg2+, Ca2+
can completely inhibit splicing of a group II intron
construct. Consequently, at least one Ca2+-specific
binding pocket must exist, where the affinity is more
than 1000 higher than for Mg2+ (to reach 99%
inhibition). Such an increase in affinity only requires
an additional binding energy of 17 kJ mol1, this
means to one additional hydrogen bond of a
coordinated water molecule. Hence, together with
the increased ionic radius (66 pm versus 99 pm) and
higher maximal coordination number (6 versus 8),
such specific binding pockets can be easily envi-
saged.
(iv) The observed folding heterogeneity of a group II
intron ribozyme in the presence of Ca2+ by smFRET
could also be true for other ribozymes when being
accelerated with different metal ions. The small
FRET differences observed with the group II intron
make it impossible to see the same in bulk
experiments. Consequently future smFRET studies
might reveal highly interesting and unprecedented
aspects of how different metal ions influence and
control folding and activity of ribozymes.
(v) Evaluation of the available data in the recent
literature shows that in the HH ribozyme the rate
is majorly governed by the metal ion affinity to the
phosphate group(s) (Figure 4b) following a clear
trend. It will be interesting to see if this is also true
for other catalytic RNAs, if not for the more complex
large ones, than at least for the small ribozymes.
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ABSTRACT: Since the discovery of catalytic RNA molecules (ribozymes), intense
research has been devoted to understand their structure and activity. Among RNA
molecules, the large ribozymes, namely group I and group II introns and RNase P, are
of special importance. The first two ribozymes are known for their ability to perform
self-splicing while RNase P is responsible for the 50-end maturation of tRNA in bac-
teria, archea, and eukaryotes. All three groups of ribozymes show a significant require-
ment for metal ions in order to establish the active tertiary structure that enables
catalysis. The primary role of both monovalent and divalent metal ions is to screen the
negative charge associated with the phosphate sugar backbone, but the metal ions also
play an active role in catalysis. Biochemical and biophysical investigations, supported
by recent findings from X-ray crystal structures, allow clarifying and rationalizing both
the structural and catalytic roles of metal ions in large ribozymes. In particular, the
‘‘two-metal-ion mechanism’’, describing how metal ions in the active center take part in
catalysis, has been largely corroborated.
KEYWORDS: catalysis � folding � group I introns � group II introns � metal ions �
ribozymes � RNase P
1. INTRODUCTION
The word ribozyme, coined more than twenty years ago, refers to catalytic
RNAs, i.e., RNA molecules that can perform catalysis without the aid of a
protein [1–3]. The reactions catalyzed by ribozymes include mainly cleaving
or splicing of RNA/DNA sequences [4], but other catalytic functions have
also been described [5,6] (see also further chapters in this volume). Different
types of ribozymes have been identified, but in general, ribozymes can be
divided into two classes according to their size: the small, cleaving ribozymes
(see Chapter 6) and the large, splicing (with the exception of RNase P)
ribozymes.
Ribozymes need the help of metal ions for both folding and catalysis
[1,7–14]. The polyanionic nature of the RNA backbone is compensated by
monovalent and divalent metal ions that primarily act as charge-screening
agents. The majority of Mn1 present is thus diffusely bound to RNA in an
unspecific way [15,16]. On the other hand, X-ray structures of large RNAs
show that roughly 10% of the negative charge is neutralized by specifically
bound Mn1 [17].
In the process of folding, RNAs create pockets of high negative potential
that is neutralized by interaction with divalent [18–22] or monovalent
[20,22,23] metal ions. This neutralization allows the RNA molecule to fold
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into the complex active structure that is crucial for catalysis. Moreover,
recent crystal structures show that divalent metal ions are located within the
catalytic core, suggesting their direct involvement in catalysis [21,24,25].
The key players in RNA catalysis are limited: sugar, phosphodiester
groups, and the four nucleobases; very few, when compared to proteins,
where a broader chemical diversity is granted by numerous amino acids.
Therefore, RNA needs a complex landscape of folding and activation in
order to create specific active sites. Cofactors, such as metal ions, are crucial
to create the active site and perform catalysis. The assistance of such
‘‘co-actors’’ allows RNA to perform catalysis despite the restricted variety of
functional groups, whose pKa values are far away from neutrality, that is,
the physiological pH range [12,22].
Metal ions can promote catalysis in different ways: they can stabilize the
active tertiary structure through electrostatic interactions, they can directly
participate in acid–base catalysis by activating the nucleophile or by stabi-
lizing the leaving group or they can modify the pKa of a functional group
[26–28]. For example, their coordination to nucleobases causes large pKa
shifts both in amino and imino protons [26,28–31]. Such acidified protons
can therefore participate actively in catalysis: hydrogen bonds can be
strengthened and different tautomers stabilized, so changing the aspect of
the catalytic core of the ribozyme.
The best way to describe the direct participation of metal ions in catalysis
of RNA molecules is the ‘‘two-metal-ion mechanism’’ proposed years ago
for polymerases [32–34], kinases [35], the hydrolysis of ATP and other
nucleoside 50-triphosphates [36] (depending on the positioning of the metal
ions at the triphosphate residue either a kinase-type [35,36,188] or a poly-
merase-type [36,188–190] reaction occurs [36,188]), and ribozymes [37].
Due to the strict requirement of metal ions in both folding and activity,
ribozymes can be considered as obligate metalloenzymes [38]. This was
opposed for a long time, as there are some cases in which Mg21 (the usual
cofactor in RNA catalysis) can be substituted by high concentrations of
monovalent metal ions [22,39,40]. However, recently it was reviewed that
metal ions do not need to be directly coordinated to the atoms participating
in catalysis but they can exert their influence also from a long distance [41],
strengthening the hypothesis that ribozymes are in fact metalloenzymes.
Along the same line, dependence of the reaction rate on metal ion con-
centration has been shown for large ribozymes, and it has recently been
reviewed how ribozyme activity can be tuned by metal ions [42]. A distinction
between the structural and catalytic role of metal ions is not always straight-
forward as these two processes are directly linked to each other: many spec-
troscopic and biochemical methods have been developed in order to distinguish
the multiple roles of metal ions in small and large ribozymes, each of them
providing different information [43–45] (see also Chapter 2 of this volume).
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In Chapter 6 of this volume, the interaction of metal ions with small
ribozymes is extensively described; Chapter 8 deals with the spliceosome, and
Chapter 9 with the ribosome. The present chapter provides a concise over-
view on the role played by metal ions in large ribozymes, i.e., group I and II
introns and RNase P (Figure 1), as it is emerging from recent X-ray crystal
structure data. Indeed, the first X-ray structure of a group II intron ribozyme
from Oceanobacillus iheyensis by Pyle and coworkers in 2008 [46] gave a first
picture of this class of large ribozymes. Moreover, due to the similarity of
group II intron ribozymes to the eukaryotic spliceosome, the recently solved
crystal structure allows to extend theories and hypotheses concerning the
spliceosome structure and function [47–51] (see also Chapter 8).
This chapter is divided into four parts, followed by short concluding
remarks. In the first part a brief basic description of the role of metal ions in
folding and catalysis of RNAs is given. The following three parts are dedi-
cated to the three known large ribozymes, group I and II introns and RNase
P, respectively (Figure 1). A strong focus will be directed to studies reported
in the last few years, in order to confirm (or not) the already established
properties of these fascinating molecules.
2. METAL IONS IN FOLDING AND CATALYSIS:
A BRIEF OVERVIEW
2.1. Folding Pathways
In the last few years many papers, reviews, and book chapters have focused
on the understanding of the thermodynamic and kinetic aspects of RNA
folding [14,52–55].
Figure 1. Schematic secondary structures of (a) group I and (b) group II intron
ribozymes, as well as (c) RNAse P.
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RNA folding is generally hierarchical, meaning that the tertiary structure
formation takes place only after the secondary structure has been established
[55,56] (Figure 2). The secondary structure comprises all the hydrogen
bonded base pairs within the RNA sequence (the helical/stem part) as well as
the unpaired nucleotides, arranged in loops and bulges. On the other hand,
the tertiary structure describes all three-dimensional contacts that normally
take place between various secondary structure elements [57,58]. One of the
most common tertiary contacts in RNA architecture is the so-called tetra-
loop/tetraloop receptor interaction, which has been found to be extremely
dependent on metal ion concentration [59].
The secondary structure is usually stable in a large variety of experimental
conditions and normally requires only monovalent ions in concentrations
ranging from 50 to 100mM. Because of the electrostatic repulsions within
the phosphodiester backbone, the absence of metal ions hampers the for-
mation of a secondary structure, but a very low ionic strength, less than
1mM, is mostly enough to allow the formation of the secondary structure.
The folding landscape to the active tertiary structure, usually reached only in
the presence of divalent metal ions, is quite rugged for many RNA mole-
cules: many intermediates can occur before the molecule adopts the active
form, and the rate of unfolding of these off-pathway intermediates (kinetic
traps) determines the effectiveness of the folding [60]. Interestingly, it has
been shown that several RNA molecules follow a folding pathway without
kinetic traps [61,62].
K1 is the most common among the monovalent metal ions used in vitro
[63], and only in a few cases it is substituted by Na1 and Li1 [64]. Whereas
monovalent metal ions are needed for formation of the secondary structure,
divalent metal ions are essential to reach the tertiary structure (Figure 2),
and only rarely they can be substituted by a molar concentration of
monovalent metal ions [22]. Compared to monovalent metal ions, fewer
Figure 2. Cartoon representing the folding pathway of large RNAs. Starting from a
single strand structure, monovalent metal ions acting as charge screening units allow
the establishment of the secondary structure. Tertiary contacts promoted by divalent
metal ions lead to the folding into the compact tertiary structure (adapted from [22]).
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di/multivalent metal ions are needed to compensate the high negative charge
accumulated in specific regions of folded RNA, as originally predicted by
the counterion condensation theory developed by Manning [65].
The most common divalent metal ion found as cofactor both in folding
and catalysis (see below) is Mg21. This ion is very abundant in nature and
plays the role of a cofactor in many biomacromolecules. In a few cases, it can
be replaced by Ca21, Mn21, Zn21, Cd21, and Pb21, but it remains unique in
its way of interaction with RNA, that makes it the best candidate for RNA
folding (and catalysis, see below). Mg21 can interact with RNA in three
different ways: (i) by simply screening the negative charge through electro-
static interactions, (ii) by creating a net of hydrogen bonds between its
coordinated water molecules and specific RNA motifs in so-called outer-
sphere interactions, (iii) by directly interacting with phosphoryl oxygens,
purine N7, guanosine O6, uracil O4, and ribose 20-OH sites, through so-
called innersphere interaction. For a more detailed description of the dif-
ferent metal ion binding modes refer to Chapter 1 of the present volume.
Being a divalent ion, Mg21 better satisfies the requirements for positive
charges within folded RNAs compared to monovalent metal ions [66].
Moreover, small cations usually provide better stabilization of the phos-
phate sugar backbone by packing it more closely [67].
In folded RNA, metal ions are normally found in the major groove, where
a significant negative charge is accumulated [68]. In RNA tertiary structure
many specific RNA-binding motifs have been identified. Among them are
the tandem G–U pair motif [18], the loop E motif (particularly suitable for
Mg21 binding) [69], and the A platform motif (specific for K1 binding) [23]
(see also Chapter 1).
The presence of Mg21 in the active site of many ribozymes, as postulated
by biochemical studies and confirmed by crystallographic data (see below),
explains why the active tertiary structure is often established only in the
presence of Mg21. It also suggests that, very often, structural and catalytic
roles of metal ions are hardly separable.
2.2. Metal Ion Involvement in Catalysis
Large ribozymes catalyze trans-esterification reactions (Figure 3) through
a SN2 mechanism that yields the formation of a 5
0-phosphate and a
30-hydroxyl terminus in the first step. The reaction is accompanied by a
configuration inversion of the non-bridging phosphate oxygens that are
stereochemically distinct. The nucleophile employed in the reaction is dif-
ferent for each type of ribozyme. Group I and II introns perform two sub-
sequent trans-esterification reactions that end up with the ligation of two
exons and the excision of the intron. These reactions can be accelerated by
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the presence of metal ions. But which metal ions show the best performances
in catalysis of biological relevance? Mg21, together with Na1, K1, and Ca21
are the most abundant metal ions in cells. Mn21 has similar physico-che-
mical properties as Mg21, but it is not as abundant as the latter and it can
also be redox-active. Metal ions are normally needed at millimolar con-
centration in order to perform a structural and/or a catalytic role, therefore
their solubility in water at neutral pH is important, and a large number of
metal ions are thus excluded from the use in catalysis under biological
conditions. A metal ion involved in catalysis should be able to coordinate,
stabilize, and activate different ligands, with kinetic and thermodynamic
properties that match with the catalyzed reaction. To act as catalyst, a metal
ion must form a thermodynamically favorable interaction with the ligand
but at the same time it must be sufficiently dynamic to adapt to the coor-
dination requirements within the catalytic reaction pathway. Depending on
the kinetics of ligand exchange, metal ions have been divided into three
groups (see for example [45]). The metals in the first and the third group
show too high or too low mobility, respectively, to be active in catalysis. The
majority of alkali and alkaline earth metals belongs to the first group, whilst
metal ions like Al31, Be21, Cr31, and Co31 belong to the third group. The
second group contains those metal ions whose exchange rates (kex(H2O)) fall
into an intermediate range, and Mg21 is one of them.
Another important parameter to consider when describing metal ions is
their binding affinity to different ligands. In general, metals can be grouped
Figure 3. Phosphodiester transfer reaction catalyzed by large ribozymes. (a) The
nucleophile (Nuc-OH) attacks the scissile phosphate. (b) The transition state is sta-
bilized by the presence of two metal ions: one activates the nucleophile while the
other stabilizes the leaving group, following a ‘‘two-metal-ion mechanism’’. (c) A 50-
phosphate and a 30-hydroxyl terminus are formed.
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into two classes: the hard and the soft ones. The hard metals, small and
difficult to polarize, preferentially interact with hard ligands, such as oxygen
sites. On the other hand, the soft ones, being large and easily polarizable,
prefer, e.g., sulfur residues. The biologically relevant metal ions Na1, K1,
Mg21, and Ca21 belong to the first class, and are consequently good part-
ners for interactions with the hard phosphate oxygens within the active site
of the ribozymes. Nevertheless, the overall physico-chemical properties of
Mg21 make it the best adapted cofactor for catalysis performed by large
ribozymes.
The role of metal ions in enhancing catalysis has been extensively studied
[10,11,45]. For this reason, only the different ways of action of metal ions
in ribozyme catalysis are described shortly here. There are two methods
by which metal ions enhance catalysis in large ribozymes: a direct and an
indirect way. The direct way consists of four different subgroups. Accord-
ingly, metal ions can intervene by (i) stabilization of the leaving group, (ii)
activation of the nucleophile, (iii) coordination to the non-bridging phos-
phoryl oxygen, and (iv) a concurrent interaction with the nucleophile and
the non-bridging phosphoryl oxygen. An accurate localization of the metal
ions within the catalytic core (i.e., a description of their coordination
pattern) allows to understand how these metal ions facilitate splicing. Both,
biochemical and structural data indicate the simultaneous presence of two or
three catalytic metal ions within the active core of large ribozymes (see
below). Up to now, the best mechanistic description of how these metal ions
participate in catalysis is the ‘‘two-metal-ion mechanism’’, proposed to be
valid also for ribozymes in 1993 by T. A. Steitz and J. A. Steitz [37].
In this mechanism one metal ion is responsible for the activation of the
entering nucleophile while the other stabilizes the leaving group, in a general
acid–base catalysis (Figure 3). In the case of ribozymes, the coordination of
Mg21 to the oxygens at the active site should activate the nucleophile and
stabilize the scissile phosphate group, while the other Mg21 should screen
and stabilize the negative charge of the leaving group.
Finally, the indirect effect of metal ions in catalysis also deserves men-
tioning. It was shown that breaking a metal–RNA interaction can lead to a
strong decrease in the catalytic activity, even if the metal is far away from the
active site [23,70]. In a recent review [41] the authors invite the readers to
broaden the definition of metal ion-assisted catalysis. In addition to the
direct coordination of divalent metal ions in catalysis, they list at least three
other mechanisms by which metal ions can assist and enhance catalysis:
(i) they can perform electrostatic and structural stabilization of the transi-
tion state via outersphere interactions; (ii) they can stabilize the transition
state by long-range electrostatic contacts, and (iii) they can stimulate the
shift of the pKa of some nucleotides, thereby rendering nucleobases or sugar
residues able to actively participate in catalysis. In principle, given the latter
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three ways of interaction, the catalytic role of divalent metal ions could
be fulfilled by different cations, including monovalent metal ions or poly-
amines. Nevertheless, it is probable that ribozymes preferentially employ
Mg21 (1–2mM) and K1 (around 100mM), being the most abundant metal
ions within the cell, by using different mechanisms.
Mg21 is considered the natural cofactor of large ribozymes, but in a few
cases it can be substituted by other divalent ions. This substitution causes
a modification in ribozyme activity, but rarely clear correlations between
the physico-chemical properties of the metal ions and the activity of the
ribozymes have been found [42]. Such a correlation, as found for the
Hammerhead ribozyme [42], allows to better understand the mechanism
employed by different metal ions in catalysis.
3. GROUP I INTRON RIBOZYMES
3.1. General Remarks on Group I Introns
Introns are non-coding sequences of a pre-RNA that need to be removed
from the primary transcript to yield a functional RNA. Most genes are in
fact primarily transcribed into RNA precursors that contain both coding
and non-coding sequences. The non-coding sequences must be removed in
order to obtain the mature RNAs. Several genes can contain different
introns, and the alternative splicing of these introns is one reason for the
incredible complexity of the eukaryotic system [48]. Group I introns are self-
splicing introns, i.e., large ribozymes discovered more than twenty years ago
that are able to splice themselves without the aid of a protein. They occur
naturally in bacteria and bacteriophages [71], but also in the mitochondria of
some animals [3].
Self-splicing introns are extremely interesting: they can migrate, inserting
themselves at different positions of the host genome, thereby becoming
mobile genetic elements responsible for genome diversification [72–75]. In
this sense, they could potentially be engineered and used for biomedical
applications [76]. Moreover, their existence strengthens the hypothesis of the
‘‘RNA world’’: a single molecule able to transport genetic information and
to perform chemical reactions [77].
The first group I intron ribozyme (Tetrahymena thermophila) was dis-
covered in 1982, by Cech and coworkers, and in 1986 it was shown to be a
true metalloenzyme [78,79]. Group I intron ribozymes are abundant in
nature: more than 2000 sequences have been discovered so far [80]. In spite
of the poor sequence conservation, group I introns have been classified into
13 subgroups [80].
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They generally comprise 200–1500 nucleotides and present a secondary
structure which consists of ten base-paired elements (P1–P10) capped by
loops and connected by junctions (Figure 1a). Two helical domains can be
recognized, P4–P6 and P3–P9, while the region P1, where the 50-splice site is
located, docks at the interface between the two domains. Helix P10 is formed
after the first step of splicing [80,81].
Group I intron splicing consists of two subsequent trans-esterification
reactions between which a conformational change occurs. They use an
exogenous guanosine or guanosine triphosphate as nucleophile to cleave the
50-splice site (Figure 4). In the first splicing step, the 30-OH of the external
guanosine attacks the phosphodiester bond at the 50-splice site, at the P1 site.
A conserved G–U wobble pair located in P1 contributes to the recognition
of the 50-splice site. Helix P10 is formed after the first step of splicing and
includes base pairs between the intron and the 30-exon. After an internal
rearrangement, a second trans-esterification reaction leads to the excision of
the intron and the re-ligation of the adjacent exons.
Figure 4. Schematic representation of the self-splicing of group I intron ribozymes.
An external guanosine (oG; shown in red) acts as the nucleophile in the first step of
the splicing. After a conformational change, the conserved 30-terminal nucleotide
of the intron (OG in the text) replaces oG in the binding pocket and prepares the
30-exon for ligation. The second trans-esterification leads to the ligation of the two
exons and the excision of the intron (adapted from [2]).
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Recent studies have provided many data and information on the
mechanism of folding and catalysis [80–82]. As expected, group I introns
require divalent metal ions for both correct folding and catalysis [18–20,
83–88]. In the last twenty years, much research was dedicated to the eluci-
dation of crystal structures of group I intron ribozymes to obtain further
insights into both structure and activity and to verify the data coming from
biochemical studies. Between 2004 and 2005, three different groups solved
crystal structures of group I introns, originating from different organisms.
The structures of group I introns from the purple bacterium Azoarcus
[24,89], the ciliate Tetrahymena thermophila [90], and the Staphylococcus
aureus bacteriophage Twort [91] were published. Further studies were per-
formed by Lipchock and Strobel, in order to crystallize the intron at dif-
ferent stages of the splicing/ligation process [92]. A close analysis of these
structures together with the already available data from the crystal structure
of the non-catalytic P4–P6 domain [93] of Tetrahymena thermophila allowed
to understand the organization of the molecule around its catalytic core, as
well as to elucidate the role of metal ions in this complex picture [80,82] (see
also Section 3.3).
3.2. Metal Ions in Folding
The role of metal ions in folding and stabilization of the tertiary structure of
the group I introns is by now universally acknowledged [14,81]. For exam-
ple, it was shown that the Tetrahymena group I intron folds very slowly
in the presence of Mg21 from an unfolded state, at low ionic strength, but, if
the ribozyme is pre-folded in the presence of Na1, the Mg21-mediated
refolding is very fast [94]. In the case of the Azoarcus group I intron, sub-
millimolar concentrations of Mg21 are sufficient for the assembly of the
internal helices, while millimolar concentrations of Mg21 are required for
tertiary structure stabilization. This amount of Mg21 almost coincides with
activity requirements [95]. It was also shown that, even if many cations could
promote folding and assembly, no active tertiary structure was formed in the
absence of Mg21 [84].
Recently, the influence of the divalent alkaline earth ions in the folding of
the Tetrahymena group I intron by non-denaturing gel electrophoresis and
Brownian dynamic simulations was described [85]. The authors show that
the stabilization of the RNA tertiary structure can be described in terms
of charge density of the cation used as cofactor. This parameter indeed
accounts for both the ability of the metal ion to approach the negatively
charged RNA (electrostatic effects) and the excluded volume between the
cations. The higher the charge density is, the better is the stabilization. Con-
sequently, the ribozyme is better stabilized by the small Mg21. The authors
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suggest that non-specific polyelectrolyte effects play a crucial role in folding
and recommend to the readers to take into account size and shape of the
cations in the stabilization of RNA tertiary structures. These findings con-
firm previous studies in which metal ions were replaced by polyamines [96].
In a successive paper [97], the same authors studied the counterion-
dependent collapse of Azoarcus and Tetrahymena group I introns by means
of small-angle X-ray scattering (SAXS). This technique allows to follow
changes in size and shape of biomolecules. They evaluated the variation of
the radius of gyration of the two ribozymes in the presence of several metal
ions at different concentrations confirming the folding pathways of the
two ribozymes: the Tetrahymena group I intron follows a three-state model
(the native structure is reached through metastable misfolded intermediates)
[97–99] while the folding of the smaller Azoarcus group I intron can be
approximated with a two-state reaction, where the native state is reached
through a compact native-like intermediate [95,97]. This means that in the
latter case the neutralization of the negative charge of the phosphate
backbone and the formation of tertiary contacts take place almost simul-
taneously. In general, for both RNAs, the collapse to the native state
becomes more cooperative with the increase of the charge density of
the counterions. But, due to different folding mechanisms, the collapse of the
Azoarcus group I intron is less sensitive to the differences among the various
metal ions used, while the second transition to the native state of the
Tetrahymena group I intron is strongly affected by size and valence of the
counterions, being favored by Mg21 and Ca21more than by Sr21 and Ba21.
This is most likely due to Mg21 being specifically bound to certain structural
motifs. Nevertheless, the authors point out that even if polyelectrolyte effects
represent a strong driving force in RNA compaction, there are cases in
which direct coordination of metal ions within specific sites of RNA
determine the formation of a compact structure [97].
The folding pathways of the Azoarcus group I intron was additionally
examined in detail by means of SAXS [100]. It was confirmed that collapse
and tertiary folding for the Azoarcus ribozyme occur within almost the same
time-scales, but it also emerged that heterogeneity of folding kinetics
strongly depends on Mg21 concentration.
The data derived from X-ray structures support the evidence of the
structural role played by Mg21 (Figure 5). In the following we will discuss
this point using the example of the Azoarcus bacterial group I intron in
complex with its 5’- and 3’-exons [20]. The crystal structure of the Azoarcus
group I intron was obtained in two different ways and solved at two different
resolutions (3.1 and 3.4 A˚, Figure 5) [24,89]. Analysis of the structures
reveals the presence of eighteen specifically bound K1 and Mg21 ions. In
particular, five of the observed metal ions are located within the center of the
ribozyme, interacting with sugar and phosphate oxygen atoms mainly
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through innersphere coordination, and comprise biochemically relevant
contacts. These five metals can be described as a ‘‘metal ion core’’ of the
intron, as they lie within 12 A˚ of the scissile phosphate. M1 and M2,
described as catalytic metal ions on the basis of biochemical data, are located
close to the scissile phosphodiester and are found to be important to activate
the substrate, stabilize the transition state, and form the architecture of the
active site. Their catalytic activity was confirmed by the observation that the
breaking of the direct contacts between these metal ions and the RNA via
sulfur or amino substitutions caused a strong decrease in the splicing
activity. The other three metals are not directly positioned in the active site
but they have been found to be important for activity. Concerning the other
metal ions, contacts to different regions of the helices were found. The
coordination of the eighteen metal ions found in the structure can be sum-
marized as follows: six of them are coordinated to two or more secondary
Figure 5. Crystal structure of the Azoarcus group I intron. (a) The pre-2S deoxy-OG
structure (3.1 A˚ resolution) shows the intron with its exons before the second step of
splicing (pre-2S) [89]. The colored spheres indicate metal ions: K1 (purple) and Mg21
(green). (b) Active site with two metal ions M1 and M2 in the crystal structure of the
pre–2S ribo–OG Azoarcus group I intron (3.4 A˚ resolution). The 20-OH of the OG is
decisive for binding of M2. Inner sphere metal coordination is shown with dashed
lines [24]. The two Mg21 ions are 3.9 A˚ apart, suggesting a ‘‘two-metal-ion
mechanism’’. With the exception of the catalytic center, the location of the metal ions
within the two structures agrees quite well [20]. The 50-exon is indicated in yellow, the
30-exon in blue and the coordinating oxygens as red spheres. The arrow indicates the
scissile phosphate bond. The figures were prepared with MOLMOL [187] using PDB
ID 1U6B for (a) and 1ZZN for (b).
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structure elements and are responsible for tertiary contacts between distinct
parts of the intron; the others are either directly coordinated to phosphate
oxygens in the backbone or positioned in the negative major groove. It is
also worth noting that K1 and Mg21 interact in a different manner with the
RNA. Whereas K1 mostly binds innersphere, Mg21 coordinates to
uncharged functional groups through a water molecule. Interestingly, the
two Mg21 ions within the catalytic region each show five innersphere
interactions (see Figure 5). The involvement of these two metal ions in
catalysis is discussed in the following section.
3.3. Metal Ions in Catalysis
Large ribozymes need divalent metal ions in order to perform splicing. Even
though Mg21 remains the most important cofactor for both folding and
catalysis, it has been shown that the activity of the Tetrahymena group I
intron is maintained in the presence of either Mg21 or Mn21 [83]. In con-
trast, Ca21 only promotes folding, but does not support catalytic activity
[98]. Even more interesting, it is possible to properly engineer in vitro both
the Tetrahymena [101,102] and Azoarcus [103] group I introns in a way that
they selectively require Ca21 in splicing.
In Section 2.2, the ‘‘two-metal-ion mechanism’’ responsible for catalysis of
protein enzymes involved in phosphoryl transfer processes has been descri-
bed. The analysis of the numerous data acquired by biochemical experiments
on the Tetrahymena group I intron confirms the overall picture of a
‘‘two-metal-ion mechanism’’, but adds the possibility of the involvement of a
third metal in the active site [86–88]. The scheme of actions of the three
metals in the active site is illustrated in Figure 6a: MB activates the endo-
genous guanosine that acts as nucleophile; MA neutralizes the charge of
the leaving group while MC stabilizes the geometry of the active site.
Thio-rescue experiments on the Tetrahymena group I intron helped to
identify the coordination sphere of each of the three metal ions. MB coor-
dinates to the 30-OH nucleophile of the attacking guanosine; MA binds the
30-oxygen of the leaving group, as well as the pro-Sp non-bridging oxygen of
the scissile phosphate; finally, MC coordinates to the 2
0-OH of the guano-
sine, as well as the pro-Sp non-bridging oxygen of the scissile phosphate
(Figure 6a). In contrast, the X-ray structural data suggest that the active site
contains less than three metal ions [24,92] (Figure 5). In this regard, it is
worth noting that the catalytic core of the first X-ray structures published of
the group I introns from Tetrahymena [90], Twort [91], and deoxy-OG
Azoarcus [89] contained only one of the two catalytic Mg21 ions [82].
In both the Tetrahymena and Twort group I introns crystal structures the
scissile phosphate is missing. Nevertheless, in the Tetrahymena group I
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intron the found metal ion is located very closely to both O20 and O30 of OG
(conserved terminal nucleotide of the intron) in two of the four molecules of
the asymmetric unit [90], suggesting that it shares the characteristics of both
MB and MC. On the other hand, in the Twort group I intron the metal ion in
the active site seems to be the biochemically identified MA [91]. In the crystal
structure of the Azoarcus group I intron published by Stahley and Strobel in
2005 [24], the presence of two Mg21 in the active site strongly supports
the ‘‘two-metal-ion mechanism’’ of catalysis. In fact, the distance between
the two metal ions is 3.9 A˚ and their coordination sphere resembles the one
observed for RNA and DNA polymerases. These two metal ions, M1 and
M2 (see Figure 5), fulfill all the biochemical requirements: M1 binds the
nucleophile of the second step of the splicing and can be described as the
biochemically termed MA; M2 shares characteristics of both MB and MC,
including coordination of O30 and O20 of OG. It has also been suggested that
M2 could be assigned to MC, and possible explanations for the lack of MB in
the active site have been proposed [45]. For example, (i) the metal absent in
the crystal structure could be weakly bound to the catalytic core and con-
sequently cannot be accurately located; (ii) the arrangement of the catalytic
Figure 6. Transition state models for the splicing/cleavage of the three large ribo-
zymes, as derived from biochemical studies. (a) Group I introns. The model is based
on biochemical investigations on the Tetrahymena ribozyme, which employs the
oligonucleotide CCCUCU3’xA as substrate, where X is either oxygen or sulfur, under
reaction conditions that mimic the first step of splicing [87,88]. (b) Transition state of
the second step of splicing as inferred by biochemical experiments on the yeast
mitochondrial group II intron Sc.ai5g [148]. (c) Transition state model for the
hydrolysis of the scissile phosphate of pre-tRNA catalyzed by RNase P, as deduced
by several biochemical studies [155,156]. Most of the Mg21 interactions have not yet
been confirmed.
211MULTIPLE ROLES OF METAL IONS IN LARGE RIBOZYMES
Met. Ions Life Sci. 2011, 9, 197–234
site within the crystal structure is incompatible with the binding of the third
metal ion.
Recently, Lipchock and Strobel published three new crystal structures of
the Azoarcus group I intron [92]. One crystal structure comprises the intron in
the presence of the spliced exons, while the other two structures shed light on
the role of metal ions in the active site during the second step of splicing. They
observed that a relaxed active site is obtained after ligation, in which metal ion
coordination is lost but tertiary interactions between the exon and the intron
are maintained. Interestingly, in all three structures they observed the presence
of M1 and M2 in the active site. The detailed analysis of the crystal data,
supported by additional biochemical experiments, lead the authors to suggest
the presence of a change in the substrate–metal coordination preceding the
release of ligated exons. These findings create the foundation for a revised
model of substrate binding and docking, giving new insights into the com-
plicated and intriguing landscape of group I introns splicing mechanism.
In general, structural and biochemical data on group I introns correlate
quite well. As shown above, the localization of metal ions in the crystal
structures of group I intron ribozymes confirmed their expected role in both
folding and catalysis of these complex molecular machines.
Due to the increasing number of crystal structures of different group I
introns from different organisms, the interest in defining more accurately the
catalytic core of these ribozymes continues, resulting in new findings.
Recently, Piccirilli, Herschlag, and coworkers analyzed in detail the nature
of the active site of the Tetrahymena group I intron by means of double-
mutant cycles [104,105]. The different crystal structures available show a
different architecture around the 20-OH group of the conserved residue
adenosine A261 (numbering in Tetrahymena), whose involvement in cata-
lysis has been demonstrated in the past [106]. With the use of the double-
mutant cycles the authors could prove which of the interactions involving
the 20-OH group of A261 and the guanosine nucleophile are involved in
catalysis. The hydrogen bond interaction between the 20-OH group of A261
and the NH2 group of the guanosine, that is formed not immediately after
guanosine binding but during the catalytic cycle, seems to be of particular
importance. Finally, they proved its role in the structural organization of the
active site of the ribozyme before catalysis.
4. GROUP II INTRON RIBOZYMES
4.1. General Remarks on Group II Introns
Group II intron ribozymes are the second class of large self-splicing mole-
cules. They are second in size only to ribosomal RNA and were identified as
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an independent class in 1982 [107]. Their length varies from 600 to about
2500 nucleotides, and they are found primarily in organellar genes of plants,
fungi, bacteria, and lower eukaryotes [108,109]. Recently, a group II intron
was found in an animal mitochondria genome [110]. Based on the conserved
features of their secondary structure, most group II introns can be further
classified into two subclasses, IIA and IIB, which can be divided again
into smaller groups [73,111,112]. More recently, a new class was identified,
the bacterial class IIC [112]. Generally, group II introns of this latter class
are smaller and thought to be the most primitive group II introns [46].
Moreover, they exhibit differences with respect to the other two classes
in terms of exon/intron binding site interaction and the self-splicing pathway
in vitro [113]. In general, these group II introns can efficiently self-splice
in vitro in the presence of high concentrations of metal ions [108], which are
needed for the folding process and for the stabilization of the tertiary
structure [108]. However, recently it was shown that only low Mg21 con-
centrations are sufficient to fold the yeast mitochondrial group II intron
Sc.ai5g (from Saccharomyces cerevisiae) if the natural protein cofactor
Mss116 is present in vitro [114]. On the other hand, in vivo group II introns
require protein cofactors for both the splicing [74,108] and the stabilization
of the tertiary structure [115].
Group II introns are phylogenetically related to a large part of the human
genome [116] and are considered to be direct ancestors of the eukaryotic
spliceosome [47,117], which is responsible for the splicing of nuclear pre-
mRNA. The role of metal ions in folding and activity of this fascinating
molecular machine is reviewed in Chapter 8 of this volume.
The primary sequence of group II intron ribozymes is not well conserved,
but biochemical and mutational studies show that these ribozymes are
formed by a conserved set of six domains, that contain well-defined sec-
ondary structure elements [109,111,112,118] (Figure 1b). These six domains
fold independently [119]: when the individual domains are added together
in trans (i.e., not covalently bound) in the presence of the right amount of
metal ions they fold into the active tertiary structure [120]. Any of the six
domains has its own function within the molecule [121]. Domain 1 (D1) is
the largest one; it is an independent folding unit and provides the scaffold for
docking of the other domains. Its folding is the rate determining step for the
folding of the entire ribozyme. Moreover, D1 recognizes the correct splice
sites. This domain is normally divided into four subdomains and it contains
regions forming tertiary contacts important for catalysis. The docking
between D1 and domain 5 (D5) represents the minimal structure necessary
for catalytic activity. D5 is the most conserved domain: it adopts the form of
a stable hairpin capped with a well known GNRA tetraloop motif [122]. The
interaction between D5 and the central core of D1 through the z–z’ and k–k’
contacts is essential for catalytic activity. Domains 2 (D2) and 3 (D3) play a
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secondary role with respect to D1 and D5 in both folding and catalysis.
Nevertheless, D2 stabilizes the folding of the entire ribozyme and D3
increases the rate of catalysis. Domain 4 (D4) does not contribute to splicing
but can contain an open reading frame that can encode a maturase protein,
possibly useful for splicing and intron mobility in vivo [75]. Finally, domain 6
(D6) contains the conserved bulged adenosine that acts as the nucleophile
during the first step of splicing.
Like group I introns, also group II introns perform self-splicing by two
sequential trans-esterification reactions. But, in contrast to group I introns,
they use the 20-OH of an internal adenosine as the nucleophile in the first
step of the splicing, the so-called branch point adenosine. This 20-OH attacks
the scissile phosphate bond at the 50-splice site in a SN2-type reaction. It has
been shown that this reversible step represents the rate determining step of
the self-splicing reaction [123]. The released 50-exon remains in contact
with the intron through base pairs involving a different region of D1. In the
second step of splicing, the 30-OH terminus of the 50-exon attacks the
phosphate at the 30-splice site. In this way, the intron is released in the form
of a lariat, resembling the mechanism of splicing of the eukaryotic spliceo-
some (Figure 7). When the branch adenosine is missing, a water molecule
can act as nucleophile [117]. This hydrolytic pathway has been observed to
work also in vivo. The splicing reaction is fully reversible, making these
molecules mobile genetic elements [74,75]. This is also reflected by their
Figure 7. (a) Self-splicing mechanism of group II intron ribozymes. In the first step,
the internal branch adenosine acts as a nucleophile attacking the scissile phosphate
bond at the 50-splice site via a SN2 mechanism. In the second step, the two exons are
ligated and the intron is excised as a lariat. (b) This splicing mechanism resembles the
one performed by the eukaryotic spliceosome, in which the excision of the introns
and the ligation of the exons are reached by the cooperative work of five RNAs and
several proteins (adapted from [22]).
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relationship with the spliceosome, various components of telomerase and the
LINE-element form of the transposons [25,74,116].
4.2. Metal Ions in Folding
The folding process of group II introns is strongly dependent on metal ions:
monovalent (usually Na1 and K1) as well as divalent metal ions (Mg21) are
intrinsically tied to RNA for charge compensation, while specifically inter-
acting metal ions have been proposed to play a direct role in catalysis [46].
Noteworthy, different group II introns originating from several organisms
require different amounts of metal ions in vitro for proper folding and
catalysis, despite their conserved secondary structure: up to 2 M K1 and
between 0.1 and 100mM Mg21 (Table 1).
One of the best examined group II intron constructs is the so called D135
ribozyme, a shortened construct of the yeast mitochondrial intron Sc.ai5g,
comprising only domains 1, 3, and 5 [62]. It was shown that the folding of
the model D135 ribozyme is rapid at 100mM Mg21 concentration while it
is very slow at physiological Mg21 concentration (2–3mM) [124,125]. The
D135 ribozyme folds into a discrete tertiary structure via a direct pathway
without kinetic traps [126]. The collapse of D1 is the rate determining step
in this folding process [127], and strongly depends on metal ion concentra-
tion. Biochemical studies allowed to identify the crucial tertiary contacts
responsible for folding and to locate metal ions in specific positions. In
particular, it was found that the k–z element is a divalent ion binding pocket
that behaves as a Mg21-dependent switch responsible for the initiation of
D135 folding [126,128]. It has also been shown that the amount of Mg21
needed for folding is not affected by the presence of 0.5MKCl. It seems that
monovalent ions do not compete with Mg21 binding sites, suggesting a high
level of specificity of the metal ion binding sites of D135 [127]. The folding of
D135 is reversible: i.e., the urea-denaturated state can be refolded in the
presence of the right amount of Mg21 [125]. These findings are in line with a
two-state folding pathway [125] that does not include kinetic traps. This is
intriguing considering the complexity of these large molecules and contrasts
with the rugged folding pathways followed by the other large ribozymes.
A recent review [54] analyzes in detail the folding landscape of group II
introns comparing the folding pathways in non-physiological and at near-
physiological conditions, as well as describing the role of proteins that
facilitate folding in vivo. The authors finally propose the folding strategy
used by group II introns as a model for the folding of large RNAs.
Recently Sigel, Rueda, and coworkers [129] used single molecule Fo¨rster
resonance energy transfer (smFRET) to study the influence of Mg21 in the
folding of the D135 ribozyme. They confirm that the folding takes place
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without kinetic traps and identify previously not characterized on-pathway
folding intermediates. D135 folds to a more stable near-native state, from
which the active structure is reached by substrate binding. The folding of
D135 strongly depends on Mg21 concentration and the increase of Mg21
concentration causes structural dynamics that allows the establishment of
the folded active state. In a successive work, the same authors studied with
the same technique the influence of Ca21 in the folding pathway of D135
[130]. It was found that Ca21 perturbs the global 3D architecture of this
molecule, besides creating two distinctly different subpopulations that can-
not switch between each other [130].
4.3. Metal Ion Binding Sites
Specifically interacting metal ions can both stabilize the tertiary structure and
directly participate in the self-splicing reaction. By means of Tb31-mediated
cleavage (see Chapter 2) metal ion binding sites could be located in domains 1,
2, 5, and 6 of the yeast mitochondrial group II intron Sc.ai5g [131]. The
majority of the binding sites is located within the core of the active tertiary
structure of the intron, including the bulge of the catalytic D5. Some other
metals are assumed to play a structural role, as they appear in regions critical
for the achievement of the tertiary structure. Successive work performed on
the bI1 group II intron showed the existence of a Mg21 binding site close to
the branching adenosine of D6, responsible for the first step of splicing [132].
Further on, interesting insights on the localization of metal ions in the
structure of single domains coming from NMR technique were published
recently. In the last few years NMR has established itself as a powerful
method to determine RNA structures [133–135]. Also the detection of metal
ion binding sites is possible by using NMR-active isotopes [136], mimicking
ions [137] or paramagnetic ions [138].
Sigel and coworkers recently described the solution structure of domain 6
of the yeast mitochondrial group II intron Sc.ai5g [139]. They studied the
truncated but catalytically active construct derived from the wild-type D6
sequence, in which the internal loop is missing (Figure 8). The splicing
activity with this shortened D6-27 was only slightly reduced, confirming the
recent hypothesis on the branching mechanism [140]. Based on the NMR
solution structure at least four or five Mg21 were localized by Mg21 titra-
tions studies. These ions are specifically bound at different positions in D6-
27: one at the 50-end of the hairpin, one at the tandem C–G base pair in
helix 1, one in the branch region, and one or two in the tetraloop (Figure 8).
Interestingly, both NMR and fluorescence studies show that the local
structure of the branch point does not change upon metal binding. They also
determined the intrinsic affinities of the different Mg21 ions coordinated to
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D6-27 [141]. In a successive recent publication they used 15N NMR to define
the coordination sphere of the metal ions coordinated in D6-27 [142]. Despite
the intrinsic lability of Mg21 coordination, that hampers solution studies, they
found a direct innersphere interaction betweenMg21 and N7 of a purine in the
tetraloop. Concerning the critical Mg21 located in the adenosine branch point,
the authors suggest a specific outersphere contact between [Mg(H2O)6]
21 and
the flanking G–U wobble close to the branch adenosine, but no direct inter-
action between Mg21 and the adenine N7. As a consequence, the branch
adenosine is more free to act as a nucleophile, the long-range electrostatic
interaction with the close Mg21 possibly helping to activate it [41].
A similar approach, based on NMR, was used to prove that micromolar
amounts of Mg21 or Cd21 promote the formation of the 50-splice site
recognition complex. It was shown that, irrespective of the nature of the
ions, divalent metal ions are needed to promote the formation of the EBS1
(exon binding site 1)–IBS1 (intron binding site 1) complex. Circular
dichroism spectroscopy was used to prove the efficiency of monovalent
metal ions in the EBS1–IBS1 docking [143].
4.4. Metal Ion-Promoted Activity
The presence of Mg21 is crucial for the activity of group II introns, and no
other divalent metal ion has shown a better performance in catalysis of these
Figure 8. (a) Secondary structure of the shortened domain 6 of the yeast mito-
chondrial group II intron Sc.ai5g (D6-27) used for the experiments described in
[139,141,142]. The branch adenosine is indicated in red. (b) Tertiary structure of D6-
27 with the Mg21 ions in green as emerged from NMR investigations. This figure was
prepared with MOLMOL [187] using PDB ID 2AHT.
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ribozymes [42]. Along the same line as for the folding process, the require-
ment of Mg21 in catalysis varies among different group II introns (Table 1).
Just to cite an example, although being encoded on the same RNA strand,
the Pl.lsu/2 is active at very low concentration of Mg21 (about 0.1mM),
while Pl.lsu/1 needs at least 100 mM Mg21 to effectively carry out catalysis
in vitro (Table 1 in Section 4.2). Although Mg21 is the natural cofactor for
ribozyme catalysis, it can be partially substituted by Mn21 [123]. However,
in general, no enhancement in catalysis has been observed by replacing
Mg21 with other divalent metal ions. A recent publication dealing with the
splicing of the yeast mitochondrial group II intron Sc.ai5g showed that Ca21
is a good inhibitor of the first step of splicing: for example, the reaction rate
is decreased to half in the presence of Ca21 and a 100-fold excess of Mg21
[144]. This strong inhibition was not expected, as Ca21 and Mg21 show
similar coordinating properties, though the intrinsic affinity of Ca21
towards nucleic acids and derivatives is known to be lower [17,145]. Cor-
responding experiments indicate that the presence of 10mM Ca21, Mn21,
Ni21, Zn21, Cd21, Pb21 or [Co(NH3)6]
31 with 90mMMg21 causes a serious
decrease in the rate of the first step of splicing and, in some cases, provokes
the degradation of the RNA [144]. The authors point out that the effect of
the different metal ions in folding and catalysis of group II introns does not
fit to the Irving–Williams series [146], but suggest the existence of specific
binding pockets in group II introns to which different metal ions can bind
more or less specifically.
Concerning the specific way of catalysis, in the past it was suggested that
one Mg21 is involved in the catalytic process by stabilizing the 30-oxoanion
leaving group [147]. More recent studies suggest the direct involvement of
two metal ions in the catalytic activity of group II introns [148,149] (Figure
6b). Moreover, two recent crystal structures of a group IIC intron solved by
Pyle and coworkers in 2008 show the presence of two metal ions in close
proximity to the catalytic center [46,150]. Subsequent to the publication of
these crystal structures several papers appeared, with the aim to better
analyze the newest findings and describe their biological implications. It has
been suggested that the basic tertiary structures of different group II introns
are similar and quite conserved. The analysis of all the data available
allowed to depict a meticulous picture of the architecture of these large
ribozymes, with consequent implications for biological systems [25,47–50].
Both crystal structures of the intact self-spliced group IIC intron ribozyme
from Oceanobacillus iheyensis [46,150] confirmed many of the biochemically
predicted tertiary contacts [151]. In general, the structures show the catalytic
domain 5 (D5) surrounded and stabilized by the other domains of the intron
(Figure 9), and confirm the presence of metal ion binding sites within the
catalytic core [135,149]. The high negative charge accumulated in the
proximity of the backbone of the catalytic triad and the bulge within D5 is
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screened by the presence of two specifically coordinated metal ions, M1 and
M2. Soaking experiments with Yb31 suggested that these ions could be
Mg21. Within the crystal structure containing also the ligated exons, M1 is
bound to the intron by three innersphere contacts, whereas M2 shows two
innersphere contacts to the intron and directly coordinates O30 of the exonic
U4. Both M1 and M2 show short contacts with the scissile phosphate
(Figure 9). This is consistent with biochemical studies [148]. The observed
arrangement predestines the two ions for catalysis and fits well with the
polarity and ionic position expected for a two-ion mechanism. The distance
between the two metal ions is about 3.7 A˚, consistent with the distance
usually found within the two metal ions involved in catalysis in other
phosphodiesterase protein enzymes and in group I introns [24]. They reside
on the surface of D5 and they are accessible to both 30- and 50-splice sites. All
these evidences suggest that the self-splicing of the group II introns occurs
also via a ‘‘two-metal-ion mechanism’’. However, this evidence is not yet
Figure 9. (a) Crystal structure of the group IIC intron from Oceanobacillus
iheyensis, in which the intron has been co-crystallized with ligated exons. The
structure depicts a state in which the exons have been ligated but not yet released
[150]. The catalytic domain 5 (in blue) represents the core of this compact structure,
surrounded by the other domains. The colored spheres indicate metal ions: K1
(purple) and Mg21 (green). (b) A detailed view on the coordination sphere of the
catalytic metal ions M1 and M2 (green spheres). The 50-exon is indicated in yellow,
the 30-exon in blue and the coordinating oxygens as red spheres. Innersphere metal
coordination is shown with dashed lines. Both figures were prepared with MOLMOL
[187] using PDB ID 3EOG.
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conclusive. In fact, electron density for D6 that contains the branch-ade-
nosine is missing in the crystal structure. This is somehow surprising as the
intron was crystallized from a full length construct that included D6. Why is
there no electron density for D6? There may be two reasons: D6 is dis-
ordered in the crystal or it is absent, excised after splicing in vitro. It is known
that D6 is very mobile, which is important for its function. In order to
answer this question, Pyle and coworkers performed further biochemical
studies on the Oceanobacillus iheyensis construct before and after crystal-
lization [151]. They realized that after splicing in vitro this ribozyme causes
the excision of D6, and suggested that the encoded maturase protein
(without which group IIC introns cannot perform the branching in vitro)
may help in avoiding this event [25]. Nevertheless, the careful analysis of the
D1–D5 scaffold obtained from the X-ray analysis in conjunction with
numerous previous biochemical evidences can help in localizing D6 [25]. It
should dock to a specific part of D1, including the k region, and the branch
adenosine should be in close proximity to the scissile phosphodiester linkage
at the 50-splice site, where the metal ion M1 has been suggested to be located.
5. RNASE P
5.1. General Remarks on RNase P
Nuclear ribonuclease P (RNase P) is a RNA–protein complex that contains a
catalytically active part formed by a RNA molecule (200–400 nucleotides)
and one or more protein subunits (120–1000 amino acids). The protein
subunit is essential in vivo for substrate recognition [152], but the findings that
some bacterial [153] and archaeal [154] RNase P are active in vitro at high salt
concentration without the presence of the protein, suggest that the catalytic
component is located within the RNA part, thus confirming the nature of this
ribonuclease as a large ribozyme. This ribozyme is largely conserved over all
kingdoms of life and catalyzes the hydrolysis of a phosphodiester bond of
precursor RNA substrates (e.g., tRNA, 5S rRNA) that leads to the forma-
tion of mature RNAs [2,152,155,156]. In bacteria, RNase P comprises a large
RNA subunit (400 nucleotides) and a small protein. Bacterial RNase P
RNAs have been widely studied and many of the findings have been used to
analyze their more complex archaeal and eukaryotic counterparts [155]. They
present some differences in sequence, length, and secondary structure (Figure
1c), but contain five sequence-conserved regions and several helical elements
constituting a conserved structural core [157]. The RNA subunit comprises
two independently folding domains with distinct functions: one domain
contacts the T-stem loop of the pre-tRNA substrate and the other is
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responsible for the catalytic activity [152,156]. Within the latter domain
resides helix P4, the most conserved structural element in all RNase P RNAs
that constitutes the catalytic core of the ribozyme [158]. There are two
families of bacterial RNase P RNAs, A (ancestral) and B (bacillus). They
show some different structural elements that surround the analogous con-
served structure and fold into a similar tertiary structure [155].
These special ribozymes need metal ions for three reasons: (i) stabilization
of RNA folding, (ii) ligand binding, and (iii) catalysis [152,156]. For
example, it was demonstrated that more than 100 Mg21 ions are non-spe-
cifically bound to the RNA subunit of RNase P, to screen the negative
charge of the phosphate backbone and allow the folding to the tertiary
structure, while several Mg21are specifically bound. Many roles are played
by specifically coordinated Mg21 ions (either inner- or outersphere): they
promote and stabilize the binding of RNaseP and the pre-tRNA substrate,
they stabilize the transition state for cleavage and enhance catalysis, and
they increase the reactivity [159,160]. In general, RNase P strictly requires
divalent metal ions for catalysis, mostly Mg21 and Mn21, although some
cases, in which other metal ions are employed for catalysis, have been
reported [155].
Recent analysis of crystal structures (see below) suggest that the metal ions
found in helix P4, a highly conserved motif of this large ribozyme, have a
double function, i.e., structural and catalytic [21,161]. The presence of two or
three metal ions involved in the trans-esterification reaction responsible of
the formation of mature RNA substrate has been suggested by different
chemical and biochemical studies [162,163]. The involvement of the three
metal ions in catalysis was reviewed by Kazantsev and Pace in 2006 [155],
and is in line with the observed biochemical behavior of Tetrahymena group
I intron. One metal ion binds the attacking nucleophile as well as the pro-Rp
non-bridging phosphate oxygen, thus enhancing the nucleophilicity of the
attacking group. The second metal ion binds the 30 bridging and the pro-Rp
non-bridging oxygens, while the third binds the pro-Sp non-bridging oxygen
and the 20-OH of the cleavage site (Figure 6c). The three metal ions can in
principle be described as the biochemically termed MA, MB and MC in
Tetrahymena group I intron (see above), but most of the predicted interac-
tions need to be further confirmed.
The presence of the substrate that binds to this large ribozyme and the
necessity of a conformational change of this ribozyme–substrate complex in
order to perform catalysis, make this class of ribozymes very complicated
and difficult to study. So far, no structural data for the complete RNase P,
including RNA and protein, or for the complex between RNase P and its
substrate are available. Moreover, no extensive and conclusive picture for
the transition state of the RNase P at atomic level has been provided so far.
Nevertheless, several biochemical studies and phylogenetic comparative
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analysis gave insight on structure and function of RNase P, as well as the
enzyme–substrate complex [156]. Some of these findings have been con-
firmed by recent spectroscopic data, as will be discussed in the following
section.
5.2. Metal Ion Binding Sites: Structural and Catalytic Role
of Metal Ions
In the last few years several crystal structures of RNase P were published,
comprising either the RNA subunit or the protein subunit, from different
organisms (Bacillus stearothermophilus, Thermotoga maritima, Bacillus sub-
tilis, and Staphylococcus aureus) [21,161,164–167]. Unfortunately, no high
resolution structural data for the RNA–protein complex or for the complex
comprising the pre-tRNA is available so far. For this reason, many of the
considerations regarding conformational changes and catalysis are still
based only on biochemical and biophysical studies [155,168,169].
However, it is interesting to analyze the crystal structure of the B-type
RNase P RNA from Bacillus stearothermophilus, published in 2005 [161].
The 417-nt long molecule (solved at 3.3 A˚ resolution) forms six coaxially
stacked helical domains stabilized by long-range tertiary contacts. The
chemically active core is located in the conserved fraction of the ribozyme.
In general, the structure appears unusual, as it is flat and quite extended.
First attempts were undertaken to localize metal ion binding sites within
the structure, by analyzing the anomalous signals of the heavy atom
derivatives, mainly obtained with Os(III) hexammine. It was found that
most of the metal ion binding sites lie in the major groove of double stranded
helices. But, most interesting, some of them were localized within P4, the
conserved catalytic core of this ribozyme. Three sites were found in the
major groove of P4 and two lie in proximity to the catalytic center.
Nevertheless, the authors propose that the primary role of metal ion binding
sites in helix P4 could be the screening of the negative charge accumulated
within.
Unfortunately, this full length construct was not found well suited for
crystallographic analysis of metal binding sites because of its poor crystal-
lization properties. For this reason, Pace and coworkers prepared a shorter
construct which contains the catalytic domain, whose crystallization prop-
erties are better suited for soaking experiments with different metal ions, in
order to locate the metal ion binding sites within the ribozyme (Figure 10).
In this way they could depict a more detailed map of the metal binding sites
in the catalytic core of the RNase P RNA [21]. By anomalous scattering
individual binding sites within the catalytic region were identified and
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examined for their biological meaning. To identify possible regions of metal
binding, they used a variety of metal ions, namely Mn21, Co21, Ni21, Cu21,
Au31, Pb21, La31, Pr31, Sm31, Gd31, Dy31, Yb31, Lu31 as well as Os(III)
hexammine, but only with some of them they could find the right conditions
to obtain useful derivatives. It is clear that each of these ions has its own
coordinating properties, they differ in size and charge, and they can behave
differently from Mg21.
Figure 10. Crystal structure of the short construct comprising the independently
folding catalytic domain of the Bacillus stearothermophilus RNase P RNA, used in
the soaking experiments that lead to the localization of metal ion binding sites [21].
The figure was prepared with MOLMOL [187] using PDB ID 3DHS.
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Nonetheless, identifying the metal binding sites within the structure helps
in defining the regions in which positive charge is potentially needed for
structural or catalytic reasons.
A careful examination of the results ended up with the identification of
thirteen well defined metal binding sites in the catalytic core, some of which
are formed by conserved structural elements. Indeed, one of them is in line
with the only one identified (due to the low resolution) in the crystal
structure of Thermotoga maritima RNase P RNA [164]. Three metal ion
binding sites, M10–M12, that partially overlap, are found in close proximity
to the area identified as catalytic center by various biochemical methods
[170,171]. Special attention must be dedicated to the metal ion binding site
M6: it is the only site to which Mg21 binding could be unambiguously
attributed. Nevertheless, the biochemically predicted active site resides 12 A˚
far away from site M6 found in this crystal structure, suggesting that its
function is not catalytic [21]. The two metal ion binding sites that are the best
candidates to be considered the ones directly involved in catalysis are M10
andM11, even if they are associated only diffusely to Mg21 in the absence of
substrate. Finally, the authors do not exclude that the docking of the sub-
strate leads to a conformational change allowing Mg21 ions to specifically
coordinate at the positions required for catalysis by a ‘‘two-metal-ion
mechanism’’, as proposed by previous biochemical studies [172,173]. Hence,
all these findings are not yet conclusive, and further experimental data need
to be collected to fully elucidate the multiple roles of metal ions in the
ribozyme–substrate complex.
Recently different spectroscopic techniques were applied to cast light on
the role of metal ions in these intriguing ribozymes. Fierke and coworkers
showed in 2010 for the RNase P from Bacillus subtilis in the presence of
pre-tRNA, the importance of an innersphere coordinated metal ion for
the stabilization of the ribozyme–substrate complex just before the trans-
esterification reaction, by using fluorescence techniques [174]. In fact, once
formed, the ribozyme–substrate complex undergoes a structural modifica-
tion that allows it to effectively perform catalysis. It has been suggested that
this conformational change could help to unwind the pre-tRNA, in order to
make it ready for catalysis [175], besides protecting the RNA subunit from
degradation. Briefly, after preforming the ribozyme–substrate complex in
the presence of Co(III) hexammine, Mg21 and Ca21 were added in order to
favor the stabilization of the active conformer. Kinetic and thermodynamic
fluorescent measurements showed that both metal ions stabilize the active
conformation, and micromolar apparent affinity constants were found. For
the bond cleavage to be effective, a second Mg21 ion is needed, that seems to
interact with lower affinity and whose existence confirms the different roles
played by catalytic active metal ions [159,160]. Moreover, time-resolved
Fo¨rster resonance energy transfer (trFRET) experiments, performed in the
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presence of increasing amount of Ca21, allowed to follow the conforma-
tional change undergone by the ribozyme–substrate complex before the
cleavage [174].
Very recently an interesting new method to localize metal ions within the
active site of RNase P was published [176]. The combined data coming from
NMR and XAS experiments made possible the localization of an inner-
sphere bound metal ion in the helix P4. The data are complementary, as
NMR allows to precisely identify the residues involved in the binding
whereas XAS gives information about the nature of the interaction. It is
known that the highly conserved P4 helix may contain catalytic and co-
catalytic metal ions [177,178], but a precise picture at atomic level of this
region has not yet been painted. The authors studied a stem-loop RNA that
mimics the Bacillus subtilis RNase P helix P4 and adopts a conformation
similar to that described in the crystal structure of the Bacillus stear-
othermophilus ribozyme [21,161]. Two different XAS techniques were used:
X-ray absorption near edge structure (XANES) and extended X-ray
absorption fine structure (EXAFS). It was proved that Zn21 binds to helical
P4 in a six-coordination fashion, preferentially to oxygen/nitrogen atoms
with an average distance of 2.08 A˚. NMR paramagnetic line broadening
studies, performed by adding Mn21 to the P4 mimic stem-loop, as well as the
observation of chemical shift changes induced by addition of Zn21 and
[Co(NH3)6]
31, allowed to depict a quite accurate coordination pattern
around the metal ion, that resulted to be innersphere coordinated to the
tandem purines, G22 and G23. These nucleotides have been already
identified as possible partners for metal coordination [179], but this work
allowed to distinguish between inner- and outersphere coordination. The
authors highlight the potential of joint NMR and XAS techniques in order
to assign and characterize metal ion binding sites in RNAs.
6. CONCLUDING REMARKS
The need of metal ions in both folding and catalysis of large ribozymes is out of
doubt: metal ions help ribozymes in neutralizing the negative charge intrinsi-
cally correlated to the phosphate backbone, they allow the ribozymes to fold
into the active tertiary structure and they participate actively in catalysis.
For many years several research groups around the world tried to ratio-
nalize the behavior of such fascinating molecules. Many biochemical, bio-
physical, phylogenetic, and genetic studies have been performed and allowed
to obtain a quite solid picture of the involvement of metal ions in structure
and function of these molecules. Moreover, these findings are now sup-
ported by crystallographic data. X-ray structures of many group I introns
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have been published in the last few years, and crystallographic data on
RNase P are increasing, even if crystal structures of the complete enzyme
(comprising RNA and protein subunits) and the enzyme interacting with the
pre-tRNA are still missing. Obtaining a crystal structure of the group II
intron was extremely helpful because of the parallel nature to the eukaryotic
spliceosome. A few years ago a small group IIC intron was crystallized, and
its structure was solved. This finally opened the doors to a deeper under-
standing of the complex eukaryotic world.
Even if the involvement of metal ions in structure and catalysis is
undisputed, the differentiation between the two roles remains challenging.
Many chemical, biochemical and spectroscopic techniques have been
developed with the aim of identifying and characterizing the metal ion
binding sites, but much work is still needed to better distinguish metal ions
with structural and catalytic roles.
For all three types of ribozymes discussed a ‘‘two-metal-ion mechanism’’
for catalysis seems to be supported by the experimental data. Nonetheless,
strong evidences has been found only for group I introns: careful bio-
chemical studies allowed to depict an atomic-level model of the transition
state, that have been partially confirmed by crystal structures obtained at
different stages of the splicing pathway.
Further studies are needed in order to fill the gaps existing. Clearly, many
secrets are still left to be revealed. Moreover, the numerous papers published
by different research groups in the last few years confirm these fascinating
molecules to be of wide interest.
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ABBREVIATIONS
EBS1 exon binding site 1
EXAFS extended X-ray absorption fine structure
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IBS1 intron binding site 1
Ka acidity constant
NMR nuclear magnetic resonance
RNase P ribonuclease P
SAXS small-angle X-ray scattering
smFRET single molecule Fo¨rster resonance energy transfer
trFRET time-resolved Fo¨rster resonance energy transfer
XAS X-ray absorption spectroscopy
XANES X-ray absorption near edge structure
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1. INTRODUCTION
Knowledge on the binding of biologically relevant divalent
metal ions (M2þ) to hydroxyl groups, including carbohydrates, is
very scarce.1 The reason for this lack of knowledge is that these
interactions are very weak2,3 as long as a hydroxyl group is not
deprotonated. Such a deprotonation may be metal-ion facilitated
Received: December 3, 2010
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at high pH values,4�6 that is, commonly outside of the physio-
logical pH range.
Due to our general interest in coordination chemistry7�10 and
the fact that the indicated interactions are of relevance, e.g., for
ribozymes,11,12 which are also in the focus of our interest,13�16
we initiated a study allowing an overview on metal-ion�
hydroxyl group interactions. To this end, we made use of the
equilibrium constants available in the literature17,18 by selecting
those data that we considered as most reliable.
From previous work it is known that weakly interacting or
coordinating groups can be identiﬁed and the extent of their
interaction quantiﬁed if they are linked to a stronger primary
binding site.19�22 The reason for this is that even a very weak
interaction, next to the one occurring with the primary binding
site (PBS), must be reﬂected in a stability enhancement.23�26
This stability enhancement may be tiny, and this is why error
limits of the experimental data employed are important. A tiny
stability enhancement means that the intramolecular equilibrium
1 is largely on its left side, whereas a high one indicates that
chelate formation dominates
A few general remarks about the situation depictured in
equilibrium 1 also seem appropriate at this point: In a M(PBS)
complex (the charge of PBS remaining undeﬁned), the coordina-
tion sites of the metal ion, which are not occupied by the donor
atom(s) of the primary binding site, are ﬁlled with water
molecules. Upon formation of the chelate, assuming hydroxyl-
group binding occurs inner sphere, one water molecule is
released from the coordination sphere of the metal ion. Overall,
this release will lead to an increase in entropy because the entropy
loss by coordination of the hydroxyl group will be smaller than
the entropy gain due to water release, since the hydroxyl group is
already in the open isomer restricted in its movements and
located relatively close to the metal ion. Hence, equilibrium 1 on
its way from the left to the right is expected to be partly entropy
but also partly enthalpy driven because the donor strength of the
coordinating O atom increases fromH2O to ROH (where R is an
alkyl group).27 To the best of our knowledge, no detailed study of
the thermodynamic parameters exists for any of the equilibria
discussed below. However, it is evident that a long or rigid chain
between PBS and the hydroxyl group will inhibit chelate forma-
tion. Thus, the observation that the stability decreases in the
order 5-membered > 6-membered > 7-membered ring (sections
3.3, 4.3, and 5.2) is at least tentatively understandable, though
with multidentate ligands the situation may change.27 Obviously,
a 4-membered ring is strained and therefore usually disfavored.
Clearly, the net change in ΔG will always encompass all the
indicated contributions, and chelate formation, reﬂected in a
stability enhancement, will only occur, of course, if ΔG is overall
negative (see also section 12).
In this review we will now evaluate the situation regarding
equilibrium 1 for simple ligands which carry a hydroxyl group and
as primary binding site a phosph(on)ate, carboxylate, amino,
imidazolyl, or pyridyl residue. The various ligands will be
discussed in this order including their complexes of the metal
ions, Ba2þ, Sr2þ, Ca2þ, Mg2þ, Mn2þ, Co2þ, Ni2þ, Cu2þ, Zn2þ,
Cd2þ, and Pb2þ, as far as stability data are available. At the end of
the review we will consider the ligand N-hydroxyethylglycine,
which has a glycinate-like bidentate primary binding site next to a
hydroxyl residue, and also some polyhydroxyl ligands like the
buﬀer Bistris.
It is fascinating to observe that the stability enhancement due
to a �OH/M2þ interaction can vary from about 0.05 to several
log units, depending on the primary binding site and the kind of
metal ion involved. For a few examples it will also be shown that a
decreasing solvent polarity can promote the intensity of the
�OH/M2þ interaction.
2. HOW IS THE EXTENTOF AWEAK INTERACTION BEST
QUANTIFIED?
If we deﬁne the open (op) isomer at the left in equilibrium 1 as
M(PBS�OH)op by neglecting any charges and the chelated or
closed (cl) isomer as M(PBS�OH)cl, this equilibrium can be
rewritten (eq 2)
MðPBS�OHÞop h MðPBS�OHÞcl ð2Þ
The position of this intramolecular equilibrium is deﬁned by the
dimensionless equilibrium constant, KI (eq 3)
KI ¼ ½MðPBS�OHÞcl�=½MðPBS�OHÞop� ð3Þ
Commonly employed methods for determination of complex
stability constants, like potentiometric pH titrations or spectro-
photometric measurements, do not distinguish between dif-
ferent isomeric species, that is, the total (tot) concentration of
the complex species, M(PBS�OH)tot, is determined and the
stability constant of a simple 1:1 complex is then deﬁned as given
below (charges are neglected for simplicity)24�26
Mþ PBS�OH h MðPBS�OHÞtot ð4aÞ
KMMðPBS�OHÞ ¼ ½MðPBS�OHÞtot�=ð½M�½PBS�OH�Þ ð4bÞ
Taking into account the isomer formation of equilibrium 2, one
obtains equilibrium 5
Mþ PBS�OH h MðPBS�OHÞop h MðPBS�OHÞcl ð5Þ
and the corresponding stability constant is then deﬁned by
eq 6
KMMðPBS�OHÞ ¼
½MðPBS�OHÞtot�
½M�½PBS�OH�
¼ ½MðPBS�OHÞop� þ ½MðPBS�OHÞcl�½M�½PBS�OH� ð6Þ
If no chelated isomer is formed, this expression reduces to eq 7
KMMðPBS�OHÞop ¼ ½MðPBS�OHÞop�=ð½M�½PBS�OH�Þ ð7Þ
which deﬁnes the stability of the open isomer. The combination
of eqs 3, 6, and 7 leads to eqs 8a and 8b
KMMðPBS�OHÞ ¼ KMMðPBS�OHÞop þ KI 3KMMðPBS�OHÞop ð8aÞ
¼ KMMðPBS�OHÞopð1þ KIÞ ð8bÞ
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Equation 8b can be solved for KI, giving eq 9
KI ¼ ½MðPBS�OHÞcl�½MðPBS�OHÞop�
¼
KMMðPBS�OHÞ
KMMðPBS�OHÞop
� 1 ð9Þ
A value for KI can now be calculated provided an exper-
imental value exists for KM(PBS�OH)
M and that a value for
KM(PBS�OH)op
M can be obtained. The latter point is clearly the
more diﬃcult part.
Commonly, the stability of the open isomer is obtained by
making use of the observation24 that for a family of structurally closely
related ligands (PBS) plots of log KM(PBS)
M versus pKH(PBS)
H result
in straight lines. Such a straight line is deﬁned by the slopem and
the intercept b with the y axis (= log KM(PBS)
M axis)
log KMMðPBSÞ ¼ m 3 pKHHðPBSÞ þ b ð10Þ
Once the parameters for m and b are known, one may calculate
the corresponding complex stability constant based on the also
known acidity constant of a ligand. The following is a speciﬁc
example: From the plot of the data due to a family of closely
related carboxylate ligands (CA�), that is, of log KM(CA)
M versus
pKH(CA)
H , the parameters for eq 10 follow. This allows one now to
calculate the stability of the open isomer of the complex formed,
e.g., with hydroxyacetate (HOAc�) by applying pKH(HOAc)
H (see
Figure 5 in section 4.1.2).
Hence, based on the experimentally (exp) measured stability
constants and the calculated (calc) ones the stability diﬀerence or
better the stability enhancement for a certain complex system,
which oﬀers, e.g., a hydroxyl group next to the PBS unit for M2þ
binding (eq 1), can now be deﬁned
log ΔM=PBS�OH ¼ log KMMðPBS�OHÞ � log KMMðPBS�OHÞop
ð11aÞ
¼ log KMMðPBS�OHÞexp � log KMMðPBS�OHÞcalc ¼ log Δ
ð11bÞ
The corresponding equality of the various terms in eqs 11a and
11b is evident, but it is also clear that well-deﬁned error limits are
needed for any quantitative evaluation.
With eqs 11a and 11b, eq 9 can be rewritten as given in eq 12
KI ¼ ð½MðPBS�OHÞcl�Þ=ð½MðPBS�OHÞop�Þ ¼ 10log Δ � 1
ð12Þ
and with now known values forKI, the percentages of the closed or
chelated isomers occurring in equilibria 1 and 2 follow from eq 13
%MðPBS�OHÞcl ¼ 100 3KI=ð1þ KIÞ ð13Þ
This procedure is applied in the sections to follow. Finally, it may
be added that the acidity constants of the various monoprotonated
ligands are deﬁned in the commonmanner, i.e., as given in eqs 14a
and 14b
HðPBSÞþ h PBSþHþ ð14aÞ
KHHðPBSÞ ¼ ½PBS�½Hþ�=½HðPBSÞþ� ð14bÞ
3. METAL-ION COMPLEXES WITH PHOSPH(ON)ATE
GROUPS AS PRIMARY BINDING SITES
From a coordination chemical point of view it would be
interesting to deal with a series of ligands that allow formation
of 5-, 6-, and 7-membered chelates. In this sense, the ligands
depictured in Figure 1 are the correct ones to deal with. However,
for hydroxymethyl phosphate (HMOP2�) no equilibrium data
are available,17,18 which is no surprise as HMOP2� is the phosphate
ester of the geminal diol CH2(OH)2. For the other two ligands
some though quite limited information is available, which is
discussed in the following two subsections.
Fortunately, the straight-line parameters for a number of com-
plexes with simple phosphate monoester28 and phosphonate29
ligands have been determined previously (see also below the legend
of Figure 2 in section 3.1). The parameters for those metal ions for
which also complexes with PBS�OH ligands exist are listed in
Table 1.28�31
3.1. Extent of the Hydroxyl�M2þ Interaction in Complexes
of Hydroxymethylphosphonate
From the structure of hydroxymethylphosphonate (HMP2�)
seen in Figure 1 it is evident that this ligandmay form5-membered
chelates by involving the hydroxyl group. Reliable stability con-
stants were found in ref 17 for the Mg(HMP), Ca(HMP), and
Cu(HMP) complexes. Figure 2 shows plots of log KM(R�PO3)
M
versus pKH(R�PO3)
H for the 1:1 complexes of Ca2þ, Mg2þ, and
Cu2þ with eight simple R�PO32� ligands (see legend of Figure 2),
allowing only a phosph(on)ate�M2þ interaction.28,29 The corre-
sponding least-squares reference lines, the parameters of which
are listed in Table 1, deﬁne the relation between phosph(on)ate
complex stability and phosph(on)ate group basicity. The three solid
points in Figure 2, which refer to Ca(HMP), Mg(HMP), and
Cu(HMP), are not much, yet beyond the error limits, above their
reference lines, thus proving an increased stability for these
complexes.
A quantitative evaluation of the situation reﬂected in Figure 2
is possible by calculating with pKH(HMP)
H = 6.97 (cf. ref 17) and
the straight-line equations of Table 1 (eq 10) the expected stabilities
for the M(HMP) complexes with a sole phosphonate�M2þ
coordination as seen in equilibrium 1, i.e., for the M(HMP)op
species (eq 2). The corresponding results are listed in column 3 of
Table 2; their comparison according to eqs 11a and 11b with the
Figure 1. Considered phosph(on)ate ligands containing a hydroxyl
group: hydroxymethylphosphonate (HMP2�), hydroxymethyl phos-
phate (HMOP2�), and glycerol 1-phosphate (G1P2� = R-glyceropho-
sphate; in many biochemistry texts also designated as glycerol
3-phosphate).
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measured stability constants (column 2) leads to the stability
diﬀerences given in the fourth column of Table 2. Evidently all
three M(HMP) complexes are more stable than expected on the
basis of the basicity of the HMP2��phosphonate group.
As indicated in section 2, any increased stability must be
attributed24 to a further metal-ion-binding site interaction, i.e., in
the present case to the oxygen of the HMP2��hydroxyl group
(Figure 1). Consequently, 5-membered chelates, M(HMP)cl, must
be formed to some extent and, thus, equilibria 1 and 2 operate.
Application of the evaluation procedure described in section
2 (eqs 11a�13) gives the results summarized in Table 2
(columns 4�6). It is evident that for all three complexes studied
at least some chelate formation occurs; the formation degrees vary
between about 20% and 50%.
The above results may be generalized, and the take home
message then is as follows: The hydroxyl group, if supported by a
suitably located primary binding site, may coordinate to the
alkaline earth metal ions as well as to the divalent metal ions of
the second half of the 3d transition series. This statement is
conﬁrmed in the sections to follow.
3.2. Metal-Ion�Glycerol 1-Phosphate Systems: A Decreas-
ing Solvent Polarity Favors Hydroxyl�M2þ Interactions
Glycerol 1-phosphate (G1P2�) is, together with dihydroxy-
acetone phosphate, involved in the so-called R-glyceropho-
sphate shuttle. Both compounds are important intermediates
in biological processes,32�34 and many of these also depend on
metal ions,35 as, for example, the R-glycerophosphate shuttle, im-
portant for the synthesis of adenosine 50-triphosphate (ATP4�)36
and related reactions,37 which depend on the presence of
Ca2þ.36,37
Space-ﬁlling molecular models show that a phosphate-coordi-
nated metal ion may easily reach the oxygen of the neighboring
hydroxyl group inG1P2� to form a7-membered ring (see Figure 1).
However, stability constant measurements in aqueous solution
(25 C; I = 0.1 M, NaNO3)38 showed no stability enhancements,
that is, all the log ΔM/G1P values (eqs 11a and 11b) were between
�0.06 ( 0.07 (Ni2þ) and 0.05 ( 0.08 (Mn2þ) log units for the
corresponding M(G1P) complexes of Mn2þ, Co2þ, Ni2þ, Cu2þ,
Zn2þ, or Cd2þ. In other words, they were all zero within the error
limits, meaning that at best a formation degree of about 20%may be
reached for the M(G1P)cl isomer.
There is a small discrepancy regarding the alkaline earth metal-
ion complexes formed with G1P2�, which possibly may be ex-
plained by the fact that Schwarzenbach and Anderegg39 determined
their values at 20 C (I = 0.1 M, KCl) whereas those measured by
Liang andH. Sigel et al.38 (see also ref 25) refer to 25 C (I = 0.1M,
NaNO3). The corresponding results are as follows
(i) ref 39: pKH(G1P)
H = 6.07; log KCa(G1P)
Ca = 1.66 ( 0.05, and
log KMg(G1P)
Mg = 1.80 ( 0.05
(ii) ref 38: pKH(G1P)
H = 6.23 ( 0.01; log KCa(G1P)Ca = 1.43 (
0.05, and log KMg(G1P)
Mg = 1.63 ( 0.03
Application of the straight-line parameters of Table 1 leads for
(i) to log ΔCa/G1P = 0.23( 0.07 and log ΔMg/G1P = 0.27( 0.06,
thus giving%Ca(G1P)cl = 41( 9 and%Mg(G1P)cl = 46( 7, and
for (ii) to logΔCa/G1P =�0.02( 0.05 and logΔMg/G1P = 0.06(
0.04, thus giving % Ca(G1P)cl < 7 and % Mg(G1P)cl = 13 ( 8.
The discrepancy may be due to the diﬀerent experimental
conditions but possibly also due to traces of free phosphate in the
early measurements. In any case, we believe that the values from
refs 25 and 38 are closer to the “truth”, yet at the same time, one
Table 1. Straight-Line Parameters for M2þ�Phosphate
Monoester or �Phosphonate Complex Stabilities and
Phosph(on)ate Group Basicities (25 C, I = 0.1M, NaNO3)a,b
% (v/v) 1,4-dioxane M2þ m b SD
0 Ca2þ 0.131( 0.020 0.636( 0.131 0.048
0 Mg2þ 0.208( 0.015 0.272( 0.097 0.033
0 Cu2þ 0.465( 0.025 �0.015( 0.164 0.057
30 Cu2þ 0.559 ( 0.015 �0.089( 0.106 0.03
50 Cu2þ 0.571( 0.022 0.190( 0.160 0.03
a Slopes (m) and intercepts (b) for the straight-line plots of log
KH(R�PO3)
H (eqs 4a and 4b) versus pKH(R�PO3)
H (eqs 14a and 14b) as
deﬁned by eq 10 and as calculated by the least-squares procedure from the
equilibrium constants for simple R�PO32�/Hþ/M2þ systems (R =
noncoordinating residue; for the ligands involved, see legends of Figures 2
and 3, vide infra) obtained in aqueous solutions28,29 and in water
containing 30% or 50% (v/v) 1,4-dioxane.30 The errors given with m
and b correspond to one standard deviation (1σ). The column at the right
lists three times the standard deviations (SD) resulting from the diﬀer-
ences between the experimental and the calculated values for the various
ligand systems. The listed SD values (3σ) are considered as reasonable
error limits for any stability constant calculation in the pKH(R�PO3)
H range
5�8 for aqueous solutions, 6�8.5 for 30%, and 6.5�9 for 50% (v/v) 1,4-
dioxane�water mixtures. bThe ﬁrst three entries are from Tables 5 and 6
in ref 29 and the last two entries from Table 2 of ref 30. Lists of the above
parameters are also found in refs 25 and 31.
Figure 2. Evidence for an enhanced stability of the Ca2þ (2), Mg2þ
(9), and Cu2þ (b) 1:1 complexes of HMP2� based on the relationship
between log KM(R�PO3)
M and pKH(R�PO3)
H for M(R�PO3) complexes of
some simple phosphate monoester and phosphonate ligands
(R�PO32�) (4, 0, O): 4-nitrophenyl phosphate (NPhP2�), phenyl
phosphate (PhP2�), uridine 50-monophosphate (UMP2�), D-ribose
5-monophosphate (RibMP2�), thymidine (=1-(20-deoxy-β-D-ribofu-
ranosyl)thymine) 50-monophosphate (dTMP2�), n-butyl phosphate
(BuP2�), methanephosphonate (MeP2�), and ethanephosphonate
(EtP2�) (from left to right). The least-squares reference lines (eq 10)
are drawn through the corresponding eight data sets taken from ref 28 for
the phosphate monoesters and from ref 29 for the phosphonates.
The points due to the equilibriumconstants for theM2þ/HMP2� systems
(2,9,b) are based on the values listed inTable 2 (column2 and footnote
b). The vertical dotted lines emphasize the stability diﬀerences to the
reference lines; they equal log ΔM/HMP as deﬁned in eqs 11a and 11b for
the M(HMP) complexes. All plotted equilibrium constants refer to
aqueous solutions at 25 C and I = 0.1 M.
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cannot exclude the possibility that traces of M(G1P)cl are
formed, especially in the case of Mg(G1P)cl.
However, the results seen in Figure 3 (cf. refs 25 and 38�40)
prove that under special conditions 7-membered chelates may
form in M(G1P) systems. These experiments38 were originally
initiated by the fact that in proteins41 or in active-site cavities
of enzymes42 the so-called “eﬀective” or “equivalent-solution”
dielectric constants (permittivities) are reduced compared to the
situation in bulk water, namely, e.g., from about 80 to 35.42 The
same is true for certain folds in RNA,14 and it has been shown
recently43 that a decreased solvent permittivity indeed increases
the metal-ion aﬃnities of the RNA.
From Figure 3 it is evident that the overall stability of the Cu2þ
complexes increases drastically with increasing amounts of 1,4-
dioxane, i.e., with a decreasing solvent polarity. More important
in the present context, however, is the observation that the solid
points due to the data pairs for the Cu(G1P) complexes are more
and more above the reference lines. Since the vertical distances
between these points and their reference lines correspond to log
ΔM/G1P as deﬁned by eqs 11a and 11b, it is clear that the
intramolecular interaction between Cu2þ and the�OH group in
the Cu(G1P) complex increases with increasing amounts of 1,4-
dioxane.
Application of the straight-line equations in Table 1 and of the
acidity constants of H(G1P)� (Table 3, column 4) allows an
exact quantiﬁcation of the stability increases, log ΔM/G1P. These
results are summarized in Table 3 together with some pertinent
information about the solvents employed.44
The degree of formation of the chelated isomer of Cu(G1P) is
quite pronounced with about 40% in 50% (v/v) 1,4-dioxane�
watermixtures, and therefore, under these conditions equilibria 1
and 2 are important.
3.3. Some Generalizations Regarding Phosph(on)ate Li-
gands with a Weakly Coordinating Second Site
It is interesting to note that dihydroxyacetone phosphate
(DHAP2�; HO�CH2�C(O)�CH2�O�PO32�), which is part
of the mentionedR-glycerophosphate shuttle (section 3.2, open-
ing paragraph) and has a carbonyl oxygen neighboring the
phosphate group, meaning that its structure is rather similar to
the one of G1P (Figure 1), may also form 7-membered chelates.
Indeed, the M(DHAP) complexes show practically identical
properties as the M(G1P) species if formation of the closed
isomers is considered. In aqueous solution the concentration of
M(DHAP)cl is also diminishingly small, but again, a decreas-
ing solvent polarity facilitates the intramolecular �CO/M2þ
interaction.25,38 In both species, M(G1P)cl and M(DHAP)cl, as
far as they exist, the �OH group at C3 (see Figure 1) is most
likely not involved in an interaction with M2þ; otherwise, larger
stability enhancements (log ΔM/PBS�OH; eqs 11a and 11b)
would be expected. Yet, most remarkably, the oxygen sites at
C2, i.e., in the carbonyl group of DHAP2�, and in the hydroxyl
group of G1P2�, behave quite alike in their metal-ion-binding
properties. It may be added that for glycol phosphate (2-hydro-
xyethyl phosphate) no stability constants seem to be available.17,18
It is further worthwhile to mention that the ether oxygen in the
dianion of (phosphonomethoxy)ethane (PME2�; CH3CH2�
O�CH2�PO32�) can also participate in formation of 5-membered
Table 2. Comparison of theMeasured Stability Constants,KM(HMP)exp
M (eqs 4a, 4b, and 6), of the 1:1 Complexes Formed between
Hydroxymethylphosphonate (HMP2�) and Several M2þ with the Stability Constants, KM(HMP)op
M (eq 7), for the Isomers with a
Sole PhosphonateCoordination ofM2þ, and Extent of the Intramolecular Chelate FormationAccording to Equilibria 1and 2 in the
M(HMP) Complexes As Deﬁned by KI (eqs 3, 9, and 12) and % M(HMP)cl (eq 13) for Aqueous Solution at 25 C and I = 0.1 M
M2þ log KM(HMP)exp
M a log KM(HMP)op
M b log ΔM/HMP KI % M(HMP)cl
Mg2þ 1.84( 0.10c 1.72( 0.03 0.12 ( 0.10 0.32 (0.05/0.66)d 24 (5/40)d
Ca2þ 1.68( 0.06 1.55( 0.05 0.13( 0.08 0.35 ( 0.24 26 ( 13
Cu2þ 3.53( 0.06 3.23( 0.06 0.30( 0.08 1.00( 0.39 50 ( 10
aAll values are from ref 17. Since no error limits are given in ref 17 an error limit of(0.06 log unit is assumed, except in the case where the constant had to
be corrected, chere an error of (0.10 log unit is applied. bCalculated with the straight-line equations deﬁned in Table 1 for simple phosph(on)ate
complexes and pKH(HMP)
H = 6.97.17 c In ref 17 the value of 1.92 is listed for I = 0.1 M, which was kept constant with a tetraalkyl ammonium salt; to make
the value comparable with solutions, where I = 0.1 M is kept constant with Naþ/Kþ, 0.08 log unit was deducted giving the above constant of 1.84. dThe
lower and upper limits are given, respectively.
Figure 3. Evidence for an additional enhanced stability of the Cu(G1P)
complexes (b) in 1,4-dioxane�water mixtures as solvents based on the
relationship between log KCu(R�PO3)
Cu and pKH(R�PO3)
H for the Cu2þ
1:1 complexes of 4-nitrophenyl phosphate (1), phenyl phosphate (2),
D-ribose 5-monophosphate (3), n-butyl phosphate (4), uridine 50-
monophosphate (5), thymidine 50-monophosphate (6), methanepho-
sphonate (7), and ethanephosphonate (8) in water and in water contain-
ing 30% or 50% (v/v) 1,4-dioxane (adapted from ref 25). The least-
squares lines are drawn in each case through the data shown (O);28�30
the equations for these reference lines are given in Table 1. The data
points due to the methanephosphonate system in the mixed solvents
(X) (see ref 30) are shown to prove that simple phosphonates ﬁt within
the experimental error limits on the reference lines established with
phosphate monoester systems (for details see ref 40). The data pairs for
the points due to the Cu2þ 1:1 complexes formedwithG1P2� (b) in the
three mentioned solvents are taken from Table 3 in ref 38 (see also
Table 3 in section 3.2). The vertical dotted line emphasizes the stability
diﬀerence to the corresponding reference line; these diﬀerences are
equal to logΔCu/G1P (eqs 11a and 11b), the values of which are listed in
column 7 of Table 3. All of the plotted equilibrium constants refer to
25 C and I = 0.1 M (NaNO3).
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chelates in aqueous solution.25,29,45,46 The formation degrees of the
M(PME)cl species vary depending on the metal ion involved
between about 15% (Ba2þ) and 67% (Cu2þ).25 Enlargement
of the chelate to a 6-membered ring, as it occurs with the anion of
(2-phosphonoethoxy)ethane (PEE2�; CH3CH2�O�CH2CH2�
PO3
2�),47 reduces the formation degrees of the M(PEE)cl
species signiﬁcantly, that is, in aqueous solution the stability
enhancement (log ΔM/PEE; eqs 11a and 11b) for the com-
plexes of Ba2þ, Sr2þ, Ca2þ, Mg2þ, Mn2þ, and Cd2þ is zero
within the error limits and for the 3d transition ions, Co2þ,
Ni2þ, Cu2þ, and Zn2þ, it is small, being for Cu(PEE) only
0.17 ( 0.07 log unit, which amounts to a formation degree for
Cu(PEE)cl of 32%.
47
Generalization of the described results leads to the conclusion
that in phosph(on)ate complexes with an oxygen atom in the
second binding site the formation degree of the closed species,
M(PBS�OH)cl (eq 1), depends strongly on the size of the chelate
ring and decreases in the order 5-membered > 6-membered >
7-membered ring.
Finally, since only a few studies in mixed solvents exist (see
also section 4.4), we would like to point out that the properties of
Cu(PME) were also quantiﬁed in the presence of 1,4-dioxane.25
However, in this case there is no signiﬁcant diﬀerence in the
formation degree of Cu(PME)cl in water and in water containing
30% or 50% (v/v) 1,4-dioxane; it amounts in all three solvents to
about 62%.25,30 In this case the promoting eﬀect of the ether
�O/Cu2þ interaction by the decreasing solvent polarity is oﬀset
by the solvation of the terminating �CH2CH3 residue by the
ethylene bridges of 1,4-dioxane, which thus inhibits sterically the
ether �O/Cu2þ coordination.
4. METAL-ION COMPLEXES WITH CARBOXYLATE
GROUPS AS PRIMARY BINDING SITES
The most typical ligand to be considered in this section
regarding an evaluation of the binding strength of a hydroxyl
group is clearly hydroxyacetate (HOAc�; see Figure 4). Close-
ly related to HOAc� is lactate, i.e., D-2-hydroxypropanoate
(2HOPr�). For reasons of comparison, two ligands with an ether
oxygen atom will also be taken into account, namely, methoxy-
acetate (CH3OAc
�) and ethoxyacetate (EtOAc�) (see Figure 4).
Though quite a number of studies exist,17,18 which deal with
equilibrium constants involving the four ligands seen in Figure 4,
no straight-line correlations for log KM(CA)
M versus pKH(CA)
H plots,
which can be employed here, are available. Please note, the
abbreviation CA� represents in this context simple carboxylate
ligands like formate, acetate, or propionate. Unfortunately, the
largest parts of the available equilibrium constants have been
determined at an ionic strength (I) of either 0.1 or 2M, with only
a few metal ions studied under both conditions.17,18 We decided
therefore to evaluate the available data at I = 0.1 and 2 M
independently of each other and to construct for both conditions
the necessary reference lines; I = 0.1 M will be dealt with in
section 4.1 and I = 2 M in section 4.2.
4.1. Extent of Chelate Formation in Complexes of Hydro-
xyacetate and Related Ligands at I = 0.1 M
4.1.1. Construction of the Reference Lines for Several
M2þ�Carboxylate Systems. The acidity constants of simple
carboxylate ligands, H(CA), together with the corresponding
stability constants of various metal-ion complexes, M(CA)þ,
were collected from the literature17,48,49 and are summarized in
Table 4. Plots of the log KM(CA)
M versus pKH(CA)
H data resulted, as
expected, in straight lines. The results of the corresponding least-
squares calculations are summarized in Table 5 for the seven
metal ions that could be considered.
The slopes (m) and intercepts (b = y0) for the Cu
2þ and Zn2þ
systems have previously been determined as mCu = 0.170 (
0.035 (1σ), y0/Cu = 0.965 ( 0.159 and mZn = 0.039 ( 0.031,
y0/Zn = 0.802( 0.141, respectively (see the legend to Figure 2 in
ref 45), in good agreement with the present values, meaning that
the results overlap within the error limits (1σ). It should be
mentioned that the straight line for the Mn2þ/Hþ/CA� system
Table 3. Negative Logarithms of the Acidity Constants (eqs 14a and 14b) of H(G1P)� and Logarithms of the Stability Constants
of the Corresponding Cu(G1P) Complexes (eqs 4a, 4b, and 5) As Determined by Potentiometric pH Titrations38 in Dependence
on the Amount of 1,4-Dioxane Added to Water and on the Resulting Dielectric Constanta,b
% (v/v) dioxane mole fraction dioxane εc pKH(G1P)
H log KCu(G1P)
Cu log KCu(G1P)calc
Cu log ΔCu/G1P KI % Cu(G1P)cl
0 0 78.5 6.23( 0.01 2.83( 0.05 2.88 ( 0.06 �0.05( 0.08 0 (<0.08) 0 (<7)
30 0.083 52.7 6.94( 0.01 3.85( 0.02 3.79( 0.03 0.06( 0.04 0.15 ( 0.10 13 ( 7
50 0.175 35.2 7.39( 0.03 4.65( 0.02 4.41( 0.03 0.24( 0.04 0.74 ( 0.14 42 ( 5
aThe stability constants for a pure Cu2þ�phosphate residue coordination, i.e., for M(G1P)op (eq 7), were calculated (calc) with the listed acidity
constants and the straight-line equations given in Table 1; the resulting stability diﬀerences, logΔCu/G1P, are deﬁned by eqs 11a and 11b. The extent of
chelate formation according to equilibrium 1 in the Cu(G1P) complexes is quantiﬁed by the dimensionless equilibrium constant KI (eqs 3 and 12) and
the percentage of the closed isomer, Cu(G1P)cl (eq 13) (25C; I = 0.1 M, NaNO3). The values in columns 2 and 3 are taken from Table 3 in ref 38. The
values listed in columns 6�9 are revised25 compared to those given in ref 38. bThe error limits given for data from our own laboratories (which applies to
the above values) are three times the standard error of themean value or the sum of the probable systematic errors, whichever is larger. The error limits of
all derived data, e.g., log ΔCu/G1P, were calculated according to the error propagation after Gauss.
cThe dielectric constants (permittivities) for the 1,
4-dioxane�water mixtures are interpolated from the data given in ref 44.
Figure 4. Carboxylate ligands which allow formation of 5-membered
chelates involving the oxygen atom of a hydroxyl or ether group:
Hydroxyacetate (= glycolate, HOAc�), D-2-hydroxypropanoate
(= lactate; 2HOPr�), methoxyacetate (CH3OAc
�), and ethoxyacetate
(EtOAc�). Where needed, all four ligands are abbreviated with the
symbol OAc� (see section 4.1.2).
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is deﬁned by only two data points (see Table 4 and Figure 5 in
section 4.1.2) and that for the Sr2þ/Hþ/CA� system the same
slope (m) was assumed as determined for the Ba2þ/Hþ/CA�
system (see footnotes in Table 5). However, this is not a problem
because the slopes m are small as are the needed extrapolations;
moreover, these shortcomings in the Sr2þ and Mn2þ systems
were also taken into account in the applied error limits.
Table 6 lists the deviations from the least-squares line for each
individual complex of the ligands listed in Table 4 (column 2).
There is a single deviation of 0.12 log unit for the Cu2þ/Hþ/Pr�
system (Table 6, entry 14); all other deviations are mostly below
(0.07 log unit. To provide a reliable error limit for any stability
constant calculated with the equations of Table 5 and a given
pKH(CA)
H value, for each of the seven metal ions treated, the
standard deviation of the data points from the relevant least-
squares line was calculated; the corresponding values are given in
Table 6 in the bottom row following the SD term.
Users of the results described in this section are recommended
to apply the equations of Table 5 for carboxylate ligands in the
pKH(CA)
H range of 2.5�5 and to consider as error limits of the
calculated stability constant log KM(CA)
M three times the standard
deviation (SD) given in the bottom row of Table 6 for the
corresponding metal-ion system. An application of this proce-
dure is given below in the next section.
4.1.2. Extent of Chelate Formation in Metal-Ion Com-
plexes Formed with Hydroxy Carboxylates and Related
Ligands.Are the stabilities of theM(HOCA)þ complexes solely
determined by the coordinating properties of the carboxylate
group or does the hydroxyl group also have an effect? The answer
to this question may be obtained by making use of the straight-
line correlations for log KM(CA)
M versus pKH(CA)
H plots as estab-
lished in the preceding section. Four examples of such plots are
shown in Figure 5 for the 1:1 complexes of Ba2þ, Ca2þ, Mn2þ,
Table 4. Logarithms of the Stability Constants for the 1:1 Complexes (eqs 4a, 4b, and 6) Formed between Several Divalent Metal
Ions (M2þ) and Simple Carboxylate Ligands (CA�) As Well As Negative Logarithms of the Acidity Constants (eqs 14a and 14b)
of the Corresponding H(CA) Species, Mostly Determined by Potentiometric pH Titrations, for Aqueous Solutions at 25 C and
I = 0.1 Ma
log KM(CA)
M for M2þ =
no.b CA�a pKH(CA)
H Ba2þ Sr2þ Ca2þ Mg2þ Mn2þ Cu2þ Zn2þ
1 ClAc� 2.71( 0.02 1.46( 0.13 0.84c
2 HCOO� 3.58( 0.01 1.58( 0.04 0.95( 0.03
3 Ac� 4.57( 0.01 1.73( 0.04 0.93( 0.03
4 2MPr� 4.67 ( 0.01 1.79( 0.03 1.01 ( 0.02
5 3MBu� 4.61( 0.01 1.70( 0.03 0.96( 0.03
6 4MVa� 4.68( 0.01 1.73( 0.04 0.99( 0.04
7 5MHx� 4.69 ( 0.01 1.79( 0.07 0.99 ( 0.04
8 6MHp� 4.72( 0.01 1.80( 0.04 1.02( 0.05
9 ClAc� 2.69( 0.04 0.14( 0.05 0.23( 0.04
10 BrAc� 2.71 0.10d
11 HCOO� 3.57( 0.03 0.32e 0.38e 1.61( 0.04 1.01( 0.06
12 Bz� 4.01 ( 0.02 0.70f
13 Ac� 4.56( 0.03 0.44( 0.05 0.47( 0.04 0.55( 0.05 0.51( 0.05 0.80 1.79( 0.06 1.07( 0.07
14 Pr� 4.69( 0.03 0.34 0.43 0.50 0.54 1.91 1.01
a In most instances the ionic strength (I) was kept constant with NaNO3. In those cases where an error limit is given, it is taken from the cited references.
bThe ligand abbreviations are deﬁned as ClAc� = chloroacetate, HCOO� = formate, Ac� = acetate, 2MPr� = 2-methylpropanoate, 3MBu� =
3-methylbutanoate, 4MVa� = 4-methylvalerate = 4-methylpentanoate, 5MHx� = 5-methylhexanoate, 6MHp� = 6-methylheptanoate, BrAc� =
bromoacetate, Bz� = benzoate, Pr� = propanoate. The values for entry 1 in columns 3 and 9 are from ref 48, those in entries 2�8 are from ref 49, and
those in entries 9�14 are from ref 17. cThis value is an estimate: For 30 C and I = 0.5M, logK = 0.56 is listed in ref 17. For Zn(HCOO)þ the diﬀerence of
the values given for 30 (I = 0.5M) and 25 C (I = 0.1M) equals 0.28 log unit;17 hence, logKZn(ClAc)Zn = 0.56( 0.28 = 0.84. dEstimated value: For 25 C and
I = 0 M, log K = 0.24 is listed in ref 17. On the basis of comparisons in ref 17, between I = 0.1 M and I = 0 M the mentioned constant is reduced to log
KBa(BrAc)
Ba = 0.10. eCorrected values: For 30 C (I = 0.5M), listed in ref 17, logK = 0.27 and 0.34 for Ca(HCOO)þ andMg(HCOO)þ, respectively. These
values are corrected by 0.05 and 0.04 log unit based on the diﬀerences for M(Ac)þ complexes at 30 (I = 0.5 M) and 25 C (I = 0.1 M).17 fFor 25 C (I =
1M), logK = 0.62 is listed in ref 17; this value is corrected by 0.08 log unit based on values for M(Ac)þ complexes at 25 (I = 1M) and 25 C (I = 0.1M).17
Table 5. Straight-Line Parameters for M2þ 1:1 Complexes
Formed with Simple Carboxylate Ligands (CA�), Valid for
Aqueous Solutions at 25 C and I = 0.1 Ma,b
M2þ m b
Ba2þ 0.148( 0.054 �0.298( 0.221
Sr2þ 0.148 �0.235
Ca2þ 0.197( 0.023 �0.385( 0.093
Mg2þ 0.151( 0.007 �0.170 ( 0.026
Mn2þ 0.182 �0.029
Cu2þ 0.169( 0.025 0.994( 0.109
Zn2þ 0.060 ( 0.022 0.724( 0.095
aThe slopes (m) and intercepts (b) for the straight reference lines from
plots of log KM(CA)
M versus pKH(CA)
H were calculated by the least-squares
procedure from the experimentally determined equilibrium constants
listed in Table 4 (see also Figure 5). In the case of Sr2þ the slope,
m = 0.148, of Ba2þ was also applied. bThe straight-line equation is
deﬁned by eq 10. With a known pKH(CA)
H value of any carboxylate
derivative, the stability constant, log KM(CA)
M , for the corresponding
M(CA)þ complex can be calculated. The errors given with the slopesm
and intercepts b correspond to one standard deviation (1σ).
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and Cu2þwith simple CA� ligands that have no binding site next
to the carboxylate group (open symbols). The solid symbols refer
to the HOAc� complexes of the mentioned metal ions. Evi-
dently, the data points for all M(HOAc)þ complexes are far
above their corresponding reference lines, indicating chelate
formation according to equilibrium 1.
A quantitative evaluation of the situation seen in Figure 5 is
possible by applying pKH(HOAc)
H and the straight-line param-
eters listed in Table 5 to eq 10. The results deﬁne the stabil-
ities of the open isomers of the M(HOAc)þ complexes in which
M2þ is solely bound to the carboxylate group (eq 1). These
log KM(HOAc)op
M values are listed in column 4 of Table 7.
Comparison of these values with the experimentally determined
stability constants (column 3) according to eqs 11a and 11b
provides the stability enhancement, log ΔM/HOAc, which quan-
tiﬁes the intensity of the�OH/M2þ interaction in the individual
M(HOAc)þ complexes. Now use can be made of eqs 12 and 13,
which results in the formation degrees of the chelated species.
The corresponding percentages are listed in column 7 of Table 7.
The analogous results for the M(2HOPr)þ and M(CH3OAc)
þ
complexes are also summarized in Table 7.
Comparison of the results assembled in Table 7, where
OAc� = HOAc�, 2HOPr�, or CH3OAc
�, with those of Table 2
shows that with a singly negatively charged carboxylate group as a
primary binding site, compared with the situation of the 2-fold
negatively charged phosphonate group, the formation degrees of
the chelated species are considerably larger. Indeed, the stability
enhancements, log ΔM/PBS�OH, for Mg
2þ, Ca2þ, and Cu2þ, for
which a direct comparison is possible, are by about 0.4�0.65 log
units larger for the M(HOAc)þ species, compared with the
M(HMP) ones.
Interestingly, replacement of a H atom in the methylene unit
of HOAc� by a CH3 group leading to 2HOPr
� (see Figure 4) has
no signiﬁcant inﬂuence on the observed stability enhancements
(log ΔM/OAc) and the formation degrees of the closed species
(%M(OAc)cl
þ) (see Table 7, columns 5 and 7). In fact, the values
are mostly the same within the error limits for the M(HOAc)þ
and M(2HOPr)þ species.
Even though only two systems are available (Ca2þand Cu2þ)
for which the H atom of the OH group in HOAc� was replaced
by CH3, giving an ether oxygen as a potential binding site, it
seems clear that the methyl group inhibits somewhat the O/M2þ
interaction, that is, % M(HOAc)þ > % M(CH3OAc)
þ. Since
in both cases the diﬀerence between log ΔM/HOAc and log
ΔM/CH3OAc amounts to about 0.4 log unit, and this despite the
fact that one example is from an alkali earth metal ion (Ca2þ) and
the other one from a 3d transition-metal ion (Cu2þ), one may
conclude that the ether oxygen is a poorer ligand also for the
other metal ions which appear in Table 7.
Another remarkable result is the observation that Ca2þ has an
especially pronounced aﬃnity toward the �OH site. For both
types of complexes, M(HOAc)þ and M(2HOPr)þ, the series
holds: Ba(OAc)cl
þ < Sr(OAc)cl
þ < Ca(OAc)cl
þ > Mg(OAc)cl
þ.
Indeed, more astonishing is that % Ca(OAc)cl
þ is very similar
to % Cu(OAc)cl
þ (Table 7) and this despite the fact that the
Cu(OAc)þ complexes are by a factor of about 20 (or more)more
stable than the Ca(OAc)þ ones (Table 7, column 3). It is
interesting to note in this context that Ca2þ is able to inhibit
strongly the Mg2þ-promoted self-splicing reaction of a RNA
(group II intron).50,51 With regard to biological systems52 it is
further noteworthy that Mg2þ and Mn2þ have within the error
Figure 5. Evidence for an enhanced complex stability of the Ba2þ(b),
Ca2þ (2), Mn2þ (9), and Cu2þ (b) 1:1 complexes of HOAc� based on
the relationship between log KM(CA)
M and pKH(CA)
H for the simple carbox-
ylate ligands (CA�) listed in Table 4. The parameters of the corresponding
least-squares reference lines (eq 10) are summarized in Table 5. The data
for the points due to the equilibriumconstants of theM2þ/HOAc� systems
are given in Table 7. The vertical dotted lines emphasize the stability
diﬀerences to the reference lines; they equal log ΔM/HOAc , as deﬁned in
eqs 11a and 11b (see also Table 7, column 5). All plotted equilibrium
constants refer to aqueous solutions at 25 C and I = 0.1 M.
Table 6. Logarithmic Diﬀerences between the Experimen-
tally Determined Stability Constants (log KM(CA)
M of Table 4)
of the M2þ Complexes for the Simple Carboxylate Ligands
(CA�) Listed in Column 2 of Table 4 and the Least-Squares
Lines of the log KM(CA)
M versus pKH(CA)
H Plots as Deﬁned in
Table 5 (the bottom line of the table gives the standard
deviation (SD)b resulting from the listed diﬀerences)
M(CA)þ complexes for M2þ =
no.a CA�a Ba2þ Sr2þ Ca2þ Mg2þ Mn2þ Cu2þ Zn2þ
1 ClAc� 0.01 �0.05
2 HCOO� �0.02 0.01
3 Ac� �0.04 �0.07
4 2MPr� 0.01 0.01
5 3MBu� �0.07 �0.04
6 4MVa� �0.06 �0.01
7 5MHx� 0.00 �0.02
8 6MHp� 0.01 0.01
9 ClAc� 0.00 �0.01
10 BrAc� 0.00
11 HCOO� 0.00 0.01 0.01 0.07
12 Bz� 0.00
13 Ac� 0.06 0.03 0.04 �0.01 0.00 0.03 0.07
14 Pr� �0.06 �0.03 �0.04 0.00 0.12 0.00
SDb 0.035 0.04c 0.016 0.01c 0.04c 0.015 0.013
aThe entry numbers correspond to those of Table 4 to facilitate
comparisons. For the deﬁnition of the abbreviations see footnote “a”
of Table 4. bThe standard deviation (SD) times three is considered as a
reasonable error limit for any calculation of the stability of a M(CA)þ
complex based on the straight lines deﬁned in Table 5 for the pKa range
2.5�5. c Error limit enlarged from 0.03 to 0.04 (Sr2þ), from 0.005 to
0.01 (Mg2þ), and from 0.00 to 0.04 (Mn2þ).
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limits the same aﬃnity toward the �OH group when already
bound to the primary carboxylate site (Table 7).
4.2. Extent of Chelate Formation in Complexes of Hydro-
xyacetate-Type Ligands at I = 2 M
Acidity constants of simple carboxylate ligands, H(CA), and
the stability constants of their corresponding metal-ion com-
plexes, M(CA)þ, at I = 2 M, as taken from refs 53 and 17,
are listed in Table 8. As expected, plots of log KM(CA)
M versus
pKH(CA)
H result in straight lines, and these are deﬁned by the
parameters summarized in Table 9. Interestingly, the slopes
m of the plots are considerably steeper at I = 2 M than at I =
0.1 M (cf. Table 5). This is most likely the consequence of the
high salt concentration (NaClO4) which “uses” a large part of the
water molecules for its own solvation, leaving the carboxylate
groups more exposed, that is, less screened by H2O molecules.
Table 7. Comparison of the Measured (exp) Stability Constants, KM(OAc)exp
M (eqs 4a, 4b, and 6), of the M2þ 1:1 Complexes
Formed by Hydroxyacetate (HOAc�)b and the Related Ligands D-2-Hydroxypropanoate (2HOPr� = lactate)b and Methoxy-
acetate (CH3OAc
�),b with the Calculated Stability Constants for the Open Isomers with a Sole Carboxylate�M2þ Coordination,
KM(OAc)op
M (eqs 1 and 7)a
OAc� M2þ log KM(OAc)exp
M c log KM(OAc)op
M log ΔM/OAc KI % M(OAc)cl
þ
HOAc� Ba2þ 0.66( 0.06 0.24( 0.11 0.42( 0.13 1.63( 0.76 62( 11
Sr2þ 0.80( 0.06 0.30( 0.12 0.50( 0.13 2.16( 0.98 68( 10
Ca2þ 1.11( 0.06 0.33( 0.05 0.78( 0.08 5.03( 1.08 83( 3
Mg2þ 0.92( 0.06 0.38( 0.03 0.54( 0.07 2.47( 0.54 71( 4
Mn2þ 1.23( 0.10d 0.63( 0.12 0.60( 0.16 2.98( 1.43 75( 9
Cu2þ 2.40( 0.06 1.61( 0.05 0.79( 0.08 5.17( 1.11 84( 3
Zn2þ 1.98( 0.04 0.94( 0.04 1.04( 0.06 9.96( 1.43 91( 1
2HOPr� Ba2þ 0.55( 0.06 0.24( 0.11 0.31 ( 0.13 1.04( 0.59 51( 14
Sr2þ 0.70( 0.06 0.31( 0.12 0.39( 0.13 1.45( 0.76 59 ( 13
Ca2þ 1.07( 0.06 0.34( 0.05 0.73( 0.08 4.37( 0.97 81 ( 3
Mg2þ 0.93( 0.06 0.38( 0.03 0.55( 0.07 2.55( 0.55 72 ( 4
Mn2þ 1.19( 0.06 0.64( 0.12 0.55( 0.13 2.55( 1.10 72 ( 9
Cu2þ 2.54( 0.06 1.61( 0.05 0.93( 0.08 7.51( 1.53 88 ( 2
Zn2þ 1.86( 0.06 0.94( 0.04 0.92( 0.07 7.32( 1.38 88 ( 2
CH3OAc
� Ca2þ 0.70( 0.10e 0.27( 0.05 0.43 ( 0.11 1.69( 0.69 63( 10
Cu2þ 1.92( 0.10f 1.56 ( 0.05 0.36( 0.11 1.29( 0.59 56( 11
aThe observed stability increase is expressed by log ΔM/OAc (eqs 11a and 11b). The extent of chelate formation according to the intramolecular
equilibria 1 and 2 for the M(OAc)þ complexes is quantiﬁed by the dimensionless equilibrium constant KI (eqs 7 and 9) and the percentage of closed
isomers M(OAc)cl
þ (eq 13). All data refer to aqueous solutions at 25 C and I = 0.1 M.17 bThe corresponding acidity constants (eqs 14a and 14b) are
pKH(HOAc)
H = 3.62( 0.03, pKH(2HOPr)H = 3.66( 0.03, and pKH(CH3OAc)
H = 3.32.17 c If available, the error limits given in the literature17 are cited; otherwise,
an error of(0.06 log unit is assumed. In those instances, where a value had to be corrected for a change in ionic strength, an error limit of(0.10 log unit
is used. dCorrected value: For 25 C and I = 0 M, log K = 1.58 is listed in ref 17. On the basis of the comparisons for Mg(HOAc)þ and Co(HOAc)þ
between I = 0.1M and I = 0M, the mentioned constant was reduced by 0.35 log unit. eCorrected value: For 25 C and I = 0M, logK = 1.12 is listed in ref
17. On the basis of comparisons forM(HOAc)þwithM2þ =Mg2þ, Ca2þ, and Ba2þ between I = 0.1M and I = 0M, thementioned constant was reduced
by 0.42 log unit. fCorrected value: For 25 C and I = 1M, log K = 1.83 is listed in ref 17. On the basis of the diﬀerence of 0.09 log units for Cu(HOAc)þ
between the values at I = 0.1 and 1 M, the mentioned value is enhanced: 1.83 þ 0.09 = 1.92.
Table 8. Logarithms of the Stability Constants for the 1:1 Complexes (eqs 4a, 4b, and 6) Formed between Several Divalent Ions
(M2þ) and Simple Carboxylate Ligands (CA�) As Well As Negative Logarithms of the Acidity Constants (eqs 14a and 14b) of the
Corresponding H(CA) Species, Mostly Determined by Potentiometric pH Titrations, for Aqueous Solutions at 25 C and I = 2 M
(NaClO4)
a
log KM(CA)
M for M2þ =
no.b CA�c pKH(CA)
H Co2þ Ni2þ Cu2þ Zn2þ Cd2þ Pb2þ
1 ClAc� 2.74 0.00( 0.04 0.20( 0.03 1.26( 0.19 0.40( 0.02 0.84 ( 0.01 1.3
2 HCOO� 3.73 0.40( 0.05 0.46( 0.02 1.65( 0.06 0.70( 0.03 1.02( 0.02 1.44
3 Ac� 4.80( 0.01 0.66( 0.04 0.72( 0.02 2.11( 0.01 0.85( 0.04 1.08( 0.04 1.91 ( 0.03
4 Pr� 4.89 0.70( 0.03 0.73( 0.03 2.16( 0.01 1.00 ( 0.03 1.23( 0.03 2.07( 0.06
5 Bu� 4.86 0.66( 0.01 0.73( 0.02 2.08( 0.02 0.98 ( 0.05 1.20( 0.03 2.17( 0.06
6 PhAc� 4.30( 0.04 0.62 0.65 1.15
a In those instances where an error limit is given, it is taken from the cited references. The acidity constants in column 3 are from ref 17. The value for
formate is interpolated from those given for I = 1 and 3M; this agrees with the observations made for acetate. bThe stability constants listed in rows 1�5
are from ref 53 except those for Pb(ClAc)þ, Pb(HCOO)þ, and Cd(HCOO)þ which are from ref 17; the same holds for the stability constants given in
the ﬁnal row. c For the deﬁnition of the ligand abbreviations see footnote a of Table 4; in addition, Bu� = butanoate, PhAc� = phenylacetate.
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Table 10 provides the diﬀerences of the individual complex
stability constants from the reference lines. The resulting values
for the standard deviation (SD) are given in the bottom row of
Table 10. These values times three are recommended as reason-
able error limits for any log KM(CA)
M calculation with the straight-
line parameters of Table 9. It may be emphasized that the
evaluation indicated in this and the preceding paragraph follows
exactly the procedure described in more detail in section 4.1.1 for
I = 0.1 M.
As an example, Figure 6 shows the plots for the systems with
Co2þ, Zn2þ, and Cu2þ. In all three instances the data points
(solid symbols) of the M2þ/Hþ/HOAc� systems are far above
their reference lines demonstrating unequivocally that the hydroxyl
group of hydroxyacetate participates in metal-ion binding and that
equilibrium 1 operates also under the present conditions deﬁned by
I = 2 M.
A quantitative evaluation of the results seen in Figure 6 is
given in Table 11 for the biologically essential metal ions52
Co2þ, Ni2þ, Cu2þ, and Zn2þ as well as for the commonly toxic
ones, i.e., Cd2þ and Pb2þ.54 Next to HOAc� also the ligands
2HOPr� (lactate) as well as the alkyl derivatives of HOAc�,
that is, CH3OAc
� and EtOAc�, are considered (see
Figure 4).17,53,55 The evaluation follows the pathway given in
section 4.1.2 by applying eqs 7 and 9�13.
There are many comparisons possible; a few are given below:
(i) A comparisonwith the results obtained at I=0.1M(Table 7)
is possible only for a few instances, namely, for Cu(HOAc)þ,
Zn(HOAc)þ, Cu(2HOPr)þ, and Cu(CH3OAc)
þ. In three
cases the values at I = 0.1 (Table 7) and 2 M (Table 11) for
log ΔM/OAc and % M(OAc)cl
þ are identical within the error
limits. Only for Cu(2HOPr)cl
þ do the values not overlap, but
% Cu(2HOPr)cl
þ are with 88( 2% (Table 7) and 82( 3%
(Table 11), still very similar. This allows the conclusion that a
change in I from 0.1 to 2Mdoes not aﬀect equilibrium 1 very
signiﬁcantly. This observation is important because it means
that the results of Tables 7 and 11 complement each other,
and thus, generalizations with systems containing another
primary binding site become possible (see section 9).
(ii) The formation degrees of the M(HOAc)þ and the
M(2HOPr)þ complexes (Table 11) are identical within
the error limits for a given metal ion. This means that the
additional methyl group present at the carbon which
carries the �OH group has no remarkable inﬂuence on
complex stability.
(iii) Replacement of the H atom in the �OH group of HOAc�
by aCH3 group leads to an ether oxygen. This ether oxygen is
clearly less suitable for an�O/M2þ interaction than the one
of the �OH group. Indeed, for the three examples where a
comparison is possible, i.e., the Co2þ, Ni2þ, and Cu2þ
Table 9. Straight-Line Parameters (eq 10) for M2þ1:1
Complexes Formed with Simple Carboxylate Ligands (CA�),
Valid for Aqueous Solutions at 25 C and I = 2M (NaClO4)a,b
M2þ m b
Co2þ 0.311( 0.032 �0.804( 0.138
Ni2þ 0.249( 0.014 �0.469 ( 0.062
Cu2þ 0.408( 0.016 0.139( 0.067
Zn2þ 0.253( 0.032 �0.279( 0.139
Cd2þ 0.156( 0.031 0.427( 0.134
Pb2þ 0.385( 0.075 0.159( 0.322
aThe slopes (m) and intercepts (b) for the straight reference lines from
plots of log KM(CA)
M versus pKH(CA)
H were calculated by the least-squares
procedure from the experimentally determined equilibrium constants
listed in Table 8 (see also Figure 6). bThe straight-line equation is
deﬁned by eq 10. With a known pKH(CA)
H value of any carboxylate
derivative the stability constant (log KM(CA)
M ) of the corresponding
M(CA)þ complex (eqs 4a, 4b, and 6) can be calculated; the errors given
with m and b correspond to one standard deviation (1σ).
Table 10. Logarithmic Diﬀerences between Experimentally
Determined Stability Constants (log KM(CA)
M ; Table 8) of the
M2þ Complexes for the Simple Carboxylate Ligands (CA�)
Listed in Column 2 of Table 8b and the Least-Squares Lines of
the log KM(CA)
M versus pKH(CA)
H Plots as Deﬁned in Table 9a
M(CA)þ complexes for M2þ =
no.b CA�d Co2þ Ni2þ Cu2þ Zn2þ Cd2þ Pb2þ
1 ClAc� �0.05 �0.01 0.00 �0.01 �0.01 0.09
2 HCOO� 0.04 0.00 �0.01 0.04 0.01 �0.16
3 Ac� �0.03 �0.01 0.01 �0.09 �0.10 �0.10
4 Pr� �0.02 �0.02 0.03 0.04 0.04 0.03
5 Bu� �0.05 �0.01 �0.04 0.03 0.01 0.14
6 PhAc� 0.09 0.05 0.05
SDc 0.023 0.010 0.012 0.025 0.027 0.057
aThe bottom line of the table gives the standard deviation (SD)d
resulting from the listed diﬀerences. bThe entry numbers correspond
to those of Table 8 to facilitate comparisons. cThe standard deviation
(SD) times three is considered as a reasonable error limit for any
calculation of the stability of a M(CA)þ complex based on the straight
lines deﬁned in Table 9 in the pKH(CA)
H range of about 2.5�5. d For the
deﬁnition of the ligand abbreviations see footnote a of Table 4 and c of
Table 8.
Figure 6. Evidence for an enhanced complex stability of the Co2þ (2),
Zn2þ (9), and Cu2þ (b) 1:1 complexes of HOAc� based on the
relationship between log KM(CA)
M and pKH(CA)
H for the simple carboxylate
ligands (CA�) listed in Table 8. The parameters of the corresponding
least-squares reference lines (eq 10) are summarized in Table 9. The data
for the points due to the equilibrium constants for the M2þ/HOAc�
systems are given in Table 11. The vertical dotted lines emphasize the
stability diﬀerences to the reference lines; they equal log ΔM/HOAc, as
deﬁned in eqs 11a and 11b (see also Table 11, column 5). All plotted
equilibrium constants refer to aqueous solutions at 25 C and I = 2 M.
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systems (Table 11), the log ΔM/OAc values decrease due to
methylation by about (on average) 0.4 log unit. Replacement
of the methyl group by an ethyl moiety diminishes the
interaction further but only marginally.
4.3. Effect of Chelate-Ring Enlargement on the Hydro-
xyl�Metal-Ion Interaction
Hydroxyacetate (HOAc�) is the prime ligand considered in
section 4 so far. It is thus natural to continue with its chain-enlarged
analogues 3-hydroxypropanoate (3HOPr�; HO�CH2CH2�
COO�) and 4-hydroxybutanoate (4HOBu�; HO�CH2CH2�
CH2�COO�); these ligands may form with M2þ 6- or 7-mem-
bered chelates, whereas HOAc� forms 5-membered ones as we
have already seen (sections 4.1.2 and 4.2).
The available stability constants of M(3HOPr)þ and
M(4HOBu)þ complexes17 are listed in column 4 of Table 12,
where OCA� = 3HOPr� and 4HOBu�; most of the experimental
data were obtained at I = 2 M. Application of the straight-line
parameters of Table 9 (and where appropriate of Table 5),
together with the acidity constants, allowed one to calculate the
stability of the open isomers (eqs 1 and 7) (Table 12, column 5).
The resulting stability diﬀerences, logΔM/OCA (eqs 11a and 11b),
appear in the last column of Table 12.
There is a discrepancy regarding the results for theCu(3HOPr)þ
complex; however, we are convinced that the result listed for I =
0.1M is themore correct one because from a coordination chemical
point of view it makes much more sense than the negative value
obtained for log ΔCu/3HOPr at I = 2 M. Though the results for the
Zn2þ, Cd2þ, and Pb2þ complexes are practically zero within the
error limits, small amounts of M(OCA)cl
þ species still may form.
However, the logΔM/3HOPr values for theM(3HOPr)
þ complexes
with Co2þ, Ni2þ, and Cu2þ (at I = 0.1 M) are clearly positive.
Hence, in these instances 6-membered chelates form. The forma-
tion degree of the M(3HOPr)cl
þ isomers is not overwhelming but
from logΔM/3HOPr = 0.3 follows a formation degree of about 50%.
Despite the fact that this number is remarkable, it is much smaller
than the formation degrees found in Tables 7 and 11 for the
corresponding M(HOAc)þ complexes, and this means that the
5-membered chelates are more stable than the 6-membered ones.
The log ΔM/4HOBu values (Table 12, column 6) for the
M(4HOBu)þ complexes are throughout either zero within
the error limits or even negative. The only exception seems
to be the value at I = 2 M for Cd(4HOBu)þ. However, we do
not believe that this value is correct, the stability constant for
Cd(4HOBu)þ compared to the one for Zn(4HOBu)þ appears
to us as too large (see column 4 of Table 12). In fact, the same
also holds for the values of Cd(3HOPr)þ and Zn(3HOPr)þ;
commonly these values are more similar or the trend is even reverse
(see also Table 11). To conclude, we consider the result obtained at
I = 1 M for Cd(4HOBu)þ as the correct one, and this then means
that throughout only traces of M(4HOBu)cl
þ species are formed, if
at all.
The overall result thus is, in accord with the conclusions
presented in section 3.3, that the stability of the chelates decreases
with increasing ring size in the order 5-membered > 6-membered >
7-membered ring.
Table 11. Comparison of the Measured (exp) Stability Constants, KM(OAc)exp
M (eqs 4a, 4b, and 6), of the M2þ 1:1 Complexes
Formed by Hydroxyacetate (HOAc�)b and the Related Ligands D-2-Hydroxypropanoate (2HOPr� = lactate),b Methoxyacetate
(CH3OAc
�),b and Ethoxyacetate (EtOAc�),b with the Calculated Stability Constants for the Open Isomers with a Sole
Carboxylate�M2þ Coordination, KM(OAc)opM (eqs 1 and 7)a
OAc� M2þ log KM(OAc)exp
M c log KM(OAc)op
M log ΔM/OAc KI % M(OAc)cl
þ
HOAc�d Co2þ 1.48( 0.03 0.36 ( 0.07 1.12( 0.08 12.18( 2.31 92( 1
Ni2þ 1.69( 0.02 0.46 ( 0.03 1.23( 0.04 15.98( 1.41 94( 1
Cu2þ 2.43( 0.03 1.66 ( 0.04 0.77( 0.05 4.89( 0.68 83( 2
Zn2þ 1.72( 0.06 0.67 ( 0.07 1.05( 0.09 10.22( 2.38 91( 2
Cd2þ 1.51( 0.02 1.01 ( 0.08 0.50( 0.08 2.16( 0.60 68( 6
Pb2þ 2.12( 0.10 1.60 ( 0.17 0.52( 0.20 2.31( 1.50 70( 14
2HOPr�e Co2þ 1.39( 0.06 0.38( 0.07 1.01( 0.09 9.23( 2.17 90( 2
Ni2þ 1.57( 0.06 0.48( 0.03 1.09( 0.07 11.30( 1.90 92( 1
Cu2þ 2.43( 0.06 1.69( 0.04 0.74( 0.07 4.50( 0.91 82( 3
Cd2þ 1.40( 0.08 1.02( 0.08 0.38( 0.11 1.40( 0.62 58( 11
Pb2þ 2.16( 0.06 1.62( 0.17 0.54( 0.18 2.47( 1.44 71( 12
CH3OAc
�e Co2þ 1.16( 0.06 0.30( 0.07 0.86 ( 0.09 6.24( 1.54 86( 3
Ni2þ 1.26( 0.06 0.42( 0.03 0.84 ( 0.07 5.92( 1.07 86( 2
Cu2þ 1.81( 0.06 1.59( 0.04 0.22 ( 0.07 0.66( 0.28 40( 10
EtOAc�e Co2þ 1.06( 0.06 0.33( 0.07 0.73( 0.09 4.37( 1.14 81( 4
Ni2þ 1.17( 0.06 0.44( 0.03 0.73( 0.07 4.37( 0.83 81( 3
Cu2þ 1.74( 0.06 1.62( 0.04 0.12( 0.07 0.32( 0.22 24( 13
aThe observed stability increase is expressed by log ΔM/OAc (eqs 11a and 11b). The extent of chelate formation according to the intramolecular
equilibria 1 and 2 for theM(OAc)þ complexes is quantiﬁed by the dimensionless equilibrium constantKI (eqs 3 and 9) and the percentage of the closed
isomers M(OAc)cl
þ (eq 13). All data refer to aqueous solutions at 25 C and I = 2 M (NaClO4).17,53 bThe corresponding acidity constants17 are
pKH(HOAc)
H = 3.74( 0.03, pKH(2HOPr)H = 3.80( 0.02, pKH(CH3OAc)
H = 3.56( 0.10 (average of the values at I = 1 and 3M), and pKH(EtOAc)H = 3.51þ 0.13
(based on HOAc�) = 3.64( 0.10. c If available, the error limits given in the literature17,53 are cited; otherwise, an error of(0.06 log unit is assumed. In
those instances where a value had to be corrected for a change in ionic strength, an error limit of(0.10 log unit is used. dThe stability constants are from
ref 53 except the one for Cu(HOAc)þ which is from ref 17 and that for Pb(HOAc)þ which is the average of the values given in ref 17 for I = 1 and 3 M.
eThese stability constants are from ref 17 (for 2HOPr�, see also ref 55).
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4.4. Decreasing Solvent Polarity Favors the Hydroxyl�
Metal-Ion Interaction in Complexes of Hydroxyacetate
and Related O Ligands But Inhibits Thioether Interactions
In section 3.3 (in the third to the last paragraph) it was already
indicated that in certain cavities of proteins or nucleic acids the
solvent polarity, that is, the permittivity, may be considerably
reduced. Such conditions can be mimicked by, e.g., addition of
1,4-dioxane to an aqueous solution (see Table 3). Below we are
investigating the eﬀect of 50% (v/v) aqueous dioxane on the
weak interactions as they may occur with a hydroxyl group, an
ether oxygen, or a thioether residue in the ligands shown in
Figure 7, i.e., hydroxyacetate (HOAc�), tetrahydrofuran-2-
carboxylate (THF2CA�), or tetrahydrothiophen-2-carboxylate
(THT2CA�). The metal ions considered are Mn2þ, Cu2þ, and
Zn2þ.
In columns 4�7 of Table 13, we list the acidity constants of
H(CA) species (eqs 14a and 14b) and the stability constants of
their corresponding M(CA)þ complexes (eqs 4a and 4b) for
several simple carboxylate ligands (CA�).56�58With these values
straight linesmay be deﬁned according to eq 10 (see also Figure 8
below); these results are given in footnote b of Table 13. The
recommended error limits for the application of the straight-line
parameters in the pKa range of about 4�7 are deﬁned in the
bottom row of Table 13 and in footnote c of the same table.
With the results of Table 13 we are now in the position to
evaluate the complex stabilities of the Mn2þ, Cu2þ, and Zn2þ
species formed with the ligands seen in Figure 7. The corre-
sponding plots are shown in Figure 8 into which also the data
points of the M2þ/Hþ/HOAc�, M2þ/Hþ/THF2CA�, and
M2þ/Hþ/THT2CA� systems have been inserted.56,58 From
the vertical dotted lines in Figure 8 it is immediately evident
that the two ligands, which oﬀer next to the carboxylate group a
further oxygen unit, form complexes which lead to a considerable
stability enhancement. Replacement of the oxygen by a sulfur
atom leads only for Cu(THT2CA)þ to a remarkable stability
enhancement, whereas the aﬃnity of Zn2þ and Mn2þ for the
thioether unit is apparently low. This is a surprising result which
needs to be discussed further (see below).
Application of eqs 6�13 allows a quantitative evaluation of the
situation seen in Figure 8. The corresponding results are
summarized in Table 14, where XCA� = HOAc�, THF2CA�,
or THT2CA�.
FromTable 14many conclusions can be drawn, a few of which
are given below:
(i) Comparison of the results obtained for an aqueous solu-
tion (Table 7) and for water containing 50% (v/v)
1,4-dioxane (Table 14) reveals that the stability enhance-
ments and consequently the formation degrees of the
chelated species, M(HOAc)cl
þ, are signiﬁcantly higher in
the water�dioxane mixture, that is, a decreasing solvent
polarity favors the �OH/M2þ interaction.
(ii) For the M(THF2CA)þ complexes no data for aqueous
solution are available. However, comparison with the data
listed at the bottom of Table 7 for M(CH3OAc)
þ suggests
that the conclusion of point (i) is also valid for ether�
metal-ion interactions.
(iii) Comparison of the results given in Table 14 for logΔM/XCA
and %M(XCA)cl
þ shows that the values for M(HOAc)þ are
clearly larger than those forM(THF2CA)þ. This means, the
�OH/M2þ interaction is more intense than the ether�O/
M2þ one.
(iv) Of general interest are also the results obtained for the
complexes of the thio ligand, THT2CA� (Figure 7), even
though sulfur sites are not in the focus of this review. Only
the Cu(THT2CA)þ complex reveals a signiﬁcant stability
enhancement in the mixed solvent, and the formation
degree of the closed species involving a metal-
ion�thioether interaction amounts to 93%. That the
thiophilicity of Mn2þ in aqueous solution is very poor is
well known,59�61 and its consequences for so-called rescue
experiments carried out with ribozymes have been point-
ed out.13,14,62,63 Thus, it is no surprise that this also holds for
an aqueous solution containing 50% (v/v) 1,4-dioxane.
However, the result obtained for Zn(THT2CA)þ is a
surprise: In aqueous solution Zn2þ shows a rather pro-
nounced thiophilicity,59�61 and this is strongly reduced
in the presence of dioxane; the stability enhancement log
Table 12. Comparison of the Measured (exp) Stability Con-
stants, KM(OCA)exp
M (eqs 4a, 4b, and 6), of the M2þ 1:1
Complexes Formed by 3-Hydroxypropanoate (3HOPr�) or
4-Hydroxybutanoate (4HOBu�) with the Calculated Stability
Constants for the Open Isomers with a Sole Carboxylate�
M2þ Coordination, KM(OCA)op
M (eqs 1 and 7)a,b
OCA� M2þ I log KM(OCA)exp
M c log KM(OCA)op
M d log ΔM/OCA
3HOPr� Co2þ 2 0.86( 0.10 0.61( 0.07 0.25( 0.12
Ni2þ 2 0.96( 0.10 0.67 ( 0.03 0.29( 0.10
Cu2þ 2 1.83 ( 0.10 2.00( 0.04 �0.17 ( 0.11
0.1 2.05( 0.10e 1.74( 0.05 0.31( 0.11
Zn2þ 2 0.86( 0.10 0.87( 0.08 �0.01( 0.13
Cd2þ 2 1.28( 0.10 1.14( 0.08 0.14( 0.13
Pb2þ 2 2.10( 0.10 1.91( 0.17 0.19( 0.20
1 1.95( 0.10 1.88( 0.17f 0.07( 0.20
4HOBu� Co2þ 2 0.47( 0.10 0.70 ( 0.07 �0.23( 0.12
Ni2þ 2 0.58( 0.10 0.74( 0.03 �0.16 ( 0.10
Cu2þ 2 1.76( 0.10 2.12 ( 0.04 �0.36( 0.11
Zn2þ 2 0.96( 0.10 0.95( 0.08 0.01 ( 0.13
Cd2þ 2 1.39( 0.10 1.18 ( 0.08 0.21( 0.13
1 1.10( 0.10 1.14( 0.08g �0.04 ( 0.13
Pb2þ 2 2.18( 0.10 2.03 ( 0.17 0.15( 0.20
aThe stability diﬀerences are expressed by log ΔM/OCA (eqs 11a and
11b) (aqueous solution; 25 C; I = 0.1 or 2 M (NaClO4)).17 bThe
corresponding acidity constants are pKH(3HOPr)
H = 4.56 (I= 2M,NaClO4)
and 4.40 (I = 0.1M) as well as pKH(4HOBu)
H = 4.85 (I = 2M,NaClO4) and
4.54 (I = 1M, NaClO4).
17 cThe error limits are (deliberately generously)
assumed to be(0.10 log unit. dCalculated with the acidity constantsb and
the straight-line parameters of Tables 5 (I = 0.1M) and 9 (I = 2M). eThis
value was determined at 30 C.17 fCalculated with pKH(3HOPr)H = 4.48
(average of the values at I = 0.1 and 2 M)b and the parameters of Table 9
(I = 2 M). gCalculated with pKH(4HOBu)
H = 4.54 (I = 1 M) and the
parameters of Table 9 (I = 2 M).
Figure 7. Indication of the structural relationship between hydroxy-
acetate (HOAc�) on the one hand and tetrahydrofuran-2-carboxylate
(THF2CA�) and tetrahydrothiophen-2-carboxylate (THT2CA�) on
the other.
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ΔZn/THT2CA = 0.14 ( 0.07 is rather small, and conse-
quently, the formation degree of Zn(THT2CA)cl
þ is low.
We assume that this is the result of the low hydrophilicity of
the tetrahydrothiophen residue which is therefore strongly
solvated by dioxane with the result that the metal-
ion�thioether interaction is somewhat inhibited. This in-
hibition is overcome by Cu2þ but not by Zn2þ.
5. METAL-ION COMPLEXES WITH AMINO GROUPS AS
PRIMARY BINDING SITES
The ligand in the focus of this section is 2-aminoethanol
(AEtOH) (Figure 9). The diﬃculty in evaluating its metal-ion
binding properties is that straight-line plots of the type log
KM(R-NH2)
M versus pKH(R-NH2)
H cannot easily be constructed because
no values for a series of simpleR�NH2 ligands exist.17,18 It would be
necessary to have data available for complexes of the ligand-type
CH3�NH2, ClCH2�NH2, FCH2�NH2, etc. This means we have
to evaluate the steric eﬀect that a CH2 residue exercises onmetal-ion
binding at an amino group in a diﬀerent way.
To achieve this goal we employed the ligands shown in Figure 9.
For seven metal ions there are enough equilibrium data regarding
2-aminoethanol available to allow an evaluation. These con-
stants together with those of related systems are collected in
Table 15.17,64�68 A few constants are given for comparison only,
like, e.g., the stability constant of the glycinate (Gly�) complex
with Mn2þ, and will not actually be used because no value for the
corresponding sarcosinate complex is available.17,18
In any case, that the replacement of a hydrogen atom by a
methyl group in NH3 leads to steric inhibition is evident, e.g.,
from a comparison of the stabilities of the Ni(NH3)
2þ and
Ni(CH3NH2)
2þ complexes at I = 0.5 M; the diﬀerence amounts
to about 0.6 log unit (= 2.77�2.19) (Table 15), and this is
despite the fact that methylamine is by Δ pKa = 1.4 more basic!
In the present evaluation process described in section 5.1, it
will be necessary to dive into a deep hole with uncertain
boundaries. However, in section 5.2 it will become obvious that
despite all initial uncertainties and assumptions clear-cut results
are obtained for aqueous solutions at 25 C and I = 0.5 M.
5.1. Estimation of Straight-Line Parameters for Complexes
Formed with RCH2�NH2 Ligands
How can we obtain log KM(RCH2�NH2)
M versus pKH(RCH2�NH2)
H
straight-line plots? Evidently, for the deﬁnition of a straight line at
least two data points are needed. Unfortunately, e.g., for Ni2þ
only one data point is available: Hþ/Ni2þ/CH3NH2 (see
Table 15). This point is inserted into Figure 10. How can we
obtain a second point? Can we correct the Hþ/Ni2þ/NH3
system for the inhibition due to a methyl group at NH3? Yes, we
can by using the available information for the Hþ/Ni2þ/Gly�
and Hþ/Ni2þ/Sar� systems. Here, the terminal amino group of
glycinate is substituted with a methyl group giving sarcosinate
(see Figure 9).
By using the slopem = 0.70 for log K versus pKa plots for amino
acetate complexes as estimated byMartin69 one can deﬁne a straight
line through the data point Hþ/Ni2þ/Gly�, that is, log KNi =
(0.70) 3pKa� 1.05, which holds for glycinate-like systems. Applica-
tion of this line to sarcosinate with pKa = 10.00 (Table 15) gives an
expected stability for the Ni(Sar)þ complex of log K = 5.95. Since
the pKa values of glycinate and sarcosinate are not far apart, the
result is not very sensitive toward the slopem used. Comparison of
the calculated value with the measured one (Table 15) gives a steric
inhibition (SI) of log SINi = (5.95( 0.10)� (5.24( 0.06) = 0.71
with an estimated error limit of (0.12.
This value for log SI agrees well with the following estimation
which is based on the Ni2þ complexes of CH3NH2 and
(CH3)2NH at I = 1.0 M.
17 If one ignores the small basicity
diﬀerence, i.e., ΔpKa = pKH(CH3NH2)
H � pKH(CH3)2NHH = (10.84 (
0.04) � (11.02 ( 0.06) = �0.18 ( 0.07, and compares the
Table 13. Logarithms of the Stability Constants for the 1:1 Complexes (eqs 4a, 4b, and 6) Formed between Mn2þ, Cu2þ, or Zn2þ
and Simple Carboxylate Ligands (CA�) As Well As Negative Logarithms of the Acidity Constants (eqs 14a and 14b) of the
Corresponding H(CA) Species, Determined by Potentiometric pH Titrations in Water Containing 50% (v/v) 1,4-Dioxane at
25 C and I = 0.1 M (NaClO4)a
no. refd CA�e pKH(CA)
H log KMn(CA)
Mn log KCu(CA)
Cu log KZn(CA)
Zn log ΔMn log ΔCu log ΔZn
1 56 ClAc� 4.08( 0.02 1.66 2.53 1.83 �0.04 0.00 0.03
2 57 HCOO� 4.73( 0.02 1.82f 2.79( 0.02 1.96 ( 0.01 0.04 �0.01 �0.02
3 56 ClPr� 5.50( 0.02 1.88 3.13 2.17 0.01 0.02 �0.02
4 57 Bz� 5.76( 0.01 1.90f 3.24( 0.02 2.27 ( 0.02 �0.01 0.03 0.01
5 57 PhAc� 5.88( 0.01 3.22( 0.02 2.26 ( 0.02 �0.04 �0.04
6 57 Ac� 5.97( 0.01 1.97f 3.31( 0.02 2.31 ( 0.01 0.04 0.02 �0.01
7 57 PhPr� 6.18( 0.01 3.36( 0.01 2.36 ( 0.01 �0.02 �0.02
8 58 Pr� 6.29( 0.01 1.92f 3.45 2.41 �0.05 0.03 0.00
9 57 PhBu� 6.36( 0.01 3.44( 0.02 2.46 ( 0.01 �0.01 0.03
10 57 PhVa� 6.43 ( 0.01 3.48( 0.01 2.49 ( 0.01 0.00 0.04
SDc 0.016 0.007 0.009
aThe logΔ values in the three columns at the right are the logarithmic diﬀerences between themeasured stability constants (columns 5, 6, and 7) and the
calculated ones based on the straight reference lines (see Figure 8).b The bottom line of the table lists the standard deviation (SD)c resulting from the
listed diﬀerences. bThe straight-line equations, as they follow from the data in columns 4�7, are log KMn(CA)Mn = (0.123( 0.023) 3 pKH(CA)H þ (1.197(
0.126), log KCu(CA)
Cu = (0.403( 0.010) 3 pKH(CA)
H þ (0.889( 0.059), and log KZn(CA)Zn = (0.277( 0.012) 3 pKH(CA)H þ (0.667( 0.071). cThe standard
deviation (SD) times three is considered as a reasonable error limit for any calculation of the stability of a M(CA)þ complex based on the straight-line
equations given above.b dThe constants listed in columns 4�7 are taken from the references given above in column 2; exceptions are deﬁned in footnote
f. e For the deﬁnition of the ligand abbreviations see footnotes a of Table 4 and c of Table 8; in addition, ClPr� = 3-chloropropanoate, PhPr� =
3-phenylpropanoate, PhBu� = 4-phenylbutanoate, PhVa� = 5-phenylvalerate = 5-phenylpentanoate. fValue from ref 56.
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stability constants of the Ni2þ complexes directly, one obtains log
SINi = log KNi(CH3NH2)
Ni � log KNi[(CH3)2NH]Ni = (2.23 ( 0.06) �
(1.47( 0.06) = 0.76( 0.08 (error estimated). For Agþ,17 despite
the very diﬀerent coordination sphere, follows in excellent agree-
ment log SIAg = log KAg(CH3NH2)
Ag � log KAg[(CH3)2NH]Ag = (3.11 (
0.06) � (2.48( 0.06) = 0.63 ( 0.08 (error estimated). Further-
more, both log SI values agree within the error limits with that
resulting from the glycinate/sarcosinate systems.
Unfortunately, no further data are available for the amines
CH3NH2 and (CH3)2NH for other metal ions;
17,18 therefore, we
use the result from the glycinate/sarcosinate systems, i.e., log SINi
= 0.71( 0.12, which is available for some other metal ions as well.
If the stability constant of theNi(NH3)
2þ complex is reduced by log
SINi, one obtains an “ammonia“ complex in which the steric
inhibition is taken into account, i.e., log KNi(NH3)SI
Ni = 2.77 �
0.71 = 2.06. This value is represented by the arrowhead in the
Ni2þ part of Figure 10. Now two points are available and a
straight line can be deﬁned, the parameters of which are listed in
Table 16 below, and thus, a stability constant for log
KNi(AEtOH)op
Ni can be calculated (see section 5.2). On the basis
of the various uncertainties, including in the slope m, we apply
the generous error limit of (0.20 log unit (compare this with
the situation graphically described in Figure 10 and you will
note that this error limit is generous indeed).
Because in the case of Cu2þ the data pair Hþ/Cu2þ/CH3NH2
is available (Table 15), the procedure described above can
analogously be applied for Cu2þ (Figure 10). The resulting
straight-line parameters are listed in Table 16; because in this
case the slope m is somewhat larger, we use(0.25 log unit as an
(oversized) error limit for a calculation at pKH(AEtOH)
H = 9.62.
Table 14. Comparison of the Measured Stability Constants, KM(XCA)
M (eqs 4a, 4b, and 6), of M(HOAc)þ and Some Related
Complexes with the Calculated Stability Constants, KM(XCA)op
M (eqs 1 and 7), for Isomers with a Sole Carboxylate Coordination of
M2þ, and Extent of Intramolecular Chelate Formation According to Equilibria 1 and 2 in the M(XCA)þComplexes As Deﬁned by
KI (eqs 3 and 9) and % M(XCA)cl
þ (eq 13) for Aqueous Solutions Containing 50% (v/v) 1,4-Dioxane at 25 C and I = 0.1 M
(NaClO4)
a,b
XCA� M2þ log KM(XCA)
M log KM(XCA)op
M log ΔM/XCA KI % M(XCA)cl
þ
HOAc� Mn2þ 2.48( 0.06 1.80( 0.05 0.68 ( 0.08 3.79( 0.86 79( 4
Cu2þ 3.96( 0.06 2.86( 0.02 1.10 ( 0.06 11.59( 1.83 92( 1
Zn2þ 3.26( 0.06 2.02( 0.03 1.24 ( 0.07 16.38( 2.68 94( 1
THF2CA� Mn2þ 2.36( 0.06 1.81 ( 0.05 0.55( 0.08 2.55( 0.64 72( 5
Cu2þ 3.72( 0.06 2.88 ( 0.02 0.84( 0.06 5.92( 1.01 86( 2
Zn2þ 3.07( 0.06 2.04 ( 0.03 1.03( 0.07 9.72( 1.66 91( 2
THT2CA� Mn2þ 1.80( 0.06 1.88( 0.05 �0.08( 0.08 0 0
Cu2þ 4.31( 0.06 3.14( 0.02 1.17( 0.06 13.79 ( 2.15 93( 1
Zn2þ 2.35( 0.06 2.21( 0.03 0.14( 0.07 0.38 ( 0.21 28( 11
aThe stability constants listed in column 3 are for the M(HOAc)þ and M(THF2CA)þ complexes of Cu2þ and Zn2þ from ref 58 and those for
Mn(HOAc)þ, Mn(THF2CA)þ, andM(THT2CA)þ from ref 56. The error limits are for all cases assumed to be within(0.06 log unit. The error limits
of the derived data in the table were calculated according to the error propagation after Gauss. bThe acidity constants of the monoprotonated ligands are
pKH(HOAc)
H = 4.88( 0.03 (cf. ref 58), pKH(THF2CA)H = 4.95( 0.01 (cf. ref 58), and pKH(THF2CA)H = 5.58( 0.01 (cf. ref 56). These values, together with the
straight-line equations deﬁned in footnote b of Table 13, were used to calculate the values listed for log KM(XCA)op
M .
Figure 9. Structures of 2-aminoethanol (AEtOH) and some related
ligands needed for evaluation of the properties of its complexes, that is,
of ammonia (NH3), methylamine (CH3�NH2), glycinate (Gly�), and
sarcosinate (Sar�).
Figure 8. Evidence for an enhanced complex stability of the Mn2þ,
Cu2þ, and Zn2þ 1:1 complexes of HOAc� and THF2CA� in contrast to
the rather diﬀerent properties of the corresponding complexes formed
with THT2CA� (see Figure 7) based on the relationship between log
KM(CA)
M and pKH(CA)
H for the simple carboxylate ligands (CA�) listed in
Table 13. The parameters of the corresponding least-squares reference
lines (eq 10) are summarized in footnote b of Table 13. The data for the
points due to the equilibrium constants of the M2þ/XCA� systems
(XCA� = HOAc�, THF2CA�, or THT2CA�) are given in Table 14.
The vertical dotted lines emphasize the stability diﬀerences to the
reference lines; they equal log ΔM/XCA, as deﬁned in eqs 11a and 11b
(see also Table 14, column 5). All plotted equilibrium constants refer to
aqueous solutions containing 50% (v/v) 1,4-dioxane at 25 C and I = 0.1
M (NaClO4).
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Since no Hþ/M2þ/CH3NH2 data are available for the Zn
2þ
system, a diﬀerent procedure needs to be applied. However, based
on the Zn2þ/Gly�/Sar� data (Table 15) the steric inhibition can
still be determined: log SIZn = 0.86 ((0.12; estimated) [= 5.17�
4.31]. The reduction of the stability constant for Zn(NH3)
2þ
(at pKH(NH3)
H = 9.33) by log SIZn gives log pKZn(NH)3SI
Zn = 2.31 �
0.86 = 1.45 ((0.16; estimated). This data pair is represented by
the arrowhead in the Zn2þ part of Figure 10. What is needed now
is the slope m that goes through the “arrowhead”.
Since such slopes are also needed for the other M2þ systems, we
calculated the averages of the straight-line slopes m resulting from
log K versus pKa plots for the pyridine,
70 o-amino(methyl)-
pyridine,70 imidazole,71 and benzimidazole72 families: The values
for mav are (M
2þ in parentheses) 0.132 (Mn2þ), 0.172 (Co2þ),
0.195 (Ni2þ), 0.396 (Cu2þ), 0.233 (Zn2þ), and 0.241 (Cd2þ).
These values can now be expressed as percentages by deﬁning once
mCu/av as 100% and oncemNi/av as 100%. Because the slopes of the
amine straight lines for the Ni2þ and Cu2þ systems have been
determined (see upper parts in Figure 10 and also Table 16), one
can now calculate the expected “amine” slopes, once via the Ni2þ
and once via the Cu2þ systems. The averages of these calculations
for the straight lines of the “amine” family are m = 0.108 (Mn2þ),
0.137 (Co2þ), 0.190 (Zn2þ), and 0.196 (Cd2þ) (see alsoTable 16).
Now, with the slope mZn = 0.190 at hand, one can draw a
straight line through the mentioned “arrowhead” (see the Zn2þ
part of Figure 10) and deﬁne in this way the straight-line
parameters. The corresponding data are listed in Table 16.
For the Mn2þ, Co2þ, and Cd2þ systems no Sar� data are
available, thus preventing calculation of the steric inhibition log
SIM for these metal ions. However, as we have seen earlier in this
section, the log SI values are rather independent from the type of
metal ion involved. Therefore, we use the average of the values
obtained for Ni2þ (log SINi = 0.71; see earlier text and Figure 10),
Cu2þ (0.67), and Zn2þ (0.86), that is, log SIM = 0.75 (with an
estimated error limit of (0.15 log unit). The corresponding
evaluation procedure is graphically shown in the lower part of
Figure 10 for theMn2þ system. Evaluation of the Co2þ andCd2þ
systems was done analogously. The resulting straight-line param-
eters are listed in Table 16.
A special case is Pb2þ because no slopesm for heteroaromatic
amine families are available as used above. However, from the
so-called Stability Ruler ofMartin65,66 it follows that Pb2þ behaves
like either Zn2þ(e.g., with Gly�, see Table 15) or Cu2þ (with O
donors, for which the slopes mCu approximately equal mPb;
67 see
also Table 9). Hence, regarding the evaluation of Pb(AEtOH)2þ
we apply the average of the slopes obtained for Cu2þ and Zn2þ,
i.e., mPb = 0.322 [= 0.5 (0.453 þ 0.190)] (see Table16). Thus,
together with the data point for Hþ/Pb2þ/NH3 (Table 15) and
the steric inhibition, log SIPb = 0.75 (see above), the straight-
line parameters can be deﬁned; the results are listed in Table 16.
To be on the safe side, we use here for the calculation with
pKH(AEtOH)
H = 9.62 (see section 5.2) as an error limit (0.3
log unit.
To conclude, the straight-line parameters summarized in
Table 16 for simple amine complexes are estimations but are
generally useful and applicable in the pKa range 9.2�10 for any
kind of evaluation. The fact that the parameters are estimations
and contain uncertainties is considered in the large error limits
recommended (Table 16, column 4); they should help to prevent
misinterpretations. Indeed, as we will see in the next section 5.2,
despite the large error limits, useful results are obtained.
5.2. Extent of Hydroxyl Group�Metal-Ion Binding in Com-
plexes of 2-Aminoethanol and Related Ligands
Stability constant data are available for 2-aminoethanol
(AEtOH), DL-1-amino-2-propanol (AiPrOH; an isopropanol
Table 15. Logarithms of the Stability Constants of Several Metal-Ion 1:1 Complexes (eqs 4a and 4b) Formed with Ligands
Containing an Amino Group (AL) and Which Are Used Toward Evaluation of the Properties of the Complexes Formed with
2-Aminoethanol (AEtOH) (eqs 4a, 4b, and 6), the Constants of Which Are also Listeda,b
log KM(AL)
M for M2þ =
AL I pKH(AL)
H Mn2þ Co2þ Ni2þ Cu2þ Zn2þ Cd2þ Pb2þ
AEtOH 0.1 9.52( 0.03 0.81 2.20 3.02( 0.04 4.50 2.41 4.10( 0.05
0.5c 9.62( 0.03 0.88d 2.23 3.12( 0.06 4.60 2.50 2.45e 4.20f
NH3 0.1 9.26( 0.05 2.08 2.73 4.10 2.33 2.57
0.5g 9.33( 0.04 0.88 2.09 2.77 4.11 2.31 2.60 1.45h
1.0 9.43( 0.05 0.90 2.10( 0.04 2.80( 0.03 4.12( 0.04 2.30( 0.10 2.62( 0.08 (1.55)h
CH3NH2 0.5 10.72( 0.06 2.19i 4.07j
1.0 10.84( 0.04 2.23 (4.11)j
Gly� 0.5 9.54( 0.03 2.60 ( 0.05 4.55( 0.04 5.63( 0.03 8.10( 0.07 4.85( 0.04 4.18 4.60( 0.20
Sar� 0.5 10.00( 0.01 5.24 7.75 4.31
a In addition, the negative logarithms of the acidity constants of the monoprotonated ligands (eqs 14a and 14b) are given (aqueous solution; 25C). bAll
constants are collected from ref 17 except where otherwise indicated; the listed error limits are those given in the literature. The two values given in
parentheses do not refer to I = 1.0 M (see below). cThe constants given for the Co2þ, Ni2þ, Cu2þ, and Zn2þ complexes are identical with those
determined by Djurdjevic and Bjerrum.64 dValue obtained by adding 0.07 log unit (average of the diﬀerences at I = 0.1 and 0.5 M for Co2þ, Ni2þ, and
Zn2þ) to 0.81. e In ref 64 the value of 2.65 log units is given for I= 2.0M; deduction of 0.20 log unit (average of the diﬀerence for Co2þ, Ni2þ, and Zn2þ at
I = 2.0 and 0.5 M) gives the listed value of 2.45. fThe diﬀerence for Cu2þ at I = 0.1 and 0.5 M equals 0.10 log unit; this value is added to 4.10 (valid at
I = 0.1M) to give 4.20 (cf. refs 65�67). The value of 4.10 is taken from the work of Hancock andNakani.68 g For Co2þ, Ni2þ, Cu2þ, Zn2þ, and Cd2þ the
values at I = 0.1 and 1.0 M are averaged and listed. In the case of Mn2þ the average of the diﬀerences (0.02 log unit) resulting at I = 0.5 and 1.0 M for
Co2þ, Ni2þ, Cu2þ, Zn2þ, and Cd2þ is deducted from 0.90 (I = 1.0 M). hThis value is based on 1.55, which holds for 5 M NH4NO3 by deducting 0.10
log unit. iThe basicity diﬀerence at I = 0.5 and 1.0M amounts to 0.12 log unit; assuming a slope ofm = 0.33 one obtains 2.23� 0.04 = 2.19. jAt I = 2.0M
4.11 was measured; the basicity diﬀerence between I = 2.0 and 0.5 M amounts to 10.80 � 10.72 = 0.08; assuming a slope of m = 0.5 one obtains
4.11 � 0.04 = 4.07 as given above.
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derivative), and 3-aminopropanol (APrOH), the structures of
which are shown in Figure 11. Having now available the straight-
line plots for simple amine complexes, an evaluation regarding
the participation of the alcoholic hydroxyl group in metal-ion
binding is possible. It may be added in this context that it was
previously concluded that the stability of amine complexes de-
creases with increasing alkyl substitution (NH3, CH3NH2,
CH3CH2NH2, (CH3)2NH, etc.) and that the “trend is attribu-
table to steric eﬀects ... with no apparent inductive contri-
bution”.73 This view concurs with ours.
On the basis of the results described in sections 3 and 4,
participation of the hydroxyl group in metal-ion binding of
AEtOH and its derivatives (Figure 11) is expected and, in fact,
already evident from Figure 10; the data points due to Hþ/
M2þ/AEtOH are always far above their reference line. Hence,
there is no doubt that equilibrium 1 operates. Indeed, Hancock74
discussed already 30 years ago the stability of AEtOH complexes in
relation to the chelate eﬀect. That the hydroxyl group is involved in
metal-ion binding of AEtOHand related ligandswas conﬁrmed for
Cu2þ by spectrophotometric and EPR studies,75 where it was
concluded that compounds of the mentioned type “act as multi-
dentate ligands through amino and hydroxyl groups”. However, in
none of the studies any quantiﬁcation regarding the position of
equilibrium 1 was attempted.
Application of the straight-line parameters assembled in
Table 16 together with the acidity constant pKH(AEtOH)
H =
9.62 allows calculation of log KM(AEtOH)op
M , that is, of the open
isomer (eqs 1, 2, and 7), and thus, the stability enhancements,
log ΔM/AEtOH (eqs 11a and 11b), can be quantiﬁed. These
results lead to the intramolecular equilibrium constants,KI (eq 12),
and the formation degrees of the chelated species (eq 13).
The corresponding results are assembled in Table 17 for seven
M(AEtOH)2þ systems; for the other two ligands considered,
AiPrOH and APrOH (Figure 11), only data for their Ni2þ
complexes are available.17
Many conclusions are possible based on the data assembled in
Table 17; a few are given below:
(i) Most impressive are probably the high formation degrees
of the chelated species which vary between about 80%
Figure 10. Graphical demonstration of the processes leading to reference
lines for log KM(RCH2�NH2)
M versus pKH(RCH2�NH2)
H plots for RCH2�
NH2 ligands (= AL), allowing thus to deﬁne the stability enhancements, log
ΔM/AEtOH (Table 17, column 4), for theM(AEtOH)
2þ complexes. In the
case of Ni2þ, one point for the reference line is deﬁned by the Hþ/Ni2þ/
CH3NH2 data (Table 15) and the other one by correcting the H
þ/Ni2þ/
NH3 system for the steric inhibition due to a methyl group. This steric
inhibition is obtained from the glycinate/sarcosinate data (see text in
section 5.1 and Table 15) and amounts to log SINi = 0.71 ((0.12; error
limit estimated). Deduction of this value from the stability constant of the
Ni(NH3)
2þ complex, log KNi(NH3)
Ni = 2.77, gives 2.06 for the sterically
inhibited coordination of Ni2þ to “NH3”; this value is represented by the
arrowhead in the Ni2þ part of the ﬁgure. Now the straight line for
Ni(RCH2�NH2)2þ complexes is deﬁned; the corresponding parameters
are listed in Table 16. The analogous evaluation procedure is shown for
the Cu2þ systems (see also the text in section 5.1). In the case of Zn2þ
only the data point represented by the arrowhead is available, and
therefore, the estimated slope, mZn = 0.190 (see text), is used to deﬁne
the reference line. In the case of Mn2þ also the position of the
arrowhead needed to be estimated, as explained in the text (section
5.1). The stability enhancements (eqs 11a and 11b) for the
M(AEtOH)2þ complexes are represented by the vertical dotted lines
seen in the ﬁgure. It needs to be emphasized that errors in the log SIM
values and in the slopes mM do not aﬀect drastically the size of the
stability enhancements, log ΔM/AEtOH (Table 17, column 4), as is
evident from the various parts of the ﬁgure, especially if one “moves”
the log SIM values within their error limits. Thus, it becomes evident
that the error limits for log KM(RCH2�NH2)
M calculations as listed in
Table 16 (column 4) are generously chosen. All equilibrium constants
used in this ﬁgure refer to aqueous solution at 25 C and I = 0.5 M; the
corresponding data are taken from Table 15.
Table 16. Estimated Straight-Line Parameters (eq 10)a for
M2þ 1:1 Complexes Formed with Simple Amine Ligands
(RCH2�NH2), Valid for Aqueous Solution at 25 C and
I = 0.5 Mb
M2þ m b log (error limits)b
Mn2þ 0.108 �0.878 0.20
Co2þ 0.137 0.062 0.20
Ni2þ 0.094 1.182 0.20
Cu2þ 0.453 �0.786 0.25
Zn2þ 0.190 �0.323 0.20
Cd2þ 0.196 0.021 0.20
Pb2þ 0.322 �2.304 0.3
aThe slopes (m) and intercepts (b) for the straight reference lines for
plots of log KM(RCH2-NH2)
M versus pKH(RCH2-NH2)
H were determined as
described in the text of section 5.1; see also Figure 10. bThe straight-line
equation is deﬁned by eq 10. With a known pKH(RCH2-NH2)
H value of any
RCH2�NH2 derivative the stability constant, log KM(RCH2-NH2)M , of the
corresponding M(RCH2�NH2)2þ complex (eqs 4a, 4b, and 6) can be
calculated. The recommended, estimated error limits given in the fourth
column should be used for any calculation in the pKa range of 9.2�10.
Figure 11. Structural relationship of DL-1-amino-2-propanol (AiPrOH;
an isopropanol derivative) and 3-aminopropanol (APrOH) with 2-ami-
noethanol (AEtOH).
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(Mn2þ) and 100% (Pb2þ); hence, the closed isomer in
equilibrium 1 strongly dominates for all M(AEtOH)2þ
systems. It is thus no surprise that for the Cu(AEtOH)2
2þ
complex (note, this is a 1:2 species) it could be shown74,75
that deprotonation of the �OH group in the alkaline pH
range (>8) is possible.
(ii) A comparison of the formation degrees of theM(HOAc)þ
systems (Tables 7 and 11) with those for the
M(AEtOH)2þ species (Table 17) shows that they are
rather similar. For Mn2þ, Cu2þ, and Pb2þ the trend is %
M(HOAc)cl
þ < % M(AEtOH)2þ, whereas for Co2þ and
Ni2þ it seems to be reverse. For Zn2þ and Cd2þ it holds %
M(HOAc)cl
þ ≈ % M(AEtOH)2þ, with the stability en-
hancements being about one-half the size for the Cd2þ
complexes compared to the Zn2þ ones in both instances.
(iii) Especially impressive is the large stability enhancement,
log ΔPb/AEtOH, which amounts to more than 3 log units,
that is, Pb2þ is outrunning Zn2þ in its aﬃnity toward the
hydroxyl group of AEtOH, i.e., log ΔZn/AEtOH amounts to
ca. 1 log unit only. Cd2þ, the softest of the threemetal ions,
reaches a log ΔCd/AEtOH value of only about 0.5 log unit.
As already indicated by Martin,65,66 the properties of Pb2þ
are diﬃcult to predict. However, the same order for the
formation degrees of chelates was found with these three
metal ions in their complexes formed with uridylyl-
(50f30)-[50]uridylate (pUpU3�). The primary binding
site for M2þ is the terminal phosphate group: An interaction
with the bridging phosphate unit occurs to 93% with Pb2þ
(log Δ = 1.16 ( 0.26), to 26% with Zn2þ (log Δ = 0.13 (
0.08), and to about 0%with Cd2þ (logΔ =�0.01( 0.06).76
(iv) Finally, the stability enhancements and formation degrees
of the Ni2þ complexes (Table 17) formed with AEtOH
and AiPrOH allow the conclusion that a methyl substitu-
tion at the ethylene bridge does not aﬀect the mentioned
properties. This is diﬀerent if the ethylene bridge is
replaced by a propylene one: Comparison of the data for
the Ni(AEtOH)2þ and Ni(APrOH)2þ complexes shows
that the 5-membered chelates are more stable than the
6-membered ones; this is in accord with the observations
made in sections 3.3 and 4.3.
5.3. Comparison of the Metal-Ion-Binding Properties of
2-Aminoethanol and Triethanolamine
In the above context it is worthwhile to include into the
considerations the ligand triethanolamine (TEA), N(CH2CH2-
OH)3, which is closely related to 2-aminoethanol (AEtOH),
NH2CH2CH2OH. This will not only hint to caveats one should
be aware of in comparisons, but in addition, these comparisonswill
provide some valuable insights.
The complexes of TEA have been studied for Co2þ, Ni2þ,
Cu2þ, Zn2þ, and Pb2þ at 25 C and I = 0.1 M (NaNO3),68
whereas those for the M(AEtOH)2þ species also refer to 25 C
but mostly to I = 0.5 M (Table 17). However, this diﬀerence in
I does not hamper the comparisons made below because, e.g., the
diﬀerence between the acidity constants at I = 0.1M (pKH(TEA)
H =
7.85( 0.10)17 and I = 0.5M (pKH(TEA)
H = 7.97( 0.07)17 is small.
Indeed, this diﬀerence leads in the case of Cu2þ to a diﬀerence in
complex stability of 0.05 log unit only (by applying the straight-
line parameters of Table 16). Hence, this and the even smaller
diﬀerences for the other metal ions are all far within the error
limits considered below.
We concentrate in our comparisons on the M(TEA)2þ com-
plexes of Cu2þ, Zn2þ, and Pb2þ, being representative examples;68
their stability constants are log KM(TEA)
M = 4.07 ( 0.03 (Cu2þ),
2.05( 0.01 (Zn2þ), and 3.39( 0.02 (Pb2þ). These values are by
0.43( 0.07 (Cu2þ), 0.36( 0.06 (Zn2þ), and 0.71( 0.05 (Pb2þ)
log units smaller if compared with the corresponding ones given in
Table 15 (I = 0.1 M) for the M(AEtOH)2þ species. Despite the
Table 17. Comparison of the Measured Stability Constants, KM(AEtOH)exp
M (eqs 4a, 4b, and 6), of the 1:1 Complexes Formed
between 2-Aminoethanol (AEtOH) and Several M2þ with the Stability Constants, KM(AEtOH)op
M (eq 7), for Isomers with a Sole
�NH2 Group Coordination at M2þa
M2þ log KM(AEtOH)exp
M b log KM(AEtOH)op
M c log ΔM/AEtOH KI % M(AEtOH)cl
2þ
Mn2þ 0.88( 0.10 0.16( 0.20 0.72( 0.22 4.35( 2.77 81( 10
Co2þ 2.23( 0.06 1.38( 0.20 0.85( 0.21 6.08 ( 3.40 86( 7
Ni2þ 3.12( 0.06 2.09( 0.20 1.03( 0.21 9.72( 5.15 91( 4
Cu2þ 4.60( 0.06 3.57( 0.25 1.03( 0.26 9.72( 6.34 91 ( 6
Zn2þ 2.50 ( 0.06 1.51( 0.20 0.99( 0.21 8.77( 4.70 90( 5
Cd2þ 2.45( 0.10 1.91( 0.20 0.54( 0.22 2.47( 1.79 71( 15
Pb2þ 4.20( 0.10 0.8 ( 0.3 3.40( 0.32 2511( 1829 100( 0.07
AiPrOHd
Ni2þ 3.15( 0.10e 2.08( 0.20 1.07( 0.22 10.75( 6.05 91( 4
APrOHd
Ni2þ 2.77 ( 0.10f 2.14( 0.20 0.63( 0.22 3.27( 2.20 77( 13
aThe observed stability increase is expressed by logΔM/AEtOH (eqs 11a and 11b). The extent of intramolecular chelate formation according to equilibria
1 and 2 in the M(AEtOH)2þ complexes is quantiﬁed by KI (eqs 3, 9, 12) and %M(AEtOH)cl
2þ (eq 13) for aqueous solutions at 25 C and I = 0.5 M. In
the two bottom entries the corresponding results for the Ni2þ complexes of DL-1-amino-2-propanol (AiPrOH) and 3-aminopropanol (APrOH)
are given. bAll values are from refs 17, 64, and 68 (see also the top rows in Table 15). Since mostly no error limits are given in the references (see
Table 15) an error limit of(0.06 log unit is assumed, except in those cases where the constant had to be corrected due to a change in I; here an error limit
of (0.10 log unit is applied. cCalculated with the straight-line equations deﬁned in Table 16 for a simple M2þ�amino group coordination and
pKH(AEtOH)
H = 9.62.17 dThe acidity constants (25 C; I = 0.5 M) are pKH(AiPrOH)H = 9.60 and pKH(APrOH)H = 10.23.17 e In ref 17, log KNi(AiPrOH)Ni = 3.20 is
given for I = 1.0 M (25 C); from this value 0.05 log unit is deducted to adjust it for I = 0.5 M. f In ref 17, log KNi(APrOH)Ni = 2.82 is given for I = 1.0 M
(25 C); deduction of 0.05 log unit gives the above value for I = 0.5 M.
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higher potential denticity of TEA, this reduced stability might at
ﬁrst sight lead to the conclusion that M2þ�hydroxyl group
binding is reduced due to steric crowding of the three CH2CH2-
OH chains. However, this conclusion would mean that the
diﬀerences in basicity between TEA and AEtOH are ignored
because pKH(TEA)
H = 7.97( 0.07 (I = 0.5 M)17 and pKH(AEtOH)H =
9.62 ( 0.03 (I = 0.5 M; Table 15).
Application of this pKH(TEA)
H value to the straight-line parameters
valid for RCH2NH2 species (Table 16) gives stability constants for
an openM(TEA)2þ isomer inwhich no steric crowding of the three
CH2CH2OH residues is considered, i.e., only one residue
“exists”. We deﬁne this species as M(TEA)op(1)
2þ and obtain
for logKM(TEA)op(1)
M = 2.82( 0.25 (Cu2þ), 1.19( 0.20 (Zn2þ),
and 0.26( 0.30 (Pb2þ). Comparison of these calculated values
with the measured ones (at I = 0.1 M)68 according to eqs 11a
and 11b gives the stability enhancements logΔM/TEA(1) = 1.25
( 0.25 (Cu2þ), 0.86 ( 0.20 (Zn2þ), and 3.13 ( 0.30 (Pb2þ).
These stability enhancements are within their error limits
identical with those observed for the M(AEtOH)2þ species,
that is, log ΔM/AEtOH = 1.03 ( 0.26 (Cu2þ), 0.99 ( 0.21
(Zn2þ), and 3.40( 0.32 (Pb2þ) (see Table 17), indicating that
the M2þ�OH interaction in the M(TEA)cl(1)2þ isomers is at least
as intense as in the M(AEtOH)cl
2þ species.
Though the evaluation procedure in the preceding paragraph
certainly describes the situation better than if the basicity
diﬀerences between TEA and AEtOH are ignored, it is not really
satisfying because the calculations are based on RCH2�NH2
reference lines (Table 16) and thus provide only the lower limits
for the M2þ�OH interactions. Correct reference lines should be
based on a series of (RCH2)3N derivatives and their complexes,
yet this information does not exist. However, in section 5.1 we
have seen that the steric inhibition introduced by replacing oneH
atom in NH3 by a RCH2 substituent amounts on average to log
SIM = 0.75 ( 0.15 for any of the divalent metal ions considered
here (see also Figure 10). If one assumes that each RCH2
substituent in TEA has the same steric eﬀect on metal-ion
coordination, overall the value should be tripled. To be on the
safe side, we shall assume only that the two extra RCH2
substituents together encompass the same steric inhibition as
the ﬁrst one; this then means that the log KM(TEA)op(1)
M values
need to be reduced further by log SIM = 0.75 ( 0.15. Then
we obtain for the open M(TEA)op(2)
2þ isomers the stability
constants log KM(TEA)op(2)
M = 2.07 ( 0.29 (Cu2þ), 0.44 ( 0.25
(Zn2þ), and �0.49 ( 0.34 (Pb2þ).
With the indicated assumption one obtains for the overall
stability increase the values logΔM/TEA(2) = 2.00( 0.29 (Cu
2þ),
1.61 ( 0.25 (Zn2þ), and 3.88 ( 0.34 (Pb2þ) due to the three
CH2CH2OH residues possibly participating in metal-ion coor-
dination in the M(TEA)2þ species. These stability enhance-
ments are by 0.97( 0.39 (Cu2þ), 0.62( 0.33 (Zn2þ), and 0.48
( 0.47 (Pb2þ) log units larger than those observed for the
M(AEtOH)2þ complexes (Table 17, column 4). These results
appear reasonable because despite all steric crowding the like-
lihood is high that out of three CH2CH2OH residues more than
one will participate in metal-ion binding. In other words, despite
the lower overall stability of the M(TEA)2þ complexes com-
pared with that of the M(AEtOH)2þ species (which is due to the
lower basicity of TEA (Δ pKa = 1.66 ( 0.08)), it is evident that
more than one of the CH2CH2OH residues participate in metal-
ion binding. A separation of the individual contribution of each
CH2CH2OH residue to the observed stability enhancement is
with the rough and limited data available in this case not advisible.
However, in principle, it could be done as shown in section 8 for
other ligands oﬀering more than one hydroxyl group for metal-
ion coordination.
Clearly, from the above evaluations it follows that the three
hydroxy groups of TEA will participate in metal-ion binding in
varying extents. Furthermore, despite all uncertainties the eva-
luations prove that the stability enhancement for the Pb(TEA)2þ
complex is especially pronounced, conﬁrming the high aﬃnity of
Pb2þ toward hydroxyl groups as it was already evident from the
Pb(AEtOH)2þ species (Table 17), where the chelated or closed
form (eq 1) reaches about 100%. This tremendous stability
increase of the Pb2þ complexes originates also in the low aﬃnity
of Pb2þ for N sites, e.g., for NH3, which is much more
pronounced for Cu2þ and Zn2þ (see Table 15).
The ligand TEA also allows interesting comparisons for the
alkaline earth ions.77 The corresponding stability constants77 at
25 C and I = 1.0 M are log KM(TEA)M = 0.24 ( 0.02 (Mg2þ),
0.78( 0.01 (Ca2þ), 0.38( 0.01 (Sr2þ), and 0.36( 0.01 (Ba2þ).
The stability of the Ca(TEA)2þ complex sticks out, and this leads
immediately to the following question: Are the hydroxyl groups
of TEA involved in M2þ binding? Here a comparison with the
stability constants of the complexes formed with ammonia is
helpful: logKM(NH3)
M = 0.24 (Mg2þ), 0.0 (Ca2þ),�0.2 (Sr2þ), and
�0.3 (Ba2þ).17 All these log K values refer to 25 C and
I = 1.0 M except the one for Mg(NH3)
2þ, which holds for I =
2 M. For the M(NH3)
2þ species the stability of the complexes
decreases with increasing ionic radii as one might have expected.
However, these stability constants for the M(NH3)
2þ species may
directly be compared with those for the M(TEA)2þ complexes
despite the diﬀerent basicities of the two ligands, pKH(NH3)
H = 9.43(
0.05 (Table 15) and pKH(TEA)
H = 8.05 ( 0.01 (cf. ref 77) (25 C;
I = 1.0 M).17,77 The reason for this is that in the case of the alkaline
earth ions the slopes m of log K versus pKa plots for ligands with
N donor sites are zero or at least very close to it,70�72 in accord with
the fact that the given stability constants for the M(NH3)
2þ
complexes are equal to those determined for the complexes formed
by the alkaline earth ions with benzimidazoles72 and ortho-methyl-
pyridines.70
Consequently, comparison of the above data is valid and
allows the following conclusions:
(i) The stability diﬀerences log ΔM/TEA follow the order
Mg2þ < Ca2þ > Sr2þ J Ba2þ.
(ii) It appears that in the Mg(TEA)2þ complex the
CH2CH2OH residues do not participate in a signiﬁcant
manner in metal-ion binding.
(iii) In contrast, in the Ca2þ, Sr2þ, and Ba2þ complexes of
TEA the CH2CH2OH residues are clearly involved in
M2þ binding. In fact, all three hydroxyl groups of TEA
coordinate to Sr2þ and Ba2þ in the solid state (see
section 11.1).
(iv) The stability enhancement, log ΔCa/TEA = 0.78, for
the Ca(TEA)2þ complex indicates chelate formation
(eqs 11a�13) on the order of 83% (not distinguishing
between the three possibilities of CH2CH2OH binding).
It is interesting to note that the mentioned 83% for
Ca(TEA)cl
2þ is within the error limits identical with the percen-
tages determined for Ca(HOAc)cl
þ and Ca(2HOPr)cl
þ (Table 7).
However, more important for the present context is the result
described in section 4.1, namely, that Ca2þ is especially suitable for
hydroxyl group binding within the alkaline earth ions. Indeed, this
is conﬁrmed by the results for the M(TEA)2þ complexes (see
point (i) above).
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6. IMIDAZOLE RESIDUE AS A PRIMARY BINDING SITE
IN LIGANDS CONTAINING ALSO A HYDROXYL GROUP
Unfortunately, literature data regarding imidazole derivatives
(ImD) are very limited.17,18 In fact, information is available only
for two ligands, namely, 2-hydroxymethylimidazole (Im2OH)
and 4-hydroxymethylimidazole (Im4OH), and their Cu2þ com-
plexes. The Cu2þ complex of 2-methylimidazole (Im2Me) is
needed for evaluation of steric eﬀects, values of pyridine (Py) are
used for correcting ionic strength (I) eﬀects, and histidine is
considered because of its tautomers (see below). The structures
of all ﬁve ligands are shown in Figure 12.
The available equilibrium constants for the mentioned sys-
tems are listed in Table 18; they are valid for aqueous solutions at
25 C but at various ionic strengths.17,57,78 Therefore, some of
the values were corrected for ionic strength eﬀects to give a series
of data valid for I = 0.5 M (see the footnotes in Table 18). The
reason for selecting I = 0.5 M is that from previous studies71 log
KM(ImD)
M versus pKH(ImD)
H straight-line plots are available. The
one for Cu2þ is deﬁned in eq 15
log KCuCuðImDÞ ¼ ð0:376 ( 0:004Þ 3 pKHHðImDÞ þ ð1:522 ( 0:025Þ
ð15Þ
These straight-line parameters are valid for the pKa range from about
4 to 8 (25 C, I = 0.5 M) with an SD value of 0.018 log unit (3σ).
However, before eq 15 can be applied, it is necessary to
consider the structure of the imidazole derivatives a bit more
in detail. The monoprotonated form of 2-methylimidazole,
H(Im2Me)þ, is a symmetrical acid (see Figure 12). The con-
sequence is that H(Im2Me)þ has two equal possibilities for the
deprotonation reaction to form neutral Im2Me; in other words,
H(Im2Me)þ is too acidic by a factor of 2, and the intrinsic
basicity is therefore quantiﬁed by the micro acidity constant
deﬁned in eqs 16a, 16b, and 16c
pka=HðIm2MeÞ ¼ pKHHðIm2MeÞ þ 0:30 ð16aÞ
¼ ð8:04 ( 0:01Þ þ 0:30 ð16bÞ
¼ 8:34 ( 0:01 ð16cÞ
Exactly the same reasonings hold for 2-hydroxymethylimidazole,
i.e., H(Im2OH)þ; consequently, in this case eqs 17a and 17b apply
pka=HðIm2OHÞ ¼ pKHHðIm2OHÞ þ 0:30 ð17aÞ
¼ 6:78þ 0:30 ¼ 7:08 ( 0:06
ðerror limit estimatedÞ ð17bÞ
How is the situation with the asymmetrical compound 4-hy-
droxymethylimidazole? For histidine it has been concluded that
in the neutral imidazole group the proton is located 80% at N1
and 20% at N3 (see Figure 12).69 Since in Im4OH the sub-
stituent, i.e., the CH2OH group, is also in position 4 just as the
glycine residue in histidine, the proton distribution is probably
similar in both instances. An exact percentage of the isomeric
distribution cannot be given, but the correction factor for
pKH(Im4OH)
H is evidently signiﬁcantly below 0.3 pK unit. Therefore,
we prefer to use in the evaluations given below the experimentally
derived acidity constant pKH(Im4OH)
H = 6.54 (Table 18).
Application of the straight-line parameters from eq 15 to-
gether with the microacidity constants for H(Im2Me)þ and
H(Im2OH)þ (eqs 16a, 16b, 16c, 17a, and 17b) and the acidity
constant for H(Im4OH)þ (Table 18) leads to the situation seen
in Figure 13. The straight line given in the ﬁgure is deﬁned by
data valid for imidazole and such derivatives that cannot exercise
any steric eﬀect on metal-ion binding at the N site. It is thus
immediately evident that the methyl group at C2 in Im2Me
hinders Cu2þ binding at N1 (or N3) very signiﬁcantly. A large
part of this steric hindrance is overcome in the Hþ/Cu2þ/
Im2OH system because the hydroxyl group of the 2-methylhy-
droxy residue participates in metal-ion binding; in other words,
we observe a relative stability enhancement. The same is
evidently true for the Im4OH ligand system.
Figure 12. Structures of 2-hydroxymethylimidazole (Im2OH) and
4-hydroxymethylimidazole (Im4OH); both ligands are able to form
5-membered chelates withmetal ions. The other ligands shown, pyridine
(Py), 2-methylimidazole (Im2Me), and histidine (His), are needed in
the evaluation procedures (section 6) of the hydroxymethylimidazoles.
Table 18. Negative Logarithms of the Acidity Constants (eqs 14a and 14b) of Several Imidazole Derivatives (ImD) and Related
Ligands (Figure 12) As Well As Logarithms of the Stability Constants (eqs 4a and 4b) of the Corresponding Cu2þ Complexes in
Aqueous Solution at 25 C and Various Ionic Strength (I)a
Py Im4OH Im2OH Im2Me
I (M) pKa log K
Cu pKa log K
Cu pKa log K
Cu pKa log K
Cu
0.1 5.26( 0.02 2.49( 0.06 6.46 3.96 7.90( 0.02
0.5 5.34( 0.05 2.60( 0.04 6.54b 4.07b 6.78c 4.09c 8.04( 0.01 3.35( 0.06
3 7.42 4.25 7.66 4.27
aThe values for pyridine (Py) are from refs 70 (I = 0.5 M) and 78 (I = 0.1 M), all others are from ref 17 except the derived values.b,c bThe diﬀerences
observed for the pyridine systems at I = 0.1 and 0.5 M were added to the Im4OH values at I = 0.1 M to obtain those for I = 0.5 M. cOn the basis of the
diﬀerences that follow from the listed values for the Im4OH systems at I = 0.5 and 3 M.
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The steric eﬀects and stability enhancements indicated inFigure 13
are quantiﬁed in Table 19. These data allow us now to deﬁne exactly
the stability enhancement due to the hydroxyl group in the
Cu(Im2OH)2þ complex. This is expressed in eqs 18a, 18b, and 18c
log ΔCu=Im2OH=cor ¼ log ΔCu=Im2OH � log ΔCu=Im2Me ð18aÞ
¼ ð�0:09 ( 0:10Þ � ð�1:31 ( 0:07Þ ð18bÞ
¼ 1:22 ( 0:12 ð18cÞ
The steric inhibition in the Cu(Im4OH)2þ species is much
less clear because the �CH2OH side chain has only one N, i.e.,
N3, at which Cu2þ may coordinate and give rise to chelate
formation. Considering that probably the tautomer of Im4OH
seen in Figure 12 dominates with 80%, the analogous correction
for the steric inhibition as expressed in eqs 18a, 18b, and 18c
would possibly be appropriate. On the other hand, one can
imagine that the steric inhibition observed for Cu(Im2Me)2þ is
only about 50% relevant for Cu(Im4OH)2þ because Cu2þmight
also bind to N1 (the H being then at N3) without any chelate
formation. Since no unequivocal decision between these two
possibilities is possible, we evaluated both of them, which means
one gives the maximal participation of the hydroxyl group in
Cu2þ binding (which we consider as the more likely situation)
and the other theminimal one. Thus, application of eqs 12 and 13
leads to the results summarized in Table 20.
From the results given in Table 20 for Cu(Im2OH)cl
þ it is clear
that 5-membered chelates form and that the hydroxyl group may
participate in metal-ion binding having an imidazole group as the
primary binding site. Though the situation with Cu�(Im4OH)2þ
is equivocal, the data still prove that chelates form. Furthermore,
these results in combination with those of Table 17 indicate, at
least for Cu2þ, that the imidazole group is a slightly better
primary binding site than an amino unit in combination with the
hydroxyl group. Considering that not only Cu2þ but also other
divalent metal ions like Mn2þ or Zn2þ as well as the alkaline earth
metal ions are able to coordinate with the imidazole group,71 one
may assume that also in these instances an interaction with a
hydroxyl group can take place if this is properly situated.
7. PYRIDYL NITROGEN IS AN IDEAL PRIMARY METAL-
ION-BINDING SITE FOR A HYDROXYL�METAL-ION
INTERACTION
The most simple compound in the present context is
o-(hydroxymethyl)pyridine (HOMPy), and there are two fortu-
nate circumstances which facilitate an evaluation of the role that
the hydroxyl group plays in this compound in metal-ion coordina-
tion: (i) the necessary straight-line parameters for log KM(PyD)
M
versus pKH(PyD)
H plots of o-methylpyridine derivatives (PyD) are
available; the corresponding parameters (as far as needed now) are
listed in Table 21;70 hence, the position of equilibrium 1 can be
calculated in a straightforward manner, based on the measured
equilibrium constants of M(HOMPy)2þ complexes.17 (ii) Several
closely related ligands together with stability constants of the
corresponding metal-ion complexes are available,17 allowing
Figure 13. Complex stabilities of the Cu2þ 1:1 complexes formed with
Im4OH, Im2OH, and Im2Me (b, see Figure 12) in relation to the
straight-reference line (eq 15, Table 19) which is based on the simple
imidazole derivatives (O; from left to right) N-(2,3,5,6-tetraﬂuorophe-
nyl)imidazole, 5-chloro-1-methylimidazole, 4-(imidazol-1-yl)aceto-
phenone, 1-methylimidazole, and imidazole (for details see ref 71).
The steric inhibition of Cu2þ coordination by the methyl group in
Im2Me is clearly seen, and consequently, the stability enhancing eﬀect of
the hydroxyl group in the two hydroxymethylimidazoles (Im4OH,
Im2OH) is evidenced. The corresponding equilibrium constants are
listed in Table 18. All plotted equilibrium constants refer to aqueous
solutions at 25 C and I = 0.5 M.
Table 19. Comparison of the Measured (exp) Stability Con-
stants, KCu(ImD)exp
Cu (eqs 4a and 4b), of the Cu2þ 1:1 Com-
plexes Formed by Im2Me, Im2OH, and Im4OH with the
Calculated (calc) Stability Constants Based on eq 15 and the
Appropriate Acidity Constantsa
Cu(ImD)2þ log KCu(ImD)exp
Cu log KCu(ImD)calc
Cu log ΔCu/ImD
Cu(Im2Me)2þ 3.35( 0.06b 4.66( 0.04c �1.31( 0.08
Cu(Im2OH)2þ 4.09( 0.10d 4.18( 0.02 �0.09( 0.10
Cu(Im4OH)2þ 4.07( 0.10d 3.98( 0.02 0.09( 0.10
a The stability diﬀerences are deﬁned by log ΔCu/ImD according
to eqs 11a and 11b. The applied (micro) acidity constants are
pka/H(Im2Me) = 8.34 (eqs 16a, 16b, and 16c), pka/H(Im2OH) = 7.08
(eqs 17a and 17b), and pKH(Im4OH)
H = 6.54 (Table 18). bValue from the
literature17 (see also Table 18); an error of (0.06 log unit is assumed.
c Since pka/H(Im2Me) is slightly larger than pKa = 8, the error limit
was doubled (see text in section 6, just below eq 15). dValue corrected
for a change in I (see Table 18); therefore, the error limit is taken as
(0.10 log unit.
Table 20. Extent of Chelate Formation According to the
Intramolecular Equilibrium 1 in the Cu�(Im2OH)2þ and
Cu(Im4OH)2þ Complexes As Quantiﬁed by the Dimensionless
Equilibrium ConstantKI (eqs 9 and 12) and the Percentage of
the Closed Isomers, Cu(ImD)cl
2þ (eq 13), in Aqueous Solution
at 25 C and I = 0.5 M
Cu(ImD)2þ
log
ΔCu/ImD
a
log
ΔCu/ImD/cor KI
%
Cu(ImD)cl
2þ
Cu(Im2Me)2þ �1.31( 0.07
Cu(Im2OH)2þ �0.09( 0.10 1.22 ( 0.12b 15.60( 4.59 94( 2
Cu(Im4OH)2þ 0.09( 0.10 1.40( 0.12 24.12( 6.94 96( 1
0.75( 0.12c 4.62( 1.55 82( 5
aValues from column 4 of Table 19. b See eqs 18a, 18b, and 18c. cAssuming
only one-half of the steric eﬀect (see text in section 6) gives log Δcor =
logΔCu/Im4OH� 0.5(�1.31( 0.07) = (0.09( 0.10) þ (0.66( 0.07) =
0.75 ( 0.12.
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interesting comparisons as we shall see below. The structures of all
the ligands to be considered are shown in Figure 14.
Figure 15 provides the straight-line plots for the complexes of
Mn2þ, Cu2þ, and Zn2þ as examples.70 The corresponding data
points for theHþ/M2þ/HOMPy systems17 are also inserted into
the ﬁgure. It is evident that these data points are by about 1
(Mn2þ) to 2.5 log units (Cu2þ) above their reference lines;
hence, the stability enhancement log ΔM/HOMPy (eqs 11a and
11b) is rather large, and therefore, the formation degree of the
chelated or closed species, M(HOMPy)cl
2þ, must be quite high.
Application of the straight-line parameters, provided in the
literature70 and assembled in Table 21, together with the acidity
constants given in footnote b of Table 22,17 allows a detailed
evaluation of the complexes of the ligands17,79 shown in Figure 14
by using eqs 10�13. The results of the corresponding calculations
are summarized in Table 22, where OPy = HOMPy, HOEPy,
DHOEPy, MOMPy, DMPy, or (HOM)2Py (see also Figure 14).
It is immediately evident from Table 22 that the formation
degrees of the chelated species as indicated in equilibrium 1 are
very high, namely, throughout at least 90%. Therefore, it is diﬃcult
to discuss the ﬁner details of the results on the basis of %
M(OPy)cl
2þ; hence, in the discussion below we use instead the
stability enhancements log ΔM/OPy (Table 22, column 5), which
are also a direct reﬂection of the intensity with which the hydroxyl
groups in the various ligands (Figure 14) participate in metal-ion
binding.24,25 Clearly, many conclusions are possible based on the
data summarized in Table 22; only a few are mentioned below:
(i) For the M(HOMPy)2þ complexes the stability enhance-
ments logΔM/HOMPy vary between about 1.1 (Mn
2þ) and
2.7 log units (Ni2þ). Compared with the results discussed
in the preceding section, these are remarkably large values.
The lower aﬃnity of Cd2þ, compared to the one of Zn2þ,
toward hydroxyl groups is conﬁrmed (see sections 4.2, 4.3
and 5.2), that is, log ΔCd/HOMPy = 1.03 ( 0.13 versus log
ΔZn/HOMPy = 1.92 ( 0.17.
Table 21. Straight-Line Parameters for the Stabilities of M2þ
1:1 Complexes of ortho-Substituted Pyridine-Type Ligands
(PyD) and Basicities of the Corresponding Pyridine Deriva-
tives (aqueous solution; 25 C, I = 0.5 M)a,b
M2þ m b SD
Mn2þ 0.052( 0.026 �0.230( 0.145 0.07
Co2þ 0.066( 0.030 �0.254( 0.167 0.08
Ni2þ 0.115( 0.037 �0.403( 0.205 0.10
Cu2þ 0.397( 0.027 �0.889 ( 0.146 0.07
Zn2þ 0.103( 0.025 �0.398( 0.128 0.08
Cd2þ 0.131( 0.031 �0.028( 0.172 0.09
aThe above listed information is collected from Tables 3 and 4 of ref 70.
The ligands employed in the determination of the reference lines are
2-methyl-5-bromopyridine, 2-amino-5-bromopyridine, tubercidin (= 7-
deazaadenosine), R-picoline (= 2-methylpyridine), and 2-aminopyri-
dine.70 bThe slopes m and intercepts b (see eq 10) for the straight-
reference lines for plots of log KM(PyD)
M versus pKH(PyD)
H were calculated70
by the least-squares procedure from the experimentally determined
equilibrium constants.70 The errors given with m and b correspond to
one standard deviation (1σ). The column at the right lists three times the
standard deviation (SD) resulting from the diﬀerences between the
experimental and the calculated values for the various ligand systems.a
The listed SD values (3σ) are considered as reasonable error limits for any
stability constant calculation in the pKa range of 3.5�7.0.
Figure 14. Chemical structures of o-(hydroxymethyl)pyridine (HOMPy),
which is able to form a 5-membered chelate, and of several other
related pyridine derivatives (OPy), that is, o-[1-(1-hydroxyethyl)]
pyridine (HOEPy), o-[1-(1,2-dihydroxyethyl)]pyridine (DHOEPy),
o-(methoxymethyl)pyridine (MOMPy), and 2,6-(dihydroxymethyl)pyri-
dine ((HOM)2Py) as well as 2,6-dimethylpyridine (DMPy) which is
needed for comparisons.
Figure 15. Evidence for an enhanced complex stability of the Mn2þ (9),
Cu2þ (b), and Zn2þ (2) 1:1 complexes of HOMPy based on the
relationship between log KM(PyD)
M and pKH(PyD)
H for the simple
o-methylpyridine-type ligands (PyD) (O, from left to right) 2-methyl-
5-bromopyridine (2M5BrPy), 2-amino-5-bromopyridine (2A5BrPy), tu-
bercidin (= 7-deazaadenosine) (Tu), 2-methylpyridine (2MPy), and
2-aminopyridine (2APy) (for details see ref 70). The parameters of the cor-
responding least-squares references lines (eq 10) are summarized in
Table 21. The data for the points due to the equilibrium constants of the
M2þ/HOMPy systems are given in Table 22. The vertical dotted lines
emphasize the stability diﬀerences to the reference lines; they equal log
ΔM/HOMPy, as deﬁned in eqs 11a and 11b (see also Table 22, column 5). All
plotted equilibriumconstants refer to aqueous solutions at 25 Cand I=0.5M.
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(ii) The stability enhancements for the M(HOMPy)2þ com-
plexes follow to a large part the Irving�Williams series,80,81
yet the value for the Ni2þ complex is byΔ logΔM/HOMPy =
0.25( 0.15 [= (2.73( 0.12)� (2.48( 0.09)] larger than
the one of the Cu2þ complex. Why? This has clearly to do
with the diﬀerent coordination spheres of the two metal
ions. Ni2þ is octahedral, and this means that upon binding
of the primary site, i.e., the pyridyl moiety, four more sites
for binding of the hydroxyl group are sterically accessible.
In contrast, Cu2þ with its Jahn�Teller-distorted coordi-
nation sphere82 prefers to coordinate further liganding
groups to its equatorial (or square-planar) sites and there
are only two of these. In other words, binding of the
hydroxyl group toNi2þ is for statistical reasons favored by a
factor of 2 (4/2) and corresponds to 0.3 log unit, which
is in accord with the above given diﬀerence. Similar
observations have been made before.83
(iii) Replacement of one of the methylene hydrogens in the
CH2�OH residue by a CH3 group does not signiﬁcantly
aﬀect hydroxyl�M2þ binding as is evident from the data for
Cu(HOMPy)2þ and Cu(HOEPy)2þ (Table 22, column 5).
(iv) As one might expect, a further hydroxyl group, as in
o-[1-(1,2-dihydroxyethyl)]pyridine (DHOEPy), leads to
a further stability enhancement of about 0.25 log unit. This
indicates that the second hydroxyl group is also partly
involved in Cu2þ binding (Table 22, rows 7 and 8), that is,
there are two diﬀerent closed isomers possible: one with
one OH group involved, and one with both OH groups
participating (see section 8). Of course, the determined
stability enhancement, logΔM/DHOEPy = 2.91, encompasses
both isomers.
(v) Replacement of the hydroxyl group inHOMPy by amethoxy
moiety giving MOMPy (Figure 14) leads to a decrease in the
stability enhancement of about 0.35 log unit. This conﬁrms
the observation of sections 4.1.2 and 4.2 that an ether oxygen
is a somewhat poorer binding site than a hydroxyl group.
(vi) o-(Hydroxymethyl)pyridine (HOMPy) has one hydro-
xymethyl residue; insertion of the same group in the other
ortho position leads to 2,6-(dihydroxymethyl)pyridine
[(HOM)2Py], and the consequence is that the stability
enhancement increases further by about 0.63 log unit
(3.11 � 2.48) in the case of Cu2þ and by about 0.39 log
unit (1.42 � 1.03) in the case of the Cd2þ complexes.
Naturally, also in the M[(HOM)2Py]2þ complexes two
closed isomers are possible, one involving only one OH
group and one which involves both OH groups. Of
course, the stability enhancement, log ΔM/(HOM)2Py,
encompasses both isomers (see section 8).
8. ISOMERICQUANTIFICATIONOFMETAL-IONBINDING
WITH LIGANDS OFFERING TWO HYDROXYL GROUPS
In the preceding section we have seen that the
ligands o-[1-(1,2-dihydroxyethyl)]pyridine (DHOEPy) and
Table 22. Comparison of the Measured (exp) Stability Constants, KM(OPy)exp
M (eqs 4a, 4b, and 6), of the M2þ 1:1 Complexes
Formed by o-(Hydroxymethyl)pyridine (HOMPy), o-[1-(1-Hydroxyethyl)]pyridine (HOEPy), o-[1-(1,2-Dihydroxy-
ethyl)]pyridine (DHOEPy), o-(Methoxymethyl)pyridine (MOMPy), 2,6-Dimethylpyridine (DMPy) (for Comparison), and
2,6-(Dihydroxymethyl)pyridine ((HOM)2Py)b with the Calculated (calc) Stability Constants for the Open Isomers with a
Sole M2þ�N Coordination (at a Single o-Substituted Pyridine, Like o-Methylpyridine or o-Aminopyridine (see Figure 15)),
KM(OPy)op
M (eqs 1 and 7)a
OPy M2þ log M(OPy)exp
M log M(OPy)op
M c log ΔM/OPy KI % M(OPy)cl
2þ
HOMPy Mn2þ 1.13( 0.15d 0.03( 0.07 1.10( 0.17 11.59( 4.80 92.1 ( 3.0
Co2þ 2.23( 0.15d 0.07( 0.08 2.16( 0.17 143.54( 56.58 99.3( 0.3
Ni2þ 2.90( 0.06e 0.17( 0.10 2.73( 0.12 536.03( 144.21 99.8( 0.1
Cu2þ 3.56( 0.06e 1.08( 0.07 2.48( 0.09 301.00( 64.11 99.7( 0.1
Zn2þ 2.03( 0.15d 0.11( 0.08 1.92( 0.17 82.18( 32.56 98.8 ( 0.5
Cd2þ 1.65( 0.10f 0.62( 0.09 1.03( 0.13 9.72( 3.32 90.7( 2.9
HOEPy Cu2þ 3.77( 0.15d 1.11( 0.07 2.66( 0.17 456.09( 174.22 99.8( 0.1
DHOEPy Cu2þ 3.88( 0.15d 0.97( 0.07 2.91( 0.17 811.83( 309.81 99.9( 0.1g
MOMPy Cu2þ 3.06( 0.15d 0.93( 0.07 2.13( 0.17 133.90( 51.42 99.3( 0.3
DMPy Ni2þ 0.20( 0.06e (0.39( 0.10)h (�0.19( 0.12)h
(HOM)2Py Cu2þ 3.81( 0.10f 0.70( 0.14h 3.11( 0.17 1287.25( 510.34 99.9( 0.1g
Cd2þ 1.79( 0.10f 0.37( 0.15h 1.42( 0.18 25.30( 10.92 96.2( 1.6g
aThe observed stability increase is expressed by log ΔM/OPy (eqs 11a and 11b). The extent of chelate formation according to the intramolecular
equilibria 1 and 2 for theM(OPy)2þ complexes is quantiﬁed by the dimensionless equilibrium constantKI (eqs 7 and 9) and the percentage of the closed
isomers, M(OPy)cl
2þ (eq 13). All data refer to aqueous solution at 25 C and I = 0.5M.17 bThe corresponding acidity constants17 at 25 C and I = 0.5M17
are pKH(HOMPy)
H = 4.95 (at I = 0.1 M, pKa = 4.90( 0.02;17 hence,ΔpKa = 0.05), pKH(HOEPy)H = 4.98 (at I = 0.1 M)þ 0.05 (correction for change in I to
0.5 M) = 5.03, pKH(DHOEPy)
H = 4.64þ 0.05 = 4.69, pKH(MOMPy)H = 4.53þ 0.05 = 4.58, pKH(DMPy)H = 6.92( 0.04, and pKH[(HOM)2Py]H = 4.49 (at 20 C:
4.39). cNote eqs 11a and 11b, i.e., logKM(OPy)calc
M = logKM(OPy)op
M . dCorrected value: On the basis of the values for Ni(HOMPy)2þ and Cu(HOMPy)2þ
at I = 0.1 and 0.5M (cf. ref 17), the values listed in ref 17 are increased by 0.13 log unit; to be on the safe side an error limit of(0.15 log unit is applied. e In
those instances where no error limit is given in the literature17(0.06 log unit is employed. fThe values given in refs 17 and 79 refer to 20 C and I = 0.5M
(NaNO3); these values were reduced by 0.05 log unit to account for the diﬀerence in temperature; an error limit of (0.10 log unit is used in these
instances. g See section 8. hApplication of the straight-reference line70 gives an expected value for the Ni2þ complex with the o-methylpyridine derivative
of 0.39( 0.10 log unit, that is, inhibition by a second o-methyl group amounts to�0.19( 0.12 log unit. Therefore, the calculated values for the Cu2þ and
Cd2þ complexes have been reduced by a further 0.19 ( 0.12 log unit assuming that inhibition in the Cu2þ and Cd2þ complexes corresponds to that
observed in the Ni2þ complex. The error limits were calculated according to the error propagation after Gauss.
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2,6-(dihydroxymethyl)pyridine ((HOM)2Py) (Figure 14), which
oﬀer two hydroxyl groups, give rise to a stability enhancement
which goes beyond that observed for the corresponding com-
plexes containing only a single hydroxyl group. Below we shall
now attempt to quantify the extent of the participation of the
second hydroxyl group in metal-ion binding.
Taking into account the additional isomer, equilibrium 5
needs to be extended to equilibrium 19 (charges are omitted
for simplicity)29,84,85
Mþ PBSðOHÞðOHÞ h M½PBSðOHÞopðOHÞop�
h M½PBSðOHÞclðOHÞop� h M½PBSðOHÞclðOHÞcl�
ð19Þ
The corresponding experimentally accessible overall stability
constant is then deﬁned by eq 20 (cf. with eqs 4a, 4b, and 6)
and the open (op) isomer (cf. with eq 7) by eq 21
KMM½PBSðOHÞðOHÞ�
¼ ð½M½PBSðOHÞopðOHÞop�� þ ½M½PBSðOHÞclðOHÞop��
þ ½M½PBSðOHÞclðOHÞcl��

=ð½M�½PBSðOHÞðOHÞ�Þ ð20Þ
KMM½PBSðOHÞopðOHÞop�
¼ ½M½PBSðOHÞopðOHÞop��=ð½M�½PBSðOHÞðOHÞ�Þ ð21Þ
The positions of the two intramolecular equilibria, which are part
of equilibrium 19, are deﬁned by the following two intramole-
cular dimensionless equilibrium constants KI(1) and KI(2)
KIð1Þ ¼ ½M½PBSðOHÞclðOHÞop��=½M½PBSðOHÞopðOHÞop��
ð22Þ
KIð2Þ ¼ ½M½PBSðOHÞclðOHÞcl��=½M½PBSðOHÞclðOHÞop��
ð23Þ
Combination of eqs 20�23 leads to eqs 24a and 24b
KMM½PBSðOHÞðOHÞ� ¼ KMM½PBSðOHÞopðOHÞop�
þ KIð1Þ 3KMM½PBSðOHÞopðOHÞop�
þ KIð1Þ 3KIð2Þ 3KMM½PBSðOHÞopðOHÞop� ð24aÞ
¼ KMM½PBSðOHÞopðOHÞop�ð1þ KIð1Þ þ KIð1Þ 3KIð2ÞÞ ð24bÞ
Of course, if the second closed isomer, M[PBS(OH)cl(OH)cl],
does not exist, KI(2) becomes zero and then eq 24b equals eq 8b.
If we deﬁne a “total” (tot) intramolecular equilibrium constant
KI(tot) as given in eq 25
KIðtotÞ ¼ KIð1Þ þ KIð1Þ 3KIð2Þ ¼ KIð1Þð1þ KIð2ÞÞ ð25Þ
we obtain eqs 26a, 26b, and 26c, which is analogous to eq 9
KIðtotÞ ¼
½M½PBSðOHÞclðOHÞop�� þ ½M½PBSðOHÞclðOHÞcl��
½M½PBSðOHÞopðOHÞop��
ð26aÞ
¼
KMM½PBSðOHÞðOHÞ�
KMM½PBSðOHÞopðOHÞop�
� 1 ð26bÞ
¼ 10log Δ � 1 ð26cÞ
Clearly, eq 26c follows from eqs 11a and 11b in analogy to eq 12.
A value for KI(tot) is easily obtained via eq 26c. What is needed,
however, is a value either forKI(1) orKI(2) to calculate the other one.
It is evident that for the present two instances the following holds:
(i) KI(1) for the Cu(DHOEPy)
2þ system is well-deﬁned by
the KI value obtained for Cu(HOEPy)
2þ (see Table 21
and compare the structures in Figure 14).
(ii) Similarly, KI for M(HOMPy)
2þ represents well KI(1) for
the M[(HOM)2Py]2þ systems if multiplied by two
because in M[(HOM)2Py]2þ there are two possibilities
for the formation of the macrochelate whereas in
M(HOMPy)2þ there is only one.
The corresponding results are summarized in Table 23, where
PBS(OH)(OH) = DHOEPy or (HOM)2Py.
The results of Table 23 reveal immediately that all three
isomers formulated in equilibrium 19 occur, the open isomer,
M[PBS(OH)op(OH)op]
2þ, being a minority species. That
Cu-[(DHOEPy)(OH)cl(OH)op]
2þ reaches apparently a some-
what larger formation degree than Cu[(DHOEPy)(OH)cl-
(OH)cl]
2þ is no surprise because the latter species is expected
to form only with strained 5-membered rings. In fact, model
building indicates that the second OH group interacts preferably
with an apical position of Cu2þ, an interaction which is com-
monly weaker than the equatorial interactions. For the
M[(HOM)2Py(OH)cl-(OH)cl]
2þ species the steric restrictions
are less demanding, both for Cu2þ and for Cd2þ. In the case of
Cu2þ the isomer with two hydroxyl groups coordinated appears
to be slightly dominating, whereas with Cd2þ the relatively low
hydroxyl�Cd2þ aﬃnity (see sections 4.2, 4.3, 5.2, and 7) is also
reﬂected here, leading for Cd[(HOM)2Py(OH)cl(OH)cl]
2þ to a
formation degree of only about 22%.
The take home message of this section is that a single primary
binding site, in the present case a pyridine residue, is enough to
facilitate binding of (at least) two hydroxyl groups, that is, the
PBS may be symmetrically located between the two hydroxyl
groups or the structure may be of an unsymmetrical nature,
meaning that ﬁrst the neighboring hydroxyl group must coordi-
nate to the metal ion before the second one is able to do so.
9. EFFECT OF THE PRIMARY BINDING SITE ON THE
EXTENT OF THE HYDROXYL�METAL-ION
INTERACTION
The ligands hydroxymethylphosphonate (HMP2�), hydroxy-
acetate (HOAc�), 2-aminoethanol (AEtOH), 2-hydroxymethyl-
imidazole (Im2OH), and o-(hydroxymethyl)pyridine (HOMPy)
are all able to form 5-membered chelates according to equilib-
rium 1 with the divalent metal ions considered in this account. In
all instances the primary binding site is considered here as being
4987 dx.doi.org/10.1021/cr100415s |Chem. Rev. 2011, 111, 4964–5003
Chemical Reviews REVIEW
(overwhelmingly) monodentate, even though indications exist
that phosph(on)ate residues may bind divalent metal ions in
equilibrium also in a semichelate fashion (for details see ref 28),
that is, one of the phosph(on)ate oxygens is inner-sphere
coordinated and another one outer-sphere with a water molecule
between the metal ion and the phosph(on)ate oxygen. For the
carboxylate group similar reasonings exist.86 In the solid state
4-membered chelates have (rarely) been observed with both
groups, but in aqueous solution such strained 4-membered rings
are not expected to persist.28
The extent of the hydroxyl�metal-ion interaction may be de-
scribed via the formationdegrees of the chelated species (eq 13) or via
the stability enhancements, log ΔM/PBS�OH (eqs 11a and 11b). We
use here the latter version because diﬀerences in the properties are
easily identiﬁed. This is evident from the following: The stability
enhancements logΔM/PBS�OH = 0.1, 0.3, 1.0, 2.0, or 3.0 correspond
to the formation degrees %M(PBS�OH)cl = 21%, 50%, 90%, 99%,
or 99.9%, respectively (for details see ref 25).
The stability enhancements, logΔM/PBS�OH, for the ﬁve ligand
systems, PBS�OH, mentioned above are collected in Table 24.
The various results are taken from Tables 2, 7, 11, 17, 20, and 22.
Next to the ligand symbols on top of the various columns of
Table 24 the ionic strength (I) is given to which the data listed be-
low in the columns refer. From the two entries for the M(HOAc)þ
complexes at I= 0.1 and 2M (columns 3 and 4) it is evident that the
ionic strength eﬀect on the diﬀerence logΔM/PBS�OH in this range
of I is small. Consequently, wemay directly compare the values valid
for the various M(PBS�OH) complexes.
Table 24 allows many comparisons; a few are given below:
(i) The most complete series for a given metal ion is the
one for Cu2þ. In this case, the stability enhancement due
to the hydroxyl�Cu2þ interaction increases in the
series Cu(HMP) < Cu(HOAc)þ < Cu(AEtOH)2þ
< Cu(Im2OH)2þ , Cu(HOMPy)2þ. This means the
more the charge on Cu2þ is neutralized by the PBS, the
less is the aﬃnity of M2þ for the hydroxyl group. It needs
to be emphasized in this context that the global overall
stability constants as deﬁned by eqs 4a and 4b do not at
all follow the above order, which is the result of the
position of the intramolecular equilibrium 1. Furthermore,
this order is also not related to the basic properties
(pKa values) of the primary binding sites (PBS).
(ii) The conclusion given in (i) also holds for theMn(PBS-OH)
complexes. In fact, the same is true for the complexes
Table 23. Formation Degrees of the Three M[PBS(OH)(OH)]2þ Isomers Seen in Equilibrium 19 for M(DHOEPy)2þ and
M[(HOM)2Py]2þ Systems; Calculated with eqs 25 and 26c As Well As eq 13 (aqueous solution; 25 C; I = 0.5 M)a,b
no.a PBS(OH)(OH) M2þ log Δ KI(tot) % M[PBS(OH)(OH)]cl(tot)
2þ % M[PBS(OH)op(OH)op]
2þ
1a DHOEPy Cu2þ 2.91( 0.17 811.83( 309.81 99.88( 0.05 0.12( 0.05
2a (HOM)2Py Cu2þ 3.11( 0.17 1287.25( 510.34 99.92( 0.03 0.08( 0.03
3a Cd2þ 1.42( 0.18 25.30( 10.92 96.20( 1.58 3.80( 1.58
no.a PBS(OH)(OH) M2þ KI(1) %M[PBS(OH)cl(OH)op]
2þ KI(2) %M[PBS(OH)cl(OH)cl]
2þ
1b DHOEPy Cu2þ 456.09( 174.22c 55( 10d 0.780( 0.320e 45( 10f
2b (HOM)2Py Cu2þ 602.00( 90.67g 48( 6d 1.138( 0.302e 52( 6f
3b Cd2þ 19.44 ( 4.70h 74( 12d 0.301( 0.215e 22( 12f
a Entries 1a and 1b, 2a and 2b, etc., go together. bThe values in columns 4�6 in the upper part of the table are from columns 5�7 of Table 21,
respectively. Note, the error limits given correspond always to 3σ, except in columns 5�7 of the lower part where they correspond to 1σ. c From
the Cu(HOEPy)2þ system of Table 21 (column 6). dCalculated with eq 22. eCalculated with eq 25. fCalculated from the diﬀerence %
M[PBS(OH)-(OH)]cl(tot)
2þ �% M[PBS(OH)cl(OH)op]2þ. Of course, the calculation can also be done via eq 23; the result is the same, but the error
limits are understandably larger. g From the Cu(HOMPy)2þ system of Table 21 (column 6); see text:KI(1) = 2(301.00( 64.11) = 602.00( 90.67 (3σ).
h From the Cd(HOMPy)2þ system of Table 21 (column 6); see text: KI(1) = 2(9.72 ( 3.32) = 19.44 ( 4.70 (3σ).
Table 24. Comparison of the Stability Enhancements, logΔM/PBS�OH (eqs 11a and 11b), for a Series of PBS�OHLigandsaWhich
Are Able To Form 5-Membered Chelates According to Equilibrium 1 in Aqueous Solution at 25 C
M2þ HMP2� (0.1 M)a HOAc� (0.1 M) HOAc� (2 M) AEtOH (0.5 M) Im2OH (0.5 M) HOMPy (0.5 M)
Ba2þ (0.10)b 0.42( 0.13
Sr2þ (0.12)b 0.50( 0.13
Ca2þ 0.13( 0.08 0.78( 0.08
Mg2þ 0.12( 0.10 0.54( 0.07
Mn2þ (0.18)b 0.60( 0.16 0.72( 0.22 1.10 ( 0.17
Co2þ (0.24)b 1.12 ( 0.08 0.85( 0.21 2.16( 0.17
Ni2þ (0.28)b 1.23( 0.04 1.03( 0.21 2.73( 0.12
Cu2þ 0.30( 0.08 0.79( 0.08 0.77( 0.05 1.03( 0.26 1.22 ( 0.12 2.48( 0.09
Zn2þ (0.25)b 1.04( 0.06 1.05( 0.09 0.99( 0.21 1.92( 0.17
Cd2þ (0.13)b 0.50( 0.08 0.54( 0.22 1.03( 0.13
Pb2þ 0.52( 0.20 3.40( 0.32
aNext to the abbreviation of the ligands the ionic strength (I) is given to which the values listed in the column refer. bThe values given in parentheses are
estimates based on general experience. The corresponding error limits are estimated as (0.15 log unit.
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of Co2þ, Ni2þ, Zn2þ, or Cd2þ, even though here
the series is M(HMP) < M(HOAc)þ ≈ M(AEtOH)2þ
< M(HOMPy)2þ. The apparent equality of the stability
enhancements (within the error limits) for several of the
M(HOAc)þ and M(AEtOH)2þ complexes is probably
real, though to some extent it could also be due to the
assumptions that had to be made in evaluating the
M(AEtOH)2þ complexes (see section 5).
(iii) It is interesting to note that the stability enhancements
observed for the Cd2þ complexes are approximately one-
half the size found for the corresponding Zn2þ species,
thus conﬁrming the somewhat reduced aﬃnity of Cd2þ
for the hydroxyl group as indicated in several preceding
sections (4.2, 4.3, 5.2, and 7).
(iv) The corresponding properties of Pb2þ depend strongly
on the PBS: With HOAc�, the PBS being a carboxylate
group, the stability enhancements observed for the Cu2þ,
Cd2þ, and Pb2þ complexes are relatively similar, whereas
for AEtOH, the PBS being now an amino group, log
ΔPb/AEtOH is outrunning strongly even the corresponding
Cu2þ value (see also sections 5.2 and 5.3 regarding the
properties of Pb2þ).
(v) The very large stability enhancements observed for the
M(HOMPy)2þ complexes (Table 24, column 7) are in
accord with the conclusion regarding the charge density on
the metal ion given in (i) because the pyridyl group is not
only a σ donor via its nitrogen but also an excellent π
acceptor, at least with transition elements, thus reducing
the charge density on the central metal ion. Indeed, the
enhanced stability of mixed ligand complexes, composed of
pyridyl residues and O-donor ligands is well known.7,87�91
(vi) Unfortunately, for M(Im2OH)2þ complexes, except for
Cu2þ, no data are available. However, from studies of
mixed ligand complexes it is known that the imidazole
group with its nitrogen is approximately in between the
properties observed for ligands with amino and pyridyl
residues.92,93 This means that the imidazole residue is a
better σ donor compared to the pyridyl moiety94 but a
poorer π acceptor. These reasonings are of relevance for
complexes formed in proteins,52 where the imidazole
group of histidine is an important binding site. Also, for
ribozymes and other nucleic acids, the imidazole unit is
part of purine residues and an eager metal-ion binding
site.1,13�15,63,95 In addition, modiﬁed DNAs with imida-
zole residues as nucleobases have been synthesized lately;
in these altered DNAs metal ions coordinate tightly to the
N3 position.10
10. EXTENT OF HYDROXYL�METAL-ION
INTERACTIONS IN COMPLEXES HAVING A BIDENTATE
PRIMARY BINDING SITE
The ligand N-hydroxyethylglycinate (HOGly�) has a glyci-
nate-like bidentate binding site which leads to 5-membered
chelates, and it oﬀers in addition an ethylhydroxy group which,
depending on the metal ion involved, may give rise to formation
of a further 5-membered chelate (Figure 16). Since the stability
constants of the M(HOGly)þ complexes of Ca2þ, Mg2þ, Mn2þ,
Co2þ, Ni2þ, Cu2þ, and Zn2þ have been measured in aqueous
solution (25 C; I = 0.1 M, KCl),96,97 these systems are ideal for
the present purpose, that is, to see to what extent the hydroxyl
group is able to participate in metal-ion binding if a bidentate
primary site is involved.
Because the N-hydroxyethyl substituent is expected to lead to
some steric hindrance in the open form of the M(HOGly)þ
complexes (in analogy to equilibria 1 and 2), this inhibition needs
to be quantiﬁed. In a ﬁrst approximation one may assume that a
methyl substituent at the amino group of glycinate mimics this
steric eﬀect well. Therefore, next to glycinate (Gly�) also sarco-
sinate (Sar� = N-methylglycinate) and their complexes are
considered in this section; the structure of these ligands is shown
in the upper part of Figure 16 together with the one of HOGly�.
Of course, a possible stability enhancement log ΔM/HOGly
according to eqs 11a and 11b can only be determined if the
stability of the open complexes, M(HOGly)op
þ , is known. These
KM(HOGly)op
M values are best determined via log KM(PBS)
M versus
pKH(PBS)
H straight-line plots (eq 10) as we have repeatedly seen in
the preceding sections. For this purpose we collected the
available stability constants of the complexes formed with the
nine amino acetates and derivatives (Aa�) shown in the middle
and lower parts of Figure 16. Not in all instances were the data for
all considered metal ions available from a single source, but still,
we collected data mainly valid for 25 C and I = 0.1M.17,22,98�105
On the other hand, for several ligands more constants are
available,100 which are close to the ones used, e.g., for Leu�
(cf. ref 22) and Gly�.87 The acidity constants of the mono-
protonated ligands and the stability constants of the complexes
employed now in the evaluation are summarized in Table 25.
In the construction of the straight-line plots we con-
sidered only the basicity of the amino nitrogen, that is, the
pKH(Aa)
H values, as this property is aﬀected by the kind of the
Figure 16. Chemical structure of N-hydroxyethylglycinate (HOGly�),
the properties of which will be compared in section 10 with those
of glycinate (Gly�) and sarcosinate (Sar� = N-methylglycinate). The
other amino acetates (Aa�), the structures of which are shown, are used
to deﬁne the straight-line plots (e.g., Figure 17): alaninate (Ala�), 2-am-
inobutanoate (ABu�), valinate (Val�), 2-aminopentanoate (APn�),
leucinate (Leu�), biocytinate (BcS� = ε-N-d-biotinyl-L-lysinate), bio-
cytinate sulfoxide (BcSO�), biocytinate sulfone (BcSO2
�), and
ε-N-acetyl-L-lysinate (AcLys�).
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nearby substituent (see Figure 16 and Table 25). The basicity
of the carboxylate group, which is further away, is hardly aﬀected
by the varying substituents as is evident from the following
acidity constants which hold for the 2-fold protonated H2(Aa)
þ
species: pKH2(Ala)
H = 2.26 ( 0.03, pKH2(AcLys)
H = 2.24 ( 0.01, and
pKH(BcS)
H = 2.26( 0.03.98 The corresponding observations have
also been made in other instances, especially in ref 100 but
also, e.g., in refs 17, 22 and 99. An additional reason for neglecting
these acidity constants is that the scatter among the results from
various authors is in part relatively large, i.e., larger than the
scatter in the pKH(Aa)
H values. This is understandable because the
low pH range around 2 is close to the limit that can be measured
with glass electrodes and where the type of calibration of the pH
meter also may aﬀect the results.
In Figure 17 three representative examples of plots of log
KM(Aa)
M versus pKH(Aa)
H are shown. In the case of Cu2þ, Zn2þ, and
Mn2þ, 16, 14, and 9 data pairs are available, respectively, as follows
from Table 25 (see the open circles in Figure 17). From all three
parts of Figure 17 it is evident that there is a signiﬁcant dependence
of log KM(Aa)
M on pKH(Aa)
H . However, the scatter of the data
points is rather large, and deletion of a single point either at the
lower or upper endof the pKH(Aa)
H scalemay aﬀect the slope,m, and
thus the least-squares treatment and its result relatively strongly.
To avoid ambiguities and also to make the matter simple, we
decided to use the slope, m = 0.7, as previously proposed by
Martin69 in all instances. Therefore, in the least-squares calcula-
tion the slopem = 0.7 was kept constant and only the intercept b
with the y axis was varied. The resulting parameters according to
eq 10 are listed in Table 26. The error limits given in column 4 are
estimates; they are based on the scatter of the data around the
straight line with a slope of 0.7 and emphasize especially the error
at pKH(Aa)
H of about 9 or 10. It needs further to be emphasized
that a change in the slope m of (0.2 in the pKH(Aa)H range of ca.
9�10 does not signiﬁcantly aﬀect the outcome of the
Table 25. Logarithms of the Stability Constants for the 1:1 Complexes (eqs 4a and 4b) Formed between Several DivalentMetal Ions
(M2þ) and Various Amino Acetate Ligands (Aa�) Including Glycinate (Gly�), Sarcosinate (Sar�), and N-Hydroxyethylglycinate
(HOGly�) (see Figure 16 for the Structures) As Well As Negative Logarithms of the Acidity Constants (eqs 14a and 14b) of the
Corresponding H(Aa)( Species, Determined by Potentiometric pH Titrations, of Aqueous Solutions at (mostly) 25 C
log KM(Aa)
M for M2þ =
Aa� I (ref)a pKH(Aa)
H Ca2þ Mg2þ Mn2þ Co2þ Ni2þ Cu2þ Zn2þ
Ala� 0.1 (98) 9.83 ( 0.03 2.67( 0.05 4.44( 0.05 8.25 ( 0.07 4.51( 0.05
0.1 (99) 9.84( 0.01 8.22( 0.02
0.1 (22) 9.82( 0.01 8.33( 0.02 4.62( 0.04
0.05�0.5 (100) 9.72( 0.05 2.60( 0.15 4.33( 0.05 5.41( 0.08 8.14( 0.10 4.63( 0.08
0.1 (17) 9.71( 0.04 1.00( 0.10b 1.54 ( 0.10b 2.45( 0.10b 4.31( 0.07 5.36( 0.04 8.11( 0.07 4.58 ( 0.07
Val� 0.1 (99) 9.66( 0.02 8.15( 0.02
0.1�0.5 (100) 9.54( 0.05 5.27( 0.05 7.98( 0.08 4.46 ( 0.06
0.15 (101)c 9.32( 0.01 2.34( 0.09 4.24 ( 0.06a
0.5 (102)d 9.48( 0.01 4.32( 0.06
0.1 (17) 9.52( 0.05 5.3( 0.1 8.10( 0.05 4.52( 0.06
Leu� 0.1 (99) 9.72( 0.01 8.19( 0.01
0.1 (103) 9.66( 0.01 2.49 ( 0.03 4.56( 0.02
0.1�0.2 (100) 9.66( 0.03 5.57( 0.05e
∼0.1 (104) 9.77( 0.06a 4.51( 0.06a 5.62( 0.06a
0.1 (17) 9.58( 0.07 5.33( 0.06a 8.14( 0.07 4.56( 0.06a
ABu� 0.1 (17) 9.63( 0.02 4.23( 0.07 5.30 ( 0.08 8.11( 0.10 4.54( 0.05
APn� 0.1 (105) 9.64( 0.01 4.15( 0.01 5.27 ( 0.02 8.12( 0.01 4.42( 0.02
AcLys� 0.1 (98) 9.63( 0.02 2.50( 0.05 4.27( 0.05 8.09( 0.06 4.51( 0.05
BcS� 0.1 (98) 9.29( 0.02 2.47( 0.05 4.10( 0.05 7.73( 0.03 4.38( 0.03
BcSO� 0.1 (98) 9.30( 0.02 2.45( 0.05 7.87 ( 0.05 4.33( 0.05
BcSO2
� 0.1 (98) 9.31( 0.03 2.44( 0.05 7.83( 0.05 4.32( 0.05
Gly� 0.1 (17) 9.57( 0.05 1.09( 0.04 1.66( 0.06a 2.80( 0.05 4.67( 0.05 5.74( 0.09 8.19( 0.04 4.96( 0.04
Sar� 0.1 (17) 9.98( 0.04 2.54 ( 0.10f 5.39( 0.06a 7.68( 0.06a 4.53( 0.06a
∼0.1 (104) 10.09( 0.06a 4.34( 0.06a
HOGly� 0.1 (96,97) 9.05( 0.01 4.32( 0.01 3.11( 0.01 4.15( 0.01 7.30 ( 0.01 9.11( 0.02 9.56( 0.01 7.57( 0.01
a In this column the ionic strength (I) applied in the experiments is listed together with the reference from where the data are taken. In those instances
where in the literature no error limit is given, it is assumed to be (0.06 log unit if nothing else is mentioned. bThe error limits of (0.10 log unit are
estimates. The constants given for the Ca2þ and Mg2þ complexes are corrected values from I = 0 to I = 0.1 M by using the corresponding diﬀerence
observed for theGly� complexes in ref 17. Ca2þ: (1.30( 0.06) [at I= 0]� 0.30 [fromGly�] = 1.00 at I= 0.1M.Mg2þ: 1.96� 0.42 = 1.54. cMeasured at
37 C.101 The value given for the Co(Val)þ complex (with an estimated error limit) is from ref 17. dMeasured at 30 C.102 eAverage of the values listed in
ref 100 for the stability of the Ni(Leu)þ complexes. fAbove, there are 9 examples which allow one to calculate the diﬀerence between the log stability
constants of the Zn2þ and Mn2þ complexes; this diﬀerence amounts to 1.99 ( 0.08 (2σ) log unit. Hence, by using the log stability constant of the
Zn(Sar)þ complex and by deducting the mentioned diﬀerence, the above given value for the Mn(Sar)þ complex is obtained, that is, (4.53 ( 0.06) �
(1.99 ( 0.08) = 2.54 ( 0.10.
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calculations for the logΔM/HOGly values. This is especially true as
the data points for the Hþ/M2þ/HOGly� systems are far above
their reference lines, thus indicating without any calculation a
large stability enhancement for the M(HOGly)þ complexes.
Two more points need to be emphasized in the context of
Figure 17
(i) The data point for a given Hþ/M2þ/Gly� system
(rhomb) is always above the straight line deﬁned by the
corresponding alaninate-type complexes. This is in accord
with the observation of Martin69 that the M(Gly)þ com-
plexes are somewhat more stable than the corresponding
M(Ala)þ species despite the lower basicity of Gly�
compared to Ala� (see also the data in Table 25).
(ii) Substitution of a methyl group at the amino nitrogen of
Gly� leads to a signiﬁcant steric inhibition of metal-ion
coordination, and therefore, not only are the stabilities of
the M(Sar)þ complexes always lower than those of the
corresponding M(Gly)þ species (despite the higher basi-
city of Sar� compared to that of Gly�) (Table 25) but also
the data points for the Hþ/M2þ/Sar� systems (full
squares) are also always below the reference lines typical
for the alaninate-type complexes (see Figure 17).
The stability constant of the open form of the M(HOGly)þ
complexes is therefore given by the intercept that follows from
pKH(HOGly)
H = 9.05 (cf. refs 96 and 97) with the straight line of the
alaninate-type complexes (Ala-type), and this value needs then to
be increased by log ΔM/Gly to obtain the glycinate-like coordina-
tion, which thereafter needs to be adjusted for the total steric
inhibition, which means that [log ΔM/Gly � (�log ΔM/Sar)]
needs to be deducted. This is expressed in eqs 27a and 27b
log KMMðHOGlyÞop ¼ log KMMðAla-typeÞ þ log ΔM=Gly
� ½log ΔM=Gly � ð�log ΔM=SarÞ� ð27aÞ
¼ log KMMðAla-typeÞ þ ð�log ΔM=SarÞ ð27bÞ
Since the values for log KM(HOGly)
M (= KM(HOGly)exp
M ) are known
(Table 25, bottom row) eqs 11a and 11b can be applied and the
stability enhancements log ΔM/HOGly can be calculated. The
corresponding results are summarized in Table 27.
From column 6 of Table 27 it is evident that the stability
enhancements for the M(HOGly)þ complexes of Mn2þ, Co2þ,
Ni2þ, Cu2þ, and Zn2þ are tremendous. Even for the lowest case,
the Mn(HOGly)þ complex, log ΔMn/HOGly still equals approxi-
mately 2.3. Consequently, it follows from eqs 12 and 13 that
the formation degree of the closed and chelated species,
Mn(HOGly)cl
þ, amounts to about 99.5%. For the most favorable
case, Ni(HOGly)cl
þ, a formation degree of practically 100%
is reached. Since the formation degrees of all the other
M(HOGly)cl
þ species (M2þ = Co2þ, Cu2þ, Zn2þ) varies only
in the indicated narrow range of 0.5%, no further calculations
were made.
Why is the stability enhancement for the Cu(HOGly)þ
complex relatively low? If we consider the equatorial square-
planar coordination sphere of Cu2þ (see also section 7, point
Figure 17. Evidence for an enhanced complex stability of the Mn2þ,
Cu2þ, and Zn2þ 1:1 complexes of HOGly� (b) based on the relation-
ship between log KM(Aa)
M and pKH(Aa)
H for the simple amino acetate
ligands (O) shown in the middle and lower parts of Figure 16. The
parameters, with slope m = 0.7 being kept ﬁxed, of the corresponding
least-squares reference lines (eq 10) are summarized in Table 26. The
data points for the Hþ/M2þ/Gly� (() and Hþ/M2þ/Sar� (9) systems
are shown for comparison. The vertical dotted lines emphasize the
(positive or negative) stability diﬀerences to the reference lines; these
diﬀerences equal log ΔM/Aa as deﬁned by eqs 11a and 11b. All plotted
equilibrium constants are listed in Table 25; they refer to aqueous
solutions (mostly) at 25 C and (mostly) I = 0.1 M.
Table 26. Straight-Line Parameters (eq 10)a for M2þ 1:1
Complexes Formed with the Simple Amino Acetate Ligands
(Aa�) Shown in the Lower Part of Figure 16, Valid for
Aqueous Solutions at 25 C and I = 0.1 Mb
M2þ m b log (error limits)
Mn2þ 0.70 �4.18 (0.2
Co2þ 0.70 �2.43 (0.15
Ni2þ 0.70 �1.37 (0.2
Cu2þ 0.70 1.36 (0.1
Zn2þ 0.70 �2.21 (0.15
aThe slopes (m) were ﬁxed at 0.70 (see text in section 10), and the
intercepts (b) for the straight reference lines from plots of log
KM(Aa)
M versus pKH(Aa)
H were calculated by the least-squares procedure
from the experimentally determined equilibrium constants listed in
Table 25 for the ligands shown in the lower part of Figure 16 (see also
Figure 17). bThe straight-line equation is deﬁned by eq 10. With a
known pKH(Aa)
H value of any amino acetate derivative (Aa�), the stability
constant logKM(Aa)
M for the correspondingM(Aa)þ complex (eqs 4a and
4b) can be calculated. The estimated error limits given in the fourth
column should be used for any calculation in the pKH(Aa)
H range of 9�10.
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(ii)), there are only 4 possibilities for coordination of a bidentate
ligand (glycinate-like binding) whereas there are 12 such possi-
bilities in an octahedral coordination sphere. Moreover, once the
glycinate-like coordination has occurred, only 1 possibility for
coordination of the hydroxyl group remains in the case of Cu2þ,
in contrast to the 3 possibilities that are oﬀered by an octahedral
sphere. Hence, this consideration alone (4/12 times 1/3)
amounts already to a statistical disadvantage for Cu2þ of about
1 log unit.
As one would expect, the global stability constants given in the
last row of Table 25 for theM(HOGly)þ complexes are in general
of a similar size or somewhat lower than those of the correspond-
ing complexes formed with iminodiacetate [= Ida2� =
HN-(CH2COO)2
2�].17,106 However, here is also a caveat needed
because in a few instances, especially with Ca2þ and Ni2þ, the
stability of the M(HOGly)þ complexes is roughly by 1 log unit
larger than the one for the M(Ida) species; this result may
be correct but is surprising, and therefore, it would be desirable
that the stabilities of the M(HOGly)þ complexes are deter-
mined again. This suggestion is even more enforced by
the observation that the stability constants of the Mn2þ, Co2þ,
Ni2þ, Cu2þ, and Zn2þ complexes formed with the buﬀer
ligand Bicinate [= N,N-bis(2-hydroxyethyl)glycinate =
(HO-CH2CH2)2NCH2COO
�]107,108 are all lower than those of
the corresponding M(HOGly)þ complexes, even though in the
M(Bicinate)þ complexes a further�CH2CH2OH residue for M2þ
binding is available. Yet, Bicinate is less basic (Δ pKa = 0.8)
96,97,108
and it could further be that the additional substituent at the amino
nitrogen rather hinders than promotes M2þ coordination (see also
sections 5.3). Furthermore, in section 5.1 we have seen that the
Ni[(CH3)2NH]
2þ complex is by ca. 0.8 log unit less stable than the
Ni(CH3NH2)
2þ one even though in this case the basicity diﬀerence
between the two ligands is small. However, it needs to be
emphasized that the conclusions presented above about the very
large stability enhancements are still valid, even if the logΔM/HOGly
values listed in Table 27 should in some instances be smaller by
about 1 log unit.
Unfortunately, the stabilities of the Ca2þ andMg2þ complexes
formed with Sar� are unknown, and reference lines like those
seen in Figure 17 could also not be deﬁned, though there is an
indication that again the M(Gly)þ complexes of Ca2þ and Mg2þ
are slightly more stable than the corresponding M(Ala)þ species
(see Table 25). However, to be on the safe side, we simply
evaluated the diﬀerences in complex stability between the
M(HOGly)þ and the corresponding M(Gly)þ species. Clearly,
this procedure provides a lower limit for the stability enhance-
ments experienced by the Mg(HOGly)þ and Ca(HOGly)þ
complexes due to coordination of the hydroxyl group (see the
two top entries in Table 27). Consequently, the formation
degrees of the closed M(HOGly)cl
þ species, calculated according
to eqs 12 and 13, based on these values, are also lower limits; they
are 96% and 99.9%, respectively. These lower limits of the
formation degrees of the chelated species are remarkably high
and worthwhile to be noted with a view toward biological
systems.
Overall, it is evident that participation of the hydroxyl group in
metal-ion binding in the M(HOGly)þ complexes is very high.
Hence, the indications given in ref 96 that at high pH values
coordinated hydroxyl groups may be deprotonated leading to
coordinated hydroxylate groups seems to be a realistic sugges-
tion, at least for Cu2þ.
11. METAL-ION COMPLEXES OF LIGANDS WITH TWO
OR MORE HYDROXYL GROUPS AND AT LEAST FOUR
BINDING SITES
11.1. Complexes of the Alkaline Earth Ions with Bistris and
Some Related Buffers: Reduced Solvent Polarity Favors
Metal-Ion�Hydroxyl Group Interactions
Despite the caveat expressed in the preceding section 10,
it is remarkable that the stability constant of the Ca(HOGly)þ
complex is evidently by about 1.2 log units larger than that
of Mg(HOGly)þ (Table 27), a result in accord with the
observations made in sections 4.1 and 5.3. This can only mean
that the coordination sphere of Ca2þ is especially ﬁtting to the
steric conditions of HOGly�. A corresponding observation109
has been made for Bistris [= 2-[bis(2-hydroxyethyl)amino]-
2(hydroxymethyl)-1,3-propanediol; see Figure 18 below], a
rather common buﬀer compound for many years.110,111 In this
case, the Ca2þ complex is favored over the Mg2þ one by 1.9 log
units (log KCa(Bistris)
Ca = 2.25( 0.02 compared to log KMg(Bistris)
Mg =
0.34( 0.05),109 conﬁrming for the Ca2þ ion its ideal aﬃnity and
geometry for hydroxyl group coordination (see also below). In
contrast, the similarity and low stability of the complexes formed
Table 27. Comparison of the Measured (exp) Stability Constants, KM(HOGly)exp
M (eqs 4a, 4b, and 6), of the M2þ 1:1 Complexes
Formed by N-Hydroxyethylglycinate (HOGly�) with the Calculated Stability Constants According to eqs 27a and 27b for the
Open Isomers with a Sole Glycinate-Like Coordination of M2þ, KM(HOGly)op
M (eqs 1 and 7)a,b
M2þ log KM(HOGly)exp
M log KM(Ala-type)
M log ΔM/Sar
c log KM(HOGly)op
M log ΔM/HOGly
Ca2þ 4.32( 0.01 1.09( 0.04d >3.2
Mg2þ 3.11( 0.01 1.66( 0.06d >1.4
Mn2þ 4.15( 0.01 2.16( 0.2 �0.27 ( 0.22 1.89( 0.30 2.26( 0.30
Co2þ 7.30( 0.01 3.91( 0.15 �0.29( 0.16 3.62( 0.22 3.68( 0.22
Ni2þ 9.11( 0.02 4.97( 0.2 �0.23( 0.21 4.74( 0.29 4.37( 0.29
Cu2þ 9.56( 0.01 7.70( 0.1 �0.67( 0.12 7.03( 0.16 2.53( 0.16
Zn2þ 7.57( 0.01 4.13( 0.15 �0.25( 0.16 3.88( 0.22 3.69( 0.22
aThe stability diﬀerences are expressed by logΔM/HOGly (eqs 11a and 11b) (aqueous solution; 25 C; I = 0.1 M). bThe values in the second column are
from the bottom row of Table 25. The values in the third column were calculated with pKH(HOGly)
H = 9.05 (refs 96 and 97) and the straight-line
parameters of Table 26. c It holds log ΔM/Sar = log KM(Sar)exp
M � log KM(Ala-type)M . The ﬁrst term at the right-hand side of this equation is taken from
Table 25 (see second to the last entries), and the second one is calculated with pKH(Sar)
H = 9.98 (or 10.09) (see Table 25, column 3) and the straight-line
parameters listed in Table 26. dThese values correspond to log KM(Gly)
M (see Table 25); in this way, a lower limit is obtained for log ΔM/HOGly, where
M2þ = Ca2þ or Mg2þ (see also text in section 10).
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with Mg2þ and Mn2þ (log KMn(Bistris)
Mn = 0.70 ( 0.05)109 are
remarkable as well. It may be added that the high stability of the
Ca(Bistris)2þ complex was conﬁrmed112 and that it was repeat-
edly pointed out that the use of this type of buﬀers can give
misleading results112�114 because the ’free’ metal-ion concentra-
tion in a system is aﬀected. This is not only true for
the formation of binary but also of ternary complexes, e.g., with
ATP4�.107,109,112�115
The points indicated above deserve a more detailed discussion
which will provide further insights into M2þ�OH interactions.
Therefore, we do not consider now only Bistris but also the two
related buﬀer ligands Tris and TEA. The corresponding struc-
tures are shown in Figure 18, and the stability constants of their
complexes formed with the alkaline earth ions are assembled in
Table 28, where those for the M(NH3)
2þ species are also given
for comparison.
The stability constants listed in the two top rows of Table 28
show that complex stability decreases for the M(NH3)
2þ and
M(Tris)2þ complexes with increasing ionic radii, that is, 0.65 Å
(Mg2þ) < 0.99 Å (Ca2þ) < 1.13 Å (Sr2þ) < 1.35 Å (Ba2þ) (see
Figure 2 in ref 77; cf. also ref 116). This is the common order in
complex stability and holds, e.g., also for the corresponding
complexes of oxalate or glycinate.81 Considering that the slopem
for log K versus pKa plots is close to zero for N ligands as
discussed in section 5.3, the stability constants for the M-
(NH3)
2þ andM(Tris)2þ complexes may in a ﬁrst approximation
directly be compared. This evidences stability diﬀerences of
about 0.3 log unit in favor of the M(Tris)2þ species of Ca2þ,
Sr2þ, and Ba2þ. From this follows (eqs 11a�13) an approximate
formation degree of about 50% for a chelated isomer involving
one HO�CH2 residue in aqueous solution. Clearly, this inter-
action is weak and does probably not occur to any signiﬁcant
extent in Mg(Tris)2þ.
For the M(TEA)2þ complexes the situation changes: The
Ca(TEA)2þ complex is now clearly the most stable one among
the alkaline earth ion species (Table 28, row 3). It appears again
that in the Mg(TEA)2þ complex none of the CH2CH2OH
residues participates in a signiﬁcant manner in metal-ion binding,
whereas for the Ca2þ, Sr2þ, and Ba2þ complexes they are clearly
important (see section 5.3).
Even in the Mg(Bistris)2þ complex, hardly a single hydroxyl
group is involved in Mg2þ binding despite the availability of ﬁve
such sites (Figure 18). This is diﬀerent with the Ca2þ, Sr2þ, and
Ba2þ complexes: If we form the diﬀerences between the stability
constants of their M(Bistris)2þ complexes and those of the
corresponding M(NH3)
2þ species, we obtain the lower limits
of the stability enhancements, log ΔM/Bistris (eqs 11a and 11b),
because the basicity of Bistris is by about 2.7 pK units lower; these
lower limits are log ΔM/Bistris = 2.25 (Ca
2þ), 1.64 (Sr2þ), and
1.15 (Ba2þ). Hence, the formation degrees for single hydroxyl
Figure 18. Chemical structures of 2-aminoethanol and of the related
buﬀer ligands 2-amino-2-(hydroxymethyl)-1,3-propanediol (Tris),
triethanolamine (TEA), and 2-[bis(2-hydroxyethyl)amino]-2-(hydroxyme-
thyl)1,3-propanediol (Bistris).
Table 28. Logarithms of the Stability Constants for the 1:1 Complexes (eqs 4a and 4b) Formed between the Alkaline Earth Ions
(M2þ) and the Ligands (L), i.e., Ammonia (NH3), 2-Amino-2-(hydroxymethyl)-1,3-propanediol (Tris), Triethanolamine (TEA),
and 2-[Bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)-1,3-propanediol (Bistris), As Well As Negative Logarithms of the Acidity
Constants (eqs 14a and 14b) of the Corresponding H(L)þ Species, Determined by Potentiometric pH Titrations in Water and
Mixed Water/Organic Solvents (25 C)a
log KM(L)
M for M2þ =
L solvent I (Inert Salt)b pKH(L)
H Mg2þ Ca2þ Sr2þ Ba2þ
NH3 H2O 1.0 (NH4NO3) 9.43( 0.05 0.24 0.0c �0.2c �0.3c
Tris H2O 1.0 (TMA
þ/Kþ) 8.31( 0.01 0.30 ( 0.01 0.25( 0.02 0.11( 0.02 0.02( 0.02
TEA H2O 1.0 (TMA
þ/Kþ) 8.05( 0.01 0.24( 0.02 0.78( 0.01 0.38( 0.01 0.36( 0.01
Bistris H2O 1.0 (TMA
þ/Kþ) 6.74( 0.01 0.34( 0.05 2.25( 0.02 1.44( 0.02 0.85 ( 0.03
Bistris 50% Diox (0.17)d 0.5 (TMAþ/Kþ) 6.72( 0.01 0.51 ( 0.02 2.91( 0.01 2.24( 0.01 1.33( 0.01
Bistris 50% CH3OH (0.31) 0.5 (TMA
þ/Kþ) 6.61( 0.01 0.43 ( 0.01 2.94( 0.01 2.22( 0.01 e
Bistris 75% DMSO (0.43)d 0.5 (TMAþ) 7.26( 0.01 0.44( 0.01 2.16( 0.02 2.19( 0.01 1.25( 0.01
Bistris 90% DMSO (0.70) 0.25 (TMAþ) 7.47( 0.01 0.91( 0.04 1.64 ( 0.01 1.87( 0.01 1.14( 0.03
Tris 90% DMSO (0.70) 0.25 (TMAþ/Rbþ) 10.11( 0.01 0.50( 0.22 0.25( 0.10 0.76( 0.06 0.41( 0.02
TEA 90% DMSO (0.70) 0.25 (TMAþ) 8.24( 0.01 0.51( 0.03 0.82( 0.02 0.80( 0.02 0.58( 0.04
aThe values for the NH3 systems are from ref 17; all others are from ref 77.
b In all instances the nitrate (NO3
�) salts were used, i.e., of the
tetramethylammonium ion (TMAþ), Kþ or Rbþ; if TMAþ and Kþ or Rbþ are listed, it means that the titration curves were the same with either cation
and no buﬀer depression was observed. c In these cases I = 2 M (NH4NO3).
17 dDiox =1,4-dioxane; DMSO = dimethylsulfoxide. The percentages are
given as v/v. The number in parentheses is the mole fraction of the organic part of the aqueous solvent mixture. eBa(NO3)2 was not soluble under the
given conditions.
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group interactions are about 99% (Ca2þ), 98% (Sr2þ), and 93%
(Ba2þ) (eqs 11a�13). Of course, the M2þ�OH interaction will
most likely be divided between several of the HO�CH2
residues.77
Before we consider the solvent inﬂuence on the stabilities of
the complexes (Table 28, lower part), it seems appropriate to
view ﬁrst the acid�base properties of the ligands. Quite
generally one expects for dissociation of a neutral species into
two charged ones an inhibition if less water for solvation of the
charged species becomes available. Indeed, e.g., for CH3COOH
it holds pKH(Ac)
H = 4.57 ( 0.01 (Table 4; 25 C; I = 0.1 M) in
water and 5.97 ( 0.01 in 50% aqueous (v/v) 1,4-dioxane
(Table 13; 25 C; I = 0.1 M), and this is also in accord with
the observations made in section 3.2 for monoprotonated
glycerol 1-phosphate (Figure 3; Table 3). In contrast, one would
expect that a protonated and charged species like in equilibria 14a
and 14b is less aﬀected by a change in the solvent because on both
sides of the equilibrium charged species occur. In fact, deprotona-
tion may even become favored because the organic part of the
solvent mixture may facilitate solvation of the uncharged species.
Indeed, e.g., for ammonia it holds pKH(NH3)
H = 9.26 ( 0.05
(Table 15; 25 C; I = 0.1 M) in water and 8.91 in 50% aqueous
(wt) methanol (25 C; I = 0.1 M),117 and for γ-picoline
(4-methylpyridine) one observes pKH(Pc)
H = 6.18 in water and
5.11 in 50% aqueous (v/v) 1,4-dioxane (25 C; I = 0.1 M).118
The properties of H(Bistris)þ in water (pKH(Bistris)
H = 6.74;
Table 28), 50% aqueous dioxane (6.72), and 50% aqueous
methanol (6.61) correspond approximately to this expectation,
meaning that the inﬂuence of these mixed solvents on the acidity
constants is small. This also holds for H(TEA)þ in going from
water (pKH(TEA)
H = 8.05; Table 28) to 90% aqueous DMSO
(8.24). However, for H(Bistris)þ the basicity increases signiﬁ-
cantly from water (pKH(Bistris)
H = 6.74; Table 28) to 90% DMSO
(7.47). This is even more true for H(Tris)þ, where the change
from water (pKH(Tris)
H = 8.31) to 90% DMSO (10.11) amounts to
an increase ofΔpKa = 1.8. This can only mean that in H(Bistris)
þ
and even more so in H(Tris)þ the proton at the nitrogen is
intramolecularly “solvated” by the hydroxyl groups under the
inﬂuence of the organic solvent molecules and that this inhibits
the release of the proton. The take home message here is that the
hydroxyl groups in Bistris and Tris can become involved in rather
strong hydrogen bonds and that thus part of the hydroxyl groups
may possibly interact in an outer-sphere manner with a partially
hydrated metal ion. In this context one should also mention that
Bistris binds alkali ions quite well in 90%DMSO; complex stability
decreases within the series Liþ (log KLi(Bistris)
Li = 0.61 ( 0.01) >
Naþ (0.54 ( 0.01) > Kþ (0.36 ( 0.01) > Rbþ (0.26 ( 0.01).77
In the discussion above about the situation in aqueous solution
we observed some selectivity of TEA toward Ca2þ and a very
pronounced one of Bistris toward the same ion. It is now
interesting to compare the stability constants valid for mixed
organic solvents (lower part of Table 28) with those for water: (i)
A subtle change in water activity by changing the solvent from
water to 50% aqueous dioxane or 50% aqueous methanol
increases the stability of the M(Bistris)2þ complexes but does
not change the stability order; it remains Mg2þ < Ca2þ > Sr2þ >
Ba2þ. (ii) A more signiﬁcant change, i.e., by going from water to
75% aqueous DMSO, leaves the stability of Ca(Bistris)2þ
practically unaﬀected but favors the stability of Sr(Bistris)2þ
considerably, with the result that now both complexes have the
same stability in this solvent. (iii) Furthermore, the change to
90% DMSO (solvent permittivity ε ≈ 47 for pure DMSO)
weakens the stability of the M(Bistris)2þ complexes, with the
exception of Mg(Bistris)2þ, and changes the stability order
completely Mg2þ < Ca2þ < Sr2þ > Ba2þ, i.e., the most stable
complex is now Sr(Bistris)2þ. (iv) A similar eﬀect is observed for
the M(TEA)2þ complexes: In water the most stable complex
is Ca(TEA)2þ, whereas in 90% DMSO Ca(TEA)2þ and
Sr(TEA)2þ have the same stability. (v) Strange enough,
Ca(Tris)2þ shows the same stability in water and 90% DMSO,
whereas for the other three metal ions complex stability in-
creases, especially for Sr(Tris)2þ, by going from water to 90%
DMSO; this leads to the irregular order for the stability of the
complexes Sr2þ > Mg2þ ≈ Ba2þ > Ca2þ.
The initially high stability of the Ca(Bistris)2þ complex in water
may be explained by postulating a cage-like orientation of the
hydroxyl groups and the nitrogen of Bistris;77,109 in this structural
arrangementCa2þwould ﬁt well, whereas the ionic radius ofMg2þ
is too small and the radii of Sr2þ and Ba2þ are too large to allow an
optimal interaction with the hydroxyl groups. This selectivity is
further promoted in the case of Coulombic interactions and
hydrogen bonds by a subtle decrease in the permittivity as it
occurs by going fromwater (ε = 78.5; cf. Table 3) to 50% aqueous
dioxane (ε = 35.2). Of course, once the concentration of the
organic molecules increases further, the M2þ�OH interactions
and the hydrogen bonds may be either favored or disturbed
depending on the ligand and metal ion involved, giving rise to
the dominating stability of the Sr2þ species.
That metal-ion�dipole interactions are important for the stabi-
lity of complexes involving hydroxyl groups is also evident from
X-ray structural studies. The structure of [Sr(TEA)2](NO3)2 shows
an approximately cubic eight-coordinated Sr2þ, which is surrounded
by the eight donor atoms of the two TEA ligands.119 The twoNO3
�
ions are not linked to the cation but interact in strong hydrogen
bonds with the OH groups of the TEA molecules. In accord with
prominent M2þ�dipole interactions, the Sr�O distances of
2.534�2.594 Å are shorter than the Sr�N bonds with 2.830 Å.119
In the related Ba2þ complex [Ba(TEA)2-(CH3COO)]CH3COO
the cation has a coordination number of nine and is bound to the
eight donor atoms of two TEAs and to an oxygen atom of one
acetate.120 The Ba�N distances are 3.025 and 3.108 Å, while the
Ba�O distances are again shorter. The latter distances are between
2.743 and 2.805 Å, and the one to the O atom of the coordinated
acetate is 2.726 Å (the other acetate is more than 5 Å away).
However, again hydrogen bonds are formed between the hydroxyl
groups of TEA and the acetate ions.120
To conclude, it is evident that the amino nitrogen and the
hydroxyl groups of TEA can bind inner-sphere to the alkaline
earth ions and that the hydroxyl groups are in addition able to
undergo hydrogen bonding. Since the structural TEA unit is also
part of Bistris (Figure 18), the same may be surmised for this
ligand, andTris also contains at least the aminoethanol unit. With
regard to aqueous solution, the M(Bistris)2þ complexes exist
certainly in the form of several isomers which are in an
intramolecular (and hence concentration-independent) equilib-
rium with each other and which diﬀer by the number of
coordinated hydroxyl groups. It seems that the one extreme is
an aminoethanol-like coordination and the other a 5- or 6-fold
coordination, depending on the steric conditions of the coordi-
nation sphere of the metal ion. Further isomers may form
through hydrogen bonding between the hydroxyl groups and
coordinated water molecules. Corresponding isomeric equilibria
are also expected to occur with the M(Tris)2þ and M(TEA)2þ
complexes.
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A ﬁnal remark: One observes in aqueous solution a stability
enhancement of log ΔM/Bistris = 2.25 (Table 28) for
Ca(Bistris)2þ, whereas for Ni(Bistris)2þ only a modest 0.82
log unit results (see Table 29). This discrepancy has certainly to
do with neglection of the basicity diﬀerence between NH3 and
Bistris, which is not acceptable in the case of Ni2þ (section 5.3).
Furthermore, it seems that the coordination sphere of Ca2þ
allows a higher ﬂexibility due to Coulombic ligand binding
compared to Ni2þ, as the latter prefers distinct directions for
ligand atom coordination due to its d-orbitals.
11.2. Complexes of Several 3d and Related Metal Ions with
Bistris and Derivatives
In section 5.2 it has been shown that the formation degree of
the chelated isomer is large for the M(AEtOH)2þ complexes,
varying between about 70% for Cd(AEtOH)cl
2þ and 100% for
Pb(AEtOH)cl
2þ (Table 17). These formation degrees are
reﬂected in the stability enhancements (eqs 11a and 11b),
log ΔCd/AEtOH = 0.54 and log ΔPb/AEtOH = 3.4, those for the
M(AEtOH)2þ complexes of Mn2þ, Co2þ, Ni2þ, Cu2þ, and
Zn2þ are in between (Table 17).
Because these results for the M(AEtOH)2þ complexes are on
solid ground, we listed the corresponding stability constants
again in Table 29, together with the stability constants for the
M(NH3)
2þ, M(Tris)2þ, M(TEA)2þ, and M(Bistris)2þ com-
plexes (Figure 18) of Mn2þ, Co2þ, Ni2þ, Cu2þ, Zn2þ, Cd2þ,
and Pb2þ. These constants should allow useful comparisons and
thus conclusions regarding the structures of these complexes.
The stability constants of the M(Tris)2þ and M(NH3)
2þ
species in Table 29 are for the Ni2þ and Cu2þ complexes
identical within their error limits. Because Tris is by 1.2 pK units
less basic than NH3, this must mean that the hydroxyl groups of
Tris are involved in metal-ion binding. The same may be
surmised for Co(Tris)2þ and Zn(Tris)2þ, which are only 0.36
and 0.37 log unit less stable than the corresponding ammonia
complexes.
A more quantitative evaluation appears possible in the case of
Tris by using the straight-line parameters listed in Table 16.
These parameters hold for RCH2�NH2 ligands, a structural unit
almost equaling the one of Tris, i.e., the R3C�NH2 unit.
Certainly, there is the possibility that a R3C residue hinders
M2þ binding at the amino group more than a RCH2 residue, but
the diﬀerence is not expected to be dramatic. More important,
the stability constants calculated for the open isomer of
M(Tris)2þ will be an upper limit because a possible small
inhibiting eﬀect of the R3C group is ignored. This means that
the values calculated for the formation degree of the species in
which the hydroxyl groups are involved in M2þ coordination are
lower limits, and thus, we cannot be misguided by the results.
Application of pKH(Tris)
H = 8.13 to the straight-line parameters
of Table 16 gives the stabilities of the open isomers of the
M(Tris)2þ species, that is, log KM(Tris)op
M = 0.00( 0.20 (Mn2þ),
1.18 ( 0.20 (Co2þ), 1.95 ( 0.20 (Ni2þ), 2.90 ( 0.25 (Cu2þ),
1.22 ( 0.20 (Zn2þ), 1.61 ( 0.20 (Cd2þ), and 0.31 ( 0.30
(Pb2þ). Together with the experimentally measured constants
(Table 29, row 3), the stability enhancements due to hydroxyl
group participation in the M(Tris)2þ complexes follow from
these data according to eqs 11a and 11b: log ΔM/Tris = ca. 0.9(
0.3 (Mn2þ; see footnote b in Table 29), 0.55( 0.20 (Co2þ), 0.79
( 0.20 (Ni2þ), 1.15( 0.25 (Cu2þ), 0.72( 0.20 (Zn2þ), 0.33(
0.20 (Cd2þ), and ca. 2.4 ( 0.4 (Pb2þ; see footnote b in
Table 29). These stability enhancements are within their error
limits nearly identical with the ones determined for the
M(AEtOH)2þ complexes (see log ΔM/AEtOH in Table 17). Of
course, this also holds for the formation degrees of the chelated
species, which reach forM(Tris)cl
2þ the following percentages: 87
( 9% (Mn2þ), 72 ( 13% (Co2þ), 84 ( 7% (Ni2þ), 93 ( 4%
(Cu2þ), 81 ( 9% (Zn2þ), 53 ( 22% (Cd2þ), and 99.6 ( 0.4%
(Pb2þ). It is remarkable that the lowest formation degree for
M(Tris)cl
2þ is reached with Cd2þ and the highest one with Pb2þ,
an observation already made for the M(AEtOH)cl
2þ species (see
above and Table 17). Overall, these results indicate that in
aqueous solution to the largest part only one of the hydroxyl
groups of Tris, aside from the amino group, is involved in metal-
ion coordination.
This agrees with an X-ray study121 of [Cu(Tris�H)(Tris)]Br
in which one Tris has lost a proton (a reaction that occurs in the
alkaline pH range) and two square-planar Cu(II) units are held
together by two H bonds of the type O�H 3 3 3O, which involve
O atoms coordinated to the metal ions. Only one hydroxyl group
of Tris (deprotonated or not) participates in Cu(II) binding; the
distances are all in the range from 1.94 (O) to 2.02 (N/O) Å.
Similar results are found for the mononuclear [Cu(Tris �
H)(Tris)(H2O)]X (X = Cl
�, Br�, I�) species,122 which contain
a distorted octahedral arrangement: The Cu�O(water) distance
is 2.37 Å, that of the second hydroxyl group of the deprotonated
Table 29. Logarithms of the Stability Constants for the 1:1 Complexes (eqs 4a, 4b, and 6) Formed between Several (Mainly 3d)
Divalent Metal Ions (M2þ) and the Ligands (L), i.e., Ammonia (NH3), 2-Aminoethanol (AEtOH), 2-Amino-2-(hydroxymethyl)-
1,3-propanediol (Tris), Triethanolamine (TEA), and 2-[Bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)-1,3-propanediol
(Bistris) (see Figure 18 for the Structures), As Well As Negative Logarithms of the Acidity Constants (eqs 14a and 14b) of the
Corresponding H(L)þ Species, Determined by Potentiometric pH Titrations, of Aqueous Solutions (25 C)a
log KM(L)
M for M2þ =
L pKH(L)
H Mn2þ Co2þ Ni2þ Cu2þ Zn2þ Cd2þ Pb2þ
NH3 9.33( 0.04 0.88( 0.06 2.09( 0.06 2.77( 0.06 4.11 ( 0.06 2.31( 0.06 2.60( 0.06 1.45( 0.10
AEtOH 9.62( 0.03 0.88( 0.10 2.23( 0.06 3.12( 0.06 4.60 ( 0.06 2.50( 0.06 2.45( 0.10 4.20( 0.10
Tris 8.13( 0.01 e0.9b 1.73( 0.02 2.74( 0.02 4.05( 0.02 1.94( 0.03 1.94( 0.02 e2.7b
TEA 7.85( 0.10 2.25( 0.05 2.76( 0.01 4.07( 0.03 2.05( 0.01 3.39( 0.02
Bistris 6.72( 0.01 0.70( 0.05 1.78( 0.03 3.59( 0.02 5.27 ( 0.01 2.38( 0.03 2.47( 0.02 4.32( 0.04
a Source of the data and ionic strength (I) of the measurements: NH3 (I = 0.5 M; from Table 15; error limits estimated), AEtOH (I = 0.5 M; from
Tables 15 and 17), Tris (I = 0.1 M),115 TEA (I = 0.1 M),17,68 and Bistris (I = 1.0 M).109 bThere are indications that the given limit for the stability
constant of Pb(Tris)2þ is close to the actual value.115 This is probably also true for Mn(Tris)2þ (see Figure 4 in ref 109).
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Tris amounts to 2.75 Å, and the distances in the basal CuN2O2
plane vary between 1.94 (O) and 2.01 Å (N/O). Hence, again
only one hydroxyl group of the Tris ligand actually
coordinates.122 However, the simultaneous coordination of two
hydroxyl groups is possible:123 The Ni(II) in the somewhat
distorted octahedral arrangement in [Ni(Tris)2](ClO4)2 is sur-
rounded by two symmetry-related Tris with Ni�O distances of
2.059 and 2.082 Å and a Ni�N one of 2.055 Å. Interestingly, in
the mixed-ligand [Zn(Tris)2(Sac)]Sac complex (where Sac =
saccharinate, i.e., the anion of saccharine, a well-known artiﬁcial
sweetener)124 one Tris coordinates with one and the other with
two hydroxyl groups: Zn(II) is in a distorted octahedron with a
Zn�N(Sac) distance of 2.098 Å, those with the Tris-N atoms
being 2.049 and 2.063 Å, and the distances to the O atoms
varying between 2.126 and 2.372 Å. Clearly, the solid state
describes the maximal numbers of the hydroxyl group participa-
tions. In aqueous solution, this number is expected to be smaller
and the interaction(s) will involve intramolecular equilibria.
For the M(TEA)2þ complexes of Co2þ, Ni2þ, Cu2þ, Zn2þ,
and Pb2þ the evaluations in section 5.3 led to the conclusion that
the hydroxyl groups of TEA participate in metal-ion binding in
varying extents. This is conﬁrmed by the solid state structures
discussed in section 11.1: In [M(TEA)2]
2þ species all four donor
atoms of a TEA molecule may bind to M2þ. Of course, for
aqueous solutions it is again expected that part of the hydroxyl
groups are released from the coordination sphere of M2þ.
However, that the hydroxyl group participation in aqueous
solution is larger in the M(TEA)2þ complexes than in those of
M(Tris)2þ follows from a comparison of the stability constants
given in Table 29: The constants for the M(TEA)2þ complexes
are either of the same size or larger than those of M(Tris)2þ,
despite the lower basicity of TEA compared with that of Tris
(ΔpKa ca. 0.3; Table 29, column 2). The stability increase is again
most remarkable for Pb(TEA)2þ.
Hydroxyl group participation must be considerably more
pronounced in the M(Bistris)2þ complexes because those with
Ni2þ, Cu2þ, Zn2þ, and Pb2þ are 0.83, 1.20, 0.33, and 0.93 log
units, respectively, more stable than their M(TEA)2þ counter-
parts, despite the signiﬁcantly lower basicity of Bistris compared
with TEA (ΔpKa = 1.13). The stabilities of the Bistris com-
plexes of Mn2þ, Co2þ, or Cd2þ are approximately of the same
size or larger than those of the Tris species. Since ΔpKa = 1.41
in this case (Table 29), hydroxyl group participation must be
more pronounced in the M(Bistris)2þ than in the M(Tris)2þ
complexes, where the formation degrees of the closed species
are already quite large as we have seen above. Unfortunately,
an exact quantitative evaluation is not possible for the
M(Bistris)2þ complexes, but all qualitative comparisons evi-
dence a signiﬁcant involvement of the various hydroxyl
groups (Figure 18) in metal-ion coordination of Bistris. For
Pb(Bistris)2þ the stability enhancement due to the hydroxyl
groups amounts to (more than) 3 log units (= log ΔPb/Bistris) as
the crude comparison with the stability of the Pb(NH3)
2þ
complex shows (Table 29), not yet taking into account the basicity
diﬀerence of 2.6 pK units between the involved ligands. Indeed,
the comparison with Pb(AEtOH)2þ indicates now a logΔPb/Bistris
value of about 4 (cf. the basicity diﬀerence and the logΔPb/AEtOH
value in Table 17).
The fact that the hydroxyl groups of Bistris play an important
role in metal-ion coordination is conﬁrmed by the ﬁve follow-
ing crystal structures with either Co2þ, Ni2þ, or Cu2þ:125 In all
instances, Bistris binds with ﬁve sites to M2þ in a distorted
octahedral geometry and only one CH3OH group of the
2-hydroxymethyl-1,3-propanediol residue (see Tris, Figure 18)
remains uncoordinated. In [Ni(Bistris)(H2O)]SO4 3 H2O and
[Cu(Bistris)(H2O)]SO4 the metal ions are ligated by four hydroxyl
oxygenatoms, thenitrogen atom, andawatermolecule.The complexes
[Ni(Bistris)(Cl)]Cl 3H2O and [Co(Bistris)-(HCOO)](HCOO)
contain the corresponding coordination sphere, butH2O is replaced
by Cl� or HCOO�, respectively.125 The [Cu(Bistris)(Cl)]Cl
complex is best considered as being trigonal bipyrimidal because
one Cu�O(hydroxyl) bond is with 2.727 Å very long whereas
the distance of the ﬁve other atoms are between 1.915 and
2.307 Å. The bond lengths in two representative examples
are as follows: (i) For [Ni(Bistris)(H2O)]SO4 it holds
Figure 19. Chemical structures of some open-chain ligands containing
hydroxyl groups next to primary binding sites, together with some
related ligands: 1,10-phenanthroline (Phen), 2,9-dimethyl-1,10-phe-
nanthroline (DMPhen), 2,9-bis(hydroxymethyl)-1,10-phenanthroline
(BHMPhen), alaninate (Ala�), N,N-bis(2-hydroxyethyl)alanine
(BHEAla�), o-(aminomethyl)pyridine (AMPy), 2-((bis(2-hydroxy-
ethyl)amino)methylpyridine (BHEAMPy), di(2-hydroxypropyl)amine
(DHPA), tri(2-hydroxypropylamine (THPA), and ethylenediamine-
N,N,N0,N0-tetraacetate (Edta4�).
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Ni�O(water) = 1.985 Å, Ni�N = 2.053 Å, the remaining for
Ni�O bonds are between 2.073 and 2.087 Å. The fact that the
Ni�O(water) bond is the shortest one may indicate that the
5-fold coordination of Bistris is not strain-free. (ii) For
[Co(Bistris)(HCOO)](HCOO) one ﬁnds Co�OOCH = 1.993 Å,
Co�N = 2.130 Å, and for the four Co�O(hydroxyl) bonds
2.105�2.131 Å.125 Again, the monodentate ligand shows the
shortest distance.
There is a further interestingX-ray structure126 of aMn(III)-Bistris
complex, [Mn(Bistris�2H)(N3)], containing a 2-fold depro-
tonated Bistris. The Mn(III) ion is coordinated by the
NO4�pentadentate chelating (Bistris�2H)2� ligand. As
expected for a d4 ion in near-octahedral geometry, it exhibits
Jahn�Teller distortion which occurs by elongation of the
O�Mn�O axis (2.208 and 2.235 Å). The other distances are
two short Mn�O bonds (1.867 and 1.907 Å), the Mn�N bond
of 2.063 Å, and a further Mn�N bond of 1.973 Å involving the
terminal N of the azide ion.126 Only highly polarizing metal ions
like Mn(III) or Cu(II) (with Tris) are able to deprotonate
HO�CH2 groups via M�O coordination. In fact, in aqueous
solution this is expected to occur only at the upper end of the
physiological pH range.
11.3. Quest for Selectivity in Metal-Ion Coordination Invol-
ving Hydroxyl Groups
To this end we consider ﬁrst the open-chain ligands seen in
Figure 19. The stability constants of the corresponding com-
plexes are assembled in entries 1�9 in Table 30.17,27,116,127�132
We shall ﬁrst compare the stability constants of the com-
plexes formed with 2,9-bis(hydroxymethyl)-1,10-phenanthroline
(BHMPhen) with those formed by 1,10-phenanthroline (Phen)
itself as well as by its 2,9-dimethyl derivative (DMPhen).17,116
From the available data it is evident (Table 30) that the steric
inhibition by methyl groups located ortho to the coordinating
pyridine-type nitrogens is enormous, varying between about
1.6 (Cd2þ) and ca. 3.9 log units (Cu2þ). With this in mind,
it is revealing to consider the stabilities of the M(BHMPhen)2þ
complexes: Since the basicities of Phen and DMPhen are sim-
ilar, we can directly compare the constants and see that in the
case of Ni2þ and Cu2þ participation of the hydroxyl groups
cannot fully compensate for the eﬀect of the ortho substituents,
whereas with Zn2þ matters are approximately balanced out.
However, with Cd2þ and Pb2þ we observe stability enhance-
ments of about 1.8 and 2.7 log units, respectively, from
M(Phen)2þ to M(BHMPhen)2þ. Of course, the true stability
enhancement due to coordination of the hydroxyl groups follows
from a comparison of the stabilities of theM(BHMPhen)2þwith
the M(DMPhen)2þ species: Not all values are available, but for
Ni2þ, Cu2þ, and Zn2þ the stability enhancements amount to
about 2.4 log units, indicating a strong coordination of the
hydroxyl groups.
The largest stability enhancement of 3.4 log units is observed
for the Cd2þ complex (Table 30). Because BHMPhen is a highly
symmetrical ligand preformed for metal-ion coordination, we
may in a ﬁrst approximation conclude that the stability enhance-
ment, log ΔCd/BHMPhen, amounts for one hydroxyl group
(ignoring any statistical eﬀects) to about 1.7 log units. From this
follows for aqueous solution a formation degree (eqs 11a�13) of
98% of the chelate involving one hydroxyl group, and the same is true
also for the other side. This result is in excellent agreement with a
recent X-ray structure133 of [Cd(BHMPhen)2](ClO4)2, in which
Cd2þ is eight-coordinate with Cd�N bonds that average 2.35 Å and
Table 30. Logarithms of the Stability Constants for the 1:1 Complexes (eqs 4a and 4b) Formed between Several Divalent Metal
Ions (M2þ) and Some Open-Chain (Figure 19) or Macrocyclic Ligands (Figure 20) (L) Bearing Next to N Sites also Hydroxyl
Groupsa,b
log KM(L)
M for M2þ =
no. L pKH(L)
H Ba2þ Sr2þ Ca2þ Mg2þ Ni2þ Cu2þ Zn2þ Cd2þ Pb2þ
1 Phen 4.92( 0.05 0.4( 0.2 0.7( 0.1 1.00( 0.10 1.48( 0.07 8.7 9.13( 0.03 6.38( 0.08 5.66 ( 0.04 4.62( 0.06
2 DMPhen 5.83( 0.04 5.0 5.2 4.1 4.1
3 BHMPhen 4.70( 0.01 2.04( 0.03 2.46( 0.03 3.74( 0.03 1.70( 0.02 7.42( 0.06 7.56( 0.03 6.56 ( 0.03 7.49( 0.03 7.32( 0.05
4 Ala� 9.71( 0.04 0.80 5.36( 0.04 8.11( 0.07 4.58( 0.07 3.98 ( 0.02 4.15
5 BHEAla� 8.47 2.26 5.98 8.34 5.16 4.97 6.20
6 AMPy 8.61 0.0c 7.11 9.5 5.28 3.95( 0.05
7 BHEAMPy 6.92( 0.01 1.0( 0.1 7.34( 0.02 9.2( 0.1 5.25 ( 0.02 5.43( 0.03
8 DHPA 8.86( 0.01 2.86( 0.01 4.58( 0.02 2.31( 0.02 2.70( 0.05
9 THPA 7.91( 0.01 3.46( 0.01 4.97( 0.01 2.98( 0.10d 3.62 ( 0.01
10 Edta4� 7.80 8.68 10.61 8.83 13.85( 0.05 14.58
11 TACDD 3.1 23.3 16.2 14.3 15.9
12 HCHTACDD 13.85( 0.05 14.58 ( 0.05 11.40( 0.05
13 TKHPTACOD 3.74 5.68 19.48 13.45 17.46 15.07
14 TODACOD 3.0 1.7 6.1 5.3 6.8
15 BHETODACOD 5.3 4.1 6.6 8.0 9.2
aData for some Edta4� complexes are given for comparison, and the acidity constants (eqs 14a and 14b) for H(L)þ species are listed only as far as
needed.b bThe constants refer to aqueous solutions at (or close to) 25 C with I at (or close to) 0.1 M. The data, including the error limits (as far as
available), are from the following sources: entries 1 and 2 from ref 17, entry 3 from ref 116, entries 4 and 5 from ref 127,17, entries 6 and 7 from ref 128,
entries 8 and 9 from ref 129, entry 10 from ref 130,17, entries 11 and 12130 and 13 from refs 130 and 131,27 and entries 14 and 15 from ref 132. c Estimate,
see ref 128. d In ref 129 in Table 1 the log stability constant 2.31( 0.02 (the same value as listed for Cd(DHPA)2þ is given for Cd(THPA)2þ); this is
evidently a typing error. In fact, from the straight-line plot in Figure 3 it follows a stability diﬀerence of 0.67 log unit, and therefore, the value given above
was correspondingly corrected; the error limit is an estimate.
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Cd�O bonds averaging 2.50 Å, indicating tight binding of the two
ligands.
From the constants listed in Table 30 it follows that for
Pb(BHMPhen)2þ at least the same formation degree for the
chelated species must be assumed as given above for the
Cd(BHMPhen)2þ species. This agrees with a crystal structure
analysis116 of [Pb(BHMPhen)(ClO4)2] 3 H2O, in which Pb
2þ is
eight coordinate: All four donor atoms of BHMPhen are bound;
the average Pb�N bonds amount to 2.486 Å, and the Pb�O-
(hydroxyl) bonds to 2.617 Å; the lone pair of Pb2þ seems to be
positioned opposite to the N atoms. One of the perchlorate O
donors is with 2.538 Å relatively close to Pb2þ; the other with
2.994 Å further away; in addition, interactions occur with two
neighboring perchlorates (2.708 and 3.026 Å).
There is also an X-ray structure of a Ca2þ complex in which
two ligand molecules are coordinated, [Ca(BHMPhen)2]-
(ClO4)2.
116 Ca2þ is eight-coordinate, with an average Ca�N
distance of 2.501 Å and Ca�O bonds of 2.422 Å. Note, here
the oxygen bonds are shorter than the N ones, which agrees with
the constants listed in Table 30. BHMPhen discriminates among
the alkali earth ions and coordinates Ca2þ especially well, the
stability enhancement, log ΔCa/BHMPhen, due to one hydroxyl
group being at least 1.5 log units. Consequently, a formation
degree of about 97% for the chelate on either side in aqueous
solution is reached. Overall, it is evident that a ligand with a
preorganized structure like BHMPhen, which locates the hydro-
xyl groups close to the metal ion, renders these hydroxyl groups
to excellent binding sites.
A comparison of the stability constants of the M(Ala)þ and
M(BHEAla)þ complexes (Figure 19) shows,127 especially if
one takes the diﬀerent basicities of the ligands into account
(Table 30), that the stability enhancement due to hydroxyethyl
groups is most pronounced for Pb(BHEAla)þ, followed by
Ca(BHEAla)þ and Cd(BHEAla)þ. Hence, hydroxyl group
binding seems at least as pronounced as discussed for the
M(TEA)2þ complexes in sections 5.3 and 11.2. For the ligands
AMPy and BHEAMPy (Figure 19) and their complexes128 the
situation is quite similar: The stability enhancement is again
largest for the Pb(BHEAMPy)2þ and Ca(BHEAMPy)2þ com-
plexes. This also holds for the available data (Table 30) of the
complexes formed with DHPA and THPA (Figure 19);129 the
most pronounced stability enhancement is observed for the
Pb(THPA)2þ complex.
From the foregoing it follows that the size of the cation and
preorganization of a ligand, as concluded before,27,128�131 are
important issues with regard to selectivity and discrimination
between diﬀerent metal ions. That this is quite a general phenom-
enon, which does not only hold for ligands containing hydroxyl
groups, follows from entry 10 of Table 30: The Ca(Edta)2�
complex is by far themost stable one among the complexes formed
with the alkaline earth ions.Of course, if the size of ametal ion does
not ﬁt well to the conditions dictated by the ligand, strain will be
created. This is possibly seen in the crystal structure129 of
[Ni(NH2�CH2CH2�NH�CH2CH2�OH)2](NO3)2. In this
complex Ni2þ is hexacoordinate, with the two ligand molecules
bound in a meridional manner. The average Ni�N bond length is
2.08Å, and that of the twoNi�Obonds is 2.15Å.Of course, at this
point one could conclude that this result simply reﬂects the larger
aﬃnity of Ni2þ toward N donors, compared with O donors.
However, one could also argue that in a strain-free situation the
two bond lengths should be more similar; after all, in Ni(H2O)6
2þ
the Ni�O distances amount to 2.06 Å only.129
In the design of ligands that lead to selectivity and to a (partial)
preorganization of the potential binding sites, macrocycles have
been employed for years.128�130 Therefore, in the remaining part
of this section we shall shortly consider the ligands shown in
Figure 20. The stability constants of the corresponding com-
plexes, as far as they are known, are listed in entries 11�15 of
Table 30.
A comparison of the stability constants of the complexes
formed with TACDD (cyclen) with those of HCHTACDD
(Figure 20)130 shows for the three metal ions studied,
Zn2þ, Cd2þ, and Pb2þ, that the initial steric inhibition due
to the cyclohexyl substituent is overcome only in the
Cd(HCHTACDD)2þ complex by coordination of the hydroxyl
group. The corresponding Zn2þ and Pb2þ complexes are less
stable than their M(TACDD)2þ species. It may be mentioned
that in the crystal structure of [Cu(HCHTACDD)](ClO4)2
Cu2þ is ﬁve-coordinate, being 0.47 Å above the plane deﬁned
by the four N atoms (average of the Cu�N distances 2.01(1) Å),
Figure 20. Chemical structures of some macrocycles, together with
derivatives carrying hydroxyl groups: 1,4,7,10-tetraazacyclododecane
(TACDD), 1-(2-hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane
(HCHTACDD), 1,4,7,10-tetrakis(2-hydroxypropyl)-1,4,7,10-tetraaza-
cyclododecane (TKHPTACDD), 1,4,10,13-tetraoxa-7,16-diazacyclooc-
tadecane (TODACOD), and 7,16-bis(2-hydroxyethyl)-1,4,10,13-tetra-
oxa-7,16-diazacyclooctadecane (BHETODACOD).
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interacting in an average distance (there are two individual
complexes in the unit cell) of 2.16(3) Å with the O of the
2-hydroxycyclohexyl residue. This indicates that in all these
M(HCHTACDD)2þ complexes the hydroxyl group coordinates
despite a reduced stability and that it helps to achieve selectivity.
The selectivity for Cd2þ coordination can be further
promoted131 by using TKHPTACDD (Figure 20) as a ligand,
that is, cyclen having four 2-hydroxypropyl substituents at the
ring nitrogens. Cd(TKHPTACDD)2þ is by 3.16 log units more
stable than the simple Cd(TACDD)2þ complex; in contrast, in
all other M(TKHPTACDD)2þ species the stability is decreased,
namely, with Cu2þ by 3.82 and with Zn2þ and Pb2þ by 2.75 and
0.83 log units, respectively. Here it may be recalled that with
simple ligands the stability enhancement due to hydroxyl group
coordination is with Cd2þ only about one-half the size as with
Zn2þ (section 9, point (iii)); now the situation is reverse.
The selectivity for Pb2þ, which exists to a certain extent
already in the macrocycle TODACOD (Table 30, row 14)
containing in its ring 2 N and 4 O atoms (Figure 20), can be
further promoted by two 2-hydroxyethyl substituents at the N
atoms.132 Pb(BHETODACOD)2þ is now by 1.2 and 2.6 log
units more stable (Table 30, row 15) than the analogous
complexes with Cd2þ and Cu2þ, respectively. Also, Ba2þ can
be discriminated toward Ca2þ by 1.2 log units using the same
ligand. In this context it is interesting that the selectivity for Ba2þ
can be further improved by forming an ethylene bridge between
the two hydroxyethyl substituents, which leads then to the
cryptand containing three 18-membered rings, each having two
N and four O atoms as potential binding sites: Now the log
stability constant of 9.5 for the Ba(cryptand)2þ complex is by
4.2 log units larger than that of the Ca2þ complex.132
These few examples demonstrate nicely how a combination of
macrocycles and well-“localized” hydroxyl groups allow the
design of ligands that favor especially large metal ions.
12. GENERAL CONCLUSIONS
Already in section 9 we have seen that for monodentate primary
binding sites the intensity of the hydroxyl�metal-ion interaction
increases with the decreasing charge present in the coordinating
atom. This leads to very high formation degrees of the closed
species; for example, for o-(hydroxymethyl)pyridine (HOMPy)
formation degrees of ca. 92% and 99% are reached with
Mn(HOMPy)cl
2þ and Zn(HOMPy)cl
2þ, respectively (Table 22).
Of course, with 2,6-(dihydroxymethyl)pyridine, due to the pre-
sence of two hydroxyl groups, their participation in metal binding
increases further (Table 22), but still, the percentages of the
complexes in which one hydroxyl group is coordinated and two
such groups are bound can be quantiﬁed (Table 23).
With regard to biological systems the observations made
with hydroxyacetate (HOAc�) are certainly of more relevance.
Despite the negatively charged carboxylate group, which con-
stitutes the primary binding site, still formation degrees of 71%,
75%, and 91% are reached for Mg(HOAc)cl
þ, Mn(HOAc)cl
þ, and
Zn(HOAc)cl
þ, respectively (Table 7). A change from the
formation of 5-membered to 6-membered chelates as they
may occur with 3-hydroxypropanoate diminishes the hydroxyl�
metal-ion interaction very signiﬁcantly (section 4.3; Table 12). On
the other hand, a decreasing solvent polarity as it results from
addition of 1,4-dioxane to an aqueous solution of the components
favors the interaction (section 4.4); such a reduced solvent polarity
is expected to occur in active site cavities of both enzymes42 and
ribozymes.43 Quite generally, a hydroxyl group is superior to an
ether oxygen when it comes to metal-ion binding.
Another observation of relevance for biological systems is the
pronounced aﬃnity of Ca2þ toward hydroxyl groups, compared
to that of the other alkaline earth ions. This becomes especially
evident from the Ca(HOAc)þ (see section 4.1.2; Table 7) and
the Ca(HOGly)þ species (section 10; Table 27), which showed
a large formation degree of the chelated species indicated in
equilibrium 1. Such a speciﬁc behavior of Ca2þ might be the
decisive factor for the atypical strong inﬂuence of Ca2þ on group
II intron ribozyme catalysis and folding,50,51,134 as well as, for
example, the in vitro selection of a group I intron that is reactive
in the presence of Ca2þ only.135
A further point that warrants emphasis is the observation that
with N-hydroxyethylglycinate (HOGly�), which oﬀers the
bidentate glycinate-like unit as the primary binding site, parti-
cipation of the hydroxyl group in metal-ion coordination
increases dramatically, leading in general to formation degrees
of above 99.5% for the M(HOGly)þ species (section 10). The
reason for this observation is evidently the “rigidity” that results
upon the glycinate-type binding; this brings the hydroxyl group
close to the vicinity of the metal ion, and in addition, the move-
ment of the hydroxyl group in space becomes restricted. This is in
line with the above-mentioned observation that 5-membered
chelates involving a hydroxyl group are more stable than 6-mem-
bered ones. With regard to biological systems, e.g., regarding
ribozymes, this insight is important because one may easily
imagine that a metal ion is orientated in a proper manner by initial
binding, leading to an �OH interaction. Even more remarkable,
such a “directed” hydroxyl�metal-ion interaction may give rise to
a stability enhancement of 2 log units (see Table 27).
As one would expect, combination of a well-suited primary
binding site with a large number of hydroxyl groups leads to
a higher complex stability and increased selectivity. For exam-
ple, some selectivity is already observed with the simple ligand
2-aminoethanol (section 5.2; Table 17), yet in ligands which
contain the residue in a manifold manner like in triethanol-
amine (section 5.3) or in buﬀers like Tris or Bistris (see
Figure 18) the selectivity toward Ca2þ (section 11.1) or Pb2þ
(section 11.2) increases. Further selectivity can be achieved
by using relatively rigid open-chain ligands, like 2,9-bis-
(hydroxymethyl)-1,10-phenanthroline (Figure 19), or by em-
ploying macrocycles as “primary binding sites”. Their
combination with hydroxyl groups allows, e.g., construction
of a ligand selective for Cd2þ, that is, its complexes with Zn2þ
or Pb2þ are of lower stability (Table 30).
From the information collected from crystal structure studies one
may in a ﬁrst approximation conclude (ignoring strained ligands and
their complexes) that the alkali earth ions bind more tightly to
the oxygens of hydroxyl groups, compared to N binding sites, i.e.,
the M�O bond distances are shorter than the M�N ones. On the
contrary, for the 3d transition-metal ions like Ni2þ or Cu2þ as well
as Cd2þ, the M�N distances are usually a bit shorter than the
M�O(hydroxyl) ones. A further point to be emphasized in the
context of these “polyhydroxyl” ligands is the observation that a
decreasing solvent polarity can enhance complex stability but also
aﬀect the selectivity, e.g., in the sense that a selectivity for Ca2þ turns
into one for Sr2þ (section 11.1; Table 28). In any case, the
summarized results indicate that in biosystems, like in the accumula-
tion of sugar moieties as in RNA (or DNA) or in polysaccharides,
due to distinct folding, high-aﬃnity sites, e.g., for Ca2þ, may be
created; Mg2þ is less apt for this type of binding.
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On the other hand, one should also realize that already a
small stability enhancement, log ΔM/PBS�OH (eqs 11a and
11b), may have dramatic eﬀects. For example, an enhancement
of only 0.1 log unit gives rise to a formation degree of about 20%
of the corresponding chelated species. In other words, one may
create in this way a special structure, e.g., toward reactivity, by
investing only about 0.6 kJ mol�1 in the change in free energy
(ΔG0).25 One may recall in this context the following order:
Stability enhancements of 0.1, 0.3, and 1 log unit give rise to
formation degrees of the chelated species of 20%, 50%, and
90%, and the ΔG0(25 C) values involved herewith correspond to
�0.57, �1.71, and �5.7 kJ mol�1, respectively.25
It is hoped that the presented results initiate searches for
metal-ion�hydroxyl group interactions in proteins (serine),
but especially in nucleic acids: In RNA, due to the presence of the
20-OH of the ribosyl residue, hydroxyl groups occur in legions.
These hydroxyl groups can be activated by metal ions leading
to a metal-ion-activated breakdown of the RNA, which can be
used to identify metal-ion binding sites within folded
RNAs.136 Most relevant, in many ribozyme reactions the
nucleophile, that is, the 20-OH or 30-OH of a speciﬁc ribose
moiety, gets activated by metal-ion binding, as directly im-
plicated by crystal structures of group I and II intron
ribozymes.11,137,138
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ABBREVIATIONS AND DEFINITIONS
See also ﬁgures containing structural formulas; for the macro-
cycles see Figure 20
Aa amino acetate
ABu 2-aminobutanoate
AcLys ε-N-acetyl-L-lysinate
AEtOH 2-aminoethanol
AiPrOH DL-1-amino-2-propanol
AL ligand with an amino group
Ala alaninate
5001 dx.doi.org/10.1021/cr100415s |Chem. Rev. 2011, 111, 4964–5003
Chemical Reviews REVIEW
AMPy o-(aminomethyl)pyridine
APn� 2-aminopentanoate = norvalinate
APrOH 3-aminopropanol
ATP4� adenosine 50-triphosphate
b intercept of a straight line with the y axis (y0)
BcS� biocytinate = ε-N-d-biotinyl-L-lysinate
BcSO� biocytinate sulfoxide
BcSO2
� biocytinate sulfone
BHEAla� N,N-bis(2-hydroxyethyl)alanine
BHEAMPy 2-((bis(2-hydroxyethyl)amino)methyl)pyridine
BHMPhen 2,9-bis(hydroxymethyl)-1,10-phenanthroline
Bistris 2-[bis(2-hydroxyethyl)amino]-2-
(hydroxymethyl)-1,3-propanediol
Bistris�2H 2-fold deprotonated Bistris
CA� carboxylate ligand
calc calculated (value)
CH3OAc
� methoxyacetate
cl closed (or chelated isomer)
DHAP2� dihydroxyacetone phosphate
(HO�CH2�C(O)�CH2�O�PO32�)
DHOEPy o-[1-(1,2-dihydroxyethyl)]pyridine
DHPA di(2-hydroxypropyl)amine
DMPhen 2,9-dimethyl-1,10-phenenthroline
DMPy 2,6-dimethylpyridine
Edta4� ethylenediamine-N,N,N0,N0-tetraacetate
EtOAc� ethoxyacetate
exp experimental (or measured value)
G1P2� glycerol 1-phosphate
Gly� glycinate
His� histidinate
HMOP2� hydroxymethyl phosphate
HMP2� hydroxymethylphosphonate
HOAc� hydroxyacetate = glycolate
4HOBu� 4-hydroxybutanoate (HO�CH2CH2CH2�COO�)
HOCA� hydroxy carboxylate
HOEPy o-[1-(1-hydroxyethyl)]pyridine
HOGly� N-hydroxyethylglycinate
HOMPy o-(hydroxymethyl)pyridine
(HOM)2Py 2,6-(dihydroxymethyl)pyridine
2HOPr� D-2-hydroxypropanoate = lactate
3HOPr� 3-hydroxypropanoate (HO�CH2CH2�COO�)
I ionic strength
Ida2� iminodiacetate
Im2Me 2-methylimidazole
Im2OH 2-hydroxymethylimidazole
Im4OH 4-hydroxymethylimidazole
ImD imidazole derivative
L general ligand
Leu� leucinate
m slope of a straight line
M2þ divalent metal ion
MOMPy o-(methoxymethyl)pyridine
OCA� hydroxy carboxylate
op open (isomer)
OPy hydroxypyridine derivative
PBS primary binding site
PEE2� (2-phosphonoethoxy)ethane
(CH3CH2�O�CH2CH2�PO32�)
Phen 1,10-phenanthroline
PME2� (phosphonomethoxy)ethane
(CH3CH2�O�CH2�PO32�)
Pr� propanoate
pUpU3� uridylyl-(50f30)-[50]uridylate
Py pyridine
PyD pyridine derivative
Sar� sarcosinate = N-methylglycinate
SD standard deviation
SI steric inhibition
TEA triethanolamine
THF2CA� tetrahydrofuran-2-carboxylate
THPA tri(2-hydroxypropyl)amine
THT2CA� tetrahydrothiophen-2-carboxylate
tot total (concentration)
Tris 2-amino-2-(hydroxymethyl)-1,3-propanediol
Tris � H monodeprotonated Tris
Val� valinate
XCA� THF2CA� or THT2CA�
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